0000746210-24-000019.txt : 20240508 0000746210-24-000019.hdr.sgml : 20240508 20240508160325 ACCESSION NUMBER: 0000746210-24-000019 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 60 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240508 DATE AS OF CHANGE: 20240508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Oblong, Inc. CENTRAL INDEX KEY: 0000746210 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] ORGANIZATION NAME: 06 Technology IRS NUMBER: 770312442 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-35376 FILM NUMBER: 24925770 BUSINESS ADDRESS: STREET 1: 110 16TH STREET STREET 2: SUITE 1400 #1024 CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 303-640-3838 MAIL ADDRESS: STREET 1: 110 16TH STREET STREET 2: SUITE 1400 #1024 CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: GLOWPOINT, INC. DATE OF NAME CHANGE: 20110809 FORMER COMPANY: FORMER CONFORMED NAME: GLOWPOINT INC DATE OF NAME CHANGE: 20031112 FORMER COMPANY: FORMER CONFORMED NAME: WIRE ONE TECHNOLOGIES INC DATE OF NAME CHANGE: 20000606 10-Q 1 glow-20240331.htm 10-Q glow-20240331
000074621012/312024Q1falsexbrli:sharesiso4217:USDiso4217:USDxbrli:sharesglow:segmentxbrli:pure00007462102024-01-012024-03-3100007462102024-05-0300007462102024-03-3100007462102023-12-3100007462102023-01-012023-03-310000746210us-gaap:PreferredStockMemberus-gaap:SeriesFPreferredStockMember2023-12-310000746210us-gaap:CommonStockMember2023-12-310000746210us-gaap:TreasuryStockCommonMember2023-12-310000746210us-gaap:AdditionalPaidInCapitalMember2023-12-310000746210us-gaap:RetainedEarningsMember2023-12-310000746210us-gaap:RetainedEarningsMember2024-01-012024-03-310000746210us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310000746210us-gaap:PreferredStockMemberus-gaap:SeriesFPreferredStockMember2024-03-310000746210us-gaap:PreferredStockMemberus-gaap:SeriesFPreferredStockMember2024-01-012024-03-310000746210us-gaap:CommonStockMember2024-01-012024-03-310000746210us-gaap:CommonStockMember2024-03-310000746210us-gaap:TreasuryStockCommonMember2024-03-310000746210us-gaap:AdditionalPaidInCapitalMember2024-03-310000746210us-gaap:RetainedEarningsMember2024-03-310000746210us-gaap:PreferredStockMemberus-gaap:SeriesFPreferredStockMember2022-12-310000746210us-gaap:CommonStockMember2022-12-310000746210us-gaap:TreasuryStockCommonMember2022-12-310000746210us-gaap:AdditionalPaidInCapitalMember2022-12-310000746210us-gaap:RetainedEarningsMember2022-12-3100007462102022-12-310000746210us-gaap:RetainedEarningsMember2023-01-012023-03-310000746210us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310000746210us-gaap:PreferredStockMemberus-gaap:SeriesFPreferredStockMember2023-01-012023-03-310000746210us-gaap:PreferredStockMemberus-gaap:SeriesFPreferredStockMember2023-03-310000746210us-gaap:CommonStockMember2023-03-310000746210us-gaap:TreasuryStockCommonMember2023-03-310000746210us-gaap:AdditionalPaidInCapitalMember2023-03-310000746210us-gaap:RetainedEarningsMember2023-03-3100007462102023-03-310000746210us-gaap:SeriesFPreferredStockMember2024-01-012024-03-310000746210us-gaap:CommonStockMember2023-01-012023-12-3100007462102021-06-2800007462102023-01-012023-12-310000746210srt:MaximumMember2024-03-310000746210us-gaap:SeriesFPreferredStockMemberus-gaap:PrivatePlacementMember2023-03-302023-03-300000746210us-gaap:SeriesFPreferredStockMemberus-gaap:PrivatePlacementMember2023-03-300000746210glow:PreferredWarrantsMemberus-gaap:PrivatePlacementMember2023-03-300000746210glow:InvestorWarrantsMemberus-gaap:PrivatePlacementMember2023-03-300000746210us-gaap:SeriesFPreferredStockMemberus-gaap:PrivatePlacementMember2023-03-312023-03-310000746210us-gaap:SeriesFPreferredStockMember2023-03-300000746210us-gaap:SeriesFPreferredStockMember2023-03-302023-03-3000007462102023-10-060000746210us-gaap:SeriesFPreferredStockMember2024-03-310000746210us-gaap:SeriesFPreferredStockMemberglow:Scenario1Member2024-01-012024-03-310000746210us-gaap:SeriesFPreferredStockMember2023-01-012023-12-310000746210us-gaap:SeriesFPreferredStockMember2023-03-312023-03-310000746210us-gaap:SeriesFPreferredStockMember2023-03-310000746210us-gaap:PreferredStockMemberus-gaap:SeriesFPreferredStockMember2023-01-012023-12-310000746210us-gaap:SeriesFPreferredStockMember2023-12-310000746210us-gaap:CommonStockMember2023-04-012024-03-310000746210glow:A2019EquityIncentivePlanMember2023-12-310000746210us-gaap:EmployeeStockOptionMember2023-01-012023-03-310000746210us-gaap:EmployeeStockOptionMember2024-01-012024-03-310000746210us-gaap:RestrictedStockMember2024-03-310000746210us-gaap:RestrictedStockMember2023-12-310000746210us-gaap:RestrictedStockMember2023-01-012023-03-310000746210us-gaap:RestrictedStockMember2024-01-012024-03-310000746210us-gaap:RestrictedStockMember2023-03-310000746210us-gaap:RestrictedStockMember2022-12-310000746210us-gaap:RestrictedStockUnitsRSUMember2022-12-310000746210us-gaap:RestrictedStockMember2023-01-012023-12-310000746210us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-12-310000746210us-gaap:RestrictedStockUnitsRSUMember2023-12-310000746210us-gaap:RestrictedStockUnitsRSUMember2024-03-310000746210us-gaap:RestrictedStockMember2024-01-012024-03-310000746210us-gaap:RestrictedStockMember2023-01-012023-03-310000746210us-gaap:EmployeeStockOptionMember2024-01-012024-03-310000746210us-gaap:EmployeeStockOptionMember2023-01-012023-03-310000746210us-gaap:ConvertibleDebtSecuritiesMember2024-01-012024-03-310000746210us-gaap:ConvertibleDebtSecuritiesMember2023-01-012023-03-310000746210glow:PreferredWarrantMember2024-01-012024-03-310000746210glow:PreferredWarrantMember2023-01-012023-03-310000746210us-gaap:WarrantMember2024-01-012024-03-310000746210us-gaap:WarrantMember2023-01-012023-03-310000746210glow:ManagedServicesMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000746210glow:CollaborationProductsMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000746210us-gaap:CorporateNonSegmentMember2024-01-012024-03-310000746210us-gaap:MaterialReconcilingItemsMemberglow:ManagedServicesMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000746210us-gaap:MaterialReconcilingItemsMemberglow:CollaborationProductsMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000746210us-gaap:MaterialReconcilingItemsMemberus-gaap:CorporateNonSegmentMember2024-01-012024-03-310000746210us-gaap:MaterialReconcilingItemsMember2024-01-012024-03-310000746210glow:ManagedServicesMemberus-gaap:CorporateNonSegmentMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000746210glow:CollaborationProductsMemberus-gaap:CorporateNonSegmentMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000746210us-gaap:CorporateNonSegmentMemberus-gaap:CorporateNonSegmentMember2024-01-012024-03-310000746210us-gaap:CorporateNonSegmentMember2024-01-012024-03-310000746210glow:ManagedServicesMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000746210glow:CollaborationProductsMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000746210us-gaap:CorporateNonSegmentMember2023-01-012023-03-310000746210us-gaap:MaterialReconcilingItemsMemberglow:ManagedServicesMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000746210us-gaap:MaterialReconcilingItemsMemberglow:CollaborationProductsMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000746210us-gaap:MaterialReconcilingItemsMemberus-gaap:CorporateNonSegmentMember2023-01-012023-03-310000746210us-gaap:MaterialReconcilingItemsMember2023-01-012023-03-310000746210glow:ManagedServicesMemberus-gaap:CorporateNonSegmentMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000746210glow:CollaborationProductsMemberus-gaap:CorporateNonSegmentMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000746210us-gaap:CorporateNonSegmentMemberus-gaap:CorporateNonSegmentMember2023-01-012023-03-310000746210us-gaap:CorporateNonSegmentMember2023-01-012023-03-310000746210country:US2024-01-012024-03-310000746210country:US2023-01-012023-03-310000746210us-gaap:NonUsMember2024-01-012024-03-310000746210us-gaap:NonUsMember2023-01-012023-03-310000746210glow:VideoCollaborationServiceMemberus-gaap:ProductConcentrationRiskMemberglow:ManagedServicesMember2024-01-012024-03-310000746210us-gaap:RevenueFromContractWithCustomerMemberglow:VideoCollaborationServiceMemberus-gaap:ProductConcentrationRiskMemberglow:ManagedServicesMember2024-01-012024-03-310000746210glow:VideoCollaborationServiceMemberus-gaap:ProductConcentrationRiskMemberglow:ManagedServicesMember2023-01-012023-03-310000746210us-gaap:RevenueFromContractWithCustomerMemberglow:VideoCollaborationServiceMemberus-gaap:ProductConcentrationRiskMemberglow:ManagedServicesMember2023-01-012023-03-310000746210glow:NetworkServicesMemberus-gaap:ProductConcentrationRiskMemberglow:ManagedServicesMember2024-01-012024-03-310000746210us-gaap:RevenueFromContractWithCustomerMemberglow:NetworkServicesMemberus-gaap:ProductConcentrationRiskMemberglow:ManagedServicesMember2024-01-012024-03-310000746210glow:NetworkServicesMemberus-gaap:ProductConcentrationRiskMemberglow:ManagedServicesMember2023-01-012023-03-310000746210us-gaap:RevenueFromContractWithCustomerMemberglow:NetworkServicesMemberus-gaap:ProductConcentrationRiskMemberglow:ManagedServicesMember2023-01-012023-03-310000746210glow:ProfessionalAndOtherServicesMemberus-gaap:ProductConcentrationRiskMemberglow:ManagedServicesMember2024-01-012024-03-310000746210us-gaap:RevenueFromContractWithCustomerMemberglow:ProfessionalAndOtherServicesMemberus-gaap:ProductConcentrationRiskMemberglow:ManagedServicesMember2024-01-012024-03-310000746210glow:ProfessionalAndOtherServicesMemberus-gaap:ProductConcentrationRiskMemberglow:ManagedServicesMember2023-01-012023-03-310000746210us-gaap:RevenueFromContractWithCustomerMemberglow:ProfessionalAndOtherServicesMemberus-gaap:ProductConcentrationRiskMemberglow:ManagedServicesMember2023-01-012023-03-310000746210glow:ManagedServicesMemberus-gaap:ProductConcentrationRiskMember2024-01-012024-03-310000746210us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMemberglow:ManagedServicesMember2024-01-012024-03-310000746210glow:ManagedServicesMemberus-gaap:ProductConcentrationRiskMember2023-01-012023-03-310000746210us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMemberglow:ManagedServicesMember2023-01-012023-03-310000746210glow:VideoCollaborationServiceMemberglow:CollaborationProductsMemberus-gaap:ProductConcentrationRiskMember2024-01-012024-03-310000746210us-gaap:RevenueFromContractWithCustomerMemberglow:VideoCollaborationServiceMemberglow:CollaborationProductsMemberus-gaap:ProductConcentrationRiskMember2024-01-012024-03-310000746210glow:VideoCollaborationServiceMemberglow:CollaborationProductsMemberus-gaap:ProductConcentrationRiskMember2023-01-012023-03-310000746210us-gaap:RevenueFromContractWithCustomerMemberglow:VideoCollaborationServiceMemberglow:CollaborationProductsMemberus-gaap:ProductConcentrationRiskMember2023-01-012023-03-310000746210us-gaap:ProductConcentrationRiskMember2024-01-012024-03-310000746210us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMember2024-01-012024-03-310000746210us-gaap:ProductConcentrationRiskMember2023-01-012023-03-310000746210us-gaap:RevenueFromContractWithCustomerMemberus-gaap:ProductConcentrationRiskMember2023-01-012023-03-310000746210us-gaap:RevenueFromContractWithCustomerMemberglow:ManagedServicesMemberus-gaap:CustomerConcentrationRiskMemberglow:CustomerNumberOneMember2024-01-012024-03-310000746210us-gaap:RevenueFromContractWithCustomerMemberglow:ManagedServicesMemberus-gaap:CustomerConcentrationRiskMemberglow:CustomerNumberOneMember2023-01-012023-03-310000746210us-gaap:AccountsReceivableMemberglow:ManagedServicesMemberus-gaap:CustomerConcentrationRiskMemberglow:CustomerNumberOneMember2024-01-012024-03-310000746210us-gaap:AccountsReceivableMemberglow:ManagedServicesMemberus-gaap:CustomerConcentrationRiskMemberglow:CustomerNumberOneMember2023-01-012023-03-310000746210us-gaap:AccountsReceivableMemberglow:CustomerNumberTwoMemberglow:ManagedServicesMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-03-310000746210us-gaap:AccountsReceivableMemberglow:CustomerNumberTwoMemberglow:ManagedServicesMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310000746210glow:CustomerNumberThreeMemberus-gaap:AccountsReceivableMemberglow:CollaborationProductsMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-03-310000746210glow:CustomerNumberThreeMemberus-gaap:AccountsReceivableMemberglow:CollaborationProductsMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310000746210us-gaap:AccountsReceivableMemberglow:CustomerNumberFourMemberglow:CollaborationProductsMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-03-310000746210us-gaap:AccountsReceivableMemberglow:CustomerNumberFourMemberglow:CollaborationProductsMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310000746210us-gaap:AccountsReceivableMemberglow:CollaborationProductsMemberus-gaap:CustomerConcentrationRiskMemberglow:CustomerNumberFiveMember2024-01-012024-03-310000746210us-gaap:AccountsReceivableMemberglow:CollaborationProductsMemberus-gaap:CustomerConcentrationRiskMemberglow:CustomerNumberFiveMember2023-01-012023-03-31

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
    Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2024.
or
    Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission file number: 001-35376
OBLONG, INC.
(Exact Name of Registrant as Specified in its Charter)
Delaware77-0312442
(State or Other Jurisdiction of Incorporation or Organization)(I.R.S. Employer Identification No.)

110 16th Street, Suite 1400-1024, Denver, CO 80202
(Address of Principal Executive Offices, including Zip Code)

(213) 683-8863 ext. 5
(Registrant’s Telephone Number, including Area Code)

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.0001 per shareOBLG
Nasdaq Capital Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes   No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company 
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.)
Yes No

The number of shares outstanding of the registrant’s common stock as of May 3, 2024 was 20,286,675.



OBLONG, INC.
Index
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements
Condensed Consolidated Balance Sheets at March 31, 2024 (unaudited) and December 31, 2023
Unaudited Condensed Consolidated Statements of Operations for the three months ended March 31, 2024 and 2023
Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three months ended March 31, 2024 and 2023
Unaudited Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2024 and 2023
Notes to unaudited Condensed Consolidated Financial Statements
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Item 4. Controls and Procedures
PART II - OTHER INFORMATION
Item 1. Legal Proceedings
Item 1A. Risk Factors
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Item 3. Defaults Upon Senior Securities
Item 4. Mine Safety Disclosures
Item 5. Other Information
Item 6. Exhibits
Signatures




CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This quarterly report on Form 10-Q (this “Report”) contains statements that are considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and its rules and regulations (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended, and its rules and regulations (the “Exchange Act”). These forward-looking statements include, but are not limited to, statements about the plans, objectives, expectations and intentions of Oblong, Inc. (“Oblong” or “we” or “us” or the “Company”). All statements other than statements of current or historical fact contained in this Report, including statements regarding Oblong’s future financial position, business strategy, budgets, projected costs and plans and objectives of management for future operations, are forward-looking statements. The words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” and similar expressions, as they relate to Oblong, are intended to identify forward-looking statements. These statements are based on Oblong’s current plans, and Oblong’s actual future activities and results of operations may be materially different from those set forth in the forward-looking statements. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from the statements made. Any or all of the forward-looking statements in this Report may turn out to be inaccurate. Oblong has based these forward-looking statements largely on its current expectations and projections about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs. The forward-looking statements can be affected by inaccurate assumptions or by known or unknown risks, uncertainties and assumptions. There are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements, including our plans, objectives, expectations and intentions and other factors that are discussed under the section entitled “Part I. Item 1A. Risk Factors” and in our consolidated financial statements and the footnotes thereto for the fiscal year ended December 31, 2023, each included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 filed with the Securities and Exchange Commission (the “SEC”) on March 19, 2024, as well as under “Part II. Item 1A. Risk Factors” in this report. Oblong undertakes no obligation to publicly revise these forward-looking statements to reflect events occurring after the date hereof. All subsequent written and oral forward-looking statements attributable to Oblong or persons acting on its behalf are expressly qualified in their entirety by the cautionary statements contained in this Report. Forward-looking statements in this Report include, among other things: opportunities for and benefits of potential strategic alternatives; our expectations and estimates relating to customer attrition, demand for our product offerings, sales cycles, future revenues, expenses, capital expenditures and cash flows; evolution of our customer solutions and our service platforms; our ability to fund operations and continue as a going concern; expectations regarding adjustments to our cost of revenue and other operating expenses; our ability to finance investments in product development and sales and marketing; the future exercise of warrants; our ability to raise capital through sales of additional equity or debt securities and/or loans from financial institutions; our beliefs about the ongoing performance and success of our Managed Service business; statements relating to market need and evolution of the industry, our solutions and our service platforms; and the adequacy of our internal controls. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, those summarized below:

our ability to raise capital in one or more debt and/or equity offerings in order to fund operations or any growth initiatives and our ability to continue as a going concern;
the impact of the issuance of our Series F Preferred Stock in the March 2023 private placements, conversions of our Series F Preferred Stock and sales of the underlying conversion shares.
customer acceptance and demand for our video collaboration services and network applications;
our ability to launch new products and offerings and to sell our solutions;
our ability to compete effectively in the video collaboration services and network services businesses;
the ongoing performance and success of our Managed Services business;
our ability to maintain and protect our proprietary rights;
our ability to withstand industry consolidation;
our ability to adapt to changes in industry structure and market conditions;
actions by our competitors, including price reductions for their competitive services;
the quality and reliability of our products and services;
the prices for our products and services and changes to our pricing model;
the success of our sales and marketing approach and efforts, and our ability to grow revenue;
customer renewal and retention rates;
the continued impact from the aftermath of the coronavirus pandemic on our revenue and results of operations;
risks related to the concentration of our customers and the degree to which our sales, now or in the future, depend on certain large client relationships;
increases in material, labor or other manufacturing-related costs;



changes in our go-to-market cost structure;
inventory management and our reliance on our supply chain;
our ability to attract and retain highly skilled personnel;
our reliance on open-source software and technology;
potential federal and state regulatory actions;
our ability to innovate technologically, and, in particular, our ability to develop next generation Oblong technology;
our ability to satisfy the standards for continued listing of our common stock on the Nasdaq Capital Market;
changes in our capital structure and/or stockholder mix;
the costs, disruption, and diversion of management’s attention associated with campaigns commenced by activist investors; and
our management’s ability to execute its plans, strategies and objectives for future operations.





PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

OBLONG, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except par value, stated value, and shares)
March 31, 2024December 31, 2023
(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents$5,360 $5,990 
Accounts receivable, net15 424 
Inventory, net127 239 
Prepaid expenses and other current assets421 243 
Total current assets5,923 6,896 
Operating lease - right of use asset, net
 17 
Other assets12 12 
Total assets$5,935 $6,925 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$351 $211 
Accrued expenses and other current liabilities1,031 1,038 
Current portion of deferred revenue105 132 
Operating lease liabilities 17 
Total current liabilities1,487 1,398 
Long-term liabilities:
Deferred revenue, net of current portion14 26 
Total liabilities1,501 1,424 
Commitments and contingencies (see Note 9)
Stockholders’ equity:
Preferred stock Series F, convertible; $.0001 par value; $1,102,150 stated value; 42,000 shares authorized, 1,008 and 1,930 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively
  
Common stock, $.0001 par value; 150,000,000 shares authorized; 20,294,228 shares issued and 20,285,675 outstanding at March 31, 2024 and 16,692,124 shares issued and 16,683,572 shares outstanding at December 31, 2023
2 2 
Treasury stock, 8,000 shares of common stock
(181)(181)
Additional paid-in capital233,980 233,911 
Accumulated deficit(229,367)(228,231)
Total stockholders' equity4,434 5,501 
Total liabilities and stockholders’ equity$5,935 $6,925 
See accompanying notes to condensed consolidated financial statements.
-1-


OBLONG, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(Unaudited)
Three Months Ended
March 31,
20242023
Revenue$626 $1,038 
Cost of revenue (exclusive of depreciation and amortization)629 762 
Gross profit(3)276 
Operating expenses:
Research and development50 6 
Sales and marketing54 218 
General and administrative1,077 1,169 
Depreciation and amortization 86 
Total operating expenses1,181 1,479 
Loss from operations(1,184)(1,203)
Interest and other expense, net 5 
Other income(48)(27)
Interest and other income, net(48)(22)
Loss before income taxes(1,136)(1,181)
Income tax expense 38 
Net loss(1,136)(1,219)
Preferred stock dividends44  
Warrant modification 25 
Net loss attributable to common stockholders$(1,180)$(1,244)
Net loss attributable to common stockholders per share:
Basic and diluted net loss per share$(0.07)$(0.60)
Weighted-average number of shares of common stock:
Basic and diluted17,123 2,065 

See accompanying notes to condensed consolidated financial statements.
-2-


OBLONG, INC.
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY
Three Months Ended March 31, 2024
(In thousands, except shares of Series F Preferred Stock)
(Unaudited)


Series F Preferred Stock
Common Stock
Treasury Stock
Shares
Amount
Shares
Amount
Shares
Amount
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at December 31, 20231,930 $ 16,692 $2 8 $(181)$233,911 $(228,231)$5,501 
Net loss
— — — — — — — (1,136)(1,136)
Stock-based compensation
— — — — — — 31 — 31 
Conversions of Series F Preferred Stock including accrued dividends of $82,000
(922)— 3,602 — — — 82 — 82 
Series F Preferred Stock dividends— — — — — — (44)— (44)
Balance at March 31, 20241,008 $ 20,294 $2 8 $(181)$233,980 $(229,367)$4,434 
















See accompanying notes to condensed consolidated financial statements.
-3-




OBLONG, INC.
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY
Three Months Ended March 31, 2023
(In thousands, except shares of Series F Preferred Stock)
(Unaudited)

Series F Preferred Stock
Common Stock
Treasury Stock
Shares
Amount
Shares
Amount
Shares
Amount
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at December 31, 2022 $ 2,071 $ 8 $(181)$227,645 $(223,847)$3,617 
Net loss
— — — — — — — (1,219)(1,219)
Stock-based compensation
— — — — — — 31 — 31 
Proceeds from private placement, net of fees and amounts held in escrow6,550 — — — — — 1,473 — 1,473 
Balance at March 31, 20236,550 $ 2,071 $ 8 $(181)$229,149 $(225,066)$3,902 
See accompanying notes to condensed consolidated financial statements.
-4-


OBLONG, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)


Three Months Ended March 31,
20242023
Cash flows from operating activities:
Net loss$(1,136)$(1,219)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization 86 
Bad debt (recovery) expense (24)
Non-cash lease expense from right-of-use asset17 43 
Stock-based compensation31 31 
Changes in operating assets and liabilities:
Accounts receivable409 47 
Inventory112 89 
Prepaid expenses and other current assets(178)(298)
Other assets 9 
Accounts payable140 23 
Accrued expenses and other current liabilities31 591 
Deferred revenue(39)(125)
Lease liabilities(17)(97)
Net cash used in operating activities(630)(844)
Cash flows from financing activities:
Proceeds from private placement, net of issuance costs and amounts in escrow 1,473 
Net cash provided by financing activities 1,473 
Decrease (increase) in cash(630)629 
Cash and cash equivalents at beginning of period5,990 3,085 
Cash and cash equivalents at end of period$5,360 $3,714 
Supplemental disclosures of cash flow information:
Reconciliation of cash and cash equivalents
Cash$4,860 $3,714 
Current certificates of deposit500  
Total cash and cash equivalents$5,360 $3,714 
Cash paid during the period for interest$5 $2 
Cash paid for income taxes$ $31 
Non-cash investing and financing activities:
Preferred stock dividends$44 $ 
Warrant modification$ $25 
See accompanying notes to condensed consolidated financial statements.
-5-



OBLONG, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
March 31, 2024
(Unaudited)

Note 1 - Business Description and Significant Accounting Policies

Business Description

Oblong, Inc. (“Oblong” or “we” or “us” or the “Company”) was formed as a Delaware corporation in May 2000 and is a provider of patented multi-stream collaboration technologies and managed services for video collaboration and network applications.

Basis of Presentation

The Company's fiscal year ends on December 31 of each calendar year. The accompanying interim Condensed Consolidated Financial Statements are unaudited and have been prepared on substantially the same basis as our annual Consolidated Financial Statements for the fiscal year ended December 31, 2023. In the opinion of the Company's management, these interim Condensed Consolidated Financial Statements reflect all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.

The December 31, 2023 year-end Condensed Consolidated Balance Sheet data in this document was derived from audited consolidated financial statements. The Condensed Consolidated Financial Statements and notes included in this quarterly report on Form 10-Q do not include all disclosures required by U.S. generally accepted accounting principles and should be read in conjunction with the Company's audited consolidated financial statements as of and for the year ended December 31, 2023 and notes thereto included in the Company's fiscal 2023 Annual Report on Form 10-K, filed with the Securities and Exchange Commission (“SEC”) on March 19, 2024 (the “2023 Annual Report”).

The results of operations and cash flows for the interim periods included in these Condensed Consolidated Financial Statements are not necessarily indicative of the results to be expected for any future period or the entire fiscal year.

Principles of Consolidation

The Condensed Consolidated Financial Statements include the accounts of Oblong and our 100%-owned subsidiaries (i) GP Communications, LLC (“GP Communications”), whose business function is to provide interstate telecommunications services for regulatory purposes, and (ii) Oblong Industries, Inc. All inter-company balances and transactions have been eliminated in consolidation. The U.S. Dollar is the functional currency for all subsidiaries.

Cash and Cash Equivalents

As of March 31, 2024, our total cash balance of $5,360,000 is available. Of this balance $500,000 was held in short-term certificates of deposit with MidFirst Bank. As of December 31, 2023, our total cash balance of $5,990,000 was available with $500,000 held in short-term certificates of deposit with MidFirst Bank. The Company considers highly liquid investments with original maturities of three months or less to be cash equivalents.

Segments

The Company currently operates in two segments: (1) “Collaboration Products” which represents the business surrounding our Mezzanine™ product offerings, and (2) “Managed Services” which represents the business surrounding managed services for video collaboration and network solutions. See Note 8 - Segment Reporting for further discussion.





-6-


Use of Estimates

Preparation of the Condensed Consolidated Financial Statements in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual amounts could differ from the estimates made. We continually evaluate estimates used in the preparation of our consolidated financial statements for reasonableness. Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation. The significant areas of estimation include determining the allowances for inventory obsolescence and estimated credit losses and the inputs used in the fair value of equity-based awards.

Intangible Assets

As of March 31, 2024 and December 31, 2023, we had no intangible assets. During the three months ended March 31, 2023, we recorded $86,000 in amortization expense related to intangible assets.

Operating Lease Right-of-use-Assets and Liabilities

In February 2024, we exited our warehouse lease in City of Industry, California, and are no longer a party to any operating leases. Right-of-use assets, net totaled $17,000 as of December 31, 2023, consisting of the warehouse lease discussed above. As of March 31, 2024, the Company had no right-of-use assets remaining. The remaining operating lease liability as of December 31, 2023 was $17,000, consisting of the warehouse lease discussed above. As of March 31, 2024, the Company had no lease liability remaining. During the three months ended March 31, 2024, we recorded $17,000 in lease expenses. During the three months ended March 31, 2023, we recorded $46,000 in lease expenses, net of common charges, and sublease proceeds of $16,000.

Significant Accounting Policies

The significant accounting policies used in preparation of these Condensed Consolidated Financial Statements are disclosed in our 2023 Annual Report, and there have been no changes to the Company’s significant accounting policies during the three months ended March 31, 2024.

Recently Issued Accounting Pronouncements

In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic280): Improvements to Reportable Segment Disclosures. The new guidance is intended to improve reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. The amendments are effective retrospectively for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. The Company is in the process of evaluating the impact that the adoption of this ASU will have on the financial statements and related disclosures, which is not expected to be material.

In December 2023, the FASB issued ASU No. 2023-09, Improvements to Tax Disclosures (Topic 740), to enhance the transparency and decision usefulness of income tax disclosures through changes to the rate reconciliation and income taxes paid information. This guidance is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is evaluating the impact of adopting this new accounting guidance on its Consolidated Financial Statements.

Note 2 - Liquidity

As of March 31, 2024, we had $5,360,000 in cash and working capital of $4,436,000. For the three months ended March 31, 2024, we incurred a net loss of $1,136,000 and used $630,000 of net cash in operating activities.

We believe that our existing cash will be sufficient to fund our operations and meet our working capital requirements for at least the next 12 months from the filing date of this Report with the SEC.







-7-


Note 3 - Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):
March 31,December 31,
20242023
Compensation costs$526 $448 
Customer deposits86 118 
Professional fees129 104 
Taxes and regulatory fees19 22 
Accrued rent170 202 
Accrued dividends on Series F Preferred Stock94 136 
Other accrued expenses and liabilities7 8 
Accrued expenses and other liabilities$1,031 $1,038 

Note 4 - Capital Stock

Common Stock

The Company’s common stock, par value $0.0001 per share (the “Common Stock”), is listed on the Nasdaq Capital Market (“Nasdaq”), under the ticker symbol “OBLG”. As of March 31, 2024, we had 150,000,000 shares of our Common Stock authorized, with 20,294,000 and 20,286,000 shares issued and outstanding, respectively.
During the three months ended March 31, 2024, 922 shares of Series F Preferred Stock, plus $82,000 accrued dividends, were converted to 3,602,103 shares of the Company’s common stock. See Note 5 - Preferred Stock, for further detail.
Common Stock activity for the three months ended March 31, 2024 is presented below (in thousands).
Issued Shares as of December 31, 20222,071 
Issuances from Preferred Stock conversions14,102 
Issuances related to warrant exercises746 
Issuances related to stock compensation180 
Common shares exchanged for prepaid warrants(407)
Issued Shares as of December 31, 202316,692 
Issuances from Preferred Stock conversions3,602 
Issued Shares as of March 31, 202420,294 
Less Treasury Shares:(8)
Outstanding Shares as of March 31, 202420,286 
Common Stock Warrants
Warrants outstanding as of March 31, 2024 are as follows:
Issue DateWarrants OutstandingExercise PriceExpiration Date
June 28, 2021750 $66.00 December 31, 2024
March 31, 20234,136,850 $1.71 September 30, 2028
4,137,600 







-8-


Warrant activity for the three months ended March 31, 2024 and the year ended December 31, 2023 is presented below.

Outstanding and Exercisable
Number of Warrants
Weighted Average Exercise Price
Warrants outstanding and exercisable, December 31, 2022343,099 $66.34 
Granted4,543,626 1.71 
Exercised(746,027)0.78 
Expired(2,601)76.93 
Forfeited(247)
Warrants outstanding and exercisable, December 31, 20234,137,850 1.72 
Expired(250)60.00 
Warrants outstanding and exercisable, March 31, 20244,137,600 $1.72 

Treasury Shares

The Company maintains treasury stock for the Common Stock shares bought back by the Company when withholding shares to cover taxes on transactions related to equity awards. There were no treasury stock transactions during the three months ended March 31, 2024 or the year ended December 31, 2023.

Note 5 - Preferred Stock

Our Certificate of Incorporation authorizes the issuance of up to 5,000,000 shares of preferred stock. As of March 31, 2024, we had 1,983,250 designated shares of preferred stock and 1,008 shares of preferred stock issued and outstanding. As of December 31, 2023, we had 1,930 shares of preferred stock issued and outstanding.

Series F Preferred Stock
On March 30, 2023, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which we issued and sold, in a private placement (the “Private Placement”) (i) 6,550 shares of our newly designated Series F Preferred Stock, $0.0001 par value per share (the “Series F Preferred Stock”), (ii) preferred warrants (the “Preferred Warrants”) to acquire 32,750 shares of Series F Preferred Stock, and (iii) common warrants (“Common Warrants” and with the Preferred Warrants the “Investor Warrants”) to acquire up to 3,830,417 shares of Common Stock. Please refer to Note 4 - Capital Stock for additional detail regarding the Series F Preferred Stock and Preferred Warrants. The terms of the Series F Preferred Stock are as set forward in the Certificate of Designations of Series F Preferred Stock of Oblong, Inc. (the “Certificate of Designations”), which was filed and became effective with the Secretary of State of the State of Delaware on March 31, 2023. The Private Placement closed on March 31, 2023, in exchange for gross and net proceeds of $6,386,000 and $5,364,000, respectively. The financing fees associated with the Purchase Agreement were $1,022,000.

The Series F Preferred Shares are convertible into fully paid and non-assessable shares of the Company’s Common Stock at the election of the holder at any time at an initial conversion price of $1.71 (the “Conversion Price”). The holders of the Series F Preferred Shares may also elect to convert their shares at an alternative conversion price equal to the lower of (i) 80% of the applicable Conversion Price as in effect on the date of the conversion, (ii) 80% of the closing price on the trading day immediately preceding the delivery of the conversion notice, and (iii) the greater of (a) the Floor Price (as defined in the Certificate of Designations) and (b) the quotient of (x) the sum of the five lowest Closing Bid Prices (as defined in the Certificate of Designations) for trading days in the 30 consecutive trading day period ending and including the trading day immediately preceding the delivery of the applicable Conversion Notice, divided by (y) five. The Conversion Price is subject to customary adjustments for stock splits, stock dividends, stock combination recapitalization, or other similar transactions involving the Common Stock, and subject to price-based adjustment, on a full ratchet basis, in the event of any issuances of our common stock, or securities convertible, exercisable or exchangeable for Common Stock, at a price below the then-applicable Conversion Price (subject to certain exceptions).

On October 6, 2023, the Company and Investors holding a majority of the outstanding shares of the Preferred Stock agreed to waive any and all provisions, terms, covenants and obligations in the Certificate of Designations or Common Warrants to the

-9-


extent such provisions permit the conversion or exercise of the Preferred Stock and the Common Warrants, respectively, to occur at a price below $0.2792. Notwithstanding anything to the contrary in the Certificate of Designations, each of the “Alternate Conversion Price” and the “Floor Price” as set forth in the Certificate of Designations shall in no event be less than $0.2792 (as adjusted for stock splits, stock dividends, stock combinations, recapitalizations and similar events).

Under the Certificate of Designations, the Series F Preferred Shares have an initial stated value of $1,000 per share (the “Stated Value”). The holders of the Series F Preferred Shares are entitled to dividends of 9% per annum, which will be payable in arrears quarterly. Accrued dividends may be paid, at our option, in cash and if not paid, shall increase the stated value of the Series F Preferred Shares. Upon the occurrence and during the continuance of a Triggering Event (as defined in the Certificate of Designations), the Series F Preferred Shares will accrue dividends at the rate of 20% per annum (the “Default Rate”). The Series F Preferred Shares have no voting rights, other than with respect to certain matters affecting the rights of the Series F Preferred Shares. On matters with respect to which the holders of the Series F Preferred Shares have a right to vote, holders of the Preferred Shares will have voting rights on an as-converted basis.

Our ability to settle conversions is subject to certain limitations set forth in the Certificate of Designations. Further, the Certificate of Designations contains a certain beneficial ownership limitation after giving effect to the issuance of shares of common stock issuable upon conversion of the Series F Preferred Shares.

The Certificate of Designations includes certain Triggering Events (as defined in the Certificate of Designations), including, among other things, (i) the failure to file and maintain an effective registration statement covering the sale of the holder’s securities registrable pursuant to the Registration Rights Agreement, (ii) the failure to pay any amounts due to the holders of the Series F Preferred Shares when due, and (iii) if Peter Holst ceases to be the chief executive officer of the Company other than because of his death, and a qualified replacement, reasonably acceptable to a majority of the holders of the Series F Preferred Shares, is not appointed within thirty (30) business days. In connection with a Triggering Event, the Default Rate is triggered. We are subject to certain affirmative and negative covenants regarding the incurrence of indebtedness, acquisition transactions, the existence of liens, the repayment of indebtedness, the payment of cash in respect of dividends (other than dividends pursuant to the Certificate of Designations), maintenance of properties and the transfer of assets, among other matters.
During the year ended December 31, 2023 and the three months ended March 31, 2024, 4,620 and 922 shares of Series F Preferred Stock, plus accrued dividends, were converted to 14,102,477 and 3,602,103 shares of the Company’s common stock, respectively. There were 1,008 shares of Series F Preferred Stock outstanding and accrued dividends of $94,000 as of March 31, 2024. Series F Preferred Stock transactions are summarized in the table below (in thousands except for shares of Series F Preferred Stock:
Series F Preferred Stock SharesPreferred Stock DividendsWeighted Average Conversion PriceCommon Shares Issued from Conversions
March 31, 2023 Issuance6,550 $ — 
2023 Accrued Dividends— $343 — 
2023 Conversions(4,620)$(211)$0.34 14,102 
December 31, 2023 Balance1,930 $132 14,102 
2024 Accrued Dividends— $44 — 
2024 Conversions(922)$(82)0.28 3,602 
March 31, 2024 Balance1,008 $94 $0.33 17,704 

Series F Preferred Stock Warrants

The Preferred Warrants are exercisable for Series F Preferred Shares at an exercise price of $975. The exercise price is subject to customary adjustments for stock splits, stock dividends, stock combination recapitalizations or other similar transactions involving the Common Stock. The Preferred Warrants expire three years from the date of issuance and are exercisable for cash. For each Preferred Warrant exercised, the Investors shall receive Common Warrants to purchase a number of shares of Common Stock equal to 100% of the number of shares of Common Stock the Investors would receive if the Series F Preferred Shares issuable upon exercise of such Warrant were converted at the applicable Conversion Price. The fair value of the Preferred Warrants was recorded within additional paid-in capital upon issuance. As of March 31, 2024, no Preferred Warrants have been exercised.

-10-



Note 6 - Stock Based Compensation

2019 Equity Incentive Plan

On December 19, 2019, the Oblong, Inc. 2019 Equity Incentive Plan (the “2019 Plan”) was approved by the Company’s stockholders at the Company’s 2019 Annual Meeting of Stockholders. The 2019 Plan is an omnibus equity incentive plan pursuant to which the Company may grant equity and cash incentive awards to certain key service providers of the Company and its subsidiaries. As of December 31, 2023, the share pool available for new grants under the 2019 Plan was 3.

Stock Options

A summary of stock option activity under our plans, and options outstanding as of, and changes made during the three months ended March 31, 2024 and year ended December 31, 2023 is presented below:

OutstandingExercisable
Number of OptionsWeighted Average Exercise PriceNumber of OptionsWeighted Average Exercise Price
Options outstanding and exercisable, December 31, 202216,668 $143.63 10,000 $206.85 
Vested 3,336 48.75
Expired(6,668)285.89(6,668)285.89
Options outstanding and exercisable, December 31, 202310,000 48.75 6,668 48.75 
Options outstanding and exercisable, March 31, 202410,000 $48.75 6,668 $48.75 
The intrinsic value of vested and unvested options was not significant for all periods presented. Stock compensation expense related to stock options for the three months ended March 31, 2024 and 2023 was $31,000 and was recorded as a general and administrative expense on our Condensed Consolidated Statements of Operations. The remaining unrecognized stock-based compensation expense for options as of March 31, 2024 is $30,000, which will be recognized over a weighted average period of 3 months.
Restricted Stock
As of March 31, 2024 and December 31, 2023, there were no outstanding restricted stock awards or restricted stock units (“Restricted Stock”). For the three months ended March 31, 2024 and 2023, there was no stock compensation expense recorded for Restricted Stock and there was no unamortized expense related to Restricted Stock. The following table shows a summary of Restricted Stock activity for the year ended December 31, 2023. There was no Restricted Stock activity during the three months ended March 31, 2024.
Restricted Stock AwardsRestricted Stock Units
SharesWeighted Average Grant PriceSharesWeighted Average Grant Price
Unvested shares, December 31, 202242 $235.87  $ 
Granted 177,564 2.14 
Vested(42)235.87 (177,564)2.14 
Unvested Shares, December 31, 2023    
Unvested Shares, March 31, 2024 $  $ 






-11-


Note 7 - Net Loss Per Share

Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. The weighted-average number of shares of common stock outstanding does not include any potentially dilutive securities or unvested Restricted Stock. Unvested Restricted Stock, although classified as issued and outstanding at March 31, 2023, was considered contingently returnable until the restrictions lapsed and was not included in the basic net loss per share calculation for the three months ended March 31, 2023. Unvested Restricted Stock does not contain non-forfeitable rights to dividends and dividend equivalents.

Diluted net loss per share is computed by giving effect to all potential shares of common stock, including stock options, preferred stock, warrants, and unvested Restricted Stock, to the extent they are dilutive. For the three months ended March 31, 2024 and 2023, all such common stock equivalents have been excluded from diluted net loss per share as the effect to net loss per share would be anti-dilutive (due to the net loss).

The following table sets forth the computation of the Company’s basic and diluted net loss per share (in thousands, except per share data):
Three Months Ended March 31,
20242023
Numerator:
Net loss$(1,136)$(1,219)
Less: preferred stock dividends(44) 
Less: warrant modification (25)
Net loss attributable to common stockholders$(1,180)$(1,244)
Denominator:
Weighted-average number of shares of common stock for basic and diluted net loss per share17,123 2,065 
Basic and diluted net loss per share$(0.07)$(0.60)

The following table represents the potential shares that were excluded from the computation of weighted-average number of shares of common stock in computing the diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect (due to the net loss):
As of March 31,
20242023
Unvested restricted stock awards 42 
Outstanding stock options10,000 10,167 
Common stock issuable upon conversion of Series F Preferred Stock (1)3,947,529 3,830,409 
Common stock issuable upon conversion of Series F Preferred Warrants (2)117,299,427  
Common stock issuable upon conversion of Common Stock warrants4,137,600 4,479,947 
(1) Calculation assumes conversion of the stated value, and accrued dividends, of the Series F Preferred Stock into Common Stock at the Floor Price as of March 31, 2024, and at the initial conversion price of $1.71 as of March 31, 2023.
(2) Calculation assumes exercise of the Series F Preferred Warrants for cash into Series F Preferred Stock and subsequent conversion of the Series F Preferred Stock into Common Stock at the Floor Price as of March 31, 2024. The Series F Preferred Stock Warrants were not exercisable as of March 31, 2023.

Note 8 - Segment Reporting

The Company currently operates in two segments: (1) “Managed Services”, which represents the business surrounding managed services for video collaboration and network applications; and (2) “Collaboration Products” which represents the business surrounding our Mezzanine™ product offerings.

Certain information concerning the Company’s segments for the three months ended March 31, 2024 and 2023 is presented in the following tables (in thousands):

-12-


Three Months Ended March 31, 2024
Managed ServicesCollaboration ProductsCorporateTotal
Revenue$522 $104 $ $626 
Cost of revenues369 260  629 
  Gross profit$153 $(156)$ $(3)
  Gross profit %29 %(150)% %
Allocated operating expenses$ $121 $ $121 
Unallocated operating expenses  1,060 1,060 
  Total operating expenses$ $121 $1,060 $1,181 
Income (loss) from operations$153 $(277)$(1,060)$(1,184)
Interest and other income, net(32)(16) (48)
Net income (loss) before tax185 (261)(1,060)(1,136)
Income tax expense    
Net income (loss)$185 $(261)$(1,060)$(1,136)

Three Months Ended March 31, 2023
Managed ServicesCollaboration ProductsCorporateTotal
Revenue$690 $348 $ $1,038 
Cost of revenues460 302  762 
Gross profit$230 $46 $ $276 
Gross profit %33 %13 %27 %
Allocated operating expenses$ $286 $ $286 
Unallocated operating expenses  1,193 1,193 
Total operating expenses$ $286 $1,193 $1,479 
Income (loss) from operations$230 $(240)$(1,193)$(1,203)
Interest and other expense (income), net3 (25) (22)
Income (loss) before income taxes227 (215)(1,193)(1,181)
Income tax expense7 31  38 
Net income (loss)$220 $(246)$(1,193)$(1,219)


Unallocated operating expenses in Corporate include costs for the three months ended March 31, 2024 and 2023 that are not specific to a particular segment but are general to the group; included are expenses incurred for administrative and accounting staff, general liability and other insurance, professional fees, and other similar corporate expenses.

For the three months ended March 31, 2024, and 2023, there was no material revenue attributable to any individual foreign country.







-13-


Revenue by geographic area is allocated as follows (in thousands):

Three Months Ended March 31,
20242023
Domestic$261 $563 
Foreign365 475 
$626 $1,038 

Disaggregated information for the Company’s revenue has been recognized in the accompanying Condensed Consolidated Statements of Operations and is presented below according to contract type (in thousands):

Three Months Ended March 31,
2024% of Revenue2023% of Revenue
Revenue: Managed Services
Video collaboration services$14 2 %$64 6 %
Network services503 80 %618 60 %
Professional and other services5 1 %8 1 %
      Total Managed Services revenue$522 83 %$690 66 %
Revenue: Collaboration Products
Visual collaboration product offerings$104 17 %$348 34 %
Total revenue$626 100 %$1,038 100 %

The Company considers a significant customer to be one that comprises more than 10% of the Company’s consolidated revenues or accounts receivable. The loss of or a reduction in sales or anticipated sales to our most significant or several of our smaller customers could have a material adverse effect on our business, financial condition, and results of operations.

Concentration of consolidated revenues was as follows:

Three Months Ended March 31,
20242023
Segment% of Revenue% of Revenue
Customer AManaged Services82 %52 %


Concentration of accounts receivable was as follows:

As of March 31, 2024
20242023
Segment% of Accounts Receivable% of Accounts Receivable
Customer AManaged Services %41 %
Customer BManaged Services %11 %
Customer CCollaboration Products %14 %
Customer DCollaboration Products %15 %
Customer ECollaboration Products73 % %



-14-


Note 9 - Commitments and Contingencies

From time to time, we are subject to various legal proceedings arising in the ordinary course of business, including proceedings for which we have insurance coverage. As of the date hereof, we are not party to any legal proceedings that we currently believe will have a material adverse effect on our business, financial position, results of operations or liquidity.

COVID-19

On March 11, 2020, the World Health Organization (“WHO”) announced that infections of the novel Coronavirus (COVID-19) had become pandemic, and on March 13, 2020, the U.S. President announced a National Emergency relating to the disease. In May 2023, the WHO declared COVID-19 over as a global health emergency. Customers generally use our Mezzanine™ products in traditional office and operating center environments such as conference rooms or other presentation spaces. Revenue declines for our Collaboration Products business are primarily due to lower demand, largely a consequence of the commercial reactions to the COVID-19 pandemic and its prolonged effects. We believe the COVID-19 pandemic fundamentally altered the way businesses consider the use of physical office spaces and, consequently, the demand for technologies that enable in-person collaboration within these spaces. Our analysis indicates that the reduced demand for our Mezzanine™ products, particularly in the aftermath of COVID-19, reflects a broader reassessment among our customers regarding the necessity and investment in collaboration solutions tailored for traditional office environments. Continuation of this trend could cause further declines in our revenue for this business. Although the Company cannot presently quantify the future financial impacts of this trend, such impacts will likely continue to have a material adverse impact on the Company’s consolidated financial condition, results of operations, and cash flows.


-15-


ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Overview

We are a provider of patented multi-stream collaboration products and managed services for video collaboration and network solutions. The Company currently operates in two segments: (1) “Collaboration Products,” which represents the business surrounding our Mezzanine™ product offerings, and (2) “Managed Services,” which represents the business surrounding managed services for video collaboration and network solutions.

Mezzanine™ Product Offerings

Our flagship product is called Mezzanine™, a family of turn-key products that enable dynamic and immersive visual collaboration across multi-users, multi-screens, multi-devices, and multi-locations (see further description of Mezzanine™ in Part I, Item 1). Mezzanine™ allows multiple people to share, control and arrange content simultaneously, from any location, enabling all participants to see the same content in its entirety at the same time in identical formats, resulting in dramatic enhancements to both in-room and virtual videoconference presentations. Applications include video telepresence, laptop and application sharing, whiteboard sharing and slides. Spatial input allows content to be spread across screens, spanning different walls, scalable to an arbitrary number of displays and interaction with our proprietary wand device. Mezzanine™ substantially enhances day-to-day virtual meetings with technology that accelerates decision making, improves communication, and increases productivity. Mezzanine™ scales up to support the most immersive and commanding innovation centers; across to link labs, conference spaces, and situation rooms; and down for the smallest work groups. Mezzanine’s digital collaboration platform can be sold as delivered systems in various configurations for small teams to total immersion experiences. The family includes the 200 Series (two display screen), 300 Series (three screen), and 600 Series (six screen). We also sell maintenance and support contracts related to Mezzanine™.

Historically, customers have used Mezzanine™ products in traditional office and operating center environments such as conference rooms or other presentation spaces. As discussed below, sales of our Mezzanine product have been adversely affected by the commercial response to the COVID-19 pandemic and its aftermath. Like many technology companies in recent months, we will continue to monitor and manage our costs relative to demand with the goal of growing the Company’s revenue in the future. To the extent we believe new investments in product development, marketing, or sales are warranted as a result of changes in market demand, we believe additional capital will be required to fund those efforts and our ongoing operations.

Managed Services for Video Collaboration

We provide a range of managed services for video collaboration, from automated to orchestrated, to simplify the user experience in an effort to drive adoption of video collaboration throughout our customers’ enterprise. We deliver our services through a hybrid service platform or as a service layer on top of our customers’ video infrastructure. We provide our customers with i) managed videoconferencing, where we set up and manage customer videoconferences and ii) remote service management, where we provide 24/7 support and management of customer video environments.

Managed Services for Network

We provide our customers with network solutions that ensure reliable, high-quality and secure traffic of video, data and internet. Network services are offered to our customers on a subscription basis. Our network services business carries variable costs associated with the purchasing and reselling of this connectivity.

Oblong’s Results of Operations

Three Months Ended March 31, 2024 (the “2024 First Quarter”) compared to the Three Months Ended March 31, 2023 (the “2023 First Quarter”)

Certain information concerning the Company’s segments for the three months ended March 31, 2024 and 2023 and is presented below (in thousands):


-16-


Three Months Ended March 31, 2024
Managed ServicesCollaboration ProductsCorporateTotal
Revenue$522 $104 $— $626 
Cost of revenues369 260 — 629 
  Gross profit$153 $(156)$— $(3)
  Gross profit %29 %(150)%— %
Allocated operating expenses$— $121 $— $121 
Unallocated operating expenses— — 1,060 1,060 
  Total operating expenses$— $121 $1,060 $1,181 
Income (loss) from operations$153 $(277)$(1,060)$(1,184)
Interest and other income, net(32)(16)— (48)
Net income (loss) before tax185 (261)(1,060)(1,136)
Income tax expense— — — — 
Net income (loss)$185 $(261)$(1,060)$(1,136)

Three Months Ended March 31, 2023
Managed ServicesCollaboration ProductsCorporateTotal
Revenue$690 $348 $— $1,038 
Cost of revenues460 302 — 762 
Gross profit$230 $46 $— $276 
Gross profit %33 %13 %27 %
Allocated operating expenses$— $286 $— $286 
Unallocated operating expenses— — 1,193 1,193 
Total operating expenses$— $286 $1,193 $1,479 
Income (loss) from operations$230 $(240)$(1,193)$(1,203)
Interest and other expense (income), net(25)— (22)
Income (loss) before income taxes227 (215)(1,193)(1,181)
Income tax expense31 — 38 
Net income (loss)$220 $(246)$(1,193)$(1,219)


Unallocated operating expenses in Corporate include costs during the 2024 and 2023 First Quarters that are not specific to a particular segment but are general to the group; included are expenses incurred for administrative and accounting staff, general liability and other insurance, professional fees, and other similar corporate expenses.

Revenue. Total revenue decreased 40% in the 2024 First Quarter compared to the 2023 First Quarter. The following table summarizes the changes in components of our revenue (in thousands), and the significant changes in revenue are discussed in more detail below.

-17-


Three Months Ended March 31,
2024% of Revenue2023% of Revenue
Revenue: Managed Services
Video collaboration services$14 %$64 %
Network services503 80 %618 60 %
Professional and other services%8%
      Total Managed Services revenue$522 83 %$690 66 %
Revenue: Collaboration Products
Visual collaboration product offerings$104 17 %$348 34 %
Total revenue$626 100 %$1,038 100 %

Managed Services

The decrease in revenue for video collaboration services is mainly attributable to lower revenue from existing customers (either from reductions in price or level of services) and loss of customers to competition.

The decrease in revenue for network services is mainly attributable to net attrition of customers and lower demand for our services given the competitive environment and pressure on pricing that exists in the network services business.

For the three months ended March 31, 2024, one customer made up 98% of Managed Services revenue. For the three months ended March 31, 2023, this same customer made up 80% of Managed Services revenue.

We expect revenue declines in our Managed Services segment will continue in the future.

Collaboration Products
Customers generally use our Mezzanine™ products in traditional office and operating center environments such as conference rooms or other presentation spaces. The year-over-year decrease in revenue for our Collaboration Products business is due to lower demand, largely a consequence of the work-place reactions to the COVID-19 pandemic and its prolonged effects. We believe the COVID-19 pandemic fundamentally altered the way businesses consider the use of physical office spaces and, consequently, the demand for technologies that enable in-person collaboration within these spaces. Our analysis indicates that the reduced demand for our Mezzanine™ products, particularly in the aftermath of COVID-19, reflects a broader reassessment among our customers regarding the necessity and investment in collaboration solutions tailored for traditional office environments.

Cost of Revenue (exclusive of depreciation and amortization). Cost of revenue, exclusive of depreciation and amortization and casualty loss, includes all internal and external costs related to the delivery of revenue. Cost of revenue also includes taxes which have been billed to customers. Cost of revenue by segment is presented in the following table (in thousands):
Three Months Ended March 31,
20242023
Cost of Revenue
Managed Services$369 $460 
Collaboration Products260 302 
Total cost of revenue$629 $762 

The decrease in our consolidated cost of revenue is mainly attributable to lower costs associated with the decrease in revenue during the same period, offset by an increase in the expense related to our reserve for obsolescence on our inventory asset for our Collaboration Products segment. Our consolidated gross profit as a percentage of revenue was 0% in the 2024 First Quarter compared to a consolidated gross profit as a percentage of revenue of 27% in the 2023 First Quarter.

-18-



Our Managed Services segment recorded a 29% gross profit as a percentage of sales for the 2024 First Quarter compared to 33% in the 2023 First Quarter. This decrease was mainly attributable to fixed overhead costs related to lower sales as addressed above.

Our Collaboration Products segment recorded a negative gross profit as a percentage of sales of 150% for the 2024 First Quarter compared to a 13% gross profit as a percentage of revenue in the 2023 First Quarter. This decrease was mainly attributable to lower sales and an increase in our inventory obsolescence reserve of $35,000 in the 2024 First Quarter compared to the 2023 First Quarter.

Operating expenses are presented in the following table (in thousands):

Three Months Ended March 31,
20242023$ Change% Change
Operating expenses:
Research and development$50 $$44 733 %
Sales and marketing54 218 (164)(75)%
General and administrative1,077 1,169 (92)(8)%
Depreciation and amortization— 86 (86)(100)%
Total operating expenses$1,181 $1,479 $(298)(20)%

Research and Development. Research and development expenses include internal and external costs related to developing features and enhancements to our existing product offerings. The increase in research and development expenses for the 2024 First Quarter compared to the 2023 First Quarter is primarily attributable to an increase in consulting, and outsourced labor costs between these periods.

Sales and Marketing Expenses. The decrease in sales and marketing expenses for 2024 First Quarter compared to the 2023 First Quarter is primarily attributable to lower personnel costs due to reduced headcount and less sales as discussed above and reduced marketing costs between these periods.

General and Administrative Expenses. General and administrative expenses include direct corporate expenses and costs of personnel in the various corporate support categories, including executive, finance and accounting, legal, human resources and information technology. The decrease in general and administrative expenses for the 2024 First Quarter compared to the 2023 First Quarter is primarily attributable to reduced overhead and professional service expenses as a result of cost-cutting measures.

Depreciation and Amortization. The decrease in depreciation and amortization expenses for the 2024 First Quarter compared to the 2023 First Quarter is attributable to the disposition and impairment of certain assets during the year ended 2023.

Interest and Other Income, Net. Interest and other income, net for the 2024 First Quarter primarily comprised of interest income related to our cash accounts, partially offset by interest expense.

Loss from Operations. The decrease in the Company’s loss from operations for the three months ended March 31, 2024 compared to the three months ended March 31, 2023 is mainly attributable to lower operating expenses, partially offset by lower gross profit, as addressed above.

Off-Balance Sheet Arrangements

As of March 31, 2024, we had no off-balance sheet arrangements.

Inflation

Management does not believe inflation had a significant effect on the Condensed Consolidated Financial Statements for the periods presented.

-19-



Critical Accounting Policies

There have been no changes to our critical accounting policies during the three months ended March 31, 2024. Critical accounting policies and the significant estimates made in accordance with such policies are regularly discussed with our Audit Committee. Those policies are discussed under “Critical Accounting Policies” in “Part II. Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” as well as in our Condensed Consolidated Financial Statements and the footnotes thereto, each included in our 2023 Annual Report.

Liquidity and Capital Resources

As of March 31, 2024, we had $5,360,000 in cash and working capital of $4,436,000. For the three months ended March 31, 2024, we incurred a net loss of $1,136,000 and used $630,000 of net cash in operating activities.

We believe that our existing cash and cash equivalents will be sufficient to fund our operations and meet our working capital requirements for at least the next 12 months from the filing date of this Report with the SEC. We believe additional capital will be required, in the long-term, to fund operations and provide growth capital including our pursuit of potential strategic alternatives and investments in technology, product development and sales and marketing. To access capital to fund operations or provide growth capital, we will need to raise capital in one or more debt and/or equity offerings. There can be no assurance that we will be successful in raising necessary capital or that any such offering will be on terms acceptable to the Company. If we are unable to raise additional capital that may be needed on terms acceptable to us, it could have a material adverse effect on the Company.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a “smaller reporting company” as defined by the rules and regulations of the SEC, we are not required to provide this information.

ITEM 4. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) as of March 31, 2024. Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of March 31, 2024, the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the SEC’s rules and forms and are designed to ensure that information required to be disclosed by the Company in the reports we file or submit under the Exchange Act is accumulated and communicated to the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

No change in our internal control over financial reporting occurred during the fiscal quarter ended March 31, 2024, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

From time to time, we are subject to various legal proceedings arising in the ordinary course of business, including proceedings for which we have insurance coverage. As of the date hereof, we are not party to any legal proceedings that we currently believe will have a material adverse effect on our business, financial position, results of operations, or liquidity.





-20-


ITEM 1A. RISK FACTORS

A description of the risks associated with our business, financial conditions and results of operations is set forth in “Part I. Item 1A. Risk Factors” of our 2023 Annual Report. Except as set forth below, there have been no material changes to these risks during the three months ended March 31, 2024. The risks described in the 2023 Annual Report are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, or future results.

We rely on a limited number of customers for a significant portion of our revenue, and the loss of any one of those customers, or several of our smaller customers, could materially harm our business. A significant portion of our revenue is generated from a limited number of customers. For the three months ended March 31, 2024, one major customer accounted for 82% of the Company’s total consolidated revenue. The composition of our significant customers will vary from period-to-period, and we expect that most of our revenue will continue, for the foreseeable future, to come from a relatively small number of customers. Consequently, our financial results may fluctuate significantly from period-to-period based on the actions of one or more significant customers. A customer may take actions that affect the Company for reasons that we cannot anticipate or control, such as reasons related to the customer’s financial condition, changes in the customer’s business strategy or operations, changes in technology and the introduction of alternative competing products, or as the result of the perceived quality or cost-effectiveness of our products. Our agreements with these customers may be canceled if we materially breach the agreement or for other reasons outside of our control such as insolvency or financial hardship that may result in a customer filing for bankruptcy court protection against unsecured creditors. If our customers were to experience losses due to a failure of a depository institution to return their deposits, it could expose us to an increased risk of nonpayment under our contracts with them. In addition, our customers may seek to renegotiate the terms of current agreements or renewals. The loss of or a reduction in sales or anticipated sales to our most significant or several of our smaller customers could have a material adverse effect on our business, financial condition, and results of operations.

We could fail to satisfy the standards to maintain our listing on a stock exchange. Our Common Stock is listed on The Nasdaq Capital Market. In order to maintain that listing, we must satisfy minimum financial and other continued listing requirements and standards. Previously, on September 21, 2023, we received a letter from the listing qualifications staff of Nasdaq providing notification that the bid price for our Common Stock had closed below $1.00 per share for the previous 30 consecutive business days and our Common Stock no longer met the minimum bid price requirement for continued listing under Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), we were provided an initial period of 180 calendar days, until March 19, 2024, in which to regain compliance. To regain compliance, the closing bid price of our Common Stock must meet or exceed $1.00 per share for a minimum of 10 consecutive business days at any time before the expiration of the initial compliance period.

On March 20, 2024, the Company received written notification from the Listing Qualifications Department of Nasdaq, granting the Company's request for a 180-day extension to regain compliance with the Bid Price Rule. The Company now has until September 16, 2024 to meet the requirement. If at any time prior to September 16, 2024, the bid price of the Company's ordinary shares closes at $1.00 per share or more for a minimum of 10 consecutive business days, the Company will regain compliance with the Bid Price Rule.

If the Company does not regain compliance with the Bid Price Rule during the additional 180-day extension, Nasdaq will provide written notification to the Company that its Common Stock will be delisted. At that time, the Company may appeal such delisting determination to a hearings panel pursuant to the procedures set forth in the applicable Nasdaq Listing Rules. There can be no assurance that such appeal would be successful.

In the event that we are unable to establish compliance, or again become non-compliant, with Rule 5550(a)(2) or other continued listing requirements of Nasdaq and cannot re-establish compliance within the required timeframe, our Common Stock could be delisted from The Nasdaq Capital Market, which could have a material adverse effect on our financial condition and which may cause the value of our Common Stock to decline. If our Common Stock is not eligible for listing or quotation on another market or exchange, trading of our Common Stock could be conducted in the over-the-counter market or on an electronic bulletin board established for unlisted securities such as the Pink Sheets or the OTC Bulletin Board. In such event, it would become more difficult to dispose of, or obtain accurate price quotations for, our Common Stock, and there would likely be a reduction in our coverage by security analysts and the news media, which could cause the price of our Common Stock to decline further. In addition, it may be difficult for us to raise additional capital if we are not listed on a national securities exchange.


-21-


While Nasdaq rules do not impose a specific limit on the number of times a listed company may effect a reverse stock split to maintain or regain compliance with Listing Rule 5810(c)(3)(A), Nasdaq has stated that a series of reverse stock splits may undermine investor confidence in securities listed on Nasdaq. Accordingly, Nasdaq may determine that it is not in the public interest to maintain our listing, even if we regain compliance with Listing Rule 5810(c)(3)(A) as a result of any reverse stock split. In addition, Nasdaq Listing Rule 5810(c)(3)(A)(iv) states that any listed company that fails to meet Listing Rule 5810(c)(3)(A) after effecting one or more reverse stock splits over the prior two-year period with a cumulative ratio of 250 shares or more to one will not be eligible for an automatic 180-day grace compliance period and the Nasdaq Listing Qualifications Department is obligated to immediately issue a delisting determination.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Unregistered Sales of Equity Securities by the Company

There have been no unregistered sales of securities by the Company during the period covered by this Report that have not been previously reported in a Current Report on Form 8-K.


ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

(c) During the period covered by this Quarterly Report on Form 10-Q, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.

-22-


ITEM 6. EXHIBITS

Exhibit
Number
Description
3.1
3.2
4.1
4.2
4.3
4.4
4.5
4.6
4.7
4.8
4.9
4.10
4.11
31.1*
31.2*
32.1**
101.INSXBRL Instance Document
101.SCHXBRL Taxonomy Extension Schema
101.CALXBRL Taxonomy Extension Calculation Linkbase
101.DEFXBRL Taxonomy Extension Definition Linkbase
101.LABXBRL Taxonomy Extension Label Linkbase
101.PREXBRL Taxonomy Extension Presentation Linkbase
* Filed herewith.
** Furnished herewith.

-23-



SIGNATURES

In accordance with the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.    

OBLONG, INC.
May 8, 2024By:/s/ Peter Holst
Peter Holst
Chief Executive Officer
(Principal Executive Officer)

May 8, 2024By:/s/ David Clark
David Clark
Chief Financial Officer
(Principal Financial and Accounting Officer)


-24-
EX-31.1 2 oblg-ex311_20240331xq1.htm EXHIBIT 31.1 Document

Exhibit 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
I, Peter Holst, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Oblong, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;  and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.
5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date: May 8, 2024
/s/ Peter Holst    
Peter Holst
Chief Executive Officer
(principal executive officer)


EX-31.2 3 oblg-ex312_20240331xq1.htm EXHIBIT 31.2 Document

Exhibit 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
I, David Clark, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Oblong, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;  and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.
5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date: May 8, 2024
/s/ David Clark    
David Clark
Chief Financial Officer
(principal financial and accounting officer)



EX-32.1 4 oblg-ex321_20240331xq1.htm EXHIBIT 32.1 Document

Exhibit 32.1
SECTION 906 CERTIFICATION
The undersigned officers of Oblong, Inc., a Delaware corporation (the "Company"), do hereby certify, in accordance with 18 U.S.C. Section 1350, as created pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1.The accompanying Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2024 (the "Report") fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: May 8, 2024
/s/ Peter Holst    
Peter Holst
Chief Executive Officer

/s/ David Clark    
David Clark
Chief Financial Officer


EX-101.SCH 5 glow-20240331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 0000008 - Disclosure - Business Description and Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - Liquidity link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Accrued Expenses and Other Current Liabilities link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Capital Stock link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Preferred Stock link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Stock Based Compensation link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Net Loss Per Share link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Segment Reporting link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - Business Description and Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - Capital Stock (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - Preferred Stock (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - Stock Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - Net Loss Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - Segment Reporting (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - Business Description and Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - Liquidity (Details) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - Accrued Expenses and Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - Capital Stock - Common Stock (Details) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - Capital Stock - Common Stock Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - Capital Stock - Warrants Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - Capital Stock - Warrants Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - Preferred Stock - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - Preferred Stock - Schedule of Series F Preferred Stock Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - Stock Based Compensation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - Stock Based Compensation - Schedule of Options Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - Stock Based Compensation - Schedule of Restricted Stock and Restricted Stock Unit Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - Net Loss Per Share - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - Net Loss Per Share - Schedule of Computation of Basic and Diluted Loss Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - Net Loss Per Share - Schedule of Effect of Antidilutive Securities (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - Segment Reporting - Schedule of Segment Reporting Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - Segment Reporting - Schedule of Disaggregation of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - Segment Reporting - Schedule of Concentration Percentage (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 glow-20240331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 7 glow-20240331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 8 glow-20240331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Pay vs Performance Disclosure [Line Items] Schedule of Accrued Expenses and Other Liabilities Schedule of Accrued Liabilities [Table Text Block] Accrued expenses and other current liabilities Accrued expenses and other current liabilities Accrued Liabilities, Current Statistical Measurement [Domain] Statistical Measurement [Domain] Number of Warrants Number Of Warrants Outstanding [Roll Forward] Number Of Warrants Outstanding Research and development Research and Development Expense Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Preferred stock, liquidation preference per share (in dollars per share) Preferred Stock, Liquidation Preference Per Share Preferred Stock, Scenario [Axis] Preferred Stock, Scenario [Axis] Preferred Stock, Scenario Award Type [Domain] Award Type [Domain] Fair Value as of Grant Date Award Grant Date Fair Value Unvested restricted shares outstanding (in shares) Beginning of year (in shares) End of year (in shares) Unvested restricted shares outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Weighted average conversion price (in dollars per share) Preferred Stock, Convertible, Weighted Average Conversion Price Preferred Stock, Convertible, Weighted Average Conversion Price Forfeited (in dollars per share) Class Of Warrant Or Right, Exercisable, Forfeited, Weighted Average Exercise Price Class Of Warrant Or Right, Exercisable, Forfeited, Weighted Average Exercise Price MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Segment Reporting [Abstract] Segment Reporting [Abstract] Accounts payable Accounts Payable, Current Restatement Determination Date: Restatement Determination Date [Axis] Interest and other income, net Interest and other income, net Nonoperating Income (Expense) Commitments and contingencies (see Note 9) Commitments and Contingencies Insider Trading Policies and Procedures [Line Items] Exercisable number of options, beginning (in shares) Exercisable number of options, ending (in shares) Exercisable number of options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Proceeds from private placement, net of issuance costs and amounts in escrow Proceeds from Issuance or Sale of Equity Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Capital Stock Equity [Text Block] Geographical [Axis] Geographical [Axis] Deferred revenue Increase (Decrease) in Contract with Customer, Liability Concentration Risk [Line Items] Concentration Risk [Line Items] Preferred stock, convertible, stated value Preferred Stock, Stated Value Preferred Stock, Stated Value Customer [Axis] Customer [Axis] Current liabilities: Liabilities, Current [Abstract] Preferred stock, convertible, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Preferred stock Series F, convertible; $.0001 par value; $1,102,150 stated value; 42,000 shares authorized, 1,008 and 1,930 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively Preferred Stock, Value, Issued Weighted Average Grant Price Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Diluted net loss per share (in dollars per share) Earnings Per Share, Diluted PEO Total Compensation Amount PEO Total Compensation Amount Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Treasury stock, shares (in shares) Treasury stock, beginning balance (in shares) Treasury stock, ending balance (in shares) Treasury Stock, Common, Shares Outstanding number of options, beginning (in shares) Outstanding and exercisable number of options, ending (in shares) Number of options, outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Trading Symbol Trading Symbol Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Net loss Net loss Net loss Net loss Net loss Net Income (Loss) Total current liabilities Liabilities, Current Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Company Selected Measure Name Company Selected Measure Name Expired (in shares) Class Of Warrant Or Right, Exercisable, Expired Class Of Warrant Or Right, Exercisable, Expired Beginning Balance (in shares) Ending Balance (in shares) Ending Balance (in shares) Shares, Issued LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Stockholders’ equity: Equity, Attributable to Parent [Abstract] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Executive Category: Executive Category [Axis] Warrant modification Less: warrant modification Warrant, Down Round Feature, Decrease in Net Income to Common Shareholder, Amount Business Description and Significant Accounting Policies Significant Accounting Policies [Text Block] Name Measure Name Name Forgone Recovery, Individual Name Equity Components [Axis] Equity Components [Axis] Exercise price (in dollars per share) Warrants outstanding, beginning (in dollars per share) Warrants outstanding, ending (in dollars per share) Warrants outstanding, ending (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Number of shares available for grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Underlying Securities Award Underlying Securities Amount Entity Small Business Entity Small Business Local Phone Number Local Phone Number Accounts receivable Increase (Decrease) in Accounts Receivable Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Accounts Receivable Accounts Receivable [Member] Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Additional General Disclosures [Abstract] Common stock issuable upon conversion of Common Stock warrants Warrant [Member] RSUs Restricted Stock Units (RSUs) [Member] Schedule of Restricted Stock and Restricted Stock Unit Activity Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Finance costs related to Series F Preferred Stock Payments of Stock Issuance Costs Forfeited (in shares) Class Of Warrant Or Right, Exercisable, Forfeited Class Of Warrant Or Right, Exercisable, Forfeited Liquidity Substantial Doubt about Going Concern [Text Block] Working capital Working Capital Positive working capital means that the company is able to pay off its short-term liabilities. Negative working capital means that a company currently is unable to meet its short-term liabilities with its current assets (cash, accounts receivable and inventory). Product and Service [Domain] Product and Service [Domain] Common stock issuable upon conversion of Series F Preferred Warrants Preferred Warrant [Member] Preferred Warrant Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Other Performance Measure, Amount Other Performance Measure, Amount Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Inventory Increase (Decrease) in Inventories Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Antidilutive securities excluded from computation of earnings per share, amount (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Award Type [Axis] Award Type [Axis] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Plan Name [Domain] Plan Name [Domain] Document Quarterly Report Document Quarterly Report Non-cash investing and financing activities: Noncash Investing and Financing Items [Abstract] Vested (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Vested in Period, Weighted Average Exercise Price Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Vested in Period, Weighted Average Exercise Price Trading Arrangement: Trading Arrangement [Axis] Granted (in shares) Class Of Warrant Or Right, Granted Class Of Warrant Or Right, Granted Use of Estimates Use of Estimates, Policy [Policy Text Block] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Entity File Number Entity File Number Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Operating lease liabilities Operating Lease, Liability, Current Preferred stock convertible, threshold consecutive trading days Preferred Stock, Convertible, Threshold Consecutive Trading Days Preferred Stock, Convertible, Threshold Consecutive Trading Days Amortization expense Amortization of Intangible Assets Entity Shell Company Entity Shell Company Recently Issued Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Restatement Determination Date Restatement Determination Date Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Schedule of Series F Preferred Stock Transactions Schedule of Stock by Class [Table Text Block] Cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Total cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Preferred stock, shares designated (in shares) Preferred Stock, Shares Designated Preferred Stock, Shares Designated Collaboration Products Collaboration Products [Member] Collaboration Products [Member] Private Placement Private Placement [Member] Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Granted (in dollars per share) Class Of Warrant Or Right, Exercisable, Granted, Weighted Average Exercise Price Class Of Warrant Or Right, Exercisable, Granted, Weighted Average Exercise Price Common stock, shares issued (in shares) Common stock, beginning balance (in shares) Common stock, ending balance (in shares) Common Stock, Shares, Issued Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Gross profit Gross Profit Current portion of deferred revenue Contract with Customer, Liability, Current Warrant modification Warrant Modification Warrant Modification Treasury stock, 8,000 shares of common stock Treasury Stock, Common, Value Security Exchange Name Security Exchange Name Expiration period Class of Warrant Or Right, Expiration Period Class of Warrant Or Right, Expiration Period Stock Options Outstanding stock options Employee Stock Option [Member] Cost not yet recognized, period for recognition Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Total operating expenses Total operating expenses Costs and Expenses Maximum Maximum [Member] Customer D Customer Number Four [Member] Customer Number Four Unamortized expense related to restricted stock Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Document Type Document Type Series F Preferred Stock Series F Preferred Stock [Member] Interest and other expense, net Other Nonoperating Expense Tabular List, Table Tabular List [Table Text Block] Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Cost of revenue (exclusive of depreciation and amortization) Cost of revenues Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Taxes and regulatory fees Accrued Sales Taxes and Regulatory Fees Accrued Sales Taxes and Regulatory Fees Stock Based Compensation Share-Based Payment Arrangement [Text Block] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Customer B Customer Number Two [Member] Customer Number Two [Member] Customer Concentration Risk Customer Concentration Risk [Member] Income Statement [Abstract] Income Statement [Abstract] Preferred stock, conversion price percentage (in percent) Preferred Stock, Convertible, Conversion Price Percentage Preferred Stock, Convertible, Conversion Price Percentage Revenue Revenue Revenue from Contract with Customer, Including Assessed Tax Proceeds from private placement, net of fees and amounts held in escrow (in shares) Proceeds from private placement, net of fees and amounts held in escrow (in shares) Number of shares issued (in shares) Stock Issued During Period, Shares, New Issues Operating expenses: Costs and Expenses [Abstract] Title of 12(b) Security Title of 12(b) Security Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Sublease income Sublease Income Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Operating Segments Operating Segments [Member] Unvested shares, Weighted Average Grant Price, Beginning (in dollars per share) Unvested shares, Weighted Average Grant Price, Ending (in dollars per share) Unvested shares, Weighted Average Grant Price (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Accrued dividends on Series F Preferred Stock Dividends Payable, Current Class of Stock [Line Items] Class of Stock [Line Items] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Warrants exercisable, beginning (in shares) Warrants exercisable, ending (in shares) Warrants exercisable, ending (in shares) Class of Warrant Or Right, Exercisable Class of Warrant Or Right, Exercisable Warrants issued (in shares) Class of Warrant or Right, Issued Class of Warrant or Right, Issued Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Entity Tax Identification Number Entity Tax Identification Number Series F Preferred Stock dividends Preferred stock dividends Accrued dividends Dividends, Preferred Stock Inventory, net Inventory, Net Managed Services Managed Services [Member] Managed Services [Member] Proceeds from private placement, net of issuance costs and amounts in escrow Proceeds from Issuance of Private Placement Statistical Measurement [Axis] Statistical Measurement [Axis] Entity Interactive Data Current Entity Interactive Data Current Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Total Shareholder Return Amount Total Shareholder Return Amount Reconciliation of cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period, Number of Shares Segments [Domain] Segments [Domain] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Consolidation Items [Domain] Consolidation Items [Domain] Accumulated deficit Retained Earnings (Accumulated Deficit) Measure: Measure [Axis] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Name Outstanding Recovery, Individual Name Issuances related to warrant exercises (in shares) Stock Issued During Period, Shares, Warrants Exercised Stock Issued During Period, Shares, Warrants Exercised Customer deposits Deposits, Current Deposits, Current Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Current assets: Assets, Current [Abstract] Entity Address, State or Province Entity Address, State or Province Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Exercised (in shares) Class Of Warrant Or Right, Exercisable, Exercised Class Of Warrant Or Right, Exercisable, Exercised Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Current certificates of deposit Certificates of Deposit, at Carrying Value PEO PEO [Member] Customer A Customer Number One [Member] Customer Number One [Member] Schedule of Common Stock Activity Schedule of Common Stock Outstanding Roll Forward [Table Text Block] Exercised (in dollars per share) Class Of Warrant Or Right, Exercised, Weighted Average Exercise Price Class Of Warrant Or Right, Exercised, Weighted Average Exercise Price Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Sale of Stock [Axis] Sale of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Customer [Domain] Customer [Domain] Net loss attributable to common stockholders Net Income (Loss) Available to Common Stockholders, Basic Number of Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Total operating lease liabilities Operating Lease, Liability Shares converted (in shares) Conversion of Stock, Shares Converted Total liabilities Liabilities Schedule of Options Granted, Exercised, Expired and Forfeited Share-Based Payment Arrangement, Activity [Table Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Exercisable vested, weighted average exercise price (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount All Executive Categories All Executive Categories [Member] Deferred revenue, net of current portion Contract with Customer, Liability, Noncurrent Long-term liabilities: Liabilities, Noncurrent [Abstract] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Plan Name [Axis] Plan Name [Axis] Accrued Expenses and Other Current Liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Exercised (in shares) Class Of Warrant Or Right, Exercised Class Of Warrant Or Right, Exercised Net loss attributable to common stockholders per share: Earnings Per Share [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward] Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward] Sales and marketing Selling and Marketing Expense Common stock, $.0001 par value; 150,000,000 shares authorized; 20,294,228 shares issued and 20,285,675 outstanding at March 31, 2024 and 16,692,124 shares issued and 16,683,572 shares outstanding at December 31, 2023 Common Stock, Value, Issued General and administrative General and Administrative Expense Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Professional fees Accrued Professional Fees, Current Non-cash lease expense from right-of-use asset Operating Lease, Right-of-Use Asset, Periodic Reduction Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Segments Segment Reporting, Policy [Policy Text Block] Total current assets Assets, Current Preferred Stock Preferred Stock [Member] Conversions, preferred stock dividends Dividends, Preferred Stock, Conversion Of Stock Dividends, Preferred Stock, Conversion Of Stock All Individuals All Individuals [Member] Supplemental disclosures of cash flow information: Supplemental Cash Flow Information [Abstract] Professional and other services Professional And Other Services [Member] Professional And Other Services [Member] Entity Filer Category Entity Filer Category Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Statement [Table] Statement [Table] Current Fiscal Year End Date Current Fiscal Year End Date PEO Name PEO Name Percentage of revenue (in percent) Concentration risk, percentage (in percent) Concentration Risk, Percentage Weighted average conversion price (in dollars per share) Preferred Stock, Convertible, Conversion Price Gross proceeds Proceeds from Issuance of Preferred Stock and Preference Stock Warrants outstanding, beginning (in shares) Warrants outstanding, ending (in shares) Warrants outstanding, ending (in shares) Class of Warrant or Right, Outstanding Preferred stock, convertible, shares authorized (in shares) Preferred Stock, Shares Authorized Granted, Weighted Average Grant Price (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Preferred stock, shares outstanding (in shares) Preferred stock, beginning balance (in shares) Preferred stock, ending balance (in shares) Preferred Stock, Shares Outstanding Net cash used in operating activities Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Options, intrinsic value, vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Class of Stock [Axis] Class of Stock [Axis] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Other accrued expenses and liabilities Other Accrued Liabilities, Current Product Concentration Risk Product Concentration Risk [Member] Corporate Unallocated operating expenses Corporate, Non-Segment [Member] Exercised (in dollars per share) Class Of Warrant Or Right, Exercisable, Exercised, Weighted Average Exercise Price Class Of Warrant Or Right, Exercisable, Exercised, Weighted Average Exercise Price Depreciation and amortization Depreciation, Depletion and Amortization Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Total stockholders' equity Beginning balance Ending balance Equity, Attributable to Parent Consolidation Items [Axis] Consolidation Items [Axis] Restricted Stock Unvested restricted stock awards Restricted Stock [Member] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Number of Warrants Number Of Exercisable [Abstract] Number Of Exercisable Subsegments Consolidation Items [Axis] Subsegments Consolidation Items [Axis] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Concentration Risk Type [Axis] Concentration Risk Type [Axis] 2019 Equity Incentive Plan 2019 Equity Incentive Plan [Member] 2019 Equity Incentive Plan [Member] Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Conversions of Series F Preferred Stock (in shares) Issuances from Preferred Stock Conversions (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Entity Emerging Growth Company Entity Emerging Growth Company Preferred Stock, Scenario [Domain] Preferred Stock, Scenario [Domain] Preferred Stock, Scenario [Domain] Intangibles, net Intangible Assets, Net (Excluding Goodwill) Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Granted (in dollars per share) Class Of Warrant Or Right, Granted, Weighted Average Exercise Price Class Of Warrant Or Right, Granted, Weighted Average Exercise Price Document Fiscal Period Focus Document Fiscal Period Focus Accrued expenses and other current liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Title Trading Arrangement, Individual Title Outstanding weighted average exercise price, beginning (in dollars per share) Outstanding and exercisable weighted average exercise price, ending (in dollars per share) Weighted average exercise price, outstanding (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Non-cash lease expense Operating Lease, Expense Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Schedule of Revenue from External Customers by Geographic Areas Revenue from External Customers by Geographic Areas [Table Text Block] Video collaboration services Video Collaboration Service [Member] Video Collaboration Service [Member] Common Stock Common Stock [Member] Individual: Individual [Axis] City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Product and Service [Axis] Product and Service [Axis] Net Loss Per Share Earnings Per Share [Text Block] Forfeited (in dollars per share) Class Of Warrant Or Right, Forfeited, Weighted Average Exercise Price Class Of Warrant Or Right, Forfeited, Weighted Average Exercise Price Expired (in shares) Class of Warrant Or Right, Expired Class of Warrant Or Right, Expired Investor Warrants Investor Warrants [Member] Investor Warrants Document Fiscal Year Focus Document Fiscal Year Focus Geographical [Domain] Geographical [Domain] Weighted-average number of shares of common stock: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Expired (in dollars per share) Class Of Warrant Or Right, Expired, Weighted Average Exercise Price Class Of Warrant Or Right, Expired, Weighted Average Exercise Price Exercise Price Award Exercise Price Cash Cash Schedule of Warrants Activity Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] ASSETS Assets [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Lease liabilities Increase (Decrease) in Operating Lease Liability Granted (in shares) Class Of Warrant Or Right, Exercisable, Granted Class Of Warrant Or Right, Exercisable, Granted Subsegments Consolidation Items [Domain] Subsegments Consolidation Items [Domain] Denominator: Denominator [Abstract] Denominator [Abstract] Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Accumulated Deficit Retained Earnings [Member] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Total liabilities and stockholders’ equity Liabilities and Equity Other assets Other Assets, Noncurrent Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Basic net loss per share (in dollars per share) Earnings Per Share, Basic Operating lease - right of use asset, net Operating Lease, Right-of-Use Asset Unrecognized stock-based compensation expense for stock options Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Accounting Policies [Abstract] Accounting Policies [Abstract] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Sale of Stock [Domain] Sale of Stock [Domain] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Number of shares issuable (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Arrangement Duration Trading Arrangement Duration Entity Address, City or Town Entity Address, City or Town Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Schedule of Segment Reporting Information Schedule of Segment Reporting Information, by Segment [Table Text Block] Cash paid for income taxes Income Taxes Paid Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Principles of Consolidation Consolidation, Policy [Policy Text Block] Preferred Warrants Preferred Warrants [Member] Preferred Warrants Document Transition Report Document Transition Report Award Timing Predetermined Award Timing Predetermined [Flag] Customer E Customer Number Five [Member] Customer Number Five Termination Date Trading Arrangement Termination Date Network services Network Services [Member] Network Services [Member] Accounts payable Increase (Decrease) in Accounts Payable Common stock, shares authorized (in shares) Common Stock, Shares Authorized Other Liabilities Disclosure [Abstract] Other Liabilities Disclosure [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] All Trading Arrangements All Trading Arrangements [Member] All Adjustments to Compensation All Adjustments to Compensation [Member] Award Timing Disclosures [Line Items] Common shares issued in conversion (in shares) Conversion of Stock, Shares Issued Forfeited (in shares) Class Of Warrant Or Right, Forfeited Class Of Warrant Or Right, Forfeited Compensation Amount Outstanding Recovery Compensation Amount Preferred stock dividends Preferred Stock Dividends Dividends Payable Bad debt (recovery) expense Accounts Receivable, Credit Loss Expense (Reversal) Common stock issuable upon conversion of Series F Preferred Stock Convertible Debt Securities [Member] Common shares exchanged for prepaid warrants (in shares) Adjustments to Additional Paid in Capital, Shares, Common Stock Exchanged For Prefunded Warrants Adjustments to Additional Paid in Capital, Shares, Common Stock Exchanged For Prefunded Warrants Weighted Average Exercise Price Weighted Average Exercise Price [Abstract] Weighted Average Exercise Price Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Insider Trading Arrangements [Line Items] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Issuances related to stock compensation (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Entity Registrant Name Entity Registrant Name Gross profit % Gross Profit, Percentage Gross Profit, Percentage Other income Other Nonoperating Income Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Award Timing Method Award Timing Method [Text Block] Weighted-average shares common stock outstanding, potentially dilutive securities or unvested restricted stock (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Other assets Increase (Decrease) in Other Operating Assets Adjustment to Compensation, Amount Adjustment to Compensation Amount Document Period End Date Document Period End Date Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Adoption Date Trading Arrangement Adoption Date Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Preferred stock dividend percentage (in percent) Preferred Stock, Dividend Rate, Percentage Preferred Stock Preferred Stock [Text Block] Revenue Revenue from Contract with Customer Benchmark [Member] Exercisable weighted average exercise price, beginning (in dollars per share) Exercisable weighted average exercise price, ending (in dollars per share) Exercisable weighted average exercise price (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Treasury Stock Treasury Stock, Common [Member] Entity Central Index Key Entity Central Index Key Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Stock option compensation expense Share-Based Payment Arrangement, Expense Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Income tax expense Income Tax Expense (Benefit) Foreign Non-US [Member] Compensation costs Employee-related Liabilities, Current Number of operating segments Number of Operating Segments Name Trading Arrangement, Individual Name Schedule of Disaggregated Revenue Information Disaggregation of Revenue [Table Text Block] Proceeds from private placement, net of fees and amounts held in escrow Stock Issued During Period, Value, New Issues Equity [Abstract] Equity [Abstract] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Warrants exercisable, beginning (in dollars per share) Warrants exercisable, ending (in dollars per share) Warrants exercisable, ending (in dollars per share) Class of Warrant Or Right, Exercisable, Exercise Price of Warrants Class of Warrant Or Right, Exercisable, Exercise Price of Warrants Preferred stock dividends Less: preferred stock dividends Preferred Stock Dividends, Income Statement Impact Amendment Flag Amendment Flag Numerator: Numerator [Abstract] Numerator [Abstract] Accrued rent Accrued Rent, Current Cash paid during the period for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Expired (in dollars per share) Class Of Warrant Or Right, Exercisable, Expired, Weighted Average Exercise Price Class Of Warrant Or Right, Exercisable, Expired, Weighted Average Exercise Price Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Diluted (in shares) Weighted-average number of shares of common stock - diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Percentage of common stock issuable (in percent) Class Of Warrant Or Right, Percentage Of Securities Called By Warrants Or Rights Class Of Warrant Or Right, Percentage Of Securities Called By Warrants Or Rights Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Scenario 1 Scenario 1 [Member] Scenario 1 Company Selected Measure Amount Company Selected Measure Amount Additional paid-in capital Additional Paid in Capital, Common Stock Additional Paid-In Capital Additional Paid-in Capital [Member] Expired (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Total assets Assets Name Awards Close in Time to MNPI Disclosures, Individual Name Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares Cover [Abstract] Customer C Customer Number Three [Member] Customer Number Three [Member] Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Domestic UNITED STATES Exercisable expired, weighted average exercise price (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expired, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expired, Weighted Average Exercise Price Allocated operating expenses Segment Reconciling Items [Member] Vested, Weighted Average Grant Price (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Non-NEOs Non-NEOs [Member] Segment Reporting Segment Reporting Disclosure [Text Block] Decrease (increase) in cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Non-PEO NEO Non-PEO NEO [Member] Equity Component [Domain] Equity Component [Domain] Adjustment to Compensation: Adjustment to Compensation [Axis] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Basic (in shares) Weighted-average number of shares of common stock - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Concentration Risk Type [Domain] Concentration Risk Type [Domain] Weighted Average Exercise Price Weighted Average Exercise Price, Exercisable [Abstract] Weighted Average Exercise Price, Exercisable Loss from operations Operating Income (Loss) Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Segments [Axis] Segments [Axis] Statement [Line Items] Statement [Line Items] Conversions of Series F Preferred Stock including accrued dividends of $82,000 Stock Issued During Period, Value, Conversion of Convertible Securities Concentration Risk [Table] Concentration Risk [Table] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] EX-101.PRE 9 glow-20240331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cover - shares
3 Months Ended
Mar. 31, 2024
May 03, 2024
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2024  
Document Transition Report false  
Entity File Number 001-35376  
Entity Registrant Name OBLONG, INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 77-0312442  
Entity Address, Address Line One 110 16th Street  
Entity Address, Address Line Two Suite 1400-1024  
Entity Address, City or Town Denver  
Entity Address, State or Province CO  
Entity Address, Postal Zip Code 80202  
City Area Code 213  
Local Phone Number 683-8863 ext. 5  
Title of 12(b) Security Common Stock, par value $0.0001 per share  
Trading Symbol OBLG  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   20,286,675
Entity Central Index Key 0000746210  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q1  
Amendment Flag false  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 5,360,000 $ 5,990,000
Accounts receivable, net 15,000 424,000
Inventory, net 127,000 239,000
Prepaid expenses and other current assets 421,000 243,000
Total current assets 5,923,000 6,896,000
Operating lease - right of use asset, net 0 17,000
Other assets 12,000 12,000
Total assets 5,935,000 6,925,000
Current liabilities:    
Accounts payable 351,000 211,000
Accrued expenses and other current liabilities 1,031,000 1,038,000
Current portion of deferred revenue 105,000 132,000
Operating lease liabilities 0 17,000
Total current liabilities 1,487,000 1,398,000
Long-term liabilities:    
Deferred revenue, net of current portion 14,000 26,000
Total liabilities 1,501,000 1,424,000
Commitments and contingencies (see Note 9)
Stockholders’ equity:    
Preferred stock Series F, convertible; $.0001 par value; $1,102,150 stated value; 42,000 shares authorized, 1,008 and 1,930 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively 0 0
Common stock, $.0001 par value; 150,000,000 shares authorized; 20,294,228 shares issued and 20,285,675 outstanding at March 31, 2024 and 16,692,124 shares issued and 16,683,572 shares outstanding at December 31, 2023 2,000 2,000
Treasury stock, 8,000 shares of common stock (181,000) (181,000)
Additional paid-in capital 233,980,000 233,911,000
Accumulated deficit (229,367,000) (228,231,000)
Total stockholders' equity 4,434,000 5,501,000
Total liabilities and stockholders’ equity $ 5,935,000 $ 6,925,000
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Preferred stock, convertible, par value (in dollars per share) $ 0.0001 $ 0.0001
Preferred stock, convertible, stated value $ 1,102,150 $ 1,102,150
Preferred stock, convertible, shares authorized (in shares) 42,000 42,000
Preferred stock, shares issued (in shares) 1,008 1,930
Preferred stock, shares outstanding (in shares) 1,008 1,930
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 150,000,000 150,000,000
Common stock, shares issued (in shares) 20,294,228 16,692,124
Common stock, shares outstanding (in shares) 20,285,675 16,683,572
Treasury stock, shares (in shares) 8,000 8,000
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Revenue $ 626 $ 1,038
Cost of revenue (exclusive of depreciation and amortization) 629 762
Gross profit (3) 276
Operating expenses:    
Research and development 50 6
Sales and marketing 54 218
General and administrative 1,077 1,169
Depreciation and amortization 0 86
Total operating expenses 1,181 1,479
Loss from operations (1,184) (1,203)
Interest and other expense, net 0 5
Other income (48) (27)
Interest and other income, net (48) (22)
Loss before income taxes (1,136) (1,181)
Income tax expense 0 38
Net loss (1,136) (1,219)
Preferred stock dividends 44 0
Warrant modification 0 25
Net loss attributable to common stockholders $ (1,180) $ (1,244)
Net loss attributable to common stockholders per share:    
Basic net loss per share (in dollars per share) $ (0.07) $ (0.60)
Diluted net loss per share (in dollars per share) $ (0.07) $ (0.60)
Weighted-average number of shares of common stock:    
Basic (in shares) 17,123 2,065
Diluted (in shares) 17,123 2,065
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Series F Preferred Stock
Preferred Stock
Series F Preferred Stock
Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Deficit
Preferred stock, beginning balance (in shares) at Dec. 31, 2022     0        
Common stock, beginning balance (in shares) at Dec. 31, 2022       2,071,000      
Treasury stock, beginning balance (in shares) at Dec. 31, 2022         8,000    
Beginning balance at Dec. 31, 2022 $ 3,617   $ 0 $ 0 $ (181) $ 227,645 $ (223,847)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (1,219)           (1,219)
Stock-based compensation 31         31  
Series F Preferred Stock dividends 0            
Proceeds from private placement, net of fees and amounts held in escrow (in shares)     6,550        
Proceeds from private placement, net of fees and amounts held in escrow 1,473         1,473  
Preferred stock, ending balance (in shares) at Mar. 31, 2023     6,550        
Common stock, ending balance (in shares) at Mar. 31, 2023       2,071,000      
Treasury stock, ending balance (in shares) at Mar. 31, 2023         8,000    
Ending balance at Mar. 31, 2023 3,902   $ 0 $ 0 $ (181) 229,149 (225,066)
Preferred stock, beginning balance (in shares) at Dec. 31, 2022     0        
Common stock, beginning balance (in shares) at Dec. 31, 2022       2,071,000      
Treasury stock, beginning balance (in shares) at Dec. 31, 2022         8,000    
Beginning balance at Dec. 31, 2022 $ 3,617   $ 0 $ 0 $ (181) 227,645 (223,847)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Conversions of Series F Preferred Stock (in shares)     (4,620) 14,102,000      
Series F Preferred Stock dividends   $ (343)          
Preferred stock, ending balance (in shares) at Dec. 31, 2023 1,930 1,930 1,930        
Common stock, ending balance (in shares) at Dec. 31, 2023 16,692,124     16,692,000      
Treasury stock, ending balance (in shares) at Dec. 31, 2023 8,000       8,000    
Ending balance at Dec. 31, 2023 $ 5,501   $ 0 $ 2 $ (181) 233,911 (228,231)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (1,136)           (1,136)
Stock-based compensation 31         31  
Conversions of Series F Preferred Stock (in shares)     (922) 3,602,000      
Conversions of Series F Preferred Stock including accrued dividends of $82,000 82         82  
Series F Preferred Stock dividends $ (44) $ (44)       (44)  
Preferred stock, ending balance (in shares) at Mar. 31, 2024 1,008 1,008 1,008        
Common stock, ending balance (in shares) at Mar. 31, 2024 20,294,228     20,294,000      
Treasury stock, ending balance (in shares) at Mar. 31, 2024 8,000     (8,000) 8,000    
Ending balance at Mar. 31, 2024 $ 4,434   $ 0 $ 2 $ (181) $ 233,980 $ (229,367)
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Parenthetical) - Series F Preferred Stock - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Mar. 31, 2023
Preferred stock dividends $ 94 $ 132 $ 0
Preferred Stock      
Preferred stock dividends $ 82    
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net loss $ (1,136) $ (1,219)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 0 86
Bad debt (recovery) expense 0 (24)
Non-cash lease expense from right-of-use asset 17 43
Stock-based compensation 31 31
Changes in operating assets and liabilities:    
Accounts receivable 409 47
Inventory 112 89
Prepaid expenses and other current assets (178) (298)
Other assets 0 9
Accounts payable 140 23
Accrued expenses and other current liabilities 31 591
Deferred revenue (39) (125)
Lease liabilities (17) (97)
Net cash used in operating activities (630) (844)
Cash flows from financing activities:    
Proceeds from private placement, net of issuance costs and amounts in escrow 0 1,473
Net cash provided by financing activities 0 1,473
Decrease (increase) in cash (630) 629
Cash and cash equivalents at beginning of period 5,990 3,085
Cash and cash equivalents at end of period 5,360 3,714
Reconciliation of cash and cash equivalents    
Cash 4,860 3,714
Current certificates of deposit 500 0
Total cash and cash equivalents 5,360 3,714
Supplemental disclosures of cash flow information:    
Cash paid during the period for interest 5 2
Cash paid for income taxes 0 31
Non-cash investing and financing activities:    
Preferred stock dividends 44 0
Warrant modification $ 0 $ 25
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Business Description and Significant Accounting Policies
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Business Description and Significant Accounting Policies
Note 1 - Business Description and Significant Accounting Policies

Business Description

Oblong, Inc. (“Oblong” or “we” or “us” or the “Company”) was formed as a Delaware corporation in May 2000 and is a provider of patented multi-stream collaboration technologies and managed services for video collaboration and network applications.

Basis of Presentation

The Company's fiscal year ends on December 31 of each calendar year. The accompanying interim Condensed Consolidated Financial Statements are unaudited and have been prepared on substantially the same basis as our annual Consolidated Financial Statements for the fiscal year ended December 31, 2023. In the opinion of the Company's management, these interim Condensed Consolidated Financial Statements reflect all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.

The December 31, 2023 year-end Condensed Consolidated Balance Sheet data in this document was derived from audited consolidated financial statements. The Condensed Consolidated Financial Statements and notes included in this quarterly report on Form 10-Q do not include all disclosures required by U.S. generally accepted accounting principles and should be read in conjunction with the Company's audited consolidated financial statements as of and for the year ended December 31, 2023 and notes thereto included in the Company's fiscal 2023 Annual Report on Form 10-K, filed with the Securities and Exchange Commission (“SEC”) on March 19, 2024 (the “2023 Annual Report”).

The results of operations and cash flows for the interim periods included in these Condensed Consolidated Financial Statements are not necessarily indicative of the results to be expected for any future period or the entire fiscal year.

Principles of Consolidation

The Condensed Consolidated Financial Statements include the accounts of Oblong and our 100%-owned subsidiaries (i) GP Communications, LLC (“GP Communications”), whose business function is to provide interstate telecommunications services for regulatory purposes, and (ii) Oblong Industries, Inc. All inter-company balances and transactions have been eliminated in consolidation. The U.S. Dollar is the functional currency for all subsidiaries.

Cash and Cash Equivalents

As of March 31, 2024, our total cash balance of $5,360,000 is available. Of this balance $500,000 was held in short-term certificates of deposit with MidFirst Bank. As of December 31, 2023, our total cash balance of $5,990,000 was available with $500,000 held in short-term certificates of deposit with MidFirst Bank. The Company considers highly liquid investments with original maturities of three months or less to be cash equivalents.

Segments

The Company currently operates in two segments: (1) “Collaboration Products” which represents the business surrounding our Mezzanine™ product offerings, and (2) “Managed Services” which represents the business surrounding managed services for video collaboration and network solutions. See Note 8 - Segment Reporting for further discussion.
Use of Estimates

Preparation of the Condensed Consolidated Financial Statements in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual amounts could differ from the estimates made. We continually evaluate estimates used in the preparation of our consolidated financial statements for reasonableness. Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation. The significant areas of estimation include determining the allowances for inventory obsolescence and estimated credit losses and the inputs used in the fair value of equity-based awards.

Intangible Assets

As of March 31, 2024 and December 31, 2023, we had no intangible assets. During the three months ended March 31, 2023, we recorded $86,000 in amortization expense related to intangible assets.

Operating Lease Right-of-use-Assets and Liabilities

In February 2024, we exited our warehouse lease in City of Industry, California, and are no longer a party to any operating leases. Right-of-use assets, net totaled $17,000 as of December 31, 2023, consisting of the warehouse lease discussed above. As of March 31, 2024, the Company had no right-of-use assets remaining. The remaining operating lease liability as of December 31, 2023 was $17,000, consisting of the warehouse lease discussed above. As of March 31, 2024, the Company had no lease liability remaining. During the three months ended March 31, 2024, we recorded $17,000 in lease expenses. During the three months ended March 31, 2023, we recorded $46,000 in lease expenses, net of common charges, and sublease proceeds of $16,000.

Significant Accounting Policies

The significant accounting policies used in preparation of these Condensed Consolidated Financial Statements are disclosed in our 2023 Annual Report, and there have been no changes to the Company’s significant accounting policies during the three months ended March 31, 2024.

Recently Issued Accounting Pronouncements

In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic280): Improvements to Reportable Segment Disclosures. The new guidance is intended to improve reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. The amendments are effective retrospectively for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. The Company is in the process of evaluating the impact that the adoption of this ASU will have on the financial statements and related disclosures, which is not expected to be material.

In December 2023, the FASB issued ASU No. 2023-09, Improvements to Tax Disclosures (Topic 740), to enhance the transparency and decision usefulness of income tax disclosures through changes to the rate reconciliation and income taxes paid information. This guidance is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is evaluating the impact of adopting this new accounting guidance on its Consolidated Financial Statements.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Liquidity
3 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Liquidity
Note 2 - Liquidity

As of March 31, 2024, we had $5,360,000 in cash and working capital of $4,436,000. For the three months ended March 31, 2024, we incurred a net loss of $1,136,000 and used $630,000 of net cash in operating activities.
We believe that our existing cash will be sufficient to fund our operations and meet our working capital requirements for at least the next 12 months from the filing date of this Report with the SEC.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accrued Expenses and Other Current Liabilities
3 Months Ended
Mar. 31, 2024
Other Liabilities Disclosure [Abstract]  
Accrued Expenses and Other Current Liabilities
Note 3 - Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):
March 31,December 31,
20242023
Compensation costs$526 $448 
Customer deposits86 118 
Professional fees129 104 
Taxes and regulatory fees19 22 
Accrued rent170 202 
Accrued dividends on Series F Preferred Stock94 136 
Other accrued expenses and liabilities
Accrued expenses and other liabilities$1,031 $1,038 
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Capital Stock
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Capital Stock
Note 4 - Capital Stock

Common Stock

The Company’s common stock, par value $0.0001 per share (the “Common Stock”), is listed on the Nasdaq Capital Market (“Nasdaq”), under the ticker symbol “OBLG”. As of March 31, 2024, we had 150,000,000 shares of our Common Stock authorized, with 20,294,000 and 20,286,000 shares issued and outstanding, respectively.
During the three months ended March 31, 2024, 922 shares of Series F Preferred Stock, plus $82,000 accrued dividends, were converted to 3,602,103 shares of the Company’s common stock. See Note 5 - Preferred Stock, for further detail.
Common Stock activity for the three months ended March 31, 2024 is presented below (in thousands).
Issued Shares as of December 31, 20222,071 
Issuances from Preferred Stock conversions14,102 
Issuances related to warrant exercises746 
Issuances related to stock compensation180 
Common shares exchanged for prepaid warrants(407)
Issued Shares as of December 31, 202316,692 
Issuances from Preferred Stock conversions3,602 
Issued Shares as of March 31, 202420,294 
Less Treasury Shares:(8)
Outstanding Shares as of March 31, 202420,286 
Common Stock Warrants
Warrants outstanding as of March 31, 2024 are as follows:
Issue DateWarrants OutstandingExercise PriceExpiration Date
June 28, 2021750 $66.00 December 31, 2024
March 31, 20234,136,850 $1.71 September 30, 2028
4,137,600 
Warrant activity for the three months ended March 31, 2024 and the year ended December 31, 2023 is presented below.

Outstanding and Exercisable
Number of Warrants
Weighted Average Exercise Price
Warrants outstanding and exercisable, December 31, 2022343,099 $66.34 
Granted4,543,626 1.71 
Exercised(746,027)0.78 
Expired(2,601)76.93 
Forfeited(247)
Warrants outstanding and exercisable, December 31, 20234,137,850 1.72 
Expired(250)60.00 
Warrants outstanding and exercisable, March 31, 20244,137,600 $1.72 

Treasury Shares

The Company maintains treasury stock for the Common Stock shares bought back by the Company when withholding shares to cover taxes on transactions related to equity awards. There were no treasury stock transactions during the three months ended March 31, 2024 or the year ended December 31, 2023.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Preferred Stock
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Preferred Stock
Note 5 - Preferred Stock

Our Certificate of Incorporation authorizes the issuance of up to 5,000,000 shares of preferred stock. As of March 31, 2024, we had 1,983,250 designated shares of preferred stock and 1,008 shares of preferred stock issued and outstanding. As of December 31, 2023, we had 1,930 shares of preferred stock issued and outstanding.

Series F Preferred Stock
On March 30, 2023, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which we issued and sold, in a private placement (the “Private Placement”) (i) 6,550 shares of our newly designated Series F Preferred Stock, $0.0001 par value per share (the “Series F Preferred Stock”), (ii) preferred warrants (the “Preferred Warrants”) to acquire 32,750 shares of Series F Preferred Stock, and (iii) common warrants (“Common Warrants” and with the Preferred Warrants the “Investor Warrants”) to acquire up to 3,830,417 shares of Common Stock. Please refer to Note 4 - Capital Stock for additional detail regarding the Series F Preferred Stock and Preferred Warrants. The terms of the Series F Preferred Stock are as set forward in the Certificate of Designations of Series F Preferred Stock of Oblong, Inc. (the “Certificate of Designations”), which was filed and became effective with the Secretary of State of the State of Delaware on March 31, 2023. The Private Placement closed on March 31, 2023, in exchange for gross and net proceeds of $6,386,000 and $5,364,000, respectively. The financing fees associated with the Purchase Agreement were $1,022,000.

The Series F Preferred Shares are convertible into fully paid and non-assessable shares of the Company’s Common Stock at the election of the holder at any time at an initial conversion price of $1.71 (the “Conversion Price”). The holders of the Series F Preferred Shares may also elect to convert their shares at an alternative conversion price equal to the lower of (i) 80% of the applicable Conversion Price as in effect on the date of the conversion, (ii) 80% of the closing price on the trading day immediately preceding the delivery of the conversion notice, and (iii) the greater of (a) the Floor Price (as defined in the Certificate of Designations) and (b) the quotient of (x) the sum of the five lowest Closing Bid Prices (as defined in the Certificate of Designations) for trading days in the 30 consecutive trading day period ending and including the trading day immediately preceding the delivery of the applicable Conversion Notice, divided by (y) five. The Conversion Price is subject to customary adjustments for stock splits, stock dividends, stock combination recapitalization, or other similar transactions involving the Common Stock, and subject to price-based adjustment, on a full ratchet basis, in the event of any issuances of our common stock, or securities convertible, exercisable or exchangeable for Common Stock, at a price below the then-applicable Conversion Price (subject to certain exceptions).

On October 6, 2023, the Company and Investors holding a majority of the outstanding shares of the Preferred Stock agreed to waive any and all provisions, terms, covenants and obligations in the Certificate of Designations or Common Warrants to the
extent such provisions permit the conversion or exercise of the Preferred Stock and the Common Warrants, respectively, to occur at a price below $0.2792. Notwithstanding anything to the contrary in the Certificate of Designations, each of the “Alternate Conversion Price” and the “Floor Price” as set forth in the Certificate of Designations shall in no event be less than $0.2792 (as adjusted for stock splits, stock dividends, stock combinations, recapitalizations and similar events).

Under the Certificate of Designations, the Series F Preferred Shares have an initial stated value of $1,000 per share (the “Stated Value”). The holders of the Series F Preferred Shares are entitled to dividends of 9% per annum, which will be payable in arrears quarterly. Accrued dividends may be paid, at our option, in cash and if not paid, shall increase the stated value of the Series F Preferred Shares. Upon the occurrence and during the continuance of a Triggering Event (as defined in the Certificate of Designations), the Series F Preferred Shares will accrue dividends at the rate of 20% per annum (the “Default Rate”). The Series F Preferred Shares have no voting rights, other than with respect to certain matters affecting the rights of the Series F Preferred Shares. On matters with respect to which the holders of the Series F Preferred Shares have a right to vote, holders of the Preferred Shares will have voting rights on an as-converted basis.

Our ability to settle conversions is subject to certain limitations set forth in the Certificate of Designations. Further, the Certificate of Designations contains a certain beneficial ownership limitation after giving effect to the issuance of shares of common stock issuable upon conversion of the Series F Preferred Shares.

The Certificate of Designations includes certain Triggering Events (as defined in the Certificate of Designations), including, among other things, (i) the failure to file and maintain an effective registration statement covering the sale of the holder’s securities registrable pursuant to the Registration Rights Agreement, (ii) the failure to pay any amounts due to the holders of the Series F Preferred Shares when due, and (iii) if Peter Holst ceases to be the chief executive officer of the Company other than because of his death, and a qualified replacement, reasonably acceptable to a majority of the holders of the Series F Preferred Shares, is not appointed within thirty (30) business days. In connection with a Triggering Event, the Default Rate is triggered. We are subject to certain affirmative and negative covenants regarding the incurrence of indebtedness, acquisition transactions, the existence of liens, the repayment of indebtedness, the payment of cash in respect of dividends (other than dividends pursuant to the Certificate of Designations), maintenance of properties and the transfer of assets, among other matters.
During the year ended December 31, 2023 and the three months ended March 31, 2024, 4,620 and 922 shares of Series F Preferred Stock, plus accrued dividends, were converted to 14,102,477 and 3,602,103 shares of the Company’s common stock, respectively. There were 1,008 shares of Series F Preferred Stock outstanding and accrued dividends of $94,000 as of March 31, 2024. Series F Preferred Stock transactions are summarized in the table below (in thousands except for shares of Series F Preferred Stock:
Series F Preferred Stock SharesPreferred Stock DividendsWeighted Average Conversion PriceCommon Shares Issued from Conversions
March 31, 2023 Issuance6,550 $— — 
2023 Accrued Dividends— $343 — 
2023 Conversions(4,620)$(211)$0.34 14,102 
December 31, 2023 Balance1,930 $132 14,102 
2024 Accrued Dividends— $44 — 
2024 Conversions(922)$(82)0.28 3,602 
March 31, 2024 Balance1,008 $94 $0.33 17,704 

Series F Preferred Stock Warrants

The Preferred Warrants are exercisable for Series F Preferred Shares at an exercise price of $975. The exercise price is subject to customary adjustments for stock splits, stock dividends, stock combination recapitalizations or other similar transactions involving the Common Stock. The Preferred Warrants expire three years from the date of issuance and are exercisable for cash. For each Preferred Warrant exercised, the Investors shall receive Common Warrants to purchase a number of shares of Common Stock equal to 100% of the number of shares of Common Stock the Investors would receive if the Series F Preferred Shares issuable upon exercise of such Warrant were converted at the applicable Conversion Price. The fair value of the Preferred Warrants was recorded within additional paid-in capital upon issuance. As of March 31, 2024, no Preferred Warrants have been exercised.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock Based Compensation
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Stock Based Compensation
Note 6 - Stock Based Compensation

2019 Equity Incentive Plan

On December 19, 2019, the Oblong, Inc. 2019 Equity Incentive Plan (the “2019 Plan”) was approved by the Company’s stockholders at the Company’s 2019 Annual Meeting of Stockholders. The 2019 Plan is an omnibus equity incentive plan pursuant to which the Company may grant equity and cash incentive awards to certain key service providers of the Company and its subsidiaries. As of December 31, 2023, the share pool available for new grants under the 2019 Plan was 3.

Stock Options

A summary of stock option activity under our plans, and options outstanding as of, and changes made during the three months ended March 31, 2024 and year ended December 31, 2023 is presented below:

OutstandingExercisable
Number of OptionsWeighted Average Exercise PriceNumber of OptionsWeighted Average Exercise Price
Options outstanding and exercisable, December 31, 202216,668 $143.63 10,000 $206.85 
Vested— 3,336 48.75
Expired(6,668)285.89(6,668)285.89
Options outstanding and exercisable, December 31, 202310,000 48.75 6,668 48.75 
Options outstanding and exercisable, March 31, 202410,000 $48.75 6,668 $48.75 
The intrinsic value of vested and unvested options was not significant for all periods presented. Stock compensation expense related to stock options for the three months ended March 31, 2024 and 2023 was $31,000 and was recorded as a general and administrative expense on our Condensed Consolidated Statements of Operations. The remaining unrecognized stock-based compensation expense for options as of March 31, 2024 is $30,000, which will be recognized over a weighted average period of 3 months.
Restricted Stock
As of March 31, 2024 and December 31, 2023, there were no outstanding restricted stock awards or restricted stock units (“Restricted Stock”). For the three months ended March 31, 2024 and 2023, there was no stock compensation expense recorded for Restricted Stock and there was no unamortized expense related to Restricted Stock. The following table shows a summary of Restricted Stock activity for the year ended December 31, 2023. There was no Restricted Stock activity during the three months ended March 31, 2024.
Restricted Stock AwardsRestricted Stock Units
SharesWeighted Average Grant PriceSharesWeighted Average Grant Price
Unvested shares, December 31, 202242 $235.87 — $— 
Granted— 177,564 2.14 
Vested(42)235.87 (177,564)2.14 
Unvested Shares, December 31, 2023— — — — 
Unvested Shares, March 31, 2024— $— — $— 
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Net Loss Per Share
3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Net Loss Per Share
Note 7 - Net Loss Per Share

Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. The weighted-average number of shares of common stock outstanding does not include any potentially dilutive securities or unvested Restricted Stock. Unvested Restricted Stock, although classified as issued and outstanding at March 31, 2023, was considered contingently returnable until the restrictions lapsed and was not included in the basic net loss per share calculation for the three months ended March 31, 2023. Unvested Restricted Stock does not contain non-forfeitable rights to dividends and dividend equivalents.

Diluted net loss per share is computed by giving effect to all potential shares of common stock, including stock options, preferred stock, warrants, and unvested Restricted Stock, to the extent they are dilutive. For the three months ended March 31, 2024 and 2023, all such common stock equivalents have been excluded from diluted net loss per share as the effect to net loss per share would be anti-dilutive (due to the net loss).

The following table sets forth the computation of the Company’s basic and diluted net loss per share (in thousands, except per share data):
Three Months Ended March 31,
20242023
Numerator:
Net loss$(1,136)$(1,219)
Less: preferred stock dividends(44)— 
Less: warrant modification— (25)
Net loss attributable to common stockholders$(1,180)$(1,244)
Denominator:
Weighted-average number of shares of common stock for basic and diluted net loss per share17,123 2,065 
Basic and diluted net loss per share$(0.07)$(0.60)

The following table represents the potential shares that were excluded from the computation of weighted-average number of shares of common stock in computing the diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect (due to the net loss):
As of March 31,
20242023
Unvested restricted stock awards— 42 
Outstanding stock options10,000 10,167 
Common stock issuable upon conversion of Series F Preferred Stock (1)3,947,529 3,830,409 
Common stock issuable upon conversion of Series F Preferred Warrants (2)117,299,427 — 
Common stock issuable upon conversion of Common Stock warrants4,137,600 4,479,947 
(1) Calculation assumes conversion of the stated value, and accrued dividends, of the Series F Preferred Stock into Common Stock at the Floor Price as of March 31, 2024, and at the initial conversion price of $1.71 as of March 31, 2023.
(2) Calculation assumes exercise of the Series F Preferred Warrants for cash into Series F Preferred Stock and subsequent conversion of the Series F Preferred Stock into Common Stock at the Floor Price as of March 31, 2024. The Series F Preferred Stock Warrants were not exercisable as of March 31, 2023.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment Reporting
3 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
Segment Reporting
Note 8 - Segment Reporting

The Company currently operates in two segments: (1) “Managed Services”, which represents the business surrounding managed services for video collaboration and network applications; and (2) “Collaboration Products” which represents the business surrounding our Mezzanine™ product offerings.

Certain information concerning the Company’s segments for the three months ended March 31, 2024 and 2023 is presented in the following tables (in thousands):
Three Months Ended March 31, 2024
Managed ServicesCollaboration ProductsCorporateTotal
Revenue$522 $104 $— $626 
Cost of revenues369 260 — 629 
  Gross profit$153 $(156)$— $(3)
  Gross profit %29 %(150)%— %
Allocated operating expenses$— $121 $— $121 
Unallocated operating expenses— — 1,060 1,060 
  Total operating expenses$— $121 $1,060 $1,181 
Income (loss) from operations$153 $(277)$(1,060)$(1,184)
Interest and other income, net(32)(16)— (48)
Net income (loss) before tax185 (261)(1,060)(1,136)
Income tax expense— — — — 
Net income (loss)$185 $(261)$(1,060)$(1,136)

Three Months Ended March 31, 2023
Managed ServicesCollaboration ProductsCorporateTotal
Revenue$690 $348 $— $1,038 
Cost of revenues460 302 — 762 
Gross profit$230 $46 $— $276 
Gross profit %33 %13 %27 %
Allocated operating expenses$— $286 $— $286 
Unallocated operating expenses— — 1,193 1,193 
Total operating expenses$— $286 $1,193 $1,479 
Income (loss) from operations$230 $(240)$(1,193)$(1,203)
Interest and other expense (income), net(25)— (22)
Income (loss) before income taxes227 (215)(1,193)(1,181)
Income tax expense31 — 38 
Net income (loss)$220 $(246)$(1,193)$(1,219)


Unallocated operating expenses in Corporate include costs for the three months ended March 31, 2024 and 2023 that are not specific to a particular segment but are general to the group; included are expenses incurred for administrative and accounting staff, general liability and other insurance, professional fees, and other similar corporate expenses.

For the three months ended March 31, 2024, and 2023, there was no material revenue attributable to any individual foreign country.
Revenue by geographic area is allocated as follows (in thousands):

Three Months Ended March 31,
20242023
Domestic$261 $563 
Foreign365 475 
$626 $1,038 

Disaggregated information for the Company’s revenue has been recognized in the accompanying Condensed Consolidated Statements of Operations and is presented below according to contract type (in thousands):

Three Months Ended March 31,
2024% of Revenue2023% of Revenue
Revenue: Managed Services
Video collaboration services$14 %$64 %
Network services503 80 %618 60 %
Professional and other services%%
      Total Managed Services revenue$522 83 %$690 66 %
Revenue: Collaboration Products
Visual collaboration product offerings$104 17 %$348 34 %
Total revenue$626 100 %$1,038 100 %

The Company considers a significant customer to be one that comprises more than 10% of the Company’s consolidated revenues or accounts receivable. The loss of or a reduction in sales or anticipated sales to our most significant or several of our smaller customers could have a material adverse effect on our business, financial condition, and results of operations.

Concentration of consolidated revenues was as follows:

Three Months Ended March 31,
20242023
Segment% of Revenue% of Revenue
Customer AManaged Services82 %52 %


Concentration of accounts receivable was as follows:

As of March 31, 2024
20242023
Segment% of Accounts Receivable% of Accounts Receivable
Customer AManaged Services— %41 %
Customer BManaged Services— %11 %
Customer CCollaboration Products— %14 %
Customer DCollaboration Products— %15 %
Customer ECollaboration Products73 %— %
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and Contingencies
3 Months Ended
Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
Note 9 - Commitments and Contingencies

From time to time, we are subject to various legal proceedings arising in the ordinary course of business, including proceedings for which we have insurance coverage. As of the date hereof, we are not party to any legal proceedings that we currently believe will have a material adverse effect on our business, financial position, results of operations or liquidity.

COVID-19

On March 11, 2020, the World Health Organization (“WHO”) announced that infections of the novel Coronavirus (COVID-19) had become pandemic, and on March 13, 2020, the U.S. President announced a National Emergency relating to the disease. In May 2023, the WHO declared COVID-19 over as a global health emergency. Customers generally use our Mezzanine™ products in traditional office and operating center environments such as conference rooms or other presentation spaces. Revenue declines for our Collaboration Products business are primarily due to lower demand, largely a consequence of the commercial reactions to the COVID-19 pandemic and its prolonged effects. We believe the COVID-19 pandemic fundamentally altered the way businesses consider the use of physical office spaces and, consequently, the demand for technologies that enable in-person collaboration within these spaces. Our analysis indicates that the reduced demand for our Mezzanine™ products, particularly in the aftermath of COVID-19, reflects a broader reassessment among our customers regarding the necessity and investment in collaboration solutions tailored for traditional office environments. Continuation of this trend could cause further declines in our revenue for this business. Although the Company cannot presently quantify the future financial impacts of this trend, such impacts will likely continue to have a material adverse impact on the Company’s consolidated financial condition, results of operations, and cash flows.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Pay vs Performance Disclosure    
Net loss $ (1,136) $ (1,219)
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Insider Trading Arrangements
3 Months Ended
Mar. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Business Description and Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation

The Company's fiscal year ends on December 31 of each calendar year. The accompanying interim Condensed Consolidated Financial Statements are unaudited and have been prepared on substantially the same basis as our annual Consolidated Financial Statements for the fiscal year ended December 31, 2023. In the opinion of the Company's management, these interim Condensed Consolidated Financial Statements reflect all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.

The December 31, 2023 year-end Condensed Consolidated Balance Sheet data in this document was derived from audited consolidated financial statements. The Condensed Consolidated Financial Statements and notes included in this quarterly report on Form 10-Q do not include all disclosures required by U.S. generally accepted accounting principles and should be read in conjunction with the Company's audited consolidated financial statements as of and for the year ended December 31, 2023 and notes thereto included in the Company's fiscal 2023 Annual Report on Form 10-K, filed with the Securities and Exchange Commission (“SEC”) on March 19, 2024 (the “2023 Annual Report”).
The results of operations and cash flows for the interim periods included in these Condensed Consolidated Financial Statements are not necessarily indicative of the results to be expected for any future period or the entire fiscal year.
Principles of Consolidation
Principles of Consolidation

The Condensed Consolidated Financial Statements include the accounts of Oblong and our 100%-owned subsidiaries (i) GP Communications, LLC (“GP Communications”), whose business function is to provide interstate telecommunications services for regulatory purposes, and (ii) Oblong Industries, Inc. All inter-company balances and transactions have been eliminated in consolidation. The U.S. Dollar is the functional currency for all subsidiaries.
Segments
Segments

The Company currently operates in two segments: (1) “Collaboration Products” which represents the business surrounding our Mezzanine™ product offerings, and (2) “Managed Services” which represents the business surrounding managed services for video collaboration and network solutions. See Note 8 - Segment Reporting for further discussion.
Use of Estimates
Use of Estimates

Preparation of the Condensed Consolidated Financial Statements in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual amounts could differ from the estimates made. We continually evaluate estimates used in the preparation of our consolidated financial statements for reasonableness. Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation. The significant areas of estimation include determining the allowances for inventory obsolescence and estimated credit losses and the inputs used in the fair value of equity-based awards.
Recently Issued Accounting Pronouncements
Recently Issued Accounting Pronouncements

In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic280): Improvements to Reportable Segment Disclosures. The new guidance is intended to improve reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. The amendments are effective retrospectively for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. The Company is in the process of evaluating the impact that the adoption of this ASU will have on the financial statements and related disclosures, which is not expected to be material.

In December 2023, the FASB issued ASU No. 2023-09, Improvements to Tax Disclosures (Topic 740), to enhance the transparency and decision usefulness of income tax disclosures through changes to the rate reconciliation and income taxes paid information. This guidance is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is evaluating the impact of adopting this new accounting guidance on its Consolidated Financial Statements.
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accrued Expenses and Other Current Liabilities (Tables)
3 Months Ended
Mar. 31, 2024
Other Liabilities Disclosure [Abstract]  
Schedule of Accrued Expenses and Other Liabilities
Accrued expenses and other current liabilities consisted of the following (in thousands):
March 31,December 31,
20242023
Compensation costs$526 $448 
Customer deposits86 118 
Professional fees129 104 
Taxes and regulatory fees19 22 
Accrued rent170 202 
Accrued dividends on Series F Preferred Stock94 136 
Other accrued expenses and liabilities
Accrued expenses and other liabilities$1,031 $1,038 
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Capital Stock (Tables)
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Schedule of Common Stock Activity
Common Stock activity for the three months ended March 31, 2024 is presented below (in thousands).
Issued Shares as of December 31, 20222,071 
Issuances from Preferred Stock conversions14,102 
Issuances related to warrant exercises746 
Issuances related to stock compensation180 
Common shares exchanged for prepaid warrants(407)
Issued Shares as of December 31, 202316,692 
Issuances from Preferred Stock conversions3,602 
Issued Shares as of March 31, 202420,294 
Less Treasury Shares:(8)
Outstanding Shares as of March 31, 202420,286 
Schedule of Warrants Activity
Warrants outstanding as of March 31, 2024 are as follows:
Issue DateWarrants OutstandingExercise PriceExpiration Date
June 28, 2021750 $66.00 December 31, 2024
March 31, 20234,136,850 $1.71 September 30, 2028
4,137,600 
Warrant activity for the three months ended March 31, 2024 and the year ended December 31, 2023 is presented below.

Outstanding and Exercisable
Number of Warrants
Weighted Average Exercise Price
Warrants outstanding and exercisable, December 31, 2022343,099 $66.34 
Granted4,543,626 1.71 
Exercised(746,027)0.78 
Expired(2,601)76.93 
Forfeited(247)
Warrants outstanding and exercisable, December 31, 20234,137,850 1.72 
Expired(250)60.00 
Warrants outstanding and exercisable, March 31, 20244,137,600 $1.72 
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Preferred Stock (Tables)
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Schedule of Series F Preferred Stock Transactions Series F Preferred Stock transactions are summarized in the table below (in thousands except for shares of Series F Preferred Stock:
Series F Preferred Stock SharesPreferred Stock DividendsWeighted Average Conversion PriceCommon Shares Issued from Conversions
March 31, 2023 Issuance6,550 $— — 
2023 Accrued Dividends— $343 — 
2023 Conversions(4,620)$(211)$0.34 14,102 
December 31, 2023 Balance1,930 $132 14,102 
2024 Accrued Dividends— $44 — 
2024 Conversions(922)$(82)0.28 3,602 
March 31, 2024 Balance1,008 $94 $0.33 17,704 
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock Based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Options Granted, Exercised, Expired and Forfeited
A summary of stock option activity under our plans, and options outstanding as of, and changes made during the three months ended March 31, 2024 and year ended December 31, 2023 is presented below:

OutstandingExercisable
Number of OptionsWeighted Average Exercise PriceNumber of OptionsWeighted Average Exercise Price
Options outstanding and exercisable, December 31, 202216,668 $143.63 10,000 $206.85 
Vested— 3,336 48.75
Expired(6,668)285.89(6,668)285.89
Options outstanding and exercisable, December 31, 202310,000 48.75 6,668 48.75 
Options outstanding and exercisable, March 31, 202410,000 $48.75 6,668 $48.75 
Schedule of Restricted Stock and Restricted Stock Unit Activity The following table shows a summary of Restricted Stock activity for the year ended December 31, 2023. There was no Restricted Stock activity during the three months ended March 31, 2024.
Restricted Stock AwardsRestricted Stock Units
SharesWeighted Average Grant PriceSharesWeighted Average Grant Price
Unvested shares, December 31, 202242 $235.87 — $— 
Granted— 177,564 2.14 
Vested(42)235.87 (177,564)2.14 
Unvested Shares, December 31, 2023— — — — 
Unvested Shares, March 31, 2024— $— — $— 
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Net Loss Per Share (Tables)
3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table sets forth the computation of the Company’s basic and diluted net loss per share (in thousands, except per share data):
Three Months Ended March 31,
20242023
Numerator:
Net loss$(1,136)$(1,219)
Less: preferred stock dividends(44)— 
Less: warrant modification— (25)
Net loss attributable to common stockholders$(1,180)$(1,244)
Denominator:
Weighted-average number of shares of common stock for basic and diluted net loss per share17,123 2,065 
Basic and diluted net loss per share$(0.07)$(0.60)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following table represents the potential shares that were excluded from the computation of weighted-average number of shares of common stock in computing the diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect (due to the net loss):
As of March 31,
20242023
Unvested restricted stock awards— 42 
Outstanding stock options10,000 10,167 
Common stock issuable upon conversion of Series F Preferred Stock (1)3,947,529 3,830,409 
Common stock issuable upon conversion of Series F Preferred Warrants (2)117,299,427 — 
Common stock issuable upon conversion of Common Stock warrants4,137,600 4,479,947 
(1) Calculation assumes conversion of the stated value, and accrued dividends, of the Series F Preferred Stock into Common Stock at the Floor Price as of March 31, 2024, and at the initial conversion price of $1.71 as of March 31, 2023.
(2) Calculation assumes exercise of the Series F Preferred Warrants for cash into Series F Preferred Stock and subsequent conversion of the Series F Preferred Stock into Common Stock at the Floor Price as of March 31, 2024. The Series F Preferred Stock Warrants were not exercisable as of March 31, 2023.
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information
Certain information concerning the Company’s segments for the three months ended March 31, 2024 and 2023 is presented in the following tables (in thousands):
Three Months Ended March 31, 2024
Managed ServicesCollaboration ProductsCorporateTotal
Revenue$522 $104 $— $626 
Cost of revenues369 260 — 629 
  Gross profit$153 $(156)$— $(3)
  Gross profit %29 %(150)%— %
Allocated operating expenses$— $121 $— $121 
Unallocated operating expenses— — 1,060 1,060 
  Total operating expenses$— $121 $1,060 $1,181 
Income (loss) from operations$153 $(277)$(1,060)$(1,184)
Interest and other income, net(32)(16)— (48)
Net income (loss) before tax185 (261)(1,060)(1,136)
Income tax expense— — — — 
Net income (loss)$185 $(261)$(1,060)$(1,136)

Three Months Ended March 31, 2023
Managed ServicesCollaboration ProductsCorporateTotal
Revenue$690 $348 $— $1,038 
Cost of revenues460 302 — 762 
Gross profit$230 $46 $— $276 
Gross profit %33 %13 %27 %
Allocated operating expenses$— $286 $— $286 
Unallocated operating expenses— — 1,193 1,193 
Total operating expenses$— $286 $1,193 $1,479 
Income (loss) from operations$230 $(240)$(1,193)$(1,203)
Interest and other expense (income), net(25)— (22)
Income (loss) before income taxes227 (215)(1,193)(1,181)
Income tax expense31 — 38 
Net income (loss)$220 $(246)$(1,193)$(1,219)
Concentration of consolidated revenues was as follows:

Three Months Ended March 31,
20242023
Segment% of Revenue% of Revenue
Customer AManaged Services82 %52 %


Concentration of accounts receivable was as follows:

As of March 31, 2024
20242023
Segment% of Accounts Receivable% of Accounts Receivable
Customer AManaged Services— %41 %
Customer BManaged Services— %11 %
Customer CCollaboration Products— %14 %
Customer DCollaboration Products— %15 %
Customer ECollaboration Products73 %— %
Schedule of Revenue from External Customers by Geographic Areas
Revenue by geographic area is allocated as follows (in thousands):

Three Months Ended March 31,
20242023
Domestic$261 $563 
Foreign365 475 
$626 $1,038 
Schedule of Disaggregated Revenue Information
Disaggregated information for the Company’s revenue has been recognized in the accompanying Condensed Consolidated Statements of Operations and is presented below according to contract type (in thousands):

Three Months Ended March 31,
2024% of Revenue2023% of Revenue
Revenue: Managed Services
Video collaboration services$14 %$64 %
Network services503 80 %618 60 %
Professional and other services%%
      Total Managed Services revenue$522 83 %$690 66 %
Revenue: Collaboration Products
Visual collaboration product offerings$104 17 %$348 34 %
Total revenue$626 100 %$1,038 100 %
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Business Description and Significant Accounting Policies (Details)
3 Months Ended
Mar. 31, 2024
USD ($)
segment
Mar. 31, 2023
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Accounting Policies [Abstract]        
Cash and cash equivalents $ 5,360,000 $ 3,714,000 $ 5,990,000 $ 3,085,000
Current certificates of deposit $ 500,000 0 500,000  
Number of operating segments | segment 2      
Intangibles, net $ 0   0  
Amortization expense   86,000    
Operating lease - right of use asset, net 0   17,000  
Total operating lease liabilities 0   $ 17,000  
Non-cash lease expense $ 17,000 46,000    
Sublease income   $ 16,000    
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Liquidity (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]        
Cash and cash equivalents $ 5,360 $ 3,714 $ 5,990 $ 3,085
Working capital 4,436      
Net loss 1,136 1,219    
Net cash used in operating activities $ 630 $ 844    
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accrued Expenses and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Other Liabilities Disclosure [Abstract]    
Compensation costs $ 526 $ 448
Customer deposits 86 118
Professional fees 129 104
Taxes and regulatory fees 19 22
Accrued rent 170 202
Accrued dividends on Series F Preferred Stock 94 136
Other accrued expenses and liabilities 7 8
Accrued expenses and other current liabilities $ 1,031 $ 1,038
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Capital Stock - Common Stock (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2024
Dec. 31, 2023
Mar. 31, 2023
Dec. 31, 2022
Class of Stock [Line Items]          
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001 $ 0.0001    
Common stock, shares authorized (in shares) 150,000,000 150,000,000 150,000,000    
Common stock, shares issued (in shares) 20,294,228 20,294,228 16,692,124    
Common stock, shares outstanding (in shares) 20,285,675 20,285,675 16,683,572    
Series F Preferred Stock          
Class of Stock [Line Items]          
Shares converted (in shares) 922   4,620    
Preferred stock dividends $ 94 $ 94 $ 132 $ 0  
Common Stock          
Class of Stock [Line Items]          
Common stock, shares issued (in shares) 20,294,000 20,294,000 16,692,000 2,071,000 2,071,000
Common stock, shares outstanding (in shares) 20,286,000 20,286,000      
Common shares issued in conversion (in shares) 3,602,103 17,704,000 14,102,477    
Preferred Stock | Series F Preferred Stock          
Class of Stock [Line Items]          
Preferred stock dividends $ 82 $ 82      
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Capital Stock - Common Stock Activity (Details) - shares
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Treasury stock, shares (in shares) 8,000 8,000
Common stock, shares outstanding (in shares) 20,285,675 16,683,572
Common Stock    
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Beginning Balance (in shares) 16,692,000 2,071,000
Issuances from Preferred Stock Conversions (in shares) 3,602,000 14,102,000
Issuances related to warrant exercises (in shares)   746,000
Issuances related to stock compensation (in shares)   180,000
Common shares exchanged for prepaid warrants (in shares)   (407,000)
Ending Balance (in shares) 20,294,000 16,692,000
Ending Balance (in shares) 20,294,000 16,692,000
Treasury stock, shares (in shares) (8,000)  
Common stock, shares outstanding (in shares) 20,286,000  
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Capital Stock - Warrants Outstanding (Details) - $ / shares
Mar. 31, 2024
Dec. 31, 2023
Mar. 31, 2023
Dec. 31, 2022
Jun. 28, 2021
Equity [Abstract]          
Warrants issued (in shares) 4,137,600   4,136,850   750
Exercise price (in dollars per share) $ 1.72 $ 1.72 $ 1.71 $ 66.34 $ 66.00
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Capital Stock - Warrants Activity (Details) - $ / shares
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Mar. 31, 2023
Jun. 28, 2021
Number of Warrants        
Warrants outstanding, beginning (in shares) 4,137,850 343,099    
Granted (in shares)   4,543,626    
Exercised (in shares)   (746,027)    
Expired (in shares) (250) (2,601)    
Forfeited (in shares)   (247)    
Warrants outstanding, ending (in shares) 4,137,600 4,137,850    
Warrants outstanding, ending (in shares) 4,137,600 4,137,850    
Weighted Average Exercise Price        
Warrants outstanding, beginning (in dollars per share) $ 1.72 $ 66.34    
Granted (in dollars per share)   1.71    
Exercised (in dollars per share)   0.78    
Expired (in dollars per share) 60.00 76.93    
Forfeited (in dollars per share)   0    
Warrants outstanding, ending (in dollars per share) 1.72 1.72    
Warrants outstanding, ending (in dollars per share) $ 1.72 $ 1.72 $ 1.71 $ 66.00
Number of Warrants        
Warrants exercisable, beginning (in shares) 4,137,850 343,099    
Granted (in shares)   4,543,626    
Exercised (in shares)   746,027    
Expired (in shares) 250 2,601    
Forfeited (in shares)   (247)    
Warrants exercisable, ending (in shares) 4,137,600 4,137,850    
Warrants exercisable, ending (in shares) 4,137,600 4,137,850    
Weighted Average Exercise Price        
Warrants exercisable, beginning (in dollars per share) $ 1.72 $ 66.34    
Granted (in dollars per share)   1.71    
Exercised (in dollars per share)   0.78    
Expired (in dollars per share) 60.00 76.93    
Forfeited (in dollars per share)   0    
Warrants exercisable, ending (in dollars per share) 1.72 1.72    
Warrants exercisable, ending (in dollars per share) $ 1.72 $ 1.72    
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Preferred Stock - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 30, 2023
Mar. 31, 2024
Mar. 31, 2024
Dec. 31, 2023
Oct. 06, 2023
Dec. 31, 2022
Jun. 28, 2021
Class of Stock [Line Items]                
Preferred stock, convertible, shares authorized (in shares)     42,000 42,000 42,000      
Preferred stock, shares designated (in shares)     1,983,250 1,983,250        
Preferred stock, shares issued (in shares)     1,008 1,008 1,930      
Preferred stock, shares outstanding (in shares)     1,008 1,008 1,930      
Preferred stock, convertible, par value (in dollars per share)     $ 0.0001 $ 0.0001 $ 0.0001      
Weighted average conversion price (in dollars per share) $ 1.71         $ 0.2792    
Warrants outstanding, ending (in dollars per share) $ 1.71   $ 1.72 $ 1.72 $ 1.72   $ 66.34 $ 66.00
Common Stock                
Class of Stock [Line Items]                
Common shares issued in conversion (in shares)     3,602,103 17,704,000 14,102,477      
Private Placement | Preferred Warrants                
Class of Stock [Line Items]                
Number of shares issuable (in shares)   32,750            
Private Placement | Investor Warrants                
Class of Stock [Line Items]                
Number of shares issuable (in shares)   3,830,417            
Series F Preferred Stock                
Class of Stock [Line Items]                
Preferred stock, shares outstanding (in shares)     1,008 1,008 1,930      
Proceeds from private placement, net of fees and amounts held in escrow (in shares) 6,550              
Weighted average conversion price (in dollars per share)   $ 1.71 $ 0.33 $ 0.33        
Preferred stock, conversion price percentage (in percent)   80.00%            
Preferred stock convertible, threshold consecutive trading days   30 days            
Preferred stock, liquidation preference per share (in dollars per share)     $ 1,000 $ 1,000        
Preferred stock dividend percentage (in percent)     9.00%          
Shares converted (in shares)     922   4,620      
Preferred stock dividends $ 0   $ 94 $ 94 $ 132      
Warrants outstanding, ending (in dollars per share)     $ 975 $ 975        
Expiration period     3 years          
Percentage of common stock issuable (in percent)     100.00% 100.00%        
Series F Preferred Stock | Scenario 1                
Class of Stock [Line Items]                
Preferred stock dividend percentage (in percent)     20.00%          
Series F Preferred Stock | Private Placement                
Class of Stock [Line Items]                
Proceeds from private placement, net of fees and amounts held in escrow (in shares)   6,550            
Preferred stock, convertible, par value (in dollars per share)   $ 0.0001            
Gross proceeds 6,386              
Proceeds from private placement, net of issuance costs and amounts in escrow 5,364              
Finance costs related to Series F Preferred Stock $ 1,022              
Maximum                
Class of Stock [Line Items]                
Preferred stock, convertible, shares authorized (in shares)     5,000,000 5,000,000        
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Preferred Stock - Schedule of Series F Preferred Stock Transactions (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 30, 2023
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Dec. 31, 2023
Oct. 06, 2023
Dec. 31, 2022
Class of Stock [Line Items]                
Preferred stock, shares outstanding (in shares)     1,008   1,008 1,930    
Accrued dividends     $ 44 $ 0        
Weighted average conversion price (in dollars per share) $ 1.71     $ 1.71     $ 0.2792  
Common Stock                
Class of Stock [Line Items]                
Conversions of Series F Preferred Stock (in shares)     3,602,000     14,102,000    
Common shares issued in conversion (in shares)     3,602,103   17,704,000 14,102,477    
Series F Preferred Stock                
Class of Stock [Line Items]                
Number of shares issued (in shares) 6,550              
Preferred stock, shares outstanding (in shares)     1,008   1,008 1,930    
Preferred Stock Dividends $ 0   $ 94 $ 0 $ 94 $ 132    
Accrued dividends     44     343    
Conversions, preferred stock dividends     $ (82)     $ (211)    
Weighted average conversion price (in dollars per share)     $ 0.28     $ 0.34    
Weighted average conversion price (in dollars per share)   $ 1.71 $ 0.33   $ 0.33      
Series F Preferred Stock | Private Placement                
Class of Stock [Line Items]                
Number of shares issued (in shares)   6,550            
Series F Preferred Stock | Preferred Stock                
Class of Stock [Line Items]                
Number of shares issued (in shares)       6,550        
Conversions of Series F Preferred Stock (in shares)     (922)     (4,620)    
Preferred stock, shares outstanding (in shares) 6,550   1,008 6,550 1,008 1,930   0
Preferred Stock Dividends     $ 82   $ 82      
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock Based Compensation - Narrative (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Options, intrinsic value, vested $ 0 $ 0    
Unrecognized stock-based compensation expense for stock options $ 30,000      
Unvested restricted shares outstanding (in shares) 0      
Stock Options        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock option compensation expense $ 31,000 31,000    
Cost not yet recognized, period for recognition 3 months      
Restricted Stock        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock option compensation expense $ 0 0    
Unamortized expense related to restricted stock $ 0 $ 0    
Unvested restricted shares outstanding (in shares) 0   0 42
2019 Equity Incentive Plan        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of shares available for grant (in shares)     3  
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock Based Compensation - Schedule of Options Outstanding (Details) - $ / shares
12 Months Ended
Dec. 31, 2023
Mar. 31, 2024
Number of Options    
Outstanding number of options, beginning (in shares) 16,668  
Vested (in shares) 0  
Expired (in shares) (6,668)  
Outstanding and exercisable number of options, ending (in shares) 10,000  
Number of options, outstanding (in shares) 10,000 10,000
Weighted Average Exercise Price    
Outstanding weighted average exercise price, beginning (in dollars per share) $ 143.63  
Vested (in dollars per share) 0  
Expired (in dollars per share) 285.89  
Outstanding and exercisable weighted average exercise price, ending (in dollars per share) 48.75  
Weighted average exercise price, outstanding (in dollars per share) $ 48.75 $ 48.75
Exercisable    
Exercisable number of options, beginning (in shares) 10,000  
Vested (in shares) 3,336  
Expired (in shares) (6,668)  
Exercisable number of options, ending (in shares) 6,668  
Exercisable number of options (in shares) 6,668 6,668
Exercisable weighted average exercise price, beginning (in dollars per share) $ 206.85  
Exercisable vested, weighted average exercise price (in dollars per share) 48.75  
Exercisable expired, weighted average exercise price (in dollars per share) 285.89  
Exercisable weighted average exercise price, ending (in dollars per share) 48.75  
Exercisable weighted average exercise price (in dollars per share) $ 48.75 $ 48.75
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock Based Compensation - Schedule of Restricted Stock and Restricted Stock Unit Activity (Details) - $ / shares
12 Months Ended
Dec. 31, 2023
Mar. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]    
Unvested restricted shares outstanding (in shares)   0
Restricted Stock    
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]    
Beginning of year (in shares) 42  
Granted (in shares) 0  
Vested (in shares) (42)  
End of year (in shares) 0  
Unvested restricted shares outstanding (in shares) 0 0
Weighted Average Grant Price    
Unvested shares, Weighted Average Grant Price, Beginning (in dollars per share) $ 235.87  
Granted, Weighted Average Grant Price (in dollars per share)  
Vested, Weighted Average Grant Price (in dollars per share) 235.87  
Unvested shares, Weighted Average Grant Price, Ending (in dollars per share) 0  
Unvested shares, Weighted Average Grant Price (in dollars per share) $ 0 $ 0
RSUs    
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]    
Beginning of year (in shares) 0  
Granted (in shares) 177,564  
Vested (in shares) (177,564)  
End of year (in shares) 0  
Unvested restricted shares outstanding (in shares) 0 0
Weighted Average Grant Price    
Unvested shares, Weighted Average Grant Price, Beginning (in dollars per share) $ 0  
Granted, Weighted Average Grant Price (in dollars per share) 2.14  
Vested, Weighted Average Grant Price (in dollars per share) 2.14  
Unvested shares, Weighted Average Grant Price, Ending (in dollars per share) 0  
Unvested shares, Weighted Average Grant Price (in dollars per share) $ 0 $ 0
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Net Loss Per Share - Narrative (Details) - $ / shares
3 Months Ended
Mar. 31, 2024
Oct. 06, 2023
Mar. 31, 2023
Earnings Per Share [Abstract]      
Weighted-average shares common stock outstanding, potentially dilutive securities or unvested restricted stock (in shares) 0    
Weighted average conversion price (in dollars per share)   $ 0.2792 $ 1.71
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Net Loss Per Share - Schedule of Computation of Basic and Diluted Loss Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Numerator:    
Net loss $ (1,136) $ (1,219)
Less: preferred stock dividends (44) 0
Less: warrant modification 0 (25)
Net loss attributable to common stockholders $ (1,180) $ (1,244)
Denominator:    
Weighted-average number of shares of common stock - basic (in shares) 17,123 2,065
Weighted-average number of shares of common stock - diluted (in shares) 17,123 2,065
Basic net loss per share (in dollars per share) $ (0.07) $ (0.60)
Diluted net loss per share (in dollars per share) $ (0.07) $ (0.60)
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Net Loss Per Share - Schedule of Effect of Antidilutive Securities (Details) - shares
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Unvested restricted stock awards    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount (in shares) 0 42
Outstanding stock options    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount (in shares) 10,000 10,167
Common stock issuable upon conversion of Series F Preferred Stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount (in shares) 3,947,529 3,830,409
Common stock issuable upon conversion of Series F Preferred Warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount (in shares) 117,299,427 0
Common stock issuable upon conversion of Common Stock warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount (in shares) 4,137,600 4,479,947
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment Reporting - Schedule of Segment Reporting Information (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2024
USD ($)
segment
Mar. 31, 2023
USD ($)
Segment Reporting Information [Line Items]    
Number of operating segments | segment 2  
Revenue $ 626 $ 1,038
Cost of revenues 629 762
Gross profit $ (3) $ 276
Gross profit % 0.00% 27.00%
Total operating expenses $ 1,181 $ 1,479
Loss from operations (1,184) (1,203)
Interest and other income, net (48) (22)
Loss before income taxes (1,136) (1,181)
Income tax expense 0 38
Net loss (1,136) (1,219)
Allocated operating expenses    
Segment Reporting Information [Line Items]    
Total operating expenses 121 286
Unallocated operating expenses    
Segment Reporting Information [Line Items]    
Total operating expenses 1,060 1,193
Unallocated operating expenses    
Segment Reporting Information [Line Items]    
Revenue 0 0
Cost of revenues 0 0
Gross profit 0 0
Total operating expenses 1,060 1,193
Loss from operations (1,060) (1,193)
Interest and other income, net 0 0
Loss before income taxes (1,060) (1,193)
Income tax expense 0 0
Net loss (1,060) (1,193)
Unallocated operating expenses | Allocated operating expenses    
Segment Reporting Information [Line Items]    
Total operating expenses 0 0
Unallocated operating expenses | Unallocated operating expenses    
Segment Reporting Information [Line Items]    
Total operating expenses 1,060 1,193
Managed Services | Operating Segments    
Segment Reporting Information [Line Items]    
Revenue 522 690
Cost of revenues 369 460
Gross profit $ 153 $ 230
Gross profit % 29.00% 33.00%
Total operating expenses $ 0 $ 0
Loss from operations 153 230
Interest and other income, net (32) (3)
Loss before income taxes 185 227
Income tax expense 0 7
Net loss 185 220
Managed Services | Operating Segments | Allocated operating expenses    
Segment Reporting Information [Line Items]    
Total operating expenses 0 0
Managed Services | Operating Segments | Unallocated operating expenses    
Segment Reporting Information [Line Items]    
Total operating expenses 0 0
Collaboration Products | Operating Segments    
Segment Reporting Information [Line Items]    
Revenue 104 348
Cost of revenues 260 302
Gross profit $ (156) $ 46
Gross profit % (150.00%) 13.00%
Total operating expenses $ 121 $ 286
Loss from operations (277) (240)
Interest and other income, net (16) (25)
Loss before income taxes (261) (215)
Income tax expense 0 31
Net loss (261) (246)
Collaboration Products | Operating Segments | Allocated operating expenses    
Segment Reporting Information [Line Items]    
Total operating expenses 121 286
Collaboration Products | Operating Segments | Unallocated operating expenses    
Segment Reporting Information [Line Items]    
Total operating expenses $ 0 $ 0
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment Reporting - Schedule of Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Disaggregation of Revenue [Line Items]    
Revenue $ 626 $ 1,038
Product Concentration Risk    
Disaggregation of Revenue [Line Items]    
Revenue $ 626 $ 1,038
Revenue | Product Concentration Risk    
Disaggregation of Revenue [Line Items]    
Percentage of revenue (in percent) 100.00% 100.00%
Managed Services | Product Concentration Risk    
Disaggregation of Revenue [Line Items]    
Revenue $ 522 $ 690
Managed Services | Revenue | Product Concentration Risk    
Disaggregation of Revenue [Line Items]    
Percentage of revenue (in percent) 83.00% 66.00%
Managed Services | Video collaboration services | Product Concentration Risk    
Disaggregation of Revenue [Line Items]    
Revenue $ 14 $ 64
Managed Services | Video collaboration services | Revenue | Product Concentration Risk    
Disaggregation of Revenue [Line Items]    
Percentage of revenue (in percent) 2.00% 6.00%
Managed Services | Network services | Product Concentration Risk    
Disaggregation of Revenue [Line Items]    
Revenue $ 503 $ 618
Managed Services | Network services | Revenue | Product Concentration Risk    
Disaggregation of Revenue [Line Items]    
Percentage of revenue (in percent) 80.00% 60.00%
Managed Services | Professional and other services | Product Concentration Risk    
Disaggregation of Revenue [Line Items]    
Revenue $ 5 $ 8
Managed Services | Professional and other services | Revenue | Product Concentration Risk    
Disaggregation of Revenue [Line Items]    
Percentage of revenue (in percent) 1.00% 1.00%
Collaboration Products | Video collaboration services | Product Concentration Risk    
Disaggregation of Revenue [Line Items]    
Revenue $ 104 $ 348
Collaboration Products | Video collaboration services | Revenue | Product Concentration Risk    
Disaggregation of Revenue [Line Items]    
Percentage of revenue (in percent) 17.00% 34.00%
Domestic    
Disaggregation of Revenue [Line Items]    
Revenue $ 261 $ 563
Foreign    
Disaggregation of Revenue [Line Items]    
Revenue $ 365 $ 475
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment Reporting - Schedule of Concentration Percentage (Details) - Customer Concentration Risk
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Customer A | Managed Services | Revenue    
Concentration Risk [Line Items]    
Concentration risk, percentage (in percent) 82.00% 52.00%
Customer A | Managed Services | Accounts Receivable    
Concentration Risk [Line Items]    
Concentration risk, percentage (in percent) 0.00% 41.00%
Customer B | Managed Services | Accounts Receivable    
Concentration Risk [Line Items]    
Concentration risk, percentage (in percent) 0.00% 11.00%
Customer C | Collaboration Products | Accounts Receivable    
Concentration Risk [Line Items]    
Concentration risk, percentage (in percent) 0.00% 14.00%
Customer D | Collaboration Products | Accounts Receivable    
Concentration Risk [Line Items]    
Concentration risk, percentage (in percent) 0.00% 15.00%
Customer E | Collaboration Products | Accounts Receivable    
Concentration Risk [Line Items]    
Concentration risk, percentage (in percent) 73.00% 0.00%
EXCEL 54 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

-8?20$3;8T.P6BP^0"X99K>]9!:GW( P \AP \ !X;"]W;W)K8F]O:RYX;6S%F4UOVS@00/\*H5-[ MR-KZ2-H&=0''\K8!7-NH@NYQP4@CFXA$>DDJ:?OK.Y3KEFKC,R.PV\ M,EL VS:C9#R^&K5*]5MQ-R MXYK!IQAYC]''X7#2J[%J0=A]'#8T#E&8K=B9BDKXH.*C;_@HT8,'V\5G8+FLTZ/9BVQ]2\/0[\_O&=0&NR MPJKRP8DC#NR/'H;=<(-@,]6Z?NTK^7R4.>+ ZEAB MNPN%PW2-+UFQY1I\,DH7<6!?%+!Q-=@GV"G,Q^3&!Z,4$8=VA&I;85VE_0"= M80Z)>"!+ <:'I!01!W;$FG]ECWVO]G^7);!+ BB ]-DA;8LH<\3G5,X$+I ;, M2Y^.2R0]0'Y-R2G)RIQR-)"67Y-1R.4I(628);!EZWO%7 M(@GEF22P9WYFT.Q%#I:+9AA!RBY)8+O04^(@@I1@DL""&4Z)%VY@M]C5/V:@ MW,>D!),$%@R).2W]C1!*,.E)!7/!_N$NI\!,;=59A/(Q*=.DH?>^_H0Y=1N' MPL>DA),&%L[O0KQ@2P?J]C;=>/VOP,)YCEE@JU77 %,U*WQ,2CII:.G\ M2=_[L/J8E'G2P.8A,%U8?4S*/&E@\Y"8PYU9RD)I8 L=28;\4>1C4A9* UOH M*.:O4>1C4A9* UN(Q!QT>D99* MLH>?IY6!*\C$I"V6!+41B#J-)62@+O>PA M,?U$+J,LE/46&AV^L5508X)=+?$6!LM+WI1KS=QAOVF87;H%?=TUS0S+5G*A M>'7X9'?XW/CN.U!+ P04 " !I@*A8[DG=_YX! (&@ &@ 'AL+U]R M96QS+W=O?P7UB?+GGV%4YD.=17WAR;V+N=3%>?% M/J7FP[FXWH=S&?MU$ZKNS+9NSV7JENW.->7Z6.Z"T\%@Y-KG&<5B]CRSM[HV MX3\3Z^WVL Z?]?K['*KTQV#W4[?'N \A%;U5V>Y"FA?N0CR^8.&$#3,'S2"H%'^H#$$C?,'32!HDC]H M"D'3_$$R0!D'!$DO6!-H+BOJK01Z*^JM!'HKZJT$ M>BOJK01Z*^JM!'HKZJT$>AOJ;01Z&^IM!'H;ZFT$>MO+QQ("O0WU-@*]#?4V M KT-]38"O0WU-@*]#?4V KT-]38"O3WJ[0GT]JBW)]#;H]Z>0&^/>OMWZAW3 M]13BH^>^QON_D^K471L>M[\M[YLOC\H-9P<_?A:_4$L#!!0 ( &F J%BH MRH?9JP$ $$: 3 6T-O;G1E;G1?5'EP97-=+GAM;,V9S6[",!"$7P7E MBHBQG=(? 9>VUY9#7\!--B0BB2W;4'C[.N%':D6C(BIU+K$2[\Z,O=)WR?1M M9\@-MG75N%E4>&\>&'-I0;5RL3;4A)U7T<$A M#IU=C2M*XX:A(&)G'=J=GPT.?:\;LK;,:+!0UK^H.E2Q;<6H?K_=!VU&UL4$L! A0#% @ :8"H6'E_A7[B!0 MLQ\ !@ ("!#@@ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ :8"H6%1"(PZ$!0 UQ8 !@ M ("!W!< 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ :8"H6%$*!TB'!@ VQP !@ ("!0BD 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ :8"H6,+%KW:8!0 "@\ !D M ("!05, 'AL+W=O&PO=V]R:W-H M965T&UL4$L! M A0#% @ :8"H6!L)1^:-!0 6PP !D ("!GV8 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ :8"H M6.Q;H_'A" BAD !D ("!4W$ 'AL+W=O@ >&PO=V]R:W-H965T&UL4$L! A0#% @ :8"H6 =+G&W^ @ @< M !D ("!O8$ 'AL+W=O&PO=V]R:W-H965T( !X;"]W;W)K&UL4$L! A0#% @ :8"H6)0?/V#E!0 0!$ !D M ("!^8T 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ :8"H6!AN]V(B P LPD !D ("!NIL 'AL+W=O M&PO=V]R:W-H965T&UL4$L! A0#% @ :8"H6&@; M(=^R @ &0D !D ("!=Z@ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ :8"H6-!LJK55!P 44H !D M ("!L+P 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ :8"H6':_7!/D! <1X !D ("! MULT 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ :8"H6+S;CF/S P '!0 !D ("!X=D 'AL+W=O&UL4$L! A0#% @ :8"H6/V5K[#! M P ^10 !D ("!=.P 'AL+W=O&PO&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 " !I@*A8 MJ,J'V:L! !!&@ $P @ %N^@ 6T-O;G1E;G1?5'EP97-= :+GAM;%!+!08 ,P S -P- !*_ ! end XML 55 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 56 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 58 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 141 225 1 false 40 0 false 5 false false R1.htm 0000001 - Document - Cover Sheet http://www.glowpoint.com/role/Cover Cover Cover 1 false false R2.htm 0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 0000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY Sheet http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY Statements 5 false false R6.htm 0000006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Parenthetical) Sheet http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYParenthetical CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Parenthetical) Statements 6 false false R7.htm 0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 0000008 - Disclosure - Business Description and Significant Accounting Policies Sheet http://www.glowpoint.com/role/BusinessDescriptionandSignificantAccountingPolicies Business Description and Significant Accounting Policies Notes 8 false false R9.htm 0000009 - Disclosure - Liquidity Sheet http://www.glowpoint.com/role/Liquidity Liquidity Notes 9 false false R10.htm 0000010 - Disclosure - Accrued Expenses and Other Current Liabilities Sheet http://www.glowpoint.com/role/AccruedExpensesandOtherCurrentLiabilities Accrued Expenses and Other Current Liabilities Notes 10 false false R11.htm 0000011 - Disclosure - Capital Stock Sheet http://www.glowpoint.com/role/CapitalStock Capital Stock Notes 11 false false R12.htm 0000012 - Disclosure - Preferred Stock Sheet http://www.glowpoint.com/role/PreferredStock Preferred Stock Notes 12 false false R13.htm 0000013 - Disclosure - Stock Based Compensation Sheet http://www.glowpoint.com/role/StockBasedCompensation Stock Based Compensation Notes 13 false false R14.htm 0000014 - Disclosure - Net Loss Per Share Sheet http://www.glowpoint.com/role/NetLossPerShare Net Loss Per Share Notes 14 false false R15.htm 0000015 - Disclosure - Segment Reporting Sheet http://www.glowpoint.com/role/SegmentReporting Segment Reporting Notes 15 false false R16.htm 0000016 - Disclosure - Commitments and Contingencies Sheet http://www.glowpoint.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 16 false false R17.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 17 false false R18.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 18 false false R19.htm 9954471 - Disclosure - Business Description and Significant Accounting Policies (Policies) Sheet http://www.glowpoint.com/role/BusinessDescriptionandSignificantAccountingPoliciesPolicies Business Description and Significant Accounting Policies (Policies) Policies http://www.glowpoint.com/role/BusinessDescriptionandSignificantAccountingPolicies 19 false false R20.htm 9954472 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) Sheet http://www.glowpoint.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables Accrued Expenses and Other Current Liabilities (Tables) Tables http://www.glowpoint.com/role/AccruedExpensesandOtherCurrentLiabilities 20 false false R21.htm 9954473 - Disclosure - Capital Stock (Tables) Sheet http://www.glowpoint.com/role/CapitalStockTables Capital Stock (Tables) Tables http://www.glowpoint.com/role/CapitalStock 21 false false R22.htm 9954474 - Disclosure - Preferred Stock (Tables) Sheet http://www.glowpoint.com/role/PreferredStockTables Preferred Stock (Tables) Tables http://www.glowpoint.com/role/PreferredStock 22 false false R23.htm 9954475 - Disclosure - Stock Based Compensation (Tables) Sheet http://www.glowpoint.com/role/StockBasedCompensationTables Stock Based Compensation (Tables) Tables http://www.glowpoint.com/role/StockBasedCompensation 23 false false R24.htm 9954476 - Disclosure - Net Loss Per Share (Tables) Sheet http://www.glowpoint.com/role/NetLossPerShareTables Net Loss Per Share (Tables) Tables http://www.glowpoint.com/role/NetLossPerShare 24 false false R25.htm 9954477 - Disclosure - Segment Reporting (Tables) Sheet http://www.glowpoint.com/role/SegmentReportingTables Segment Reporting (Tables) Tables http://www.glowpoint.com/role/SegmentReporting 25 false false R26.htm 9954478 - Disclosure - Business Description and Significant Accounting Policies (Details) Sheet http://www.glowpoint.com/role/BusinessDescriptionandSignificantAccountingPoliciesDetails Business Description and Significant Accounting Policies (Details) Details http://www.glowpoint.com/role/BusinessDescriptionandSignificantAccountingPoliciesPolicies 26 false false R27.htm 9954479 - Disclosure - Liquidity (Details) Sheet http://www.glowpoint.com/role/LiquidityDetails Liquidity (Details) Details http://www.glowpoint.com/role/Liquidity 27 false false R28.htm 9954480 - Disclosure - Accrued Expenses and Other Current Liabilities (Details) Sheet http://www.glowpoint.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails Accrued Expenses and Other Current Liabilities (Details) Details http://www.glowpoint.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables 28 false false R29.htm 9954481 - Disclosure - Capital Stock - Common Stock (Details) Sheet http://www.glowpoint.com/role/CapitalStockCommonStockDetails Capital Stock - Common Stock (Details) Details 29 false false R30.htm 9954482 - Disclosure - Capital Stock - Common Stock Activity (Details) Sheet http://www.glowpoint.com/role/CapitalStockCommonStockActivityDetails Capital Stock - Common Stock Activity (Details) Details 30 false false R31.htm 9954483 - Disclosure - Capital Stock - Warrants Outstanding (Details) Sheet http://www.glowpoint.com/role/CapitalStockWarrantsOutstandingDetails Capital Stock - Warrants Outstanding (Details) Details 31 false false R32.htm 9954484 - Disclosure - Capital Stock - Warrants Activity (Details) Sheet http://www.glowpoint.com/role/CapitalStockWarrantsActivityDetails Capital Stock - Warrants Activity (Details) Details 32 false false R33.htm 9954485 - Disclosure - Preferred Stock - Narrative (Details) Sheet http://www.glowpoint.com/role/PreferredStockNarrativeDetails Preferred Stock - Narrative (Details) Details 33 false false R34.htm 9954486 - Disclosure - Preferred Stock - Schedule of Series F Preferred Stock Transactions (Details) Sheet http://www.glowpoint.com/role/PreferredStockScheduleofSeriesFPreferredStockTransactionsDetails Preferred Stock - Schedule of Series F Preferred Stock Transactions (Details) Details 34 false false R35.htm 9954487 - Disclosure - Stock Based Compensation - Narrative (Details) Sheet http://www.glowpoint.com/role/StockBasedCompensationNarrativeDetails Stock Based Compensation - Narrative (Details) Details 35 false false R36.htm 9954488 - Disclosure - Stock Based Compensation - Schedule of Options Outstanding (Details) Sheet http://www.glowpoint.com/role/StockBasedCompensationScheduleofOptionsOutstandingDetails Stock Based Compensation - Schedule of Options Outstanding (Details) Details 36 false false R37.htm 9954489 - Disclosure - Stock Based Compensation - Schedule of Restricted Stock and Restricted Stock Unit Activity (Details) Sheet http://www.glowpoint.com/role/StockBasedCompensationScheduleofRestrictedStockandRestrictedStockUnitActivityDetails Stock Based Compensation - Schedule of Restricted Stock and Restricted Stock Unit Activity (Details) Details 37 false false R38.htm 9954490 - Disclosure - Net Loss Per Share - Narrative (Details) Sheet http://www.glowpoint.com/role/NetLossPerShareNarrativeDetails Net Loss Per Share - Narrative (Details) Details 38 false false R39.htm 9954491 - Disclosure - Net Loss Per Share - Schedule of Computation of Basic and Diluted Loss Per Share (Details) Sheet http://www.glowpoint.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedLossPerShareDetails Net Loss Per Share - Schedule of Computation of Basic and Diluted Loss Per Share (Details) Details 39 false false R40.htm 9954492 - Disclosure - Net Loss Per Share - Schedule of Effect of Antidilutive Securities (Details) Sheet http://www.glowpoint.com/role/NetLossPerShareScheduleofEffectofAntidilutiveSecuritiesDetails Net Loss Per Share - Schedule of Effect of Antidilutive Securities (Details) Details 40 false false R41.htm 9954493 - Disclosure - Segment Reporting - Schedule of Segment Reporting Information (Details) Sheet http://www.glowpoint.com/role/SegmentReportingScheduleofSegmentReportingInformationDetails Segment Reporting - Schedule of Segment Reporting Information (Details) Details 41 false false R42.htm 9954494 - Disclosure - Segment Reporting - Schedule of Disaggregation of Revenue (Details) Sheet http://www.glowpoint.com/role/SegmentReportingScheduleofDisaggregationofRevenueDetails Segment Reporting - Schedule of Disaggregation of Revenue (Details) Details 42 false false R43.htm 9954495 - Disclosure - Segment Reporting - Schedule of Concentration Percentage (Details) Sheet http://www.glowpoint.com/role/SegmentReportingScheduleofConcentrationPercentageDetails Segment Reporting - Schedule of Concentration Percentage (Details) Details 43 false false All Reports Book All Reports glow-20240331.htm glow-20240331.xsd glow-20240331_cal.xml glow-20240331_def.xml glow-20240331_lab.xml glow-20240331_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 60 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "glow-20240331.htm": { "nsprefix": "glow", "nsuri": "http://www.glowpoint.com/20240331", "dts": { "inline": { "local": [ "glow-20240331.htm" ] }, "schema": { "local": [ "glow-20240331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] }, "calculationLink": { "local": [ "glow-20240331_cal.xml" ] }, "definitionLink": { "local": [ "glow-20240331_def.xml" ] }, "labelLink": { "local": [ "glow-20240331_lab.xml" ] }, "presentationLink": { "local": [ "glow-20240331_pre.xml" ] } }, "keyStandard": 188, "keyCustom": 37, "axisStandard": 16, "axisCustom": 1, "memberStandard": 22, "memberCustom": 15, "hidden": { "total": 5, "http://xbrl.sec.gov/dei/2023": 5 }, "contextCount": 141, "entityCount": 1, "segmentCount": 40, "elementCount": 435, "unitCount": 5, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 540, "http://xbrl.sec.gov/dei/2023": 30, "http://xbrl.sec.gov/ecd/2023": 4 }, "report": { "R1": { "role": "http://www.glowpoint.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "longName": "0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:AccountsReceivableNetCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "unique": true } }, "R3": { "role": "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "longName": "0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "glow:PreferredStockStatedValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "unique": true } }, "R4": { "role": "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "longName": "0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ResearchAndDevelopmentExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "unique": true } }, "R5": { "role": "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY", "longName": "0000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY", "shortName": "CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-20", "name": "us-gaap:PreferredStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-26", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "unique": true } }, "R6": { "role": "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYParenthetical", "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Parenthetical)", "shortName": "CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-48", "name": "us-gaap:DividendsPayableCurrentAndNoncurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true }, "uniqueAnchor": null }, "R7": { "role": "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "longName": "0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "unique": true } }, "R8": { "role": "http://www.glowpoint.com/role/BusinessDescriptionandSignificantAccountingPolicies", "longName": "0000008 - Disclosure - Business Description and Significant Accounting Policies", "shortName": "Business Description and Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.glowpoint.com/role/Liquidity", "longName": "0000009 - Disclosure - Liquidity", "shortName": "Liquidity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.glowpoint.com/role/AccruedExpensesandOtherCurrentLiabilities", "longName": "0000010 - Disclosure - Accrued Expenses and Other Current Liabilities", "shortName": "Accrued Expenses and Other Current Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.glowpoint.com/role/CapitalStock", "longName": "0000011 - Disclosure - Capital Stock", "shortName": "Capital Stock", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.glowpoint.com/role/PreferredStock", "longName": "0000012 - Disclosure - Preferred Stock", "shortName": "Preferred Stock", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PreferredStockTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PreferredStockTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.glowpoint.com/role/StockBasedCompensation", "longName": "0000013 - Disclosure - Stock Based Compensation", "shortName": "Stock Based Compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.glowpoint.com/role/NetLossPerShare", "longName": "0000014 - Disclosure - Net Loss Per Share", "shortName": "Net Loss Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.glowpoint.com/role/SegmentReporting", "longName": "0000015 - Disclosure - Segment Reporting", "shortName": "Segment Reporting", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.glowpoint.com/role/CommitmentsandContingencies", "longName": "0000016 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true } }, "R17": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true }, "uniqueAnchor": null }, "R18": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.glowpoint.com/role/BusinessDescriptionandSignificantAccountingPoliciesPolicies", "longName": "9954471 - Disclosure - Business Description and Significant Accounting Policies (Policies)", "shortName": "Business Description and Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.glowpoint.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables", "longName": "9954472 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)", "shortName": "Accrued Expenses and Other Current Liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.glowpoint.com/role/CapitalStockTables", "longName": "9954473 - Disclosure - Capital Stock (Tables)", "shortName": "Capital Stock (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.glowpoint.com/role/PreferredStockTables", "longName": "9954474 - Disclosure - Preferred Stock (Tables)", "shortName": "Preferred Stock (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfStockByClassTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfStockByClassTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.glowpoint.com/role/StockBasedCompensationTables", "longName": "9954475 - Disclosure - Stock Based Compensation (Tables)", "shortName": "Stock Based Compensation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.glowpoint.com/role/NetLossPerShareTables", "longName": "9954476 - Disclosure - Net Loss Per Share (Tables)", "shortName": "Net Loss Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.glowpoint.com/role/SegmentReportingTables", "longName": "9954477 - Disclosure - Segment Reporting (Tables)", "shortName": "Segment Reporting (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.glowpoint.com/role/BusinessDescriptionandSignificantAccountingPoliciesDetails", "longName": "9954478 - Disclosure - Business Description and Significant Accounting Policies (Details)", "shortName": "Business Description and Significant Accounting Policies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "26", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:CertificatesOfDepositAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "unique": true } }, "R27": { "role": "http://www.glowpoint.com/role/LiquidityDetails", "longName": "9954479 - Disclosure - Liquidity (Details)", "shortName": "Liquidity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "glow:WorkingCapital", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "unique": true } }, "R28": { "role": "http://www.glowpoint.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails", "longName": "9954480 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)", "shortName": "Accrued Expenses and Other Current Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.glowpoint.com/role/CapitalStockCommonStockDetails", "longName": "9954481 - Disclosure - Capital Stock - Common Stock (Details)", "shortName": "Capital Stock - Common Stock (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true }, "uniqueAnchor": null }, "R30": { "role": "http://www.glowpoint.com/role/CapitalStockCommonStockActivityDetails", "longName": "9954482 - Disclosure - Capital Stock - Common Stock Activity (Details)", "shortName": "Capital Stock - Common Stock Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:TreasuryStockCommonShares", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-21", "name": "us-gaap:SharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "unique": true } }, "R31": { "role": "http://www.glowpoint.com/role/CapitalStockWarrantsOutstandingDetails", "longName": "9954483 - Disclosure - Capital Stock - Warrants Outstanding (Details)", "shortName": "Capital Stock - Warrants Outstanding (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "c-3", "name": "glow:ClassOfWarrantOrRightIssued", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "glow:ClassOfWarrantOrRightIssued", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.glowpoint.com/role/CapitalStockWarrantsActivityDetails", "longName": "9954484 - Disclosure - Capital Stock - Warrants Activity (Details)", "shortName": "Capital Stock - Warrants Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "glow:ClassOfWarrantOrRightExercisable", "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-25", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "glow:ClassOfWarrantOrRightExercisable", "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "unique": true } }, "R33": { "role": "http://www.glowpoint.com/role/PreferredStockNarrativeDetails", "longName": "9954485 - Disclosure - Preferred Stock - Narrative (Details)", "shortName": "Preferred Stock - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:PreferredStockSharesAuthorized", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-42", "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "us-gaap:PreferredStockTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "unique": true } }, "R34": { "role": "http://www.glowpoint.com/role/PreferredStockScheduleofSeriesFPreferredStockTransactionsDetails", "longName": "9954486 - Disclosure - Preferred Stock - Schedule of Series F Preferred Stock Transactions (Details)", "shortName": "Preferred Stock - Schedule of Series F Preferred Stock Transactions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:PreferredStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:PreferredStockSharesIssued", "span", "div", "us-gaap:PreferredStockTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-35", "name": "glow:DividendsPreferredStockConversionOfStock", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "unique": true } }, "R35": { "role": "http://www.glowpoint.com/role/StockBasedCompensationNarrativeDetails", "longName": "9954487 - Disclosure - Stock Based Compensation - Narrative (Details)", "shortName": "Stock Based Compensation - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "span", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "span", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.glowpoint.com/role/StockBasedCompensationScheduleofOptionsOutstandingDetails", "longName": "9954488 - Disclosure - Stock Based Compensation - Schedule of Options Outstanding (Details)", "shortName": "Stock Based Compensation - Schedule of Options Outstanding (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "c-25", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-25", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.glowpoint.com/role/StockBasedCompensationScheduleofRestrictedStockandRestrictedStockUnitActivityDetails", "longName": "9954489 - Disclosure - Stock Based Compensation - Schedule of Restricted Stock and Restricted Stock Unit Activity (Details)", "shortName": "Stock Based Compensation - Schedule of Restricted Stock and Restricted Stock Unit Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "span", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-66", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "unique": true } }, "R38": { "role": "http://www.glowpoint.com/role/NetLossPerShareNarrativeDetails", "longName": "9954490 - Disclosure - Net Loss Per Share - Narrative (Details)", "shortName": "Net Loss Per Share - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.glowpoint.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedLossPerShareDetails", "longName": "9954491 - Disclosure - Net Loss Per Share - Schedule of Computation of Basic and Diluted Loss Per Share (Details)", "shortName": "Net Loss Per Share - Schedule of Computation of Basic and Diluted Loss Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true }, "uniqueAnchor": null }, "R40": { "role": "http://www.glowpoint.com/role/NetLossPerShareScheduleofEffectofAntidilutiveSecuritiesDetails", "longName": "9954492 - Disclosure - Net Loss Per Share - Schedule of Effect of Antidilutive Securities (Details)", "shortName": "Net Loss Per Share - Schedule of Effect of Antidilutive Securities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c-70", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-70", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.glowpoint.com/role/SegmentReportingScheduleofSegmentReportingInformationDetails", "longName": "9954493 - Disclosure - Segment Reporting - Schedule of Segment Reporting Information (Details)", "shortName": "Segment Reporting - Schedule of Segment Reporting Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "glow:GrossProfitPercentage", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "unique": true } }, "R42": { "role": "http://www.glowpoint.com/role/SegmentReportingScheduleofDisaggregationofRevenueDetails", "longName": "9954494 - Disclosure - Segment Reporting - Schedule of Disaggregation of Revenue (Details)", "shortName": "Segment Reporting - Schedule of Disaggregation of Revenue (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-126", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "unique": true } }, "R43": { "role": "http://www.glowpoint.com/role/SegmentReportingScheduleofConcentrationPercentageDetails", "longName": "9954495 - Disclosure - Segment Reporting - Schedule of Concentration Percentage (Details)", "shortName": "Segment Reporting - Schedule of Concentration Percentage (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-130", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-130", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "glow-20240331.htm", "first": true, "unique": true } } }, "tag": { "glow_A2019EquityIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "A2019EquityIncentivePlanMember", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2019 Equity Incentive Plan", "label": "2019 Equity Incentive Plan [Member]", "documentation": "2019 Equity Incentive Plan [Member]" } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Accounting Policies [Abstract]", "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "presentation": [ "http://www.glowpoint.com/role/AccruedExpensesandOtherCurrentLiabilities" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued Expenses and Other Current Liabilities", "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]", "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period." } } }, "auth_ref": [ "r13" ] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r12", "r521" ] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableMember", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofConcentrationPercentageDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Receivable", "label": "Accounts Receivable [Member]", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r486" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, net", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r214", "r215" ] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 }, "http://www.glowpoint.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.glowpoint.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails", "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued expenses and other current liabilities", "totalLabel": "Accrued expenses and other current liabilities", "label": "Accrued Liabilities, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r15" ] }, "us-gaap_AccruedProfessionalFeesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedProfessionalFeesCurrent", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.glowpoint.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Professional fees", "label": "Accrued Professional Fees, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r15" ] }, "us-gaap_AccruedRentCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedRentCurrent", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.glowpoint.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued rent", "label": "Accrued Rent, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for contractual rent under lease arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r15", "r502" ] }, "glow_AccruedSalesTaxesAndRegulatoryFees": { "xbrltype": "monetaryItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "AccruedSalesTaxesAndRegulatoryFees", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.glowpoint.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Taxes and regulatory fees", "label": "Accrued Sales Taxes and Regulatory Fees", "documentation": "Accrued Sales Taxes and Regulatory Fees" } } }, "auth_ref": [] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r573" ] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital, Common Stock", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r73" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-In Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r315", "r316", "r317", "r396", "r627", "r628", "r629", "r673", "r689" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r579" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r579" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r579" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r579" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r61", "r62", "r280" ] }, "glow_AdjustmentsToAdditionalPaidInCapitalSharesCommonStockExchangedForPrefundedWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "AdjustmentsToAdditionalPaidInCapitalSharesCommonStockExchangedForPrefundedWarrants", "presentation": [ "http://www.glowpoint.com/role/CapitalStockCommonStockActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Common shares exchanged for prepaid warrants (in shares)", "label": "Adjustments to Additional Paid in Capital, Shares, Common Stock Exchanged For Prefunded Warrants", "documentation": "Adjustments to Additional Paid in Capital, Shares, Common Stock Exchanged For Prefunded Warrants" } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r544", "r555", "r565", "r590" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r547", "r558", "r568", "r593" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r579" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r586" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r551", "r559", "r569", "r586", "r594", "r598", "r606" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r604" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock option compensation expense", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r310", "r318" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://www.glowpoint.com/role/BusinessDescriptionandSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization expense", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r5", "r44", "r46" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.glowpoint.com/role/NetLossPerShareScheduleofEffectofAntidilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive securities excluded from computation of earnings per share, amount (in shares)", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r167" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://www.glowpoint.com/role/NetLossPerShareScheduleofEffectofAntidilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities [Axis]", "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r28" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://www.glowpoint.com/role/NetLossPerShareScheduleofEffectofAntidilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://www.glowpoint.com/role/NetLossPerShareScheduleofEffectofAntidilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities, Name [Domain]", "label": "Antidilutive Securities, Name [Domain]", "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r28" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r96", "r115", "r137", "r178", "r199", "r205", "r216", "r238", "r239", "r241", "r242", "r243", "r245", "r247", "r249", "r250", "r324", "r326", "r338", "r355", "r435", "r521", "r535", "r639", "r640", "r676" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "ASSETS", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r112", "r120", "r137", "r216", "r238", "r239", "r241", "r242", "r243", "r245", "r247", "r249", "r250", "r324", "r326", "r338", "r521", "r639", "r640", "r676" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets:", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r601" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r602" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r597" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r597" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r597" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r597" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r597" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r597" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationNarrativeDetails", "http://www.glowpoint.com/role/StockBasedCompensationScheduleofRestrictedStockandRestrictedStockUnitActivityDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Axis]", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r600" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r599" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r598" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r598" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://www.glowpoint.com/role/BusinessDescriptionandSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Basis of Accounting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_Cash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Cash", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash", "label": "Cash", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r102", "r357", "r407", "r430", "r521", "r535", "r619" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 }, "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.glowpoint.com/role/BusinessDescriptionandSignificantAccountingPoliciesDetails", "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.glowpoint.com/role/LiquidityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "periodStartLabel": "Cash and cash equivalents at beginning of period", "periodEndLabel": "Cash and cash equivalents at end of period", "totalLabel": "Total cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r23", "r85", "r134" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Reconciliation of cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Decrease (increase) in cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r85" ] }, "us-gaap_CertificatesOfDepositAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CertificatesOfDepositAtCarryingValue", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.glowpoint.com/role/BusinessDescriptionandSignificantAccountingPoliciesDetails", "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Current certificates of deposit", "label": "Certificates of Deposit, at Carrying Value", "documentation": "A savings certificate entitling the Entity (that is, bearer) to receive interest at an established maturity date, based upon a fixed interest rate. A certificate of deposit may be issued in any denomination. Certificates of deposit are generally issued by commercial banks and, therefore, insured by the FDIC (up to the prescribed limit). Certificates of deposit generally restrict holders from withdrawing funds on demand without the incurrence of penalties. Generally, only certificates of deposit with original maturities of three months or less qualify as cash equivalents. Original maturity means original maturity to the entity holding the investment. As a related example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months." } } }, "auth_ref": [ "r619" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r577" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY", "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYParenthetical", "http://www.glowpoint.com/role/CapitalStockCommonStockDetails", "http://www.glowpoint.com/role/PreferredStockNarrativeDetails", "http://www.glowpoint.com/role/PreferredStockScheduleofSeriesFPreferredStockTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r108", "r116", "r117", "r118", "r137", "r157", "r161", "r164", "r166", "r172", "r173", "r216", "r238", "r241", "r242", "r243", "r249", "r250", "r253", "r254", "r258", "r261", "r268", "r338", "r391", "r392", "r393", "r394", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r408", "r422", "r444", "r461", "r479", "r480", "r481", "r482", "r483", "r612", "r625", "r630" ] }, "us-gaap_ClassOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockLineItems", "presentation": [ "http://www.glowpoint.com/role/CapitalStockCommonStockActivityDetails", "http://www.glowpoint.com/role/CapitalStockCommonStockDetails", "http://www.glowpoint.com/role/PreferredStockNarrativeDetails", "http://www.glowpoint.com/role/PreferredStockScheduleofSeriesFPreferredStockTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Line Items]", "label": "Class of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r116", "r117", "r118", "r172", "r253", "r254", "r256", "r258", "r261", "r266", "r268", "r391", "r392", "r393", "r394", "r510", "r612", "r625" ] }, "us-gaap_ClassOfWarrantOrRightAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightAxis", "presentation": [ "http://www.glowpoint.com/role/PreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Warrant or Right [Axis]", "label": "Class of Warrant or Right [Axis]", "documentation": "Information by type of warrant or right issued." } } }, "auth_ref": [ "r58" ] }, "us-gaap_ClassOfWarrantOrRightDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightDomain", "presentation": [ "http://www.glowpoint.com/role/PreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Warrant or Right [Domain]", "label": "Class of Warrant or Right [Domain]", "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "auth_ref": [] }, "glow_ClassOfWarrantOrRightExercisable": { "xbrltype": "sharesItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "ClassOfWarrantOrRightExercisable", "presentation": [ "http://www.glowpoint.com/role/CapitalStockWarrantsActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Warrants exercisable, beginning (in shares)", "periodEndLabel": "Warrants exercisable, ending (in shares)", "terseLabel": "Warrants exercisable, ending (in shares)", "label": "Class of Warrant Or Right, Exercisable", "documentation": "Class of Warrant Or Right, Exercisable" } } }, "auth_ref": [] }, "glow_ClassOfWarrantOrRightExercisableExercisePriceOfWarrants": { "xbrltype": "perShareItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "ClassOfWarrantOrRightExercisableExercisePriceOfWarrants", "presentation": [ "http://www.glowpoint.com/role/CapitalStockWarrantsActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Warrants exercisable, beginning (in dollars per share)", "periodEndLabel": "Warrants exercisable, ending (in dollars per share)", "terseLabel": "Warrants exercisable, ending (in dollars per share)", "label": "Class of Warrant Or Right, Exercisable, Exercise Price of Warrants", "documentation": "Class of Warrant Or Right, Exercisable, Exercise Price of Warrants" } } }, "auth_ref": [] }, "glow_ClassOfWarrantOrRightExercisableExercised": { "xbrltype": "sharesItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "ClassOfWarrantOrRightExercisableExercised", "presentation": [ "http://www.glowpoint.com/role/CapitalStockWarrantsActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Exercised (in shares)", "label": "Class Of Warrant Or Right, Exercisable, Exercised", "documentation": "Class Of Warrant Or Right, Exercisable, Exercised" } } }, "auth_ref": [] }, "glow_ClassOfWarrantOrRightExercisableExercisedWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "ClassOfWarrantOrRightExercisableExercisedWeightedAverageExercisePrice", "presentation": [ "http://www.glowpoint.com/role/CapitalStockWarrantsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercised (in dollars per share)", "label": "Class Of Warrant Or Right, Exercisable, Exercised, Weighted Average Exercise Price", "documentation": "Class Of Warrant Or Right, Exercisable, Exercised, Weighted Average Exercise Price" } } }, "auth_ref": [] }, "glow_ClassOfWarrantOrRightExercisableExpired": { "xbrltype": "sharesItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "ClassOfWarrantOrRightExercisableExpired", "presentation": [ "http://www.glowpoint.com/role/CapitalStockWarrantsActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Expired (in shares)", "label": "Class Of Warrant Or Right, Exercisable, Expired", "documentation": "Class Of Warrant Or Right, Exercisable, Expired" } } }, "auth_ref": [] }, "glow_ClassOfWarrantOrRightExercisableExpiredWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "ClassOfWarrantOrRightExercisableExpiredWeightedAverageExercisePrice", "presentation": [ "http://www.glowpoint.com/role/CapitalStockWarrantsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expired (in dollars per share)", "label": "Class Of Warrant Or Right, Exercisable, Expired, Weighted Average Exercise Price", "documentation": "Class Of Warrant Or Right, Exercisable, Expired, Weighted Average Exercise Price" } } }, "auth_ref": [] }, "glow_ClassOfWarrantOrRightExercisableForfeited": { "xbrltype": "sharesItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "ClassOfWarrantOrRightExercisableForfeited", "presentation": [ "http://www.glowpoint.com/role/CapitalStockWarrantsActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Forfeited (in shares)", "label": "Class Of Warrant Or Right, Exercisable, Forfeited", "documentation": "Class Of Warrant Or Right, Exercisable, Forfeited" } } }, "auth_ref": [] }, "glow_ClassOfWarrantOrRightExercisableForfeitedWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "ClassOfWarrantOrRightExercisableForfeitedWeightedAverageExercisePrice", "presentation": [ "http://www.glowpoint.com/role/CapitalStockWarrantsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forfeited (in dollars per share)", "label": "Class Of Warrant Or Right, Exercisable, Forfeited, Weighted Average Exercise Price", "documentation": "Class Of Warrant Or Right, Exercisable, Forfeited, Weighted Average Exercise Price" } } }, "auth_ref": [] }, "glow_ClassOfWarrantOrRightExercisableGranted": { "xbrltype": "sharesItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "ClassOfWarrantOrRightExercisableGranted", "presentation": [ "http://www.glowpoint.com/role/CapitalStockWarrantsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in shares)", "label": "Class Of Warrant Or Right, Exercisable, Granted", "documentation": "Class Of Warrant Or Right, Exercisable, Granted" } } }, "auth_ref": [] }, "glow_ClassOfWarrantOrRightExercisableGrantedWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "ClassOfWarrantOrRightExercisableGrantedWeightedAverageExercisePrice", "presentation": [ "http://www.glowpoint.com/role/CapitalStockWarrantsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in dollars per share)", "label": "Class Of Warrant Or Right, Exercisable, Granted, Weighted Average Exercise Price", "documentation": "Class Of Warrant Or Right, Exercisable, Granted, Weighted Average Exercise Price" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://www.glowpoint.com/role/CapitalStockWarrantsActivityDetails", "http://www.glowpoint.com/role/CapitalStockWarrantsOutstandingDetails", "http://www.glowpoint.com/role/PreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Exercise price (in dollars per share)", "periodStartLabel": "Warrants outstanding, beginning (in dollars per share)", "periodEndLabel": "Warrants outstanding, ending (in dollars per share)", "terseLabel": "Warrants outstanding, ending (in dollars per share)", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r269" ] }, "glow_ClassOfWarrantOrRightExercised": { "xbrltype": "sharesItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "ClassOfWarrantOrRightExercised", "presentation": [ "http://www.glowpoint.com/role/CapitalStockWarrantsActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Exercised (in shares)", "label": "Class Of Warrant Or Right, Exercised", "documentation": "Class Of Warrant Or Right, Exercised" } } }, "auth_ref": [] }, "glow_ClassOfWarrantOrRightExercisedWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "ClassOfWarrantOrRightExercisedWeightedAverageExercisePrice", "presentation": [ "http://www.glowpoint.com/role/CapitalStockWarrantsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercised (in dollars per share)", "label": "Class Of Warrant Or Right, Exercised, Weighted Average Exercise Price", "documentation": "Class Of Warrant Or Right, Exercised, Weighted Average Exercise Price" } } }, "auth_ref": [] }, "glow_ClassOfWarrantOrRightExpirationPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "ClassOfWarrantOrRightExpirationPeriod", "presentation": [ "http://www.glowpoint.com/role/PreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expiration period", "label": "Class of Warrant Or Right, Expiration Period", "documentation": "Class of Warrant Or Right, Expiration Period" } } }, "auth_ref": [] }, "glow_ClassOfWarrantOrRightExpired": { "xbrltype": "sharesItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "ClassOfWarrantOrRightExpired", "presentation": [ "http://www.glowpoint.com/role/CapitalStockWarrantsActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Expired (in shares)", "label": "Class of Warrant Or Right, Expired", "documentation": "Class of Warrant Or Right, Expired" } } }, "auth_ref": [] }, "glow_ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice", "presentation": [ "http://www.glowpoint.com/role/CapitalStockWarrantsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expired (in dollars per share)", "label": "Class Of Warrant Or Right, Expired, Weighted Average Exercise Price", "documentation": "Class Of Warrant Or Right, Expired, Weighted Average Exercise Price" } } }, "auth_ref": [] }, "glow_ClassOfWarrantOrRightForfeited": { "xbrltype": "sharesItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "ClassOfWarrantOrRightForfeited", "presentation": [ "http://www.glowpoint.com/role/CapitalStockWarrantsActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Forfeited (in shares)", "label": "Class Of Warrant Or Right, Forfeited", "documentation": "Class Of Warrant Or Right, Forfeited" } } }, "auth_ref": [] }, "glow_ClassOfWarrantOrRightForfeitedWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "ClassOfWarrantOrRightForfeitedWeightedAverageExercisePrice", "presentation": [ "http://www.glowpoint.com/role/CapitalStockWarrantsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forfeited (in dollars per share)", "label": "Class Of Warrant Or Right, Forfeited, Weighted Average Exercise Price", "documentation": "Class Of Warrant Or Right, Forfeited, Weighted Average Exercise Price" } } }, "auth_ref": [] }, "glow_ClassOfWarrantOrRightGranted": { "xbrltype": "sharesItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "ClassOfWarrantOrRightGranted", "presentation": [ "http://www.glowpoint.com/role/CapitalStockWarrantsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in shares)", "label": "Class Of Warrant Or Right, Granted", "documentation": "Class Of Warrant Or Right, Granted" } } }, "auth_ref": [] }, "glow_ClassOfWarrantOrRightGrantedWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "ClassOfWarrantOrRightGrantedWeightedAverageExercisePrice", "presentation": [ "http://www.glowpoint.com/role/CapitalStockWarrantsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in dollars per share)", "label": "Class Of Warrant Or Right, Granted, Weighted Average Exercise Price", "documentation": "Class Of Warrant Or Right, Granted, Weighted Average Exercise Price" } } }, "auth_ref": [] }, "glow_ClassOfWarrantOrRightIssued": { "xbrltype": "sharesItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "ClassOfWarrantOrRightIssued", "presentation": [ "http://www.glowpoint.com/role/CapitalStockWarrantsOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants issued (in shares)", "label": "Class of Warrant or Right, Issued", "documentation": "Class of Warrant or Right, Issued" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://www.glowpoint.com/role/PreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares issuable (in shares)", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares." } } }, "auth_ref": [ "r269" ] }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightOutstanding", "presentation": [ "http://www.glowpoint.com/role/CapitalStockWarrantsActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Warrants outstanding, beginning (in shares)", "periodEndLabel": "Warrants outstanding, ending (in shares)", "terseLabel": "Warrants outstanding, ending (in shares)", "label": "Class of Warrant or Right, Outstanding", "documentation": "Number of warrants or rights outstanding." } } }, "auth_ref": [] }, "glow_ClassOfWarrantOrRightPercentageOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "percentItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "ClassOfWarrantOrRightPercentageOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://www.glowpoint.com/role/PreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of common stock issuable (in percent)", "label": "Class Of Warrant Or Right, Percentage Of Securities Called By Warrants Or Rights", "documentation": "Class Of Warrant Or Right, Percentage Of Securities Called By Warrants Or Rights" } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r578" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r578" ] }, "glow_CollaborationProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "CollaborationProductsMember", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofConcentrationPercentageDetails", "http://www.glowpoint.com/role/SegmentReportingScheduleofDisaggregationofRevenueDetails", "http://www.glowpoint.com/role/SegmentReportingScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collaboration Products", "label": "Collaboration Products [Member]", "documentation": "Collaboration Products [Member]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingencies (see Note 9)", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r17", "r66", "r356", "r421" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies Disclosure [Abstract]", "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.glowpoint.com/role/CommitmentsandContingencies" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r90", "r232", "r233", "r487", "r636" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY", "http://www.glowpoint.com/role/CapitalStockCommonStockActivityDetails", "http://www.glowpoint.com/role/CapitalStockCommonStockDetails", "http://www.glowpoint.com/role/PreferredStockNarrativeDetails", "http://www.glowpoint.com/role/PreferredStockScheduleofSeriesFPreferredStockTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r524", "r525", "r526", "r528", "r529", "r530", "r531", "r627", "r628", "r673", "r688", "r689" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.glowpoint.com/role/CapitalStockCommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value (in dollars per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r72" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.glowpoint.com/role/CapitalStockCommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r72", "r422" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY", "http://www.glowpoint.com/role/CapitalStockCommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares issued (in shares)", "periodStartLabel": "Common stock, beginning balance (in shares)", "periodEndLabel": "Common stock, ending balance (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r72" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.glowpoint.com/role/CapitalStockCommonStockActivityDetails", "http://www.glowpoint.com/role/CapitalStockCommonStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares outstanding (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r6", "r72", "r422", "r441", "r689", "r690" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, $.0001 par value; 150,000,000 shares authorized; 20,294,228 shares issued and 20,285,675 outstanding at March\u00a031, 2024 and 16,692,124 shares issued and 16,683,572 shares outstanding at December\u00a031, 2023", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r72", "r359", "r521" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r583" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r582" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r584" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r581" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofConcentrationPercentageDetails", "http://www.glowpoint.com/role/SegmentReportingScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Domain]", "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r30", "r33", "r64", "r65", "r213", "r486" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofConcentrationPercentageDetails", "http://www.glowpoint.com/role/SegmentReportingScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Axis]", "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r30", "r33", "r64", "r65", "r213", "r389", "r486" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofConcentrationPercentageDetails", "http://www.glowpoint.com/role/SegmentReportingScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Axis]", "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r30", "r33", "r64", "r65", "r213", "r486", "r614" ] }, "us-gaap_ConcentrationRiskLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskLineItems", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofConcentrationPercentageDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk [Line Items]", "label": "Concentration Risk [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r486" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofConcentrationPercentageDetails", "http://www.glowpoint.com/role/SegmentReportingScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Percentage of revenue (in percent)", "terseLabel": "Concentration risk, percentage (in percent)", "label": "Concentration Risk, Percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r30", "r33", "r64", "r65", "r213" ] }, "us-gaap_ConcentrationRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTable", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofConcentrationPercentageDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk [Table]", "label": "Concentration Risk [Table]", "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark." } } }, "auth_ref": [ "r29", "r30", "r33", "r34", "r64", "r95", "r486" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofConcentrationPercentageDetails", "http://www.glowpoint.com/role/SegmentReportingScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Domain]", "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r30", "r33", "r64", "r65", "r213", "r486" ] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsAxis", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Axis]", "label": "Consolidation Items [Axis]" } } }, "auth_ref": [ "r138", "r180", "r197", "r198", "r199", "r200", "r201", "r203", "r207", "r238", "r239", "r240", "r241", "r243", "r244", "r246", "r248", "r249", "r639", "r640" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsDomain", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Domain]", "label": "Consolidation Items [Domain]" } } }, "auth_ref": [ "r138", "r180", "r197", "r198", "r199", "r200", "r201", "r203", "r207", "r238", "r239", "r240", "r241", "r243", "r244", "r246", "r248", "r249", "r639", "r640" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://www.glowpoint.com/role/BusinessDescriptionandSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Principles of Consolidation", "label": "Consolidation, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r63", "r503" ] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Current portion of deferred revenue", "label": "Contract with Customer, Liability, Current", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r271", "r272", "r275" ] }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue, net of current portion", "label": "Contract with Customer, Liability, Noncurrent", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent." } } }, "auth_ref": [ "r271", "r272", "r275" ] }, "us-gaap_ConversionOfStockSharesConverted1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockSharesConverted1", "presentation": [ "http://www.glowpoint.com/role/CapitalStockCommonStockDetails", "http://www.glowpoint.com/role/PreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares converted (in shares)", "label": "Conversion of Stock, Shares Converted", "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r25", "r26", "r27" ] }, "us-gaap_ConversionOfStockSharesIssued1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockSharesIssued1", "presentation": [ "http://www.glowpoint.com/role/CapitalStockCommonStockDetails", "http://www.glowpoint.com/role/PreferredStockNarrativeDetails", "http://www.glowpoint.com/role/PreferredStockScheduleofSeriesFPreferredStockTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common shares issued in conversion (in shares)", "label": "Conversion of Stock, Shares Issued", "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r25", "r26", "r27" ] }, "us-gaap_ConvertibleDebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleDebtSecuritiesMember", "presentation": [ "http://www.glowpoint.com/role/NetLossPerShareScheduleofEffectofAntidilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issuable upon conversion of Series F Preferred Stock", "label": "Convertible Debt Securities [Member]", "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder." } } }, "auth_ref": [ "r645" ] }, "us-gaap_CorporateNonSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CorporateNonSegmentMember", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate", "verboseLabel": "Unallocated operating expenses", "label": "Corporate, Non-Segment [Member]", "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment." } } }, "auth_ref": [ "r9", "r198", "r199", "r200", "r201", "r207", "r633" ] }, "us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.glowpoint.com/role/SegmentReportingScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Cost of revenue (exclusive of depreciation and amortization)", "terseLabel": "Cost of revenues", "label": "Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization", "documentation": "Cost of product sold and service rendered, excluding depreciation, depletion, and amortization." } } }, "auth_ref": [ "r617", "r618" ] }, "us-gaap_CostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpenses", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.glowpoint.com/role/SegmentReportingScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "verboseLabel": "Total operating expenses", "label": "Costs and Expenses", "documentation": "Total costs of sales and operating expenses for the period." } } }, "auth_ref": [ "r80" ] }, "us-gaap_CostsAndExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpensesAbstract", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Operating expenses:", "label": "Costs and Expenses [Abstract]" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofConcentrationPercentageDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer Concentration Risk", "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r31", "r213" ] }, "glow_CustomerNumberFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "CustomerNumberFiveMember", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofConcentrationPercentageDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer E", "label": "Customer Number Five [Member]", "documentation": "Customer Number Five" } } }, "auth_ref": [] }, "glow_CustomerNumberFourMember": { "xbrltype": "domainItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "CustomerNumberFourMember", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofConcentrationPercentageDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer D", "label": "Customer Number Four [Member]", "documentation": "Customer Number Four" } } }, "auth_ref": [] }, "glow_CustomerNumberOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "CustomerNumberOneMember", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofConcentrationPercentageDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer A", "label": "Customer Number One [Member]", "documentation": "Customer Number One [Member]" } } }, "auth_ref": [] }, "glow_CustomerNumberThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "CustomerNumberThreeMember", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofConcentrationPercentageDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer C", "label": "Customer Number Three [Member]", "documentation": "Customer Number Three [Member]" } } }, "auth_ref": [] }, "glow_CustomerNumberTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "CustomerNumberTwoMember", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofConcentrationPercentageDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer B", "label": "Customer Number Two [Member]", "documentation": "Customer Number Two [Member]" } } }, "auth_ref": [] }, "glow_DenominatorAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "DenominatorAbstract", "presentation": [ "http://www.glowpoint.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedLossPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Denominator:", "label": "Denominator [Abstract]", "documentation": "Denominator [Abstract]" } } }, "auth_ref": [] }, "glow_DepositsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "DepositsCurrent", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.glowpoint.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer deposits", "label": "Deposits, Current", "documentation": "Deposits, Current" } } }, "auth_ref": [] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationAndAmortization", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization, Nonproduction", "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production." } } }, "auth_ref": [ "r5", "r47" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "verboseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r5", "r183" ] }, "us-gaap_DisaggregationOfRevenueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueLineItems", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Line Items]", "label": "Disaggregation of Revenue [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r274", "r511", "r512", "r513", "r514", "r515", "r516", "r517" ] }, "us-gaap_DisaggregationOfRevenueTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTable", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Table]", "label": "Disaggregation of Revenue [Table]", "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r274", "r511", "r512", "r513", "r514", "r515", "r516", "r517" ] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Disaggregated Revenue Information", "label": "Disaggregation of Revenue [Table Text Block]", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r644" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensation" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Based Compensation", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r278", "r283", "r311", "r312", "r314", "r519" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement [Abstract]", "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DividendsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPayableCurrent", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.glowpoint.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued dividends on Series F Preferred Stock", "label": "Dividends Payable, Current", "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r15" ] }, "us-gaap_DividendsPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPayableCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYParenthetical", "http://www.glowpoint.com/role/CapitalStockCommonStockDetails", "http://www.glowpoint.com/role/PreferredStockNarrativeDetails", "http://www.glowpoint.com/role/PreferredStockScheduleofSeriesFPreferredStockTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock dividends", "verboseLabel": "Preferred Stock Dividends", "label": "Dividends Payable", "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding." } } }, "auth_ref": [ "r69", "r70", "r97", "r532", "r685" ] }, "us-gaap_DividendsPreferredStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPreferredStock", "crdr": "debit", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY", "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.glowpoint.com/role/PreferredStockScheduleofSeriesFPreferredStockTransactionsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Series F Preferred Stock dividends", "terseLabel": "Preferred stock dividends", "verboseLabel": "Accrued dividends", "label": "Dividends, Preferred Stock", "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK)." } } }, "auth_ref": [ "r3", "r94" ] }, "glow_DividendsPreferredStockConversionOfStock": { "xbrltype": "monetaryItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "DividendsPreferredStockConversionOfStock", "crdr": "debit", "presentation": [ "http://www.glowpoint.com/role/PreferredStockScheduleofSeriesFPreferredStockTransactionsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Conversions, preferred stock dividends", "label": "Dividends, Preferred Stock, Conversion Of Stock", "documentation": "Dividends, Preferred Stock, Conversion Of Stock" } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r539" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r572" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss attributable to common stockholders per share:", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.glowpoint.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedLossPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic net loss per share (in dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r126", "r144", "r145", "r146", "r147", "r148", "r153", "r157", "r164", "r165", "r166", "r170", "r336", "r337", "r353", "r364", "r504" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.glowpoint.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedLossPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted net loss per share (in dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r126", "r144", "r145", "r146", "r147", "r148", "r157", "r164", "r165", "r166", "r170", "r336", "r337", "r353", "r364", "r504" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.glowpoint.com/role/NetLossPerShare" ], "lang": { "en-us": { "role": { "terseLabel": "Net Loss Per Share", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r152", "r167", "r168", "r169" ] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.glowpoint.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation costs", "label": "Employee-related Liabilities, Current", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r15" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unamortized expense related to restricted stock", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r313" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost not yet recognized, period for recognition", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r313" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "crdr": "debit", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized stock-based compensation expense for stock options", "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "documentation": "Amount of cost to be recognized for option under share-based payment arrangement." } } }, "auth_ref": [ "r672" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://www.glowpoint.com/role/NetLossPerShareScheduleofEffectofAntidilutiveSecuritiesDetails", "http://www.glowpoint.com/role/StockBasedCompensationNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Options", "verboseLabel": "Outstanding stock options", "label": "Employee Stock Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r537" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r537" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r537" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r611" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r537" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r537" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r537" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r537" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Equity [Abstract]", "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY", "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYParenthetical", "http://www.glowpoint.com/role/CapitalStockCommonStockActivityDetails", "http://www.glowpoint.com/role/CapitalStockCommonStockDetails", "http://www.glowpoint.com/role/PreferredStockNarrativeDetails", "http://www.glowpoint.com/role/PreferredStockScheduleofSeriesFPreferredStockTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r6", "r109", "r123", "r124", "r125", "r139", "r140", "r141", "r143", "r149", "r151", "r171", "r217", "r218", "r270", "r315", "r316", "r317", "r321", "r322", "r328", "r329", "r330", "r331", "r332", "r333", "r335", "r339", "r340", "r341", "r342", "r343", "r344", "r348", "r384", "r385", "r386", "r396", "r461" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r580" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r544", "r555", "r565", "r590" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r541", "r552", "r562", "r587" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r586" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r548", "r559", "r569", "r594" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r548", "r559", "r569", "r594" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r548", "r559", "r569", "r594" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r548", "r559", "r569", "r594" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r548", "r559", "r569", "r594" ] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "General and administrative", "label": "General and Administrative Expense", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r82", "r446" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.glowpoint.com/role/SegmentReportingScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r81", "r137", "r178", "r198", "r204", "r207", "r216", "r238", "r239", "r241", "r242", "r243", "r245", "r247", "r249", "r250", "r338", "r506", "r639" ] }, "glow_GrossProfitPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "GrossProfitPercentage", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross profit %", "label": "Gross Profit, Percentage", "documentation": "Gross Profit, Percentage" } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.glowpoint.com/role/SegmentReportingScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Loss before income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r78", "r99", "r178", "r198", "r204", "r207", "r354", "r362", "r506" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.glowpoint.com/role/SegmentReportingScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax expense", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r101", "r107", "r150", "r151", "r186", "r320", "r323", "r365" ] }, "us-gaap_IncomeTaxesPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaid", "crdr": "credit", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash paid for income taxes", "label": "Income Taxes Paid", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income." } } }, "auth_ref": [ "r22", "r24" ] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable", "label": "Increase (Decrease) in Accounts Payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r4" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r4" ] }, "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued expenses and other current liabilities", "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities", "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other." } } }, "auth_ref": [ "r623" ] }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInContractWithCustomerLiability", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue", "label": "Increase (Decrease) in Contract with Customer, Liability", "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r351", "r623" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Inventory", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r4" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in operating assets and liabilities:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingLeaseLiability", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Lease liabilities", "label": "Increase (Decrease) in Operating Lease Liability", "documentation": "Amount of increase (decrease) in obligation for operating lease." } } }, "auth_ref": [ "r615", "r623" ] }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingAssets", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Other assets", "label": "Increase (Decrease) in Other Operating Assets", "documentation": "Amount of increase (decrease) in operating assets classified as other." } } }, "auth_ref": [ "r4" ] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other current assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r4" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY", "http://www.glowpoint.com/role/CapitalStockCommonStockActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "presentation": [ "http://www.glowpoint.com/role/NetLossPerShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average shares common stock outstanding, potentially dilutive securities or unvested restricted stock (in shares)", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r158", "r159", "r160", "r166", "r282" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r551", "r559", "r569", "r586", "r594", "r598", "r606" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r604" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r540", "r610" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r540", "r610" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r540", "r610" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "presentation": [ "http://www.glowpoint.com/role/BusinessDescriptionandSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangibles, net", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r43", "r45" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash paid during the period for interest", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r130", "r132", "r133" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory, net", "label": "Inventory, Net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r119", "r501", "r521" ] }, "glow_InvestorWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "InvestorWarrantsMember", "presentation": [ "http://www.glowpoint.com/role/PreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investor Warrants", "label": "Investor Warrants [Member]", "documentation": "Investor Warrants" } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r14", "r137", "r216", "r238", "r239", "r241", "r242", "r243", "r245", "r247", "r249", "r250", "r325", "r326", "r327", "r338", "r420", "r505", "r535", "r639", "r676", "r677" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and stockholders\u2019 equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r77", "r98", "r361", "r521", "r626", "r634", "r674" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r16", "r113", "r137", "r216", "r238", "r239", "r241", "r242", "r243", "r245", "r247", "r249", "r250", "r325", "r326", "r327", "r338", "r521", "r639", "r676", "r677" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities:", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesNoncurrentAbstract", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term liabilities:", "label": "Liabilities, Noncurrent [Abstract]" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofConcentrationPercentageDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer [Axis]", "label": "Customer [Axis]" } } }, "auth_ref": [ "r213", "r513", "r644", "r686", "r687" ] }, "glow_ManagedServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "ManagedServicesMember", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofConcentrationPercentageDetails", "http://www.glowpoint.com/role/SegmentReportingScheduleofDisaggregationofRevenueDetails", "http://www.glowpoint.com/role/SegmentReportingScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Managed Services", "label": "Managed Services [Member]", "documentation": "Managed Services [Member]" } } }, "auth_ref": [] }, "us-gaap_MaterialReconcilingItemsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MaterialReconcilingItemsMember", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Allocated operating expenses", "label": "Segment Reconciling Items [Member]", "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity." } } }, "auth_ref": [ "r41" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.glowpoint.com/role/PreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]" } } }, "auth_ref": [ "r234", "r235", "r236", "r237", "r277", "r350", "r383", "r412", "r413", "r466", "r469", "r473", "r474", "r476", "r497", "r498", "r508", "r510", "r518", "r523", "r641", "r678", "r679", "r680", "r681", "r682", "r683" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r578" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r578" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r597" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r605" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofConcentrationPercentageDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer [Domain]", "label": "Customer [Domain]" } } }, "auth_ref": [ "r213", "r513", "r644", "r686", "r687" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r579" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r131" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from financing activities:", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.glowpoint.com/role/LiquidityDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities", "negatedLabel": "Net cash used in operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r85", "r86", "r87" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from operating activities:", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0, "order": 2.0 }, "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY", "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.glowpoint.com/role/LiquidityDetails", "http://www.glowpoint.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedLossPerShareDetails", "http://www.glowpoint.com/role/SegmentReportingScheduleofSegmentReportingInformationDetails", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "terseLabel": "Net loss", "verboseLabel": "Net loss", "negatedLabel": "Net loss", "netLabel": "Net loss", "label": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r79", "r87", "r100", "r111", "r121", "r122", "r125", "r137", "r142", "r144", "r145", "r146", "r147", "r150", "r151", "r162", "r178", "r198", "r204", "r207", "r216", "r238", "r239", "r241", "r242", "r243", "r245", "r247", "r249", "r250", "r337", "r338", "r363", "r443", "r459", "r460", "r506", "r533", "r639" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.glowpoint.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedLossPerShareDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss attributable to common stockholders", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r129", "r144", "r145", "r146", "r147", "r153", "r154", "r163", "r166", "r178", "r198", "r204", "r207", "r506" ] }, "glow_NetworkServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "NetworkServicesMember", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Network services", "label": "Network Services [Member]", "documentation": "Network Services [Member]" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.glowpoint.com/role/BusinessDescriptionandSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Recently Issued Accounting Pronouncements", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r578" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r548", "r559", "r569", "r586", "r594" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r576" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r575" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r586" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r605" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r605" ] }, "us-gaap_NonUsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonUsMember", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign", "label": "Non-US [Member]", "documentation": "Countries excluding the United States of America (US)." } } }, "auth_ref": [ "r691", "r692", "r693", "r694" ] }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncashInvestingAndFinancingItemsAbstract", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash investing and financing activities:", "label": "Noncash Investing and Financing Items [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.glowpoint.com/role/SegmentReportingScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Interest and other income, net", "negatedLabel": "Interest and other income, net", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r83" ] }, "glow_NumberOfExercisableAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "NumberOfExercisableAbstract", "presentation": [ "http://www.glowpoint.com/role/CapitalStockWarrantsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Warrants", "label": "Number Of Exercisable [Abstract]", "documentation": "Number Of Exercisable" } } }, "auth_ref": [] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfOperatingSegments", "presentation": [ "http://www.glowpoint.com/role/BusinessDescriptionandSignificantAccountingPoliciesDetails", "http://www.glowpoint.com/role/SegmentReportingScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of operating segments", "label": "Number of Operating Segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r632" ] }, "glow_NumberOfWarrantsOutstandingRollForward": { "xbrltype": "stringItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "NumberOfWarrantsOutstandingRollForward", "presentation": [ "http://www.glowpoint.com/role/CapitalStockWarrantsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Warrants", "label": "Number Of Warrants Outstanding [Roll Forward]", "documentation": "Number Of Warrants Outstanding" } } }, "auth_ref": [] }, "glow_NumeratorAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "NumeratorAbstract", "presentation": [ "http://www.glowpoint.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedLossPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Numerator:", "label": "Numerator [Abstract]", "documentation": "Numerator [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.glowpoint.com/role/SegmentReportingScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r178", "r198", "r204", "r207", "r506" ] }, "us-gaap_OperatingLeaseExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseExpense", "crdr": "debit", "presentation": [ "http://www.glowpoint.com/role/BusinessDescriptionandSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash lease expense", "label": "Operating Lease, Expense", "documentation": "Amount of operating lease expense. Excludes sublease income." } } }, "auth_ref": [ "r675" ] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "presentation": [ "http://www.glowpoint.com/role/BusinessDescriptionandSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total operating lease liabilities", "label": "Operating Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r346" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "verboseLabel": "Operating lease liabilities", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r346" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.glowpoint.com/role/BusinessDescriptionandSignificantAccountingPoliciesDetails", "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease - right of use asset, net", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r345" ] }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash lease expense from right-of-use asset", "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction", "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease." } } }, "auth_ref": [ "r624" ] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingSegmentsMember", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Segments", "label": "Operating Segments [Member]", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r197", "r198", "r199", "r200", "r201", "r207" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.glowpoint.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other accrued expenses and liabilities", "label": "Other Accrued Liabilities, Current", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r15" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r114" ] }, "us-gaap_OtherLiabilitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Other Liabilities Disclosure [Abstract]", "label": "Other Liabilities Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherNonoperatingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingExpense", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Interest and other expense, net", "label": "Other Nonoperating Expense", "documentation": "Amount of expense related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r84" ] }, "us-gaap_OtherNonoperatingIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncome", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other income", "label": "Other Nonoperating Income", "documentation": "Amount of income related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r128" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r578" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r546", "r557", "r567", "r592" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r549", "r560", "r570", "r595" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r549", "r560", "r570", "r595" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r574" ] }, "us-gaap_PaymentsOfStockIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfStockIssuanceCosts", "crdr": "credit", "presentation": [ "http://www.glowpoint.com/role/PreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finance costs related to Series F Preferred Stock", "label": "Payments of Stock Issuance Costs", "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security." } } }, "auth_ref": [ "r21" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r577" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r577" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r576" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r586" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r579" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r575" ] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name [Axis]", "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name [Domain]", "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671" ] }, "us-gaap_PreferredStockConvertibleConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockConvertibleConversionPrice", "presentation": [ "http://www.glowpoint.com/role/NetLossPerShareNarrativeDetails", "http://www.glowpoint.com/role/PreferredStockNarrativeDetails", "http://www.glowpoint.com/role/PreferredStockScheduleofSeriesFPreferredStockTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average conversion price (in dollars per share)", "label": "Preferred Stock, Convertible, Conversion Price", "documentation": "Per share conversion price of preferred stock." } } }, "auth_ref": [ "r255" ] }, "glow_PreferredStockConvertibleConversionPricePercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "PreferredStockConvertibleConversionPricePercentage", "presentation": [ "http://www.glowpoint.com/role/PreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, conversion price percentage (in percent)", "label": "Preferred Stock, Convertible, Conversion Price Percentage", "documentation": "Preferred Stock, Convertible, Conversion Price Percentage" } } }, "auth_ref": [] }, "glow_PreferredStockConvertibleThresholdConsecutiveTradingDays": { "xbrltype": "durationItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "PreferredStockConvertibleThresholdConsecutiveTradingDays", "presentation": [ "http://www.glowpoint.com/role/PreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock convertible, threshold consecutive trading days", "label": "Preferred Stock, Convertible, Threshold Consecutive Trading Days", "documentation": "Preferred Stock, Convertible, Threshold Consecutive Trading Days" } } }, "auth_ref": [] }, "glow_PreferredStockConvertibleWeightedAverageConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "PreferredStockConvertibleWeightedAverageConversionPrice", "presentation": [ "http://www.glowpoint.com/role/PreferredStockScheduleofSeriesFPreferredStockTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average conversion price (in dollars per share)", "label": "Preferred Stock, Convertible, Weighted Average Conversion Price", "documentation": "Preferred Stock, Convertible, Weighted Average Conversion Price" } } }, "auth_ref": [] }, "us-gaap_PreferredStockDividendRatePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockDividendRatePercentage", "presentation": [ "http://www.glowpoint.com/role/PreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Preferred stock dividend percentage (in percent)", "label": "Preferred Stock, Dividend Rate, Percentage", "documentation": "The percentage rate used to calculate dividend payments on preferred stock." } } }, "auth_ref": [ "r254", "r467", "r470", "r472", "r477" ] }, "us-gaap_PreferredStockDividendsIncomeStatementImpact": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockDividendsIncomeStatementImpact", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.glowpoint.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedLossPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock dividends", "negatedTerseLabel": "Less: preferred stock dividends", "label": "Preferred Stock Dividends, Income Statement Impact", "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders." } } }, "auth_ref": [] }, "us-gaap_PreferredStockLiquidationPreference": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockLiquidationPreference", "presentation": [ "http://www.glowpoint.com/role/PreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, liquidation preference per share (in dollars per share)", "label": "Preferred Stock, Liquidation Preference Per Share", "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share." } } }, "auth_ref": [ "r52", "r53", "r71", "r625", "r642" ] }, "us-gaap_PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockMember", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY", "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYParenthetical", "http://www.glowpoint.com/role/CapitalStockCommonStockDetails", "http://www.glowpoint.com/role/PreferredStockScheduleofSeriesFPreferredStockTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred Stock", "label": "Preferred Stock [Member]", "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company." } } }, "auth_ref": [ "r524", "r525", "r528", "r529", "r530", "r531", "r688", "r689" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.glowpoint.com/role/PreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, convertible, par value (in dollars per share)", "label": "Preferred Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r71", "r253" ] }, "glow_PreferredStockScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "PreferredStockScenarioAxis", "presentation": [ "http://www.glowpoint.com/role/PreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred Stock, Scenario [Axis]", "label": "Preferred Stock, Scenario [Axis]", "documentation": "Preferred Stock, Scenario" } } }, "auth_ref": [] }, "glow_PreferredStockScenarioDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "PreferredStockScenarioDomain", "presentation": [ "http://www.glowpoint.com/role/PreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred Stock, Scenario [Domain]", "label": "Preferred Stock, Scenario [Domain]", "documentation": "Preferred Stock, Scenario [Domain]" } } }, "auth_ref": [] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.glowpoint.com/role/PreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, convertible, shares authorized (in shares)", "label": "Preferred Stock, Shares Authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r71", "r422" ] }, "glow_PreferredStockSharesDesignated": { "xbrltype": "sharesItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "PreferredStockSharesDesignated", "presentation": [ "http://www.glowpoint.com/role/PreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares designated (in shares)", "label": "Preferred Stock, Shares Designated", "documentation": "Preferred Stock, Shares Designated" } } }, "auth_ref": [] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.glowpoint.com/role/PreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares issued (in shares)", "label": "Preferred Stock, Shares Issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r71", "r253" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY", "http://www.glowpoint.com/role/PreferredStockNarrativeDetails", "http://www.glowpoint.com/role/PreferredStockScheduleofSeriesFPreferredStockTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares outstanding (in shares)", "periodStartLabel": "Preferred stock, beginning balance (in shares)", "periodEndLabel": "Preferred stock, ending balance (in shares)", "label": "Preferred Stock, Shares Outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r71", "r422", "r441", "r689", "r690" ] }, "glow_PreferredStockStatedValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "PreferredStockStatedValue", "crdr": "debit", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, convertible, stated value", "label": "Preferred Stock, Stated Value", "documentation": "Preferred Stock, Stated Value" } } }, "auth_ref": [] }, "us-gaap_PreferredStockTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockTextBlock", "presentation": [ "http://www.glowpoint.com/role/PreferredStock" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred Stock", "label": "Preferred Stock [Text Block]", "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock." } } }, "auth_ref": [ "r91" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock Series F, convertible; $.0001 par value; $1,102,150 stated value; 42,000 shares authorized, 1,008 and 1,930 shares issued and outstanding at March\u00a031, 2024 and December\u00a031, 2023, respectively", "label": "Preferred Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r71", "r358", "r521" ] }, "glow_PreferredWarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "PreferredWarrantMember", "presentation": [ "http://www.glowpoint.com/role/NetLossPerShareScheduleofEffectofAntidilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issuable upon conversion of Series F Preferred Warrants", "label": "Preferred Warrant [Member]", "documentation": "Preferred Warrant" } } }, "auth_ref": [] }, "glow_PreferredWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "PreferredWarrantsMember", "presentation": [ "http://www.glowpoint.com/role/PreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred Warrants", "label": "Preferred Warrants [Member]", "documentation": "Preferred Warrants" } } }, "auth_ref": [] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "label": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r622" ] }, "us-gaap_PrivatePlacementMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrivatePlacementMember", "presentation": [ "http://www.glowpoint.com/role/PreferredStockNarrativeDetails", "http://www.glowpoint.com/role/PreferredStockScheduleofSeriesFPreferredStockTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Private Placement", "label": "Private Placement [Member]", "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock", "crdr": "debit", "presentation": [ "http://www.glowpoint.com/role/PreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross proceeds", "label": "Proceeds from Issuance of Preferred Stock and Preference Stock", "documentation": "Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation." } } }, "auth_ref": [ "r2" ] }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfPrivatePlacement", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from private placement, net of issuance costs and amounts in escrow", "label": "Proceeds from Issuance of Private Placement", "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement." } } }, "auth_ref": [ "r2" ] }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOrSaleOfEquity", "crdr": "debit", "presentation": [ "http://www.glowpoint.com/role/PreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from private placement, net of issuance costs and amounts in escrow", "label": "Proceeds from Issuance or Sale of Equity", "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity." } } }, "auth_ref": [ "r2", "r391" ] }, "us-gaap_ProductConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductConcentrationRiskMember", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product Concentration Risk", "label": "Product Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence." } } }, "auth_ref": [ "r32" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Axis]", "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r209", "r352", "r377", "r378", "r379", "r380", "r381", "r382", "r499", "r511", "r522", "r616", "r637", "r638", "r644", "r686" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Domain]", "label": "Product and Service [Domain]" } } }, "auth_ref": [ "r209", "r352", "r377", "r378", "r379", "r380", "r381", "r382", "r499", "r511", "r522", "r616", "r637", "r638", "r644", "r686" ] }, "glow_ProfessionalAndOtherServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "ProfessionalAndOtherServicesMember", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Professional and other services", "label": "Professional And Other Services [Member]", "documentation": "Professional And Other Services [Member]" } } }, "auth_ref": [] }, "us-gaap_ProvisionForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProvisionForDoubtfulAccounts", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Bad debt (recovery) expense", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable." } } }, "auth_ref": [ "r127", "r219" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r574" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r574" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.glowpoint.com/role/PreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r234", "r235", "r236", "r237", "r276", "r277", "r306", "r307", "r308", "r349", "r350", "r383", "r412", "r413", "r466", "r469", "r473", "r474", "r476", "r497", "r498", "r508", "r510", "r518", "r523", "r526", "r635", "r641", "r679", "r680", "r681", "r682", "r683" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.glowpoint.com/role/PreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r234", "r235", "r236", "r237", "r276", "r277", "r306", "r307", "r308", "r349", "r350", "r383", "r412", "r413", "r466", "r469", "r473", "r474", "r476", "r497", "r498", "r508", "r510", "r518", "r523", "r526", "r635", "r641", "r679", "r680", "r681", "r682", "r683" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r541", "r552", "r562", "r587" ] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development", "label": "Research and Development Expense", "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use." } } }, "auth_ref": [ "r67", "r319", "r684" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r542", "r553", "r563", "r588" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r543", "r554", "r564", "r589" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r550", "r561", "r571", "r596" ] }, "us-gaap_RestrictedStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockMember", "presentation": [ "http://www.glowpoint.com/role/NetLossPerShareScheduleofEffectofAntidilutiveSecuritiesDetails", "http://www.glowpoint.com/role/StockBasedCompensationNarrativeDetails", "http://www.glowpoint.com/role/StockBasedCompensationScheduleofRestrictedStockandRestrictedStockUnitActivityDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Stock", "verboseLabel": "Unvested restricted stock awards", "label": "Restricted Stock [Member]", "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met." } } }, "auth_ref": [ "r28" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationScheduleofRestrictedStockandRestrictedStockUnitActivityDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "RSUs", "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated deficit", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r74", "r94", "r360", "r387", "r388", "r395", "r423", "r521" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Deficit", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r109", "r139", "r140", "r141", "r143", "r149", "r151", "r217", "r218", "r315", "r316", "r317", "r321", "r322", "r328", "r330", "r331", "r333", "r335", "r384", "r386", "r396", "r689" ] }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.glowpoint.com/role/SegmentReportingScheduleofDisaggregationofRevenueDetails", "http://www.glowpoint.com/role/SegmentReportingScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Revenue", "terseLabel": "Revenue", "label": "Revenue from Contract with Customer, Including Assessed Tax", "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise." } } }, "auth_ref": [ "r179", "r180", "r197", "r202", "r203", "r209", "r211", "r213", "r273", "r274", "r352" ] }, "us-gaap_RevenueFromContractWithCustomerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerMember", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofConcentrationPercentageDetails", "http://www.glowpoint.com/role/SegmentReportingScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue", "label": "Revenue from Contract with Customer Benchmark [Member]", "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r213", "r613" ] }, "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Revenue from External Customers by Geographic Areas", "label": "Revenue from External Customers by Geographic Areas [Table Text Block]", "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue." } } }, "auth_ref": [ "r10" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r605" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r605" ] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://www.glowpoint.com/role/PreferredStockNarrativeDetails", "http://www.glowpoint.com/role/PreferredStockScheduleofSeriesFPreferredStockTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sale of Stock [Domain]", "label": "Sale of Stock [Domain]", "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "glow_Scenario1Member": { "xbrltype": "domainItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "Scenario1Member", "presentation": [ "http://www.glowpoint.com/role/PreferredStockNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Scenario 1", "label": "Scenario 1 [Member]", "documentation": "Scenario 1" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "presentation": [ "http://www.glowpoint.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Accrued Expenses and Other Liabilities", "label": "Schedule of Accrued Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the components of accrued liabilities." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "presentation": [ "http://www.glowpoint.com/role/NetLossPerShareScheduleofEffectofAntidilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities." } } }, "auth_ref": [ "r28" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "presentation": [ "http://www.glowpoint.com/role/NetLossPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities." } } }, "auth_ref": [ "r28" ] }, "us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "presentation": [ "http://www.glowpoint.com/role/CapitalStockTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Common Stock Activity", "label": "Schedule of Common Stock Outstanding Roll Forward [Table Text Block]", "documentation": "Tabular disclosure of the change in common stock outstanding." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.glowpoint.com/role/NetLossPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r631" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r38", "r39", "r40", "r42" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r38", "r39", "r40", "r42" ] }, "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Options Granted, Exercised, Expired and Forfeited", "label": "Share-Based Payment Arrangement, Activity [Table Text Block]", "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value." } } }, "auth_ref": [ "r7", "r8", "r60" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationNarrativeDetails", "http://www.glowpoint.com/role/StockBasedCompensationScheduleofRestrictedStockandRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r279", "r281", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309" ] }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restricted Stock and Restricted Stock Unit Activity", "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]", "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfStockByClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockByClassTable", "presentation": [ "http://www.glowpoint.com/role/CapitalStockCommonStockActivityDetails", "http://www.glowpoint.com/role/CapitalStockCommonStockDetails", "http://www.glowpoint.com/role/PreferredStockNarrativeDetails", "http://www.glowpoint.com/role/PreferredStockScheduleofSeriesFPreferredStockTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Stock by Class [Table]", "label": "Schedule of Stock by Class [Table]", "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity." } } }, "auth_ref": [ "r49", "r50", "r51", "r52", "r53", "r54", "r55", "r92", "r93", "r94", "r116", "r117", "r118", "r172", "r253", "r254", "r256", "r258", "r261", "r266", "r268", "r391", "r392", "r393", "r394", "r510", "r612", "r625" ] }, "us-gaap_ScheduleOfStockByClassTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockByClassTextBlock", "presentation": [ "http://www.glowpoint.com/role/PreferredStockTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Series F Preferred Stock Transactions", "label": "Schedule of Stock by Class [Table Text Block]", "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding." } } }, "auth_ref": [ "r11", "r48", "r50", "r51", "r52", "r53", "r54", "r55", "r71", "r72", "r92", "r93", "r94" ] }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "presentation": [ "http://www.glowpoint.com/role/CapitalStockTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Warrants Activity", "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]", "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable." } } }, "auth_ref": [ "r58" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r536" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r538" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentDomain", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofConcentrationPercentageDetails", "http://www.glowpoint.com/role/SegmentReportingScheduleofDisaggregationofRevenueDetails", "http://www.glowpoint.com/role/SegmentReportingScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Domain]", "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r175", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r207", "r213", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r230", "r231", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r509", "r616", "r686" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Domain]", "label": "Geographical [Domain]" } } }, "auth_ref": [ "r211", "r212", "r409", "r410", "r411", "r468", "r471", "r475", "r478", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r500", "r512", "r526", "r644", "r686" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting [Abstract]", "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.glowpoint.com/role/SegmentReporting" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r174", "r175", "r176", "r177", "r178", "r190", "r201", "r205", "r206", "r207", "r208", "r209", "r210", "r213" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting Information [Line Items]", "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingPolicyPolicyTextBlock", "presentation": [ "http://www.glowpoint.com/role/BusinessDescriptionandSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Segments", "label": "Segment Reporting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for segment reporting." } } }, "auth_ref": [ "r191", "r192", "r193", "r194", "r195", "r196", "r211", "r507" ] }, "us-gaap_SellingAndMarketingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingAndMarketingExpense", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Sales and marketing", "label": "Selling and Marketing Expense", "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services." } } }, "auth_ref": [] }, "us-gaap_SeriesFPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesFPreferredStockMember", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY", "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYParenthetical", "http://www.glowpoint.com/role/CapitalStockCommonStockDetails", "http://www.glowpoint.com/role/PreferredStockNarrativeDetails", "http://www.glowpoint.com/role/PreferredStockScheduleofSeriesFPreferredStockTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Series F Preferred Stock", "label": "Series F Preferred Stock [Member]", "documentation": "Series F preferred stock." } } }, "auth_ref": [ "r620", "r621", "r643" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "verboseLabel": "Stock-based compensation", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r4" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationScheduleofOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Additional General Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationScheduleofRestrictedStockandRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r298" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationScheduleofRestrictedStockandRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted, Weighted Average Grant Price (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r298" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationNarrativeDetails", "http://www.glowpoint.com/role/StockBasedCompensationScheduleofRestrictedStockandRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unvested restricted shares outstanding (in shares)", "periodStartLabel": "Beginning of year (in shares)", "periodEndLabel": "End of year (in shares)", "verboseLabel": "Unvested restricted shares outstanding (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r295", "r296" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationScheduleofRestrictedStockandRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Unvested shares, Weighted Average Grant Price, Beginning (in dollars per share)", "periodEndLabel": "Unvested shares, Weighted Average Grant Price, Ending (in dollars per share)", "verboseLabel": "Unvested shares, Weighted Average Grant Price (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r295", "r296" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationScheduleofRestrictedStockandRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Grant Price", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationScheduleofRestrictedStockandRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Vested (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r299" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationScheduleofRestrictedStockandRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested, Weighted Average Grant Price (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r299" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationNarrativeDetails", "http://www.glowpoint.com/role/StockBasedCompensationScheduleofRestrictedStockandRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r279", "r281", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationScheduleofRestrictedStockandRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares available for grant (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant", "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable." } } }, "auth_ref": [ "r59" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationScheduleofOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Exercisable number of options, beginning (in shares)", "periodEndLabel": "Exercisable number of options, ending (in shares)", "verboseLabel": "Exercisable number of options (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r289" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationScheduleofOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Exercisable weighted average exercise price, beginning (in dollars per share)", "periodEndLabel": "Exercisable weighted average exercise price, ending (in dollars per share)", "verboseLabel": "Exercisable weighted average exercise price (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r289" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationScheduleofOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Expired (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period", "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements." } } }, "auth_ref": [ "r294" ] }, "glow_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriodNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriodNumberOfShares", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationScheduleofOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Expired (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period, Number of Shares", "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period, Number of Shares" } } }, "auth_ref": [] }, "glow_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredWeightedAverageExercisePrice", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationScheduleofOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable expired, weighted average exercise price (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expired, Weighted Average Exercise Price", "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expired, Weighted Average Exercise Price" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationScheduleofOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Outstanding number of options, beginning (in shares)", "periodEndLabel": "Outstanding and exercisable number of options, ending (in shares)", "verboseLabel": "Number of options, outstanding (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r287", "r288" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationScheduleofOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Options", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationScheduleofOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Outstanding weighted average exercise price, beginning (in dollars per share)", "periodEndLabel": "Outstanding and exercisable weighted average exercise price, ending (in dollars per share)", "terseLabel": "Weighted average exercise price, outstanding (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r287", "r288" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationScheduleofOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Exercise Price", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationScheduleofOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number", "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r304" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationScheduleofOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable vested, weighted average exercise price (in dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price", "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r304" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationNarrativeDetails", "http://www.glowpoint.com/role/StockBasedCompensationScheduleofRestrictedStockandRestrictedStockUnitActivityDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Domain]", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationScheduleofOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expired (in dollars per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired." } } }, "auth_ref": [ "r294" ] }, "glow_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationScheduleofOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested (in dollars per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Vested in Period, Weighted Average Exercise Price", "documentation": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Vested in Period, Weighted Average Exercise Price" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "crdr": "debit", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options, intrinsic value, vested", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable." } } }, "auth_ref": [ "r59" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "presentation": [ "http://www.glowpoint.com/role/StockBasedCompensationScheduleofOptionsOutstandingDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Vested (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares", "documentation": "Number of options vested." } } }, "auth_ref": [] }, "us-gaap_SharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssued", "presentation": [ "http://www.glowpoint.com/role/CapitalStockCommonStockActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning Balance (in shares)", "periodEndLabel": "Ending Balance (in shares)", "terseLabel": "Ending Balance (in shares)", "label": "Shares, Issued", "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury." } } }, "auth_ref": [ "r6" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.glowpoint.com/role/BusinessDescriptionandSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Business Description and Significant Accounting Policies", "label": "Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r88", "r135" ] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofConcentrationPercentageDetails", "http://www.glowpoint.com/role/SegmentReportingScheduleofDisaggregationofRevenueDetails", "http://www.glowpoint.com/role/SegmentReportingScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Axis]", "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r110", "r175", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r207", "r213", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r509", "r616", "r686" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY", "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYParenthetical", "http://www.glowpoint.com/role/CapitalStockCommonStockDetails", "http://www.glowpoint.com/role/PreferredStockNarrativeDetails", "http://www.glowpoint.com/role/PreferredStockScheduleofSeriesFPreferredStockTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Axis]", "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r108", "r116", "r117", "r118", "r137", "r157", "r161", "r164", "r166", "r172", "r173", "r216", "r238", "r241", "r242", "r243", "r249", "r250", "r253", "r254", "r258", "r261", "r268", "r338", "r391", "r392", "r393", "r394", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r408", "r422", "r444", "r461", "r479", "r480", "r481", "r482", "r483", "r612", "r625", "r630" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY", "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYParenthetical", "http://www.glowpoint.com/role/CapitalStockCommonStockActivityDetails", "http://www.glowpoint.com/role/CapitalStockCommonStockDetails", "http://www.glowpoint.com/role/PreferredStockNarrativeDetails", "http://www.glowpoint.com/role/PreferredStockScheduleofSeriesFPreferredStockTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r6", "r19", "r109", "r123", "r124", "r125", "r139", "r140", "r141", "r143", "r149", "r151", "r171", "r217", "r218", "r270", "r315", "r316", "r317", "r321", "r322", "r328", "r329", "r330", "r331", "r332", "r333", "r335", "r339", "r340", "r341", "r342", "r343", "r344", "r348", "r384", "r385", "r386", "r396", "r461" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Axis]", "label": "Geographical [Axis]" } } }, "auth_ref": [ "r211", "r212", "r409", "r410", "r411", "r468", "r471", "r475", "r478", "r485", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r500", "r512", "r526", "r644", "r686" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY", "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r139", "r140", "r141", "r171", "r352", "r390", "r408", "r414", "r415", "r416", "r417", "r418", "r419", "r422", "r425", "r426", "r427", "r428", "r429", "r431", "r432", "r433", "r434", "r436", "r437", "r438", "r439", "r440", "r442", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r461", "r527" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Stockholders' Equity [Abstract]", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY", "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r139", "r140", "r141", "r171", "r352", "r390", "r408", "r414", "r415", "r416", "r417", "r418", "r419", "r422", "r425", "r426", "r427", "r428", "r429", "r431", "r432", "r433", "r434", "r436", "r437", "r438", "r439", "r440", "r442", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r461", "r527" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r545", "r556", "r566", "r591" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY", "http://www.glowpoint.com/role/CapitalStockCommonStockActivityDetails", "http://www.glowpoint.com/role/PreferredStockScheduleofSeriesFPreferredStockTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Conversions of Series F Preferred Stock (in shares)", "verboseLabel": "Issuances from Preferred Stock Conversions (in shares)", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities." } } }, "auth_ref": [ "r6", "r18", "r52", "r94", "r251" ] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY", "http://www.glowpoint.com/role/PreferredStockNarrativeDetails", "http://www.glowpoint.com/role/PreferredStockScheduleofSeriesFPreferredStockTransactionsDetails" ], "lang": { "en-us": { "role": { "netLabel": "Proceeds from private placement, net of fees and amounts held in escrow (in shares)", "terseLabel": "Proceeds from private placement, net of fees and amounts held in escrow (in shares)", "verboseLabel": "Number of shares issued (in shares)", "label": "Stock Issued During Period, Shares, New Issues", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r6", "r71", "r72", "r94", "r391", "r461", "r480" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://www.glowpoint.com/role/CapitalStockCommonStockActivityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Issuances related to stock compensation (in shares)", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r6", "r71", "r72", "r94" ] }, "glow_StockIssuedDuringPeriodSharesWarrantsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "StockIssuedDuringPeriodSharesWarrantsExercised", "presentation": [ "http://www.glowpoint.com/role/CapitalStockCommonStockActivityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Issuances related to warrant exercises (in shares)", "label": "Stock Issued During Period, Shares, Warrants Exercised", "documentation": "Stock Issued During Period, Shares, Warrants Exercised" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "crdr": "credit", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Conversions of Series F Preferred Stock including accrued dividends of $82,000", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities." } } }, "auth_ref": [ "r6", "r19", "r94" ] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from private placement, net of fees and amounts held in escrow", "label": "Stock Issued During Period, Value, New Issues", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r6", "r71", "r72", "r94", "r396", "r461", "r480", "r534" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders' equity", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r72", "r75", "r76", "r89", "r424", "r441", "r462", "r463", "r521", "r535", "r626", "r634", "r674", "r689" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Stockholders\u2019 equity:", "label": "Equity, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.glowpoint.com/role/CapitalStock" ], "lang": { "en-us": { "role": { "terseLabel": "Capital Stock", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r91", "r136", "r252", "r254", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r267", "r270", "r334", "r464", "r465", "r484" ] }, "us-gaap_SubleaseIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubleaseIncome", "crdr": "credit", "presentation": [ "http://www.glowpoint.com/role/BusinessDescriptionandSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sublease income", "label": "Sublease Income", "documentation": "Amount of sublease income excluding finance and operating lease expense." } } }, "auth_ref": [ "r347", "r520" ] }, "us-gaap_SubsegmentsConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsegmentsConsolidationItemsAxis", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsegments Consolidation Items [Axis]", "label": "Subsegments Consolidation Items [Axis]", "documentation": "Information by subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments." } } }, "auth_ref": [] }, "us-gaap_SubsegmentsConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsegmentsConsolidationItemsDomain", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofSegmentReportingInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsegments Consolidation Items [Domain]", "label": "Subsegments Consolidation Items [Domain]", "documentation": "Subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments." } } }, "auth_ref": [] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://www.glowpoint.com/role/PreferredStockNarrativeDetails", "http://www.glowpoint.com/role/PreferredStockScheduleofSeriesFPreferredStockTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sale of Stock [Axis]", "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "presentation": [ "http://www.glowpoint.com/role/Liquidity" ], "lang": { "en-us": { "role": { "verboseLabel": "Liquidity", "label": "Substantial Doubt about Going Concern [Text Block]", "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern." } } }, "auth_ref": [ "r68" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental disclosures of cash flow information:", "label": "Supplemental Cash Flow Information [Abstract]" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r585" ] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r577" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r584" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r604" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r606" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.glowpoint.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r607" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r608" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r606" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r606" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r609" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r607" ] }, "us-gaap_TreasuryStockCommonMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonMember", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury Stock", "label": "Treasury Stock, Common [Member]", "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r56" ] }, "us-gaap_TreasuryStockCommonShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonShares", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITY", "http://www.glowpoint.com/role/CapitalStockCommonStockActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury stock, shares (in shares)", "periodStartLabel": "Treasury stock, beginning balance (in shares)", "periodEndLabel": "Treasury stock, ending balance (in shares)", "label": "Treasury Stock, Common, Shares", "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r56" ] }, "us-gaap_TreasuryStockCommonValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonValue", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Treasury stock, 8,000 shares of common stock", "label": "Treasury Stock, Common, Value", "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r20", "r56", "r57" ] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "US", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Domestic", "label": "UNITED STATES" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r603" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://www.glowpoint.com/role/BusinessDescriptionandSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Use of Estimates", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r35", "r36", "r37", "r103", "r104", "r105", "r106" ] }, "glow_VideoCollaborationServiceMember": { "xbrltype": "domainItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "VideoCollaborationServiceMember", "presentation": [ "http://www.glowpoint.com/role/SegmentReportingScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Video collaboration services", "label": "Video Collaboration Service [Member]", "documentation": "Video Collaboration Service [Member]" } } }, "auth_ref": [] }, "us-gaap_WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount", "crdr": "debit", "calculation": { "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.glowpoint.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedLossPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant modification", "negatedTerseLabel": "Less: warrant modification", "label": "Warrant, Down Round Feature, Decrease in Net Income to Common Shareholder, Amount", "documentation": "Amount of decrease in net income available to common shareholder for down round feature triggered for warrant classified as equity." } } }, "auth_ref": [ "r155", "r166" ] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://www.glowpoint.com/role/NetLossPerShareScheduleofEffectofAntidilutiveSecuritiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issuable upon conversion of Common Stock warrants", "label": "Warrant [Member]", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r524", "r525", "r528", "r529", "r530", "r531" ] }, "glow_WarrantModification": { "xbrltype": "monetaryItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "WarrantModification", "crdr": "debit", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant modification", "label": "Warrant Modification", "documentation": "Warrant Modification" } } }, "auth_ref": [] }, "glow_WeightedAverageExercisePriceAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "WeightedAverageExercisePriceAbstract", "presentation": [ "http://www.glowpoint.com/role/CapitalStockWarrantsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Exercise Price", "label": "Weighted Average Exercise Price [Abstract]", "documentation": "Weighted Average Exercise Price" } } }, "auth_ref": [] }, "glow_WeightedAverageExercisePriceExercisableAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "WeightedAverageExercisePriceExercisableAbstract", "presentation": [ "http://www.glowpoint.com/role/CapitalStockWarrantsActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Exercise Price", "label": "Weighted Average Exercise Price, Exercisable [Abstract]", "documentation": "Weighted Average Exercise Price, Exercisable" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.glowpoint.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedLossPerShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Diluted (in shares)", "terseLabel": "Weighted-average number of shares of common stock - diluted (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r156", "r166" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average number of shares of common stock:", "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://www.glowpoint.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.glowpoint.com/role/NetLossPerShareScheduleofComputationofBasicandDilutedLossPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted-average number of shares of common stock - basic (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r153", "r166" ] }, "glow_WorkingCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://www.glowpoint.com/20240331", "localname": "WorkingCapital", "crdr": "debit", "presentation": [ "http://www.glowpoint.com/role/LiquidityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Working capital", "label": "Working Capital", "documentation": "Positive working capital means that the company is able to pay off its short-term liabilities. Negative working capital means that a company currently is unable to meet its short-term liabilities with its current assets (cash, accounts receivable and inventory)." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "SubTopic": "10", "Topic": "280", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-4" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "a", "SubTopic": "10", "Topic": "280", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-30)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.30)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "25", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(CFRR 211.02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "985", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "40", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205-40/tableOfContent" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "210", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-12B" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r500": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r501": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r502": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8" }, "r503": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r504": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r505": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r506": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r507": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47" }, "r508": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r509": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r510": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r511": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r512": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r513": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r514": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r515": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r516": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r517": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r518": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r519": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r520": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r521": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r522": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r523": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r524": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r525": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r526": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r528": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r529": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r530": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r531": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r532": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "405", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480191/946-405-45-2" }, "r533": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r534": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r535": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r536": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r537": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r538": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r539": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r540": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r541": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r542": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r543": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r544": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r545": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r546": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r547": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r548": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r549": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r550": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r551": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r552": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r553": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r554": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r555": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r556": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r557": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r558": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r559": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r560": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r561": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r562": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r563": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r564": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r565": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r566": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r567": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r568": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r569": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r570": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r571": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r572": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r573": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r574": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r575": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r576": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r577": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r578": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r579": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r580": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r581": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r582": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r583": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r584": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r585": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r586": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r587": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r588": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r589": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r590": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r591": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r592": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r593": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r594": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r595": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r596": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r597": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r598": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r599": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r600": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r601": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r602": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r603": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r604": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r605": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r606": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r607": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r608": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r609": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r610": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r611": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r612": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r613": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r614": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r615": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r616": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r617": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(a))", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r618": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(d))", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r619": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r620": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r621": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r622": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r623": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r624": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r625": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r626": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r627": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r628": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r629": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r630": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r631": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r632": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r633": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r634": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r635": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r636": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r637": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r638": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r639": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r640": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r641": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r642": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r643": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r644": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r645": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r646": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r647": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r648": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r649": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r650": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r651": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r652": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r653": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r654": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r655": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r656": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r657": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r658": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r659": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r660": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r661": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r662": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r663": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r664": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r665": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r666": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r667": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r668": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r669": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r670": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r671": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r672": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r673": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r674": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r675": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4" }, "r676": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r677": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r678": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r679": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r680": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r681": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r682": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r683": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r684": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1" }, "r685": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r686": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r687": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r688": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r689": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r690": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r691": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r692": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r693": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r694": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" } } } ZIP 61 0000746210-24-000019-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000746210-24-000019-xbrl.zip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

D/;31MV4]#,#/%I=O:K5AV0%R2Z!2@BKB_X MS4Q@=*-AC_A+4#R"GYN,QOF$#HA\$E\G5)3%?\'BX.^^37R%$C%)U4]7MW^; M%7'S+T]F,#OZB/)X_!>H!S]$@4;E2*6FPO^/WYO>FTS32CRJ5W1U^@EV)_X[ M_LBGF76G@T$3 Q,3X9\9:#=]1XYMVN$/@M)6L6RX2WW5$G<'+IY" M6!*^

M)>SDN2YN@&JWOW@R7:"R\:]AY1*+)3 M)0*"BA[K.)37FZ?@+'JDX=!N;YZP+WK(X1A^;Y[P+WK<#AU M:RV!=BV_<(=6]'#'H?1[GC O>O#BT/H]3]@7/19Q#/V>)_R+'A0XJ'[/$_ B M[-WO:6E%]U$/'+(_3M*$5G2O]C@A^R,AJ^AN\*E[ R+02-%=]5.GD9D-\MP" M!7K1 P6'RX/*#^9%]](/GPB5'^R+[JT?)Q,J/_@7W6,_<"94?H 7+H\]OZ6) MO^U\=.M!@,UGO>B._>&R S*Y #.1EYT0M'>?/IN( ! TP7?-143LW0,N"(J% M\_("/[QX--P7PG@-__QAO-O#:%B4O=:Z^"Y4ONIG\^]'O<"V; ,\!<,AJ=]_ M\.U7F.2#8YATIOL7K(#VVF9<-_/H+EQ7%]_A.V<*6;!*:[F(!6$]38[K/PS? MA\7=^X]8Q(8!G9X9GZ":/['.QY'8!FP+Z]>NP_:M^TJ"T/,ELC='MOC;WN#\T_7#H/'IY^% M@;>PCJT00OTX@;AFT1S@@S&!",@IFA-\# F5IR]0<-_V(/#.T<=MB>OCP@B6 M[408SWPB9N3;H4V"FW?3B2QB??6](8:GHY!V'[SOQXM>GQZ*C^.LM\1UU@^!XG,)_+;$=?]/$\U'XF9QHP^'0/.5Y[X2/[1[#KDF MO7#ZV&GRM+@AD%-&]I$X6]SXRSZ1G7I4\#2Y6=Q8SJDA^$@<+&X\Z!#B^J1Y M5]S0T^F@]CA4YCM'S?(K#!]^S M(G/W(_F2.";$(5Q,;1/<7'G^"$F"W'DN1\]I8D?84!C6->!\L0Y9/V#UOFTX MCP069]H.L!1]*O?S+E*Y'(%"A8WB%8Q"I9[;+YT*&X 4@$ZERDT0BK#!R_T3 M2D$Q)FPT\@B6R1;$DIVSI=[9G#B%C:0>S2B1)"H8B0H;$1:?0L[%*NJ(&UK> M)XT4%%F%#OB>0:CF.-M#'>%"O4%BOLA,$Y7SC7@OOC$:V*;A, R97N2&_OCBY].) M;7\6*Q+#[!A6?%W>@HJLP0 M-D:70B=?B&L.AH8_U^/CD;P2-R+L>"N^889_V.'@*@I";TC\/'P7R3"283C# M"!R^ 0-DHJ!;ID& $91A4N9+N&/N](^.;YO_+>YI)4*9*9H0H; M(RZ*&)=L<@YL(F1P7E*E(%1Y+)-"N'T**;PEFXC')D+N(:V@2KC5!WS!HX9S MZ5KWX8#XDD1/VKX0;DNM:))<\LS9\4S1MCPEB9Z=Y2%W/27/2)[)QC/";7P* M<#9DGR1:5/4O-R!%H)X""[@C$:XFW$:@%' B*D)-;LV)0#T%%G#'(MRB;9;M M/1/GZ DGJVI1Q=VPT$XZA%]!R1>;^Y!;/0& M?AC_\OSX"S-F.+]V%^%K]^XZ'Z"@*E&7&RZ23XK$)\?2)\+M[V3GDTN3ULP* M'HE)[%>CYQPTKB%9XU15R EL*DG6.&W6.);6$&[C2 36R$ 9SV^>9,33U!HG ML%LE6>.T6>-86D.X':DL9#GPR3ZK.0EIP!U_S_;"<.P PUMMS(@]LL@O*@W1N'G-]L* M!Q=JK?;_EF:>P]E4#,=^<2_^!5"V^^//])+M(E]=J.U1""\$(\/M_M;S/\&7 MV&_VP87/)H9#^B#^LM'B%TS/\?R+_ZS1__OW MSS?7RM/SY?/-D_)T<_7S\?;Y%GY>WETK-_][]=?+NV\WRM7]CQ^W3T^W]W>S M:R_"JO^X?/KK[=VWY_N[LG)=O:HJ6JU1[XBTCMK<.EJIZ_AZ__A#^0UXQ/5< M$ (PB*EP5GHD?:I=2HIKH.:PB'UQ[9D1,C[*KQ+EHCX\T%5KE;]33IN.TET* MBY%A6;;[4G%(/[S0FS#-)"PJ>&5S8/P!(^%HP3(P-#="9W8(_#T"R45\9_Q( M1IX?EI2^YP^-$,3*>WC1M]^)50G]: (DK=3][__L@(+]O Q.^\5^^K+_^S_5 M9NWSXK^3Q2D^79TRBOP@,MQ0"3WEB9BHFQ155SQ?41L?K(^*UU?" <%;D6^' M-LSPYMT<&.X+42[-$&^K';V.,*+/_3D9GTEQ!80[L;:@PP?Z^@U3#;,XL.!* M90A##/"UBF6,*V-B^!7BQCC12]T?AF\.%%TM*VB2S:.F*C(_IV/4\T^<[YY] M^)Q-C:.EC-77.>?5=.6_MDC?4EQD_>XG-Z7?[Y#(V/Z;HF>(Q7QF3 M _FGV6-B\7ZZ+K_RAD.;ENQ3^K9#%)<:]1<9Q.H-->._PLO,(8AYJ('^H5K1 M&WJKN;&>%Q9.6>'Q2%[L #PR-[R#.S%,FJ7N_9?O]W??RLKMW56U2&!)Y\@/ M-^\&\!&N$9EINFK%")2G$3$Q%F IMJO88:!<#:@*_[ATG>#BOX"K%'JCBT;, M;&O=H1 =_W@$\,?!;:N8Z)N/ G(1__ALV<'(,<87MDM705_ZS+_7\T+P:.DG M7XD?8B]2_EGZ.79[ZK15:\QQ"\$]#*WXR_QV%6Y]6KS>T*K-9COU5JVJIEY? M-E2]455U;>50G^C4V/0 @CMWTMZ:4ZL76BC=T6=A3,GKWDP>*/#\UUM&[Z[ M=4W>@QP/P6,4YXJU6[[RK%EC#V9D8BPA)"/?>\5QIE9>J]2])H[Q9OAD*8^& MUAF"]]EXO^4A/I.">%;FMTO=5JM2TU6M7M=60JZ(%+H@ BD(/U J0Y.#UKM5 M_B]8&H%E,UL$9.(,1=+'_!?#M?]-__Y85'): HO;ZF/UJ:K<#$>.-P9@S!*+ MIO0]+9K3L-0&EC ]_-?V?8C#QZH$^?_LT=,U_!/Z*5N MNZ;5EHM# >EWB;''UXE2[<$'.-HCPP&'"IRKT'XERGV_CQFV93#W3"="F:4 M,!2$QG*3;^/5%I7K/VQ.3<@*ESXQ9NBG7NIJJCY//1\S$.EW#W3#P\!SYSPT M[&/2;.N5=KNI*_!N56F(%&A41,;U$@Z9.D#__9]M36U]#I1GXI 1 E]AT$^R M!R+[?/AC"%)?=+CP2[1%S+IY1'?(!(:E!,^]";A,,NS?!B"Q]\.$;5#$]C8<]S_D09/%/3PH0<423D@2)]PQ MD+X-;+@RE;99HAI<,J)H!0@H@>?8EA*O153XI'OZFUN?7$>-5:U'&6UB?3;9 M[@/ ]"GTS%]E963XRJOA1$3Y+QIC57&G5PD&NT7AUI#E6>*$LSGC\@E"6G1W MXIMXL,;MMZ607F7?"8^(F#GB74FV630?I4;Y,QN@QKY+=T9@&7\N!"^NC)$= M@J'\P_!_85AH)D-LPYC;UBEH6PUT:*OYUK4P($F4WAB\"&+^4C"U%"0[H0%< MM)#]Z4;6!_6C,C "NCUJ*8;C<#<#3>X_(QL-;K"S>X0_ &/ND.QBP5U0O_CH MR"K4%,L8!]4".NQ9 M(WU7D>_#E%D:"4K0T BC8,*5G5+W'R18C"<>)6EDDCN6[\0 MJYN#O/XY!YEX)L(5A0[(FZ$=AB"AB -RQ_=<5//.6"&@\L?*+K-<:/#4A=^"ELUG(C])\/$5IEU4F0=1V39@6(HCN&#Y6:8)H@LWT"Y@USNHS65 M>E4!@J^DW@B&(.O@*WYL4@";#0$(XS(:CS <6%P8(7U17GSO+1S$MZM@2Q(Z M-XOT;9=F1=*=.=QXT&"92V9(;ZN?X\?6/K!\?O&#:$#RAY?,-7[2=IE(5K5> M18M-XJ0=O%'R]"'(\+ ![4ZGVFXTL@:TZ^UJI[4Z#RS#4&UM=7;:]A'?-.]] M:%N60\3TWK^G<\[A3'<]&M:) N;XP$+9&=!P>BZ,QV@P M=H/?% M5"6@;O#FU=,DR]=DF2P!9K+@V4=X\H?!C5N=50J@FP0B%R;(95] MK32':*T$PL6TP>X,?B_=WGU-V9&D'Z89-$]TB/OI?&?I %96L;RPP@<$HQ$L M01BK-J&*1JFKU4\47/L']EE>RM-H-MS%K MTU>,7N Y4;C\E3P*Y&2NZ%.;E/09^%-+^X54>CXQ?E6,/DCK"\-Y,\8!FN;I M=7]TM7K:E7\V.PTQ>_Q97%V8/GNP%LC[NLSII.LD?C)UIUYMJ6K6V+-:JW94 M/9?8GU7(;J5&N-U9-*=;.;._O/Q_"&'RX?GY5;I:)\O;V[O+NZO?P. M3(6EF2Z?D]6Q,B3M[0DXJSEDIL0&,8"!3FMR$9*FI5^3IQ M'">% H-#!/J6KKK?W]NJV?S :.!'F"\BP(./3\&<#&'FH@Q\-)G^ 73?2E ?HOAF/@<2WP5D@(SG2HS%;34CY$KA%9 M-CS[D6XL7Q.35:?D3^B2S8K"9AW)9GMGLY\QMRA+&&ZJG] EO1\1AM%I!F^( M/3WBM#<63IUC261#R7E'G\OFG(<[3YKD/*$X[XK&@ ,,$=-8S%_%"\@CUR)*<4A5/:F)8@.647 M3JE747F$/D"(2 W;C@&95 MN7D?V#U;)C 4B/#QD&NF1#Q)^ G"?X*%&:&T=HX^ERPDCQNH]54DO[1037RP MNU8MT-'NPIS2GN'\S@+C=V:9)>7$<&7-%_?UK3U('3KB!78NL,W5?,'ZEE_^ MQ(VRR\=_*$_/E\\W/V[NGI7'FV^7C]>W=]^4K_>/?\#/RO?[^[_AWY-GG@X# M(($:B&T.6.QIU7T>V('R9T0;=3MC7J\-&]]@FS9%K57^KGP(\1E>\I65PN<5 M7C_2\A6&[09*,,VTI@6S#9_@S<"V:,057(8WP[Q6I/MTFSL M(3%<7GRCH92R_80QI[C;K;H"MQ_W(X<% =,J*1_L]@#B'W^1]!+_YQ.BT@<[=27'A^Y[CN2]E;&I< M53[P.;.+<9%?SX_7\D86KT5!XEIBW5.DYRTQ\LQ419)YO";K,@X M#@=4&7H^FA)*'[O2LL4Z0N)P!*(LJ;AV7+XLK.@#7LT!J2^9+./>+8Y'7A,@%!-$QYG)'$ M_%5*%];\U:$QGK^$2YZI%1T 63J&CZ2&/1[Y\E!,$)0W#E;C"KT)J>'"V<=8 M:7V;M90>KX-&0&:('D;I&9B,#FP\A]^8A#@[X!SGG@!JBI"J&%IHA?OI[I _ MS<.=(@PP.L;&! A0WZ;M#"R[WR?T0WW?&\)R/9PBH1@/!PH7>>M7M4(,X"H3 M[5M\._C%YABY)EC9P QTUE0@FU[D &D:6$V/KR]>";S*)IN*/*\M 0.N> MPW0!S2AQ8]PNR#7.G>QO*A$Y=H$S7,ZM4XX/81"+ \X.%F M+YAQJG8YG3Y21,?<)UW<:F1\O6*Y)@A$@!F; VL_-(4?<%40#4=<>OMX\Y?K MO=$N])'+?E(:*<\1",XD\2Z=!1(^LN(0\8;%\/HL%TR[OV7^ F]Z10MLSEE%N(R)-8-5RFQVO&'& MYKJYFEB.<(N>M&,?4#OLN!W5#&]8 MK@Y*"D)7VL41H+#P\9D#:8H6XG:]. #(F( M]/KLC+"!'#'\_(FR4V516) M:$.9/S%6C2&=.3?M, ?O D0D/H-E\9"(^K0'!H@#XI*^S83HR*,\3)F&2D[; M!-T#8'9I3"+X3(E\@?5C\R9@-@9.$: '?!YZM.,T@I4);(L,>=]I)E=\SXJH M90\R#"<)UC3-%S''IH-2ABL.'Y$?Q6+'#?"7R9OQT2N@$.A1!!S 6^'FOMDE-]Q"W7?AJC9[M8.(*"HD('YT: M(O1K'M:VC0AU2I07SZ;UMU'DNY]G(34U@@T+7=,)A3/9%5 'AZ\T(4+Y]^"U M>.V+\Z*R#M4[X"B<$$8,70O&=+P1-8&IE6C$KM*0GMF L3\ST<35]#OQ39LE MY@#=83'&Q6_Z!CX1(R$<^%[T,N!#PWOHX%,:!P2QQ!] N45Z(4K[A!S[!)<= M#RUWJK:F4AL<7= &#$7LX]0RZ">=+"!Q"F^ $-TG0QC0!4:FB>J?XYR="4-7 MDR$X-@\^S[HH4\IE8*%F J/O)!7AAVW7 @3ZV$@FVI"48M4#9AU("',<3P[5 MIN\RLX8>(@"IF[L=L-8 7N_EC>WXU''D&NINY)UT7)Q";+GT$,##7F4,V;,N;%TIL_ZU&Q; M%(94G8SC:N2T;1)3&A.N2$QAE=04DQ(R!E$+0QM4G U'!HNOT;\"K,ANDEA" M@=A$8?U5>0!3C/@TJ9/6XN52A15QH";KR+=?T18#N6?&G@2@]16LISC,M7+$ MJ7;B9%322A[()2I.0?*=11.E.V<28=E_9&_'0?T-),- ML3IDDL EX9OG ZY'X(Z:3'ADYOGEBD5B-P\5X1B1"TR-31VX%R,8]&],;-.+L:V,Y%X/CJ>MW>!IGB4 M6#PV%N>X=8B!8OA?'$D/,?;%8R5@7I$0HT9TWUSB3C3<8:R6-HB8! @2,6F0 MK1)A@B',L(P1W1LSIS4D)ZB#?\#NH;N2DU#9=/-)F(=0T,./0LXDBI*0(JY[R#E TA#,_X'FYQ MTPV0/B;2\ 2>.1V* =]XVTIRY7%"CB]Y)NA@9X*DA;D_LV0:3$$Y]^)50J\RB9\$ MX32R(KV!8^,*4\;MQBXFV$E,.TJ 5R%/P.O'[X9/,8<$G/@ MPM1?QI*[#HJA:=YSGUC$YYXT38^,CQ.BB.0!9XF<8XH^VW4]FF0VX18\ENB, M:7"J3/.>#:QZ $CSR_/!*IX*K;B %N6%N-R5CC/]3XL!%THEIX,6Q@Y"?;N9;0T-,;:%)AA[SM.^,P#+^5*YX&BQK M7W *:"\09N<\A3@E>6;G%1.1@VE?/V5HOTLL'2&F&6#\W[(#/QJQLSPT^=.. M&<3#:" +/M&D0A!YI,XWAR !#,Z#,2< THB<3V0'@(.1G63R? M'9V0"#^TP$U#YE0&DW=B1J"#\=P8/QP:GQB+$_ZGA_!3C]WO&0HK$9$AM/JX3O&%WNBBL:G28\?K)VH*SQ-6Z!&$44 NXA^?P=($PV)\8;O, M:\67/L_J6?SB7(5#^CEV>ZH,JC6F$'CU2?YE?KL*MSXM7F^TJYUV*_56K:JF M7E\VE-JN @]G&FKY];:FYS>IYLJA\F_@JU>U="I95J?RP,8A)9/9GM03RL_0 M*"H_0#!*/A(@XK(D,2ST&5CD0QV<_5%^P',*3957XJ5EK&XZ =8R>[[.3.B9 MVH/LV@(BC@3R#Y,NZW,B=W?RVPC2JWN=;5UW]D!DO*#U*$POGYZ2VCHW/LZE M:U\"/X;YZ\7W(M>J<,B8)B']_M9<< SZO>(EP8P@(&%PL0'0URY['5D?[/W, M^.O3_YO'GT+E?TMT1&(-G4DQ':P# 4;A3#MYCM(LJZ\I1:#A_]IIBLHL$IT^P1F3R^8%2!MBYCVT'""WTOXEVL, M"3Y9>3&,T052"/[O9DH;CR0(?1MKY>&-2]>:O9!XLJ2POA;@^;Z'%VXTK%@> MW:G"SP%+ ;@(92YTCOL572UU&V6]6?OMT^P"NJRBV2X8BUER8\QE$"5SGTN* M(LDWI\HW=8'X1D.^Z71$X9LU*C1V^6&B9#F;[?.IG&RT8NCX2].$I=#29R8! M"NLYI(P%'Y9:;5HV0*2*K6+S]AJ=&$/T<0+0.Q)RFSB%._525VWLRIHK*' ? M*FT3ZUK2R1H=D)%.ZJ5N'2-10A#*6;E!MW%V]/:"<5-[KM@$OT8P3N (=)Y" MX T0A%I+$",E!^->$L:FDG -86!/5;TC"&&1J/ MC8;@(O39PUSF'*0E!\+&>Z4GR!KK'.]9)L@6).O0()FV,X]D15,!C--S)KEU M/OP.)%>OE;K-TP'U]!HJ6J 6K=15=PY%"N@N"1]Q MHMYL#F[2B9/[.J$YC0G<>:ZY+"Q0Q[U'39# JHRX'U(>;D@@=8$(),_(>T'" M1NER<-V"=_/7A0/%YBEEF==_.OR^46@L:X"B06-B>E[9*4+$Q%:8TY*O)%]M M%?_+RE=-#/QUM$+P54[>AR" M?[^^>7SB=2^4F[__O'W^QU9G61;CLSH@PO(B/ &[]/!5GO9P_K,[IW-,<2\* MF\C#3,6-+$P2G4?&&),MY1FF8I$M%Z>YD)$C1HCHK8@1'16_D'L[8T\/^[B8Y$^@8M6W(1);DAN M72? :G\T5."'VLYA,G$L;DDP&Q^0WXY@,&]#/\4- M2^'%YWQ"G+1.E@DV=SW:ON(#'EXHBTS1HT88LC)GHU@R8K67B-6JG.E& M"T3TSG6:9,Q*0)+9)6:UDF1PGS6O8\#RI*_@$SS%@PHY1?O.UF_8W%/-ZC#0 M?>E&+:]]Z>.[J#E%!,^6U#9W43.26I/N7N=7HU(@WW3'G/9EE0[T-BMKL+09 M25SJ0&\>K=#!E3<SQ^"$@1+GS0J)T-N]5LD,T@G%[ M5M'Z'M@7KNW\7@K]B"Q:;9,%7KK657)Y$\I6&=5D7U&.6?GY0:2> T2T"43. MX23 T[3SER6)/'W4B$TD-P&84#SP>>L[*NK+4"W.GS MR\92N\ZOC657RT#9FX"=?DLQ)A\K'P+V]U$(^'91E&9=7"9X&T01)D! MWV*)L;7%;:]%N*.1>@ BVFX=ZD$(?'LB:&$"7;FC9R!PFP*"G4^8?E@G;IHM"-*9V\EW7:GGTBHZO06F-A;^M* M;3>9YE9^2\Y64V+J.]JKK?SMZ1PGU\;&5S6TIK>UJ/QO8&8;O&UM)NE)NMQ9,XFYI\^Z;"K?#4QN-%S7*S YYTRJ[% M[GC*O(P=\*2QM;3U F7LL11#0-)8FR.TEC3JXI"&W _H/OO$"")_')O..:OJ>'A*$9PX^$#9Y/\J.WH[ M[93;U,"J;F&PG&4HZ$.."BD%EJM2_],8/H (+UUKQA $Q9: MQ@2X-OK]NE[NM!=5G33MBT]/ZZH Y4U/G1JGI]U+L(GE#Q1$YIIF-(P39Y)*$!7[)N#-\%> 0),%\S*&=E$Q781.N4]>;B M.6QIMA:;J!9$[L&(2D.B:I>UE(I^A39U"W*@*$ADW/Z%Y]K*DT7Y&\')S.8; M"N6LC**7NO5R71?_U(<\8"2$F;P[Q=6Q+4T1CK2=8>FBQ$%0NF.:E..S)R>V M+%7"UIC6HV('AA,.F)D+F><%G=,10YL?J;UTK=V%4EZ]LO+%IZ"=!20O2U[> MSYGE7'@YK_Y>$3\)SM5_+Y MS;;"08ROQ(M\*;7I*T8/9AV%RU])S-DD@%M_YH2SVC[&!K]&SW82HABFZ0WA MVV/,BW*]$$8//:1!"YLOT$//%"DT%MBW7<,U;>JDP@5Z3K8ZNT5=A'57U,K< MOGKB7UP ,H--]+[6T0S-[-75>D?M]QJ$J'U#JQ&BU^NMWC\UK12_-/"GR1LO MI-+SB?&K8O1AS1>&\V:, Z3(!&B&MAM/25?IH?<-B.=?41#:_?$R*'9_Z_E( M]XL+$PLG"XWH*$[NOWR_O_M65F[OKH2FJ/397]W?7=_WY2[K\J]P\WCY?/M_! \1;XX=95PH$7P1A64%;(NTE )H^( MS_)6%) /QL<"+NNG:T26#;)M^>2'AO\"[(HJ:LX17;X6JG:F*H/J.%B38XP" M+U9J]:U>NJM6E5-O;YL*+55K;=;F89:_@FUEO6-%9-JKQLJQ=X7OHS6ROA< M9^&Q%$^!4^X\97FC8T50!C[8(C_@N4&@W K61L4EY"PW0BV]&""HJME(4&: M<+,W[>6KL])!:T%^5!\/SW]L4B!EDT6?&^#TO5&J@+4.A0[@/*9W?]IZ7^'4 MPUAGW"Y>71VHXI3TU?>&:<5B;UW3B1 LV%8>_K_U;+RGA*=:I6YS]W*QAV@> MG\.6J^0RR67S7-;8 Y=EBQ"W\VW4> 0F+*#IL./ALN.470AH67Y>IE_Y0-Z! M^ +[E;#^DB,?2,R@!(^[Y<80R_;_FUY8R#([\;S '-4L0OV^_\WS++H?1/Q7 MVR0W[YSMKQ-0A]\.P1_PW&4"^"DLWT&MVQ&DHHE,,SV@/MD'.<$D2]U64Y16 ME2>C(PKH7G[SO2!01K[7W_* P2DF'&;*$E]0!TNRQ"FD'RB@TSA2+77U'9*] M90*KP/24HSI80T5X<*"U=^_\U"7^7(J*VF [BH>MOEZ0]X5!VDFKZ6F#:_(^ MPK2@$VOP=S*T5>0SIX\D('2G$J,!%GDECC?"!#,9"]@^Y,X@"A[9]12>-XR% MT_2W7NJFE%47R2V3;OZ>PL89*:5>ZHK2M.]DA'>1B[0\ 8&P4T]#P_]%T%:0 MU5FVE=M/Q'%PC\:U?L3 7,&*>/HFKQ.H!7/33YQ,U@CM;&32!-]1;"UIE.\GV)HS+='$#;4I]CZN\#K@^!,4]2D)..DIKA>0UZL2?Z3/N*WA MD03K0@;&INV+U%HGM_Y%TJ,4D(C66!PKB6B!6-1:J=O.:[?W3*V)D\CT9.6/ MO(5-PEW&(V'O<#@JR.@*I21R"ED/E.-3Z.>XPB)X_SG,EN M@U30GMM_+R/^7!@1/--OF..:%]WQO&*L5SMU,EIYC,MY?DT$E^SZUK M>D."",C,W3I3*HL[43*+]/P(;T&5[)'PZDAX6JV ZH7SGN1/?,'7O8F5(2FWDW5+[^/IEW\[* MJ5/=&D]E.=4M4E>SU,VYUJ54'Z>Y<4&I2K&IH7)F^Q2[.1UKF).9?FF\V2IU MZXL92YG-NH)Y#:=.'UF%]W+Z:.-Q,U'I0WCI?/P)BOK4.>S9I#A#3+5)7VA? MFF]1J*VP2SL[ZC[IZYP*5:W1EUFH2L.NFHMU-X2GJ@*JA*+NN_1(W_,)UP5* M:+QON8U_]B'P3?=>II'ON&B;[48 F/O)WM<7BA+VW#,BY.8]] T K.T:_O@V M),, A !^W??HB9!8MV<-I6LL,4!?S.D1/I0N]W".MH\]GH)Y-R=.0&M/C%':TAO0I)<5F]B-Y)K MTEPP=3'%6'B2*Z#:*++]_^"3/O%]PKMT*Y;]:EO$M?9S9J6(W)VC@S !-FU/ M>QV#FO'Y4]Q(]'8X@D^E<37F >QB'ZA^'[AALJ0\^R^S I65!A%Z.%0_/:>W,?$3A?B1%&/KDF MID^,@-RZ,Y[*LW?E#8>>^X3-D >> Y+]<@BO95(QLOC"21/<&L,E-X);("P= MTSYVSG(_[VS)DTCZBZ.FBA&&OMV+6)?RT(,%(RTQ7Y@1TX(CO$=_1#@X;=Z) M,-OBQ99E^P\A7[X:MH,T-Y%>"8+[8@2VF37BI_-:%HM5RX5/:LL4&9#<)[EO MUVCZ'KB/YMMH*<$YX;E/&(,COKU=MY^<.J(DH*\#B"TO0L-@!OS':M:R^]2$ M0;6T+;FP448$Z!X]E^WZ"&T20A?G_0+27Y'#8%23L29"MA.%Q,(#38PT)V2W MB]-[:D94VA(+;"H]$)_&1%8Z+-I2B^G&\%T 0Q /<\UH:&+\U*;&C[XZ_)/S M1+B!MCB->JE;J]86S\&*>C VDZ4@&?/D&;.1.V,VMF/,+2>RE#&;R)C-Q)+CB3\I@8,Y<8!V;-J> " MZQQHPODP=!W35LJUYF+FBM#L(;R&/OX$17UJ"S=J4[,O#[?CD-\2!!F?Z#82 M_->R7[N_P3_QTY1+;=15P^GGD!3:*CPN? M.+2SXNQ>UCF9H9J^NUCMJO]<@1.T;6HT0O5YO]?Z)!UOY M2P-_RILOI-+SB?&K8O1AS1>&\V:, R3D!&B&MAM/25HV[S&&1K^"TA.M&@:LQXA&Q:M M,YIN,FL! 4@=8Q20B_C'Y]C&L%T*&/K29SXZU_'X@3F+GWZ/W>;RNE.OMK0& MBFQN9O,/!4!_2KG>JM8[S=1;M:J:_LJ2H6"D5CW32,NO:_6&G-,&U_6& M>+B3&>CD.,R6V3. UB^!29!NPRT+"U>@C,G<#[CP<7('^<)T((^MHNT2XWL MS1Z22#DG<0X$QO89-B:LC< G49 )!>S0<=Z\+:$L"5TP%$A"EX1^%BC8#Z&? M(R!A:KA7:#C*@V%;E5M7N3)&=F@X$KB[ ]FY=. MG7D>(*Q76XWUT!S:EN60?4-A88N$)WTZAFL2Q0B!M$Q"DX[YWI:^EX+3\YKF MV,EOFQ%+QE2R9C*5[/;NZ^K"C5LFNTV/W]1I99".OGC^9KNZ1UG,!!%/RNU& M?(=+S-Z,]C*?HMM\^<7DN90B(&EA%_!:9M)^$4V MJI>ZY\)!4H9O*L/;:V1XO+5'22Q1B31(H[!&J;MSSZ:"4)B4T><@HS/5ZFMO M6*MO,VF-'6[VVM]2,I)DI.-KI10^ZNSFSF[@4+3 $M+U@:K+38<$3>8;4^I'<5IR2.Q([$CL2.Q( M[$CL2.Q([)P#=C)Y/=KJC=U+"PNZTBJZS][TC# >$;YU^0%AFDM+S>6KA+7\ M2/Z,[, .R1/Q7VV3/,!:/.N1F-Z+2T?Y'\.)2)J/I)6Z*4D6DMB$)#8I"D3& MSDX!D.-+ ET@22#[%,BG"O>43%1:7CW1A44$($]6ULQ6;-=T(EP(MB'P(X*] MM5YM6(!%W_NO3!)67RUBK^.1'XPQ%GN^BF B;GCI6G>>:[(_LE86:-1+W;96 M!EBF-*8YOQRMY5L"2YINU1?.EJU*,6:'@Z\C'Z#"U!P[:#:EMOL^^QW:@. G M E@%%9@XB9; 7*/4[6B+IQWE/I-H1"4WD47&3E:.;ZPY3;HKHV?<,6R"#5QN MUG8^]2S)30H#B1V)'8D=B9WCQY67*%$:"=K<6$ZHR1:Z.5)'%H.2))^+C)T< M@\:YLWE;(#;/L\ZHVDPO-)H6,#M.]=%L_5VF4;)=:I 6CW?D=IC$CL2.Q([$ MCL2.Q([$CL2.^-C)=DQH36!CNH<[4R$^S9?IE+KU^N[%A"1]2.X]8^SL=LAO M6^9MUL1@WIP2? H2@UC; >6'X9N#N/U)?:O0 P<0KQ_%^ZSK "++B[!K.RYG M>76I C)0UOUQ_;"M49KTR&RMMG-1YAP1>Z2P\]%HMK@5^_*$3#&Y>(L\Q)V: MK33S:[92?(Z5&BJFKU]*WMU1Y>X8I-^ 83$!I5S7BQ[NE)59Y%.%>TH2K7RJ<$])HI5/ M%>XI2;3RJ<(])8E6/E6XIR31RJ<*]Y0D6OE4X9Z21"N?*MQ3DFCE4X5[2A*M M?*IP3TFBE4\5[BE)M/*IPCTEB58^5;BG)-'*IPKW%"7:3R'VQ8E;UB2Z#0T- M_\5V:7;97 D3D[@A\7FZ7_>WGO]IKO&-'$6.(D>1HZP<91!G]59QD)$7T,:% M%SYQC-!^)9_?;"L_LC##F0),:CO_CFEJ;5WR MLL9J/1-L@N8-X=MC[(CF>B&,'GH@OG%R 4%![M+,7B.$/_JV:[BF;3@P4[A M>T=6%64ID(5=>46OS#5+2_P[\./IC(P74NGYQ/A5,?HP_0O#>3/& 6JO)$$" M-?+1=962TP:4@+TW[?YX&4#2J%=H?MIPE/TA>J&4&$7T_9?O]W??RLKMW555 M9#)-G_W5_=WUS=W3S;4"OY[NO]]>7S[#'T_/\)\?-W?/ROU7^./^ZF]_O?]^ M??/X1,OTM#XK-W__>?O\C^*M]WG@@TCZ <\- N4&IF.Q G#L^ *O J<++6_2 M%_;AUE7"@1?!&%905LB[2?#(!"U#L*I;Y<<"+O6G:T26#>HBA\GO+G2H?S%5 MWO3("H#",48!N8A_?(Y]$]NE"Z(O?>:CZ. M\R]SC5"MS9\JXS?@/=HZ->W>TI>6W6CHU4;6=U;<:)W^Q)IZCN"7$Y,3DQ,[ MT,1XZ'/.K5,U)H-3 U$K2S%U%A[+>C!W62?5@QC+N[7^6=-6 M6@)V'6!9T2D)S%R &9?SRA.[4XYWGS[)L7)Q&Y/: M1L"3",B @,NA%[EAWKPN82R)7" $2"*71'[R"-@/D9\?&&%FN/EH.,J#85N5 M6U>Y,D9V:#@2M+N"UC2C8>30_JJ?W/Q*S MU=$U,9EU],CDLI;#C+;CFW'VJIY\9@4LYO+.?5PS02:FFEKE:NM19+SY\F M!4H1+T7\*D[+6\3K4L1+$;]$Q&LYMO=IU7-H[U,0$I,R_!QD>*;> =I"J_M= MNO&T&KMVXY&<)#E)F'5G8B1]WZ7\6TWLO=$J-^L-J:\DEYT,EV735_6#];II M8;,J32^WZ[OTNI&L)EE-F'5GXK3&WA5:N]35RTUUD;T$5&>Y[$O.=93:D%,F MFY'+-GO51F)3DY^8JJ@JRY0_"J'=D5!QO&!=6LT&38Z+%\W@8:OM^BL)T-M, M8D=B1V)'8D=B1V)'8D=B1V)'8J=($:+FAA$B\%%N7=,;DN_@J&3V73NEKEK6 MU,[N;9 E^8A$/@M1CWU03[LF#/7L,=_Z!.,:-.A5Z1FL#-IP1-S 0+SM$.=( M@5TQV&H[G;DB-5_@A!N)'8D=B1V)'8D=B1V)'8F=HF(GDR/=6KT!?&EAP5I: M\/?9FYX^QL/'MRX_>DS3;JFY?)6PEA_)GY$=V"%Y(OZK;9('6(MG/1+3>W'I M*/]C.!%)\YO44E?/Z\2%)#8I"LX8.SL%18XO"32!)$%Z#$53<\@-H7-IB7)@ M/9V2'GP/X&@%2M_WALK(MU^-D"@CQS!I.?BRXI(0*QKW"7S2<"W%H!4_ F5 M'$NQ784$IN^];76VO;!!R:QG7MIKSKS0R!0[RG@=^0 +QDKLW M,F=[:,% Y M/UDO=9KG1J.W*:3+6+;+.E=B1V)'8D=B1V)'8D=@Y/>SD&?998FA21RVC MG9EPY^JX(5YOZ=+.+ 9%27X7&3LYQG;VP^X-L=A]WT4'U69ZU<&TQ!9!2Q'2 MIEMQ'4(]ASJ$O(>2#B"RO @[,N%REA_B.B4V7!+CZ>19HG"#X$XSI^!.CH@5 M^_AK_C1[*B=C=X-,,;DXS7CN[+$F5KNUIYI81>18J7%RT#CZNJ*X.15+;+?W M4BRQB'0K-8W4-'EH&GV?!7;;':EII*;)5=.L*\N;I69CIY9[S<8B$J94)5*5 MY'+F35^HY+M+$9">=:\BW!UL(Z]UBFK]<7#J%*C M2K:5;+N51EVH!KNW,I4='1FX4:XUFU+E2MZ5O+NKREVH,)L[Q]:Q[F6GIA5< MX?)=\V7<:]G!R#'&N$"RG,?E4_*I0SXEB58^5;BG)-'*IPKWE"1:^53AGI)$ M*Y\JW%.2:.53A7N*$NVGT.@Y)*Z;F*@#.8C#.55,B1]Y :T&<>$3QPCM5_+Y MS;;"01S=2;S'@R"UZ2M&+_"<*%S^2B+@81(W)/Y,6K[:SK_6I%I;%[72:+%) M0A3#Q#*3ACNVW1?%]4(8/?0P8@638T4H71K1,4+XHV^[AFO:A@,SA0NT($=5 M46:+4Q9AY95Z9:ZB9N)?7 !&TFRB][6.9FAFKZ[6.VJ_UR!$[1M:C1"]7F_U M_JFU2_%+@\GACI'Q0BH]GQB_*D8?UGQA.&_&.$"23(!F:+OQE'25TN &Y(-5 M4.S^>!D4N[_U?"3\Q86)A9.%LR 4)\K]E^_W=]_*RNW=555DDDJ?_M7]W?7- MW=/-M0*_GNZ_WUY?/L,?3\_PGQ\W=\]/ROU7Y>KRZ:_*U^_W?SP5;X$?;ETE M''@1C&$%'PLX_Y^N$5DVR+'EDQ\:_@LP)L:RYXY3+5\+U3!3]4"#X; FQQ@% MY"+^\3G63K9+9T9?^LP_QW5*RMDL^CEV>RH?JC4F([A!QK_,;U?AUJ?%Z\UF M56^V4F_5JFKJ]65#J?5JJ]G(--3RZ\U:MC=63FKU^M88L;-;?JM)>H6\75IJ MNEYM:FAI\(L^HTQ^=36A53JK1?S\&;G.PJ)2=A7Y=PYR&'"]5J84_3SPP2+Y M <\- N4&UFY-3P7.[%EE0N7RW=]-V[GI[-SD6N#M9P=R0^!I-:V^]-1DQD6? M&^#T+-255W7ZHR[ZR@@&2M_QWGA1-6]$?'!\P ? G>)7\&Q(<+$).>W4*W$= MG6V519_[Y#+3PXI#XZHN.&$L-%;DK9U$_6",;OH$4&[: MX+6[7-OA5?QMHED48=S3=O.WB8YM]NS5LIFW](4C@FLR L3;M"QT7"489O?O MV?Y*!:\-O"$L=C(/9N5@$JSPVR'XX]*U+A/0S7 RN)-?#0IQS 5)39M6 ]N, MFA:IIEWJMA=-RZ,6^]I5HQ9#JGXQ+$!H+U0^H%:%F8T_*N0=Z^^376IXG3@7 MK)&I#[[W:@>6Z'NAT.,@,0RE$5G*9PJ7K\"KHEB! $)I;VZ MK6R]C[VZ[PCG1_S(??]G0"X1K$DSXX9A((T_L !!2Q!K0YJG!S1/\R >K=2M M"U:7]CQ,U;6]E:6=FE&6T@)*7^9[;J41O2Y0-RUIA!Y08FY.(G6!2$3XA' M/RLO)8[+X2XUL5\Q3UPZ*#OG+MVZ)M9_)=>$_??6C>'\. %SFE': &>]EE?A M.NFXB$0ZFP;/MR6=)I#.SD%"&4G/3@2W[BMQ0\\?RR#Y'N1F#%T[K7*V5FN5 MNJJZ<^$Q&1L7D&:V%YAK: :3-W;6L3(BGAW[#SX9&;85;S8R-\(+!\17S,CW M 6?Z(?%;,Z.@+0SUD9HQ0GNTC1\[ M,@M1"M?)=GQ,])NFQFFJ*M.,3YF> MMK=5TPEKD8"T4E?:K,>,CXZ,L0R.YBM48]@^,-"FD;T.1F@]KX:^TA(5B5PR M&Z(;D$L=;,Z=D]VDW;F5F/0CLM*U3^P72LLT5R&*D/\^A6[LFDVS1Z?WTIBF MD4ZE!LL@A5S . M?N$/.QQ<10&LE_@Q2Z1TC]34%DC77>HN2-M51 +:WN'/3$!M<(&TQO$IZ*SL M67K@YHQ-U@-)T]D#3BO9H)-Z"*Z(U9PDZ>02.-V8=+1:J=L1@'3RM$:;HM= MNMNDO-$N)NK&54%/D6TRU-##TIOT0+Y%K"_CGX"-!.]<3E"1QC=JJ=O4%X.O MVW9A78^J ABV9TUV&8K5[4!V6JG;KN=0#V*O9%?THRIR@B<_P=/RR.9+2//F M,#F42^10V4\)Z9P.*>VYA/0*2U,7_9P::!F8O<7)8N3;KT9(%& 4DW8,*M-* MFUY?L8,@ HHA )& 'V$SAFQO'\Q3$IB^]W9F,=-\:XA1+'P%)-QR2-_W'Q@V M'F)D9$B9TG193>R4Z6G-WM0V]+2V$+*FU;$08R08J3E!E MQ#TKI3=.-81VB58O-35.72*MT7!+G-JO,?B33NWF6JZ1=V+P9N@K0.C[;.EP MC6;N-7LA\>0#+,2S%K>N3"="X-Z\F[3$RB-8M#?]/C'# M-)YLR2#\R9-NCMKA^ 3;!H+5\JIA]Z(\*W'GZ+1R*&[R(:C6'9@.EX0^3 ^6%)FG&RDV"[C(N"#DVS& M.L=!C6,PD'#OGU7^U"-O3\Q;U<;4G^9KG"(#Y!+]:Q3!?=RIY?J)&9UI2SPA MNW*]69G9.M1+W7JYO;NO)DZ<4=+_R=+_!GY59@:HY^0>"1C]%%]]\1I")LZI M#[,*F9UND9$7V-NU)SV/--MUJB !T/O^-0/G97AE^/X8H/(_AA.E%=K2&Z5N MHR;KLITDQ:P3GAN1S,89D'I3M#S_L\IY%MX]??8P/K.Q2[K'K%+A0)/9W).[ M7<>,K[=RVNTJ0J*W9$/)AJ+N<[7S=>3VGN4^%Z)O9@K1YQ0]W<<>UQ&F=E:6 M$TT9H@UWK,C'W,YP0'B.$+*,8@.+^L!5,BY\+G&QM<6%&4$\ ,WJJUF(XRO2%10N-]\5#SSG$ZX=:> M.6GN1+EW?1%\((IGI EDX S!QGI^?9C$B5U+/CA5/EA?OW^6#Q;I7,_ M#-\WW% 9>A9+] "XRR#QN83.EBBT%\=[N^"4\2-!&%G8.O=B9S*&+!GAT&IN M.2,L$GRSU$UIW21D%%GXM#8YP(Z&+VO05HQ=X3A0N?R5!E2;!O19&I[8+=B&P M8INF,!R8_S5ZZ),0Q3!-;PC?QFQ5Q?4PE3STD/:51F9UT\E]< ,HLF^A]K:,9FMFKJ_6.VN\U"%'[ MAE8C1*_76[U_8LT&_M)@DIDR,EY(I><3XU?%Z,.:+PSGS1@'2)()T QM-YY2 M7:NVD @WH)]_14%H]\?+P-C]K>R M4S_/'U]N[R[NKV M\KOR] P7?MS\$BW(>Y[CN>^@,)PS:KR 5UYK?:97:1_J)\5 MSU?X]3>R>"T*$M*//)]5 M*K!=Y8!NS?U-$7#M%Q+6SBCAAV!87CP3PX), Z[N<.]\^ Z=Q%OL+ M$+2-@0IE3 P?*P<"I%Q@,),,>\ VNHJ (X8Y4#":X5KP$#Y957"0&=>)Y@_; M0Q@Y]IRNDI[3UXGG]#3QG!3DX2@V!B@+#8Q7HO0(<8%UR)$/;[L1C+[^HWTN;.86#H_'RYXQL/0J"#CZ@C>R M75X3)9P!(1,2K+T4W G(5L#P2=\A9JC &A7#0IIAUS^@!VJSI '/A?7#]UT, MLCKPBAGY-)D[\<)'ZK*BU",HDD!H!88_ILLVE+YA^U/?%8="V$W=VMBI+\/8 M L]6E;)#L?* MFQT.E!?BP@<1U4!A9$1I8VJ*C&#!ICUR"(+LS\C&(DU3#*#S/C1^$073+(;T M9#CM[14$T7#$UA .#( RK5A-)P^3]'SZ$=X #*8*SQ/>%BS1]IO^/2T.1:OC M4#GY@E]>]@[["F)^2CH9> 2&6S9+G[P2D-'T&?(^PB 'H_>X<"C2&H"C9= M&%'*8=@%J#JX)("&SUJF,0*>0&]?^JLPDC)=*%"Q4<%*JTMP^<5P:'NYIP$A M(2+?0$H/!R"P+,^,**FB70-L:K]B9 EA'TO"#6).SUN0$8MNV;2 .VO#3.?S M9V0 8?G ;HQ>4.)^!7Y4U%KE[S!;?"]^BTJG9'DTSH*T]]#/ZE-U<^;%&04# M2G\])%7#XK+@7Y'+PO%4&,R*VHTA1-5"GV59<2&U5M(G@ 3/^P1$R2RP4O0F M?>^2Z9['!?#]K0S/.?#Z9"E/*+*GPB0NHH\##^T@P&7'IO33S=7$!/;0NIWX M_FJ'^?[*AX35O#B3^.TY'OXT8SN>&T^CY() G\ Y*/A-R@:HX5W0]%&(RHF?[>+S MA.&!39-&3Y420A(4W8T"V?MV5J90@BDM=5$ZQ71&'J;R#Y YL]1S5[19^"36 M1B'W0F*#B$4?**^B78M;"17OS44''EP(V[*!I6#6'^R/RK<'*G,C-_;4R\KW M[U<3X;MP.Q:F9>5MX %;]^)H4#]65S;E2!YR8(*!ZB,E)SPPV&T_PR4OD M&*$'5OHH\L$$)S 97,,'&R;*UW3K6A&>><9[-.)R"9J8?J3"O3#PAZC-P6U& M'_#!MIB#A%M%''L($ U)K&VG!,B,"JK$KS&VX=,5H:?$5XB5-VCI)9.[$S"# M)%S/5,^D<_JD1#_]<9-2H^0,^?R2[":1D?_Z]BU?BH3914 MH\9K?)1K*=6Q:(3RU; =W*"O*O=]9HW'"\]UU9F+-&VP.)46_4I?&GHV ^)0 M&0,VOA]60$X-EQ5L8];Q#]OZ:H/$!-?)_07BC3Z1;JCG1BW'KT21 *C&>_WOW=:&?;(3B]KY_SSQ?]R5& MPPSSPWI,% !OGF\%Q$WC_4:I&[YYBWS/YQ5<*!_4C],=O^1>VH/O69$93G8' MWP:V.<#@%(LN,Z-T8G\' !=,D*3Q<5 +,9I3\*7U\/_M$5\_R+__;;AP&:9> M;VN?T1O I8"4Z1,,R\:&O?9QQ33W3E8QV'_PW3$MI*1>&DIDP$&QVM'_D8C:-1QXA&R-;X&6+Y'84;:"XI[U"9H;FM7K!$ MR^:*1$O!Q^:PA]F M-WFS[F^F[/]FVT>*(W;TK6^7EP^339.B;@]OL+FU?E,XV'A7>+(I' ^2NBF< M@-C0L$A5^8/$24(42P0\I @7,7TN"J8;9W.I &BHK5\F"XX:@>>BTXO&!\QU M!#85H!\_EG2:>#."LX;+;( -TQ DSD8,L6;T8@FF8#- MPR "\HPO9Q(6#1)YD0;.B2;&L&^P]#,6D;8(NK*V&P,;8..]L:@LJV $R*&1 M7@]U(\@^@G$+BBH^84LQ?6*!VPM4%) IKFUW%(6S0*79'#A12CI([>&XPI:$ M"7*6C,@F!=6M&QKNBXWADTO*B^R/*P+"6^YOK0DXI MON84(0P?=R2\>>?=Y;]YGO5F.\[: Z4)E[.U0SGH TRO7>JZBPYQ2EQX2J=, M9U25ZZGTG@E6L6R&Q7@ZPY=/3*R&:F4+%*XYSW\Y1.7Q;RKU[OOS,,H<(NR4 MNNWFDOBXBQII\K%8ERG4$8%5T?2,>5"=!T\O.<$3QVR4[Z"@B/*(]RI>OP(Z MHW(Y-3^^3\V/\P!7N@B\=96OI.='F!W)]J#>,)N"YA>A?8(IY@,/8*&DD96SFW62EVUES2;YA*SDP!]>6R Z0L T+LN@IE_>2S_$:I6U]N],PN MGZD#&DH8PKH5;R.C8AFWV(>=3F.P?@DD4D' M5A[+W0[BD%/BW*+:^ARL78>50:(+D7@ .$Z<(?0]%WZ:#):KP94Y\S>X'/=@=%& M#QR#:U=NVH M6_H7RNT04X^Y9 .)Q&9(L\7B25]/#^XP%\.%C[]$("(Q"&T'-)^8"A^,K;#Q M^'8!'8?G;B3W./@>"_OJR =#@!Y: 'GF12\#$&4#'-N:.3,$=GL4SDC'>."I MS4?/E\(U:RJI"=V3L>F4PIDH/DT3F)YL"$! O]@N=9WH;NKT0*O:2!SUF3^[ M@9M/H 0RC52?346C,.0;'AZ>X:"!>;Z7P&4] -:@>TM\Z\>PO-%4A\$(R (8 M7&3*QN.Q_F7[0'$X+ 'A,L_@@+'P-,GDA C+:<--!A\&.A,3;*D@FJ!R$T'4 M$4T0S;/[L_&>Y&\NEI16_;ARB>['<2G +!T\EX GN_$4 =TP!?>!GGL#LZX? M.2YGFFFOCQG9$0N6.=,+\^&HQP;#\)T]8)&D )S* MF,PR!9UNW+V&AW'3.F;J$6X'AI,CT0E!D2X6<'>9ODLO(P<#(A+6XV2VN.D( MJ%]KY6Z0+35S".P8I;*PO\Y6F;#3P@#77M0++U&S?/, 3@ 6D_ANBBF:4MRB MF;FXQ3'K]VA*1?E.,YSM<'S.,GS%:1*^6UG8HR/-SNJC(^ZT!S*F5*)@ .)% MY9'7B1E6V)2-?<6&SKJ(%G!UO5S7ET2 \)1TAG FB/*(-E)#8MI8Y.J4H1DE*4%=P\@U%1MQ?ET MJJ.Z?V#PR;')*V'^ P:LR#O?,*'0IXX#6/E!U.]CF(GEO/4C?B1V[D3[$*M3 MT,W..2DRX]?1PYXA#4PSE\4%("JJ%O/L)$>L#\87##)-9@/[A5=%F%9 N+G* M]>AY@R;"YD,/S &Q M(H?0LH1SJ'E&I*5@1?B3C$O\%(X=DL2.1['##_7-9(3S% C,0F(9$'T/DXAI MK)D&%[T(9F,%'R^6(W)H^"_ G]@&O3';8&*Y&.,QWECHTC[J]!#7*" 7\8_/ M<95YVZ4+I2]]YI_CDAJ_.-=X@'Z.W>92HM.IMALZ"@I>0Y]_F,N0*@#NT^+U MEE9MU!NIMVI5-?7ZLJ%4M=K46YF&6GZ]H6MY3:K5;JX<:DW?@0U;^,WUCTBA M$)$:=4S1-&,C?L4QI-M1JE;D-KYM0L<6.D"-I95#+5^3'5FD3VK9BJB0UYVT5@JIS: MDPK-!E?@XGM#+ O"BD0MZ-K)PK5L"T^5 L7FAE4[?+S2URK";^$1/4':%N;9 MSUX2QA(QN2EAM$M=5=U9(AZFH>5)>!@/OMIMV7"\V;:^Q MJWE,-@G1KV2E_N\ M6L=03J0YV W2UK9U%S,3"MM/!M;JPM"*^=@#C[3!$^6 M#CTIIKVUA#P/[;_*+.0D_P2$'5#8TN2V&+)(_6EDCXE/.TM(:2D*2"NK+,7M M:$4K=35-$%HY!]LQWH1&E27-QAW-QD< X@KUK^/Q]L4L26DJ%I\^-C,5U]!' MG6[A"4(?YV >QL+/LC$KFG>Y?"*T&S\%&9!FC1EJZHI-2,TY:CQGE M(X7O8KKK"A9HE;HM0>P$:4<>4$IFIY1VJ9O7YK2T*#>W*%-RNE>(RG40X&D! M/(]:!]A;'E;@HJD!RY,&3CJ-)4_0G([\V"Q.D28Z-CGUF9 KN.U5KNEJ3F98 M'F@\DHTOF5O'(UC,6\QTML_T;-0J^JL+#GNOLUAK55G M5S<[^HG])KP.$3AF+PO.V M+2MK@#P0_VE@^"1K>6J&"HJ)!\._]VDM*(NV<)T.N5#?HP/RH%8%T"R:>EC$ M2@GP/>4#'DB==&V]CPG_N;]E^_?^,/+*G^OZU1"%Q+L %0*P> R"@>>#W1A M9:VDTL']P0:MI))>387-,.Z3E 2S8DR^RLN-[;+,E")'\ZMDQ4PSKY#N<)7A MO\MKX.QYXO=1B*7!T.[(//L&F_VRQB0LPH#UG$DAFET'6J&EH;):ZG90\[CV3^'.=B6+S7-N@9(/<4MP@JIBNGS5UC7[. M;M1/HHEZK09F<;G6VGDKX##;C$*5LUB1A*+J!>!KWL$6ZSS.&3#8ZYD9\,-YF+ML#;6R0=)689<[=)NR;^43 ]T^&9(>BUG)C7\P3 4W'%-6&H-I MI6ZKGE<9%T&2>@K,70%7=],J3U+?B:OOZ+]?#&"M9%VN-#;#:'Q[Y],Z4HEM M4<2%A^B8QTC>65,7BP9*:',_VXIUFE1EV4#[(5===FEA@(T6@W_V+@$8(3T% M_P (NG7YQEYL9DXB?S.+37YQF\QG-\CB@/YZ:/+WQ,QP6;3Z*3]=21!O#;HL8L!UHK3\HIN@)V6 M%?0=>]X^^\0((G_,N?+BF ;/27%@UE!("@LN:;88HXP:1SSRP8=?DB* MT[ET5CP]9 2\F5W"O,G8= MGQ:<3V^K9[$C3R+R/A-@/VIVWQFH^_K6ZGYED#R657JI6R^K>K/KY+KAWB4CA4W+ M6\J1#C(2ER]UK=K"+6':_1KX]X*> +9?"=\)YO(G\2+GT=KT%:,''!F%RU_9 M?%-_M^4?+SF@TJ[,3CKY[\"?;@:]D$K/)\:OBM&'Z5\8SILQ#I 3DSD1MEN9 M0\]^(#O)$N%9&VSC9U+&N**6EMUE>1T%J5#+5=W6E;VR0_'#<9)'6NUJI][*7.JL5E4[>94Z:VF-7%(BU%:UKK9SFE2COKIH M6I9):6L_7L3-P8Q;ZJF/=83?>5^?JXL"A_OAR(0;A ^%14?"*%UFQ&\1W1[: MEN7,91+R(2KX_$6]2HT:?LEG<*^FMALX$K[!GD;]X?67Y&ZNBA5O LD]82.= ME9Y)ZUIQ(2^4>66Q:FF> MGDX*:&\,A;!UM5F?A-<&>C>OF*^KK9*7;VNEVN=SD+\ZQQVM&7. MB,P96=QOFF5#+:?=ID7F:^D*F+)=)&];HZU,YLS'"]9S02M=HC))<34MO-4<4.O 09-4UL\ M_WF"^_MGQ@>KE+#6I9HVV^)UJU5X18:L)Z'IIXKFY+)L\@^Y08MEUZN:8LE9(]?4U:R M@VC:>D)H617BJGC<'N::?8(M;.3:6BPV)$@QQ9/1V(5UJ^FA9NE6'UY?;Z<0 M*;(RJ\-54<$<#8SM)H?5E?EJ:FE)51]^FK(DQ[,R2VFBF> MJ&Y6.XM];:5C+1UKRF=?/;]/[&WCW^?K21S L9Z@)HVS5P7T]A'E7CD9'31M M_=0]XNSL+S8%'UJ%32AHM1)+&GE]^YU8E7\3WTNCNE7AHSS7D/O$&Z4N[2"O M?5[/,J>92+?*JSW-1#K9;.A(.\_9ZQ3LD$>G9\^CV^J\^ YI='HK/DB:5EE! M^)K]TG/>AUZO'R)+2]\RARQ]]V U(NLJR&J,$[XD^=3Z!GEWV M8V289^/^$=OO;G ]5,^>O[CXT9WV@.*)J*6NMHF)6.BHSFF2[39FEKKGW8F8 MK+9,1USJ:H9F]NEKOJ/U>@Q"U;V@U0L!H:_7^V0 #:9LVF0\^Z1,?W/G_ MG[UW?TX;6?K&_Q65ZVR]3A5FD;@[Y^LJQW'VN)Y-G)-XSW[?GYX2TF!T(B16 M%SO>O_[M[AE= DD$"!@GDLV 32:Z?GT=7JZ:3N?V&(3S,Y@N0EF9["Z">;R MJO??_HM@C7T^E:YRI<2KY*@MP:''SMF/H:?AA,7 ]&] G^EN^'NF/0#\,9&%S?=!M 0 M_W_)-HAD#2QF%D. !$53NUR$*EN)<7J%;NB&9-;HMLCZZ&6]!J%;BH MM6(3+*(.[44J/A.!,UL!;8K/=?DP%>Y>N_)DG:IWKT,,U"X02RB_>WLME+MS M#5OMB!W3UB[5DX0U@PWM*KKRG1E@@P9( MD:\A/*K[3+E]!E-T"C]4+O%)3%C56N^7OZ8OU/?OR'A6#%#B8)4KNF' ^)@T M"^]X80!$SY\;Z"'Z-'J^H51:PW/$VZX!/I(EOQ7V#?7Y,P/>TI?^:59'RSE M7J.;I3<33G?!;'+8J_V6UJ5YT&XH_]@H^RKO2#M;YGW5O4?O>X S^8]NARP9 M=GF)/;Q##,RP?$-/F8%[\X+/*S/PO6C%&"G(%P9X=/#>LH#1-HDU\\JTC^.$%>]TVV;FA[?%Z%-I)&'=1*V1U5DS M!:5\U"#K 3&!F@9WJ1-2"C(*5WN!AO0@"06D^#*IE0QIL'(?-C+T.QM%_G>X M&P/8C<8 Q')'7;XQD]J0=/RB":*,H=0E(A(5A)XZF+_: 7_U3I^APA4QEOU, M*5OG8= '0Z5(1)B0R4 )V4"M9]TSH]A*'L()I\OPI B. FIR2MNQ>@1 I^XK M/@L0#1@ 0C5%"G?>J8U\*8K[K. Z_.YQ9+O.:D"_ M83;CW@WX [5?W>UI.2;QY59 LA0:*Y#_G14Z)E>J+4WNJORFP!I?3DI]YT%SQ M.5-UM8Z78Y9&L5IFU&G#*?L+!S MV#M!?TY(?*4E-&Y?W R6&?J7B&#Z;&:#FD58+A(:U3WJ+E*E="H$OS=3>C.A MC'!%ZKC^SNKUH^Y&22ZXA"\R\'0RJ4S C#6=@I,/JT:&]IC!8F/+9#;@@]L3 M\^0 A@]@N+1?@3\ 50#C<+3H_*-/M@L6 2?W)=#;9*!<6!'3ZAT??,3'^2N$ M-Z*6P;%_\L_\!?7AI8'?$/_B;W',^ /P;4<6WT2P:@SN MV5A_TP<-/'5U8>HPE@5*5/?F#W MY\6U7Z+EIG441WEJEL1*5R,=;>)DG@UD M+ITTH^+I@3%A>$CM6WXC0@][$0!&G1:=?L4Q(.&8^_R5N.0DH)?2OXUT-B7^ M+#*]Z=](JH6Y!SS4!K2FWFKBB)J!PEXA&2_3FR+"@? B-N,,UEQ641+'!E5HE0$'13T?UT/LPL$"Z6S9.5;'H?,XLJD-\T A[8?&),5:J$2G5K!H!9'T%1VS\EA7=,!< MX*EYK[N!+.8:(.Z7Q?5F3DU_ATX-1?RU_G Y8;*)!@"&"%+9_V_!A)2J&Q$/ MM"[H]_62"!2=#IL@Z"I\I5OAMRRKK'3 .O5 ROZ,?Q$'^8))$8D(LAGDK(5& MKU#A([ UP=>%)P&@]=N@?NX&D2',319 Z"9V%2%WWK+B:B8RJHA"8"$HYVPB M_.%@]&(MP%<[]!.=5'T<\O#I0$Z<8DSCHR7=^':Y$-%'\:IOL(@UOOOP MXF:Y#]HO1!7=@,Z> MK!5C0O2899(G@'Z&.^/N$(QAZ/Z$>X1C].C%[R)Y9WAT7$6>]@+T5M*^J?PQ M$W$&TFF$&7I-*DDV,@M$_I^N/'G6\S.C[^])R);TV==Q$Y%0)PJE""3"CYX8 ML6Q\IUP"8G%@]%L7-UI64"=&QAR_?&1C/;0#!0>>YYE.%S+B3YVW$( M6 ZXR N/9X.!'IU;/GGP\'_^E7"X,82!+OQY^[MHEHXL&UU7H##83B!44V:P MOQC$$3BQP2(((ANJA,'55#Z%'L*PL=8T0W:D^P-Z_-81'9*&S/(OU_9A MH6@-4#!HQ(T"8V*Q,3K (NCLCF$S>/0_'0Y+:13,70BYKSRQ<#_U8,+?J*,= M8\-NPI0\%F<$HK.A^ZX#I'I#Y87FCCZ;N983'6L3 MJBP/QKMLM]XIH] 'L(&3A_'_IO) W.Z(4TI27,LV"Q=8:6V,KPKXKYC95/YD M9)AF"$M0IA;:U#R\AYD3S]'I7!3,F\^$ 7Q'IA4L&'E\!"O!&3=XLA6/H,T% MN?G\V$] 6/2@;;'H?+N)\-?,2 M!^*R^21GGCO#WS,_=N]I66..-CQY1MLES>?"Q,@7N\>3"_PQL9HS;HS%M4D3 MTN3E(R":^[+H1*:66]1O[U%VQEV$(;W2C9&VOZ_7S M7YZB!AZ:GBRQ*JRV?_#5;GAD7.M/^5QT3N2!L&MX[YQ16J,2A-@QYP M[#&R4O+U^'[?>7K\/V^\O787/W M9.YXFYL=4]!Z>/4Q,J&Y-<4/&B[I,S<$507;Q0][>8AX[?9?+YT&SFG=G%,@ M6DQ1G9Q_)L?7$)\@4N444,VV/O/9=?27]U'Q LLA!4L/O1?O$\>.>!BV6$L) M7\>_%N=D@TZSUQGB49DHZ21>+$[1FJ"P?UW^7.LW^QTM\ZM64\W\/&\HM=]L M#[*_.N100!:U5]VL5M-J34FM@AT@5C1Z$&BK4R&77#9?*"J17T?KN-:[N,Q8 MWI_<2J/JAHHH;[ATM'ER*XXRE+ABX3:;,O;<:6KI\_M<48G?6I>AFBL2TE:B M;/?FY6:W2G%>!VB)K:,57QVF[E%G^D MK)+A:'6UJAVMC,9)[813AOF-DVK(*V64S?J);%J]^J3DN-C]NFUVI75ZVS47 MBV1A1/DBZTWKTVRRLQD0JZOJ*"NIGJQ.;175J7-!W QU.6A=W+0[RS'I.I4B ME8V[:B)3*FV$DNUU!9:#!3R"].G[NELM*3&BO%_.5! M[M'N(1K1; V/VC%':;?WB!1Q/O)+:&*ZHINCAI?.EK/TL@822%V^V2_A*^%; M?47^>11KQ>Z9+W1-6KHX%"&YC=>%VIT:=DDZ3 MFN"AHK!,K<7=^.Q']@N_ZNZVQF_$*]V\RKXU;+B]0[C4CI]*AZ'. M[]!G3>6U8H<^R]JC!QS1WEIUG%H#^G,6Q7LV7_I5F2\[Q^"Y!>LZ%9TW':_A MO]7!IXP3R#A!KCJ?O]NRU7G3X.*F4\=8@.P17CN1,4#\C*QXSP3.TJ=)^5IVFW/DX:MBYM!/=![XI)LH_;# MW=V=OPQ5*M>V?._R\"D^9P: (E>1=QW &&KB)G)-X'!V%V\Z6YV]S&0J_$J55=)-(M*E7XK5_#^]CM1QW?^E19U 9<^,KK!4 M?3O5I@;+"*VHU4TMR>)."EOVRMS9&_<9NCJ/GGTF:RG[-4!^7L*E<8($O%Q')H#./P4O(4X<]L M=/4*XLEG3D+EP<4-+VB(M0_]I:Y75#4DW;XRMW:Y\Y1\=4/;C"EIK:M..U]U.=URA?JT M1!NW4#=1U'9?T>9*=#O5+6^^M'T&$V 37I@O*L^X7&RJ63%6SK^BBOJ\FS)- M-()B4[G-*Q[7P!+L&:^CVN0CQI+5F@NE3%>J5MF!J=(.3&KK>%LP5;I3* XL MUAYK0TW7C%%'[0S5\:C+F#K6M19C[4ZG/_I?;+6;E/XK7AGQH^5CM\K08WC8 M.YTQ4%N(P6^(6F92VU^2"!^P]5[4''BI:=O$W-/*MXZ"A\YDQ M:K1!K>F31[D&CJ> =C+\Z4X=:Q3Z:"/AY*UX\C/\3;J4>-(Q)"HWCRUOGKD= MQY]&.U 4+(^&T5]UL#+3Y==_L#<%MN0%;75J^Y:N))]N[ AV.5KROF5:.IHK MD6Z?WY7H'@_?%=[@:.:ZMJ*_Z&"31Z:H Z!XY@H_C#M&)<3 ?2@;NEA7^3F1 MGVE)P;UJ MWA=+T<6"!4=BQRR4.C[O4\%_Y,_7NT8!P+_FG7BQ[Y;)TMVN\DKR)X?.^/3* MZOX@&6? >(SZ55#%YNO=,U*J('.WGO68A\-F1^V6K'O'BRM]QZ>_H'$(I7?G[3$@F M\58IWE8"KM(;JJV:)\L\9EGV8)2GCH\:2V:Y)HNS;Y9BH:WK[[1QG$+L8\J M^2+.T4KU NJT,(6TU^CU*LXA/7R9ZBRAMT.LUH[394GXHKD46O:UEQWPZ,)= MF;ETC"SFI"I5[6:OJMR[6C.G5"HU42HIEW!#I8(5HUJ9#>9.$+=2J4BELG>E MDN+1LDJEAZ?.O>9@.:>O;LRYQC.+@NNP!);/R^?X*TFXW1"N7*V/8&O,2,X^AY$JOIJ2Z(X)@?YF"P2QY9]5C:^=KYCSY## MY=8Q[W]B]W=F/KGX45F',<+)$(M M-L]*;F.%XBK[BCMU -:C\75XDR 4&U= MW'0&S8P;3KL[)*J[84A7F#:T#(^WR VF_%3,.M?/SH)IG_D'69K$ D3E6Q M86_6ZKC)/_:!7H5U8&'SK3,,,])6,-*G8/&C0;0Z&U9B!YUO_ MM#+15,QK*(^,5?YKGOFGMJ5L.@+L[=UG+8(^MD8611#K%)- ,EY:AWCI2>9. MM65SHWK&,K9.G5(K.^4^M48PIP3.@\4W-D\;4GMY(8WCCZM)H7E0H;EU:I#: MSS/ZI3&9NGA6C#NHE,Z5'(E-?).&.XE>2<))PM2+<&=Y8FR\S(:^K M;9CL5ON0RU!>+)"EVH^,UU:=D]0T@J3E)L4Z#T1W;N\&%M%-6,6NDBDA<":00[RL_R9[WK: M.4TP4B7K,^KKB8)W_7D)5;.2B5BHU7("SW)\RTCJI;]0MC$YGJ$C_A%525Q9 MP#2KN6JA4YHM[A2EN/XA6LI_<"5JB5L<6KMD<_:C6%3GXL9Q,Y*!%CX(J(VS M-091Y 14Q!9[(LPHURU5H;(IBEH;Z7+6["?^G2D>K^>-]7?3I3=Y!XQ5Y3+G M:^<3YJ@V)N)L9;.0I3*Y_=4=?FYMVS5PCMEJYIXOI+2!UBT'G.Z:AFT[FF7O MXJ:M9H82ECZ@+9AKC8"EHY5GYH JM7D+#G-J.98?>-1X(,8 +!U+J]ZY*-=X MX7.'+$Q"QO< _L.[HE"E+R:R*GFY:(]-=1C3>0;JX8L!CW\SDV/IBK@D&W<( MKPAJ>EY'!BRT6@I+[=6;=#^=V>X;8]]Y=>GLK?KB"M%)?.T_N8%NI[_'TO=? MW.#_,GAIM%YB,"$"2N]Q'_8X.US4$#6U7RW@ZQ%34@1VP0:!W7V-JHCIHH@8 MYWZDY\K:PPCG/=&&Y]Y^PW0T(FHS-0MS,7&/"5&A/P0OT3]Q5M]E0_A&4&B'HB1 [:JDX%9*.OXY4]A]AWJ85Z MF4!;0<0R?2&:2]&CQ58?Z1YP"1ZNU(L*K+L]MW+H-MN:6K:50[O5'+3*=@_( M^[RCMJOI*@!+4>6DCGI2G9TUA2CXLV-MG+ D^;B&/]<^$DOD((V^@Y82^R]F M?U"Z\AO51U;^_Z 4B\O_1]7_J7-;C3M-2'P=%<4*XZNB--U:IW/\$1V&G M3.\(F-<%[.[K]6)PA%Y+ 2'-] MU /V2;<\2J9(>'5P<:.UN\U!_QSX52J5@DIE9[TGJHM=1@ >5E89^1@0+#6. MU#@9&F='72@JU3AK&+G3.AY&KK0>5KOF;$A[N:),K*R:487&[1U,X]+^YI2> MS>)35;8B2#V_F;R&W?[I6]>.98O3[ /M=G%'H:-QP2>9?P?,WZ\E\^=5=.U@ M,]%^O]'M=4Y0 IP9(E=)J?Z!K,J-9136@6VJ=4%EI?4[ZFXEKNDR)0M^5U'P M^X!6XGP+H83ENIFQ_J,N[7V:6-O43CV(!EC9L&J5!NA5',Z6N*R=##R!X%5*J'7\1X#=ZHX );Z/$=\Y$GIG'1@KE]#= MR@_')(*/"L&K)/26G1QK(:&UX\'W6>7E1VY%P0K9^\N?%'=F%PO7G84E+45+.J=>UD]XFLG=C;-S-R.-$2N?.934)"]4Q$1.>7 TT6;5A8(+UZ%\^:?(^_7A?)0ZVC-/A:LFKD^%8Z]IG)PU@L3=:H$;Z8>%+!J)8_H(P!1&.0_LHO5BY(0 M-2G3>J6J5_.S3O^)*T!NMUA[K TU73-&';4S5,>C+F/J6-=:C+4[G?[H?WM@ M+8N')G&7@QD(EJN1Q_0?5_H8%GVMVZ_ZFX\LEZYZ9CE7"YNZF_V(J[$5+PQX MKWM8PMJ/Y/AR53\L4CY?OV_UA ]48OB+&S"EKUS!>('RN^O["BR)1]?JQ/O[ MAC\H4 "! S2QD28SH F9[EA?'&N0AAB#'+TIL!B+*M/&/]6#P+-&(2^^%[CX MZZF+\P=P3%P;-)6/#V+]P*@4]U54BMLA&QR+.'(_ ?^6?GZN%FZJ$"$OXG*7S9;$J/%+%'3L#C(+.@:* MY1AV:#)%=]Z4&8 >5+ANV[B#(.FQMKW/#*!H8#$J)QQWPU@N(?I'WE<-1;># MB1L^3Q3#UGW?&EN\IK[E^Z'HLC'7[C'(*&'?;E#M32"Q;P%8J!H^FAO/,&.8 MKL>"T',(7"%\;-/^1[6/J38^E74TX]K^CANOW82_T.]'>>@&:AJAS:M1KFOG MD"H9FDL1CB>< BY"A]?#IES!R&-F<0XA"\Q'1B%6@O%]FGKT+X6!Y?H"FPPP MJ*2&^]&*I(\(5"#L>J'T#+0#>('ES(P 24M-/B+,YXB!AD )/CG7UZ.!?4'& MS/.BRMH(4(]NK#3F&\6),69;QI"I"[]DEDMF ?6I"2:T M49QIN+@#=L"/T*\&%4'^:_^]+T0EETBYN+DDN>J&,%T3F +PQL#;3+XW]4!_ M=UU(>N5[ ?LMY]L;-KO#5MEROCVMV>YTJZGBVFNVV[U*2LNJS" W\,P MUENL\6 [=@5[K8L;M:&V>UO<[*Q/!13)#2?+#=V]<(.*W*"IP[IRPQ$JWE45 M88Y \?[.?/]Z,5Z:1+9SS<33O%N^G0*;Y]2O$4TILOPQHBCGWKCA\,-T!J_* MXE7MXJ8C"Q(< 6BV$O/;8&;-$6,*2Y7?$3A3\7_X"=;U5Y)P=?#TZUZ"CEL; MXC!6F;JF-8:IH1S:R- XS6*/)>V,/SDU/[JOSCF!Z''/C+#8[K/'IPY ME^')366T\.R>VRD\5DJ=5'>?I#Z^]8D#;CMG=$>(6T96]^)&ZTKO5'JG\V'A M(CF*.VI%<6)AM%/JP['[\_^%"Z: M2>X[#^[;*+R] ^[K4P"\BKC:OKGO"(V/(RP"^9$Y[M1R-D^16*Z9LWCYK]KF M)N6?WWYJ1PC%(\S5B:ZU%K\6@_.8WQ!Z M3.[*;*:?!GN:KDB@7YIUZ0D/L79V0\4B^>G&C-5J]Y9A6K=GC"#7\$1J;'S;0U06M.W%Q9L$S.4^GNT+*U%N0K_3( M\^JWJ OE6W(<\\6;>$*>9]QG[FN;%9+9<")"+"]/HWUQTVJVEKO,;'^Z4 &2 M:II *J6'E![ERB-6+CTZ&]9IK%AZ=%%Z]):C]"?/'=ZE]0Z M6:X$LUSUI=\[G:HO'IMYS*>B0%0M;;$24C#1 ^65>6RA4E!&B9CRU=4L1XP1 M%6M;44:7PM5B40EH\SB M1->YY6A$N1@TFQ=2VNI2G6;0;?;Z6NGJ-,.FUNI74PBFW6SUVA55IU%[%97, MP4FM'JJ:*C#'53/CEI@RN[[+CFNR'%]UD<,69#D^>K7+P.DD,BGB8H]>4NZ/ MJSH=*XUO=TSP,[L_UM&PMFGM;&GD%;Z:DPG;]'15R+U2)J>ZY">>. M574?6%W&Y.#BIJ,= QQK[VV?0U) *N-$F:MJ*V](KF1N;=^**"_Y)\7YF!S7 M:@"=Y#7)$T5=NWZH&[0(=6IO.?7A,*@[!Q?C;BZ YOLAKW<_OU:!30'M2NU(ZWYE)07/^06?-1C2)KQ*QEL4$/9WKVX MZ334=K_1VSY6(\WXF@)O6$/@]1!XG?X0?:>!6FKQA M:^ZX\0HH-1&;:(IED_U4 .+.:HKA\UB#:/I2OHFN;#L&:LY?V,S MU\-,EGW1[U*6G> MJ("]X?%VN>X,.S3!6RQG15MC3LBR?8VCV@:/] Z@O]@0?\YN@?48:+N\NI[I M,R=+S@\O;H+7Y9[%BIB7?XW'&0HZKEKK_6?=T9]11C#O!02+3Q^K[QO*Z\0" M4;"0ZSP*?:"4[X-H\\B\09A,Q1"^&()$)&IBK 1IV_K(]82X=2A-&:8.,FTV MLT5U8?\]?8/"64SJ;NZQKYYKAD8036W-S"*LI4&3ZV_O"TUIZ+8C.^Z:"40(FA+;]Q\UO4-]7?D%C4#P\. M9U( [(6RIABVEC7%L%564]1%1MZ![8E-N*UD[;@Z@Y'WE=G_-I)!:]N! MYW1JQM[4R34&T7]\X8*&/]] =_%F0@DS1JRVHS7[9,:XOH6+O/88&I O3%P? M$!YOZD%Q^:"5/**/?!5/H;Y7^OVJ_[FH_N;-C'!OES8G]V0-A83@G$YSF/3#YDWP_@3=3:RGN$, MGR$&M(LL(SJZBZ[!"E-VM=K/RF??^]698;\Y[+;+7IUIPXY5U4.YTQSTRPV5 M_WFW4ZY%M)Q4)9/2=G;)2%./]);1JI;2RM+%&GGO*$V[19]&WD$J<[J6Y7I) M"I:AH#=#^N57R:F5^RJ]_B,](\VHT3]H MK2Z4*J#$CT*= (?\TPHF=^#ON.#8/D07_6]]G\'_F4_ZSXR*J$/UXJ:K'<5] MJ J.X"6?23Y;XK,U);LKXC,-KX$L-[J0?";Y[$SX3-L!GQ5NDCBLO.>NY,%: M05'RX/:]2RM2=9V+FY[6.P8V.X\[,CX>JBH>WUQY<7USEPM)^3C^S75-_]8Q M1;"1YZ1BPA#F)Q@6Q='@[S;#O\#O;J=X8/PW?9[%+MV+FW9OZUMC\@9+'0&U M1N#N!E"]BQLMHU:V!-0) &J-$5T%H(K;U-65=Y)@JR'8#B*\!F@\UD4;GL.1 M!*N[8"N09A?0GMS68"4]?"4Y9O(X%F;K+K0IKZ"C*>(SDGUTT MXEYV$'(ZY:SDI&X+BTQUET,NU;71EDPDF:BN2FB-3S3'.D6=FVY+E0<&DK=. MD;=**:B*]!/6QZJY=CJ1LP :\=H*X&W&%MZ?\HL\)^ \P!NTK/9\8IWS;+NO M:5[XRCS,O=2?D_OY5UK"%NV+FWK$.@Y#\WR,R>!=.W]B)SK M4H&K]OH#5CQ:O1?(*!.]ZM5*Z51CLTA..%E.Z)3EA&7$8[$[;;G6G41[;1 A MT2[0WMV=W!](N2\YX7@XH;>]W!_62>Z?0\+8'XY>PGTI%&@ZP:K766CO[TSN MJZVJ3ZMK<" MH9- 9[ [Z%2>Z""A4ROH#+>!3E[1_!1^\&9[H[7]A1.)GAJB M9UC@2MQ6Z&G7"SWG$'U.YWQ0&:8*HM!GFQQ6>OVG(QN*7)?=U"BIO-%6+;(O MMPAR2 8[0P8K< -O37A$[589'I%,5"LL22:JZ,KT5A9LKR(+5O*8Y+$:+;SB MF^);L1B>[3;4P5&H,9G<)I\_Z^2V!\=PITRYM%W??Z>,/7<:Q1=<1V:WG<_9 M[IKH0-SUC./E=T!+EN@?5%(C0"8S2,#7YS)_0>@/+VZT_G(?XOW>MY&HEZ@O MZ5^707TY1T!KY?G:DBGJ !S)%"6OS5?!$RIWCI=KR^^=)\XA^^T!.^DP/Z & ME6XP89YBT=XUL-/MF66_E5,4:QR"+Z[CSK.#B!=E@1X+2BQW+2E=44(FF]0+ M(FL"B:4@@IDE%93$DA"I551AS6G."H043C[0JDL^D!BJHYBI4LIT+VXZ@\-+ MF7,(+']A@;"UHN#RB %3,R70?VY3K:A82\4C880J+;+$*8E:@EA."/1XC,/Y M'V@#^.^>])_,O_\9>#K0TW)T[^TA8%,?N G?ZKFV3?S$S>ROL'P67=K=EA ]?H@6#7[N%*(E T:#RH*H$L%'C^!: MR-B2 !Y2Q+.]C7._V ;&$<[F!^:PQ[]^_VJ9 MP>1ZV&\.NVUTBT340+R8?ZLV 4^_+G_>UIK]0?97K:::^7G>4&JG.>B7&RK_ M\VZG)R>U_TEI*X=:$Y-:'<14EWZ7H94X[]1*!C]-/,:4S_"[B:_<.R8SE<^Z M9TR4MMI0M);6SFHRM!&)4B9$4>%7<]I]UAW]&0CVG7DOEK&B3'.9I9\)[>Y0 M0JY9F@$DH*E*.C-D'[Y^0&2:,OB#DMSEA%I)Y%3\HV],"=< LJZ M)9YMU:D3:TY=JC;QFL-( :4H7PV'_-,*)G>A#^MC'KA>=HATN?5]!O]G/ND_ ML_RLP<5-;UA5?>):5'>33> EGY7ALS59(Q7QV?#BIIUQE4KRF>2S,^&S]@[X MK'#B3:?R[%')@[6"HN3! CRXIC7?UBRX/J[?H7HNK?91:,)SR(W#ZK6*.U8\ MOO>;=3@K6M+IN+EGG4>&I'P<_^:Z)I8#%K'(^Y^":3ZRF0ZL]);=TK+>:(;NOBIEV+WD^'H7D^QF1LK@J, M:E5@%(]K)49W@-%#/R]Y9-&BV91%-#1L)(O,)?%'DY#]8>7SY]4?]M:V74,/ MF*G$71:B\J&R/>Q1MT@K%8;J;-,S?&4LJEM=";GZ'*M+3CA93BB0)C#/"W62^^>0[/6'HY=P7PK% MDLZC@JPP@2.L/A[J!3>=J"A$Z=H -/;(.=];?UNKP7T7#K M$R )GUK"I\"%MFW@TVO5"S[G$'^FNDH5Q)[/-L&K]/I/1R 4N>"ZH2G2JZ[W M4MD-JFEH0S+8&3)8@0N_:X(B/:W*H(ADHEIA23)119>BL6PRU6CTQ\> XO)E#;Y_%FGM#VD6R=SHKLF M.O 8Q9Q6]E#K=2NYX2]3&"3@=][I:-E=SVEU5!#ZF,_0J: /F42]1/T.4;_D M7Y=!?4E'H)_G:TNFJ -P)%/D.<0[Y(D!\H36J@%/G$/.VP.VQF%^H.B.J;C! MA'G1F:ERR9O&OVLH#ELJ?B83"0I[!E]#O2T'-U[>PC8U >6PK=ZKFT34W&#.HN?VLA/517+V%WK[CT7 M6CDI=.XFPKIGG.*-8W4;\U)"]&0@6C0P45CEW4" M<(\ /%#K#.#SB(Y&!G@4%95QT"V-;6 R0Y,!B/W 1Q0JP83!_WN, M*5-XT\17&"S(5#[KGC'A?E9;;2A:2^M0 CO\I0V_UP-%]YCBN "2&>!V;!E* MX"JZ,M,1 *&M>XK/GJ= &F44\A\_,P->'3;TD>6;05OJ7Q[R_%#3W<,UJ#^ M<\SW 6[PVS%C?B/U.]^"[8&9&S&]H@DUE0J <;0(^U0*)XT8* U\"K;U5?#P+, 'B@5"#[.&^P5D,0R0]P>UX-9. IMM?>VN =[ MEQ]RH%T/)%#7T9K]+B!SYOH6[NRUQVSB_?>OEAE,HDA4ZD&ASUK)(_H(M%<8 MY#^R?PVS;[:]4MM7"RR3^G,25QR9Z<_L:N0Q_<>5/H;Y7^OVJ_[FH]I.+1-D M\-7"_NR&M/S/!>86IE!G,+C2XB#DEW *E#$6RXXNVE[?N+C!I)/[G[ ^$/UW M,"TPQCS_P]MOS'WV]-G$,FZ!!/X3"J,G&.T#Z-0?B0D&AAX#PVR&R_-"MNF" M]XT!L79E] 8:,EHHZEI=L7PE,1QTM ;@7Z\^WDH#N>V&\%K3?W>]5_&1ST!< M2<3L3G8J$-'69SZ[CO[RWK3\F:V_75L.D8(>>C_5O6< KY 1"-P%,Y5>Q[\6 MF.ZUF@-U@+ 6IT'BQ0+Q32#MK\N?MX$OAIW,KUI--?/SW*%:S5X[^ZN\H?)? MT1EH=9M4J]GOK:54AI\?;3!P/ZOZ5VM._U:>" ^7?I;A_@MTU\G9?2*3[C,W MZ>X3DTX!:ZY ;]*"]8ZJI'0JYE.B*E?-MP'MYB*M8(NL^*RHUMX=2/(XYI]6,(GL]@>*&@%A M;GV?P?^93_K/K, I5D3J597#6(M"JRO2TR2C249;9K0UJ9X5,5K_XJ;;JZJN M1MT9K>[&PQ%F)7[BL=YM[F"?>,:MVEK3\[DB3L:L_][RU=2CK9\I(92"T)JT M[8H@-+RXZ?1/$4(UE??;VX39^0 K4P+.RVBL@D G)$CV(4:&K8N;GK9U)YK* M]['>WIWD9,G)U=WCVHB3RR6W#55,;FM5=@?LZ!F]7M;&+E]]W+_*26E,\A+F MTR?F#J&'F6Z%YR_[T?YZ%-=%\9,>; !X;[[, [\7EZ!!,-Z2%,-001 M:&(ZH(E_([E!K_H>P'\PU=%7W+&25#.A/#C+5V8>\W%B)[;[2F%C2Y!ES MW@PA5I7@;<86O+ M.>UW3OW5V2[;)!]H:F:>1Y_GP]7[M+QPJL>>LS/:3:W^Q*MC@L91$.X7U(G" MX"A"P*U:\)T590MFOTC"%89D15DZ/'S26A\_F5JF:;,#44$0X!J4@*,_HQG+ MO!?+6%$'N0 E*@';KIHKRLGM9W(5G5G'@ XU<[O@I?@XG;7W\ M>,1!V*PEGDX856WU]G(D@M?W.R=XL'IF9_-..!TQ;QE$_32(M.6NV Y:4US( M?+/\'U^9AQ^ ]E9CL%QI"5JPRG@=P'(@,V\;=T.VWSLO\3W8B_CN7MSTI/@^ M6?$]K%9\]P M=0!+'<3W6;GF7UCPZGH_T9'5-E M*>,C@U".Z%;5:D7WX.)FL'7=TBK04@?9+>%:K<3;R]6YX1"L#[4NA;DEA"J7 M>.TJ)5ZOAK5:0:Q)N'X=DO58;G*\Z(%B*NUV(NTK/R'JM MCA1WYQEDY7N\^L\G-P";=C%!*KHW( L=[6K]]6::+O5873'QMZ\/^ M8ZN_4B"4LQW3'1'X\O1EI8>2O58/C*OZU_FI@S:5%;VD1MF%1M'V<>+9:_4O M;GK#JB*Z4J,<(?AR-(I6Z5EIKS4 H%5-$-8KPSZ))1+_L\#NZ.ZESM-O[ M6')RQSVYLPH8Q!>F[N8N>WSU7#,T@JVN31WZ?H]\_KRO,/G8;LF8@_6,PUIQ MQV,8U7G.N\QT.E[&R?H+^\@7ZK6&%S=JJV1RNSQ>J9UQ7VU:D-H"5/3E^8J\ M@R3O(*V5TWM)!E+5BYMV1YZ/GZP KS8=2-40+G5 2QT$N*R5*(M,2L(=Q:^J M#$VU.TOUW6KGQ/-4E>TR4[;J"G]JUF:5I*FWCBMGI>XEAU-M[ZWV>\$]/)Z# MR>JY^(@@FV<55YLUJF+6:*OBP_']PK,.YO3^,F2D9I.:;:UFVT6F9JE>"#VU MN\=>"%+QG8/BJS;]4^U)Q5=5'*EPZXBM&D4<1>N&IZ0Y P+8MV#C?457?)BK M-88]= +%$'(6FR:,F )NOA),=/@K*$&(/!X\9S'K!O6DJ.#';]:FQ _X&OL13<>0\"Z@$[,&?=0!HUHS& MY!_")-W0@RGYP=PJ7+P8#< $7QV'A)_XP)HV+"M:'TXQM$UEHK\P>"%H#Z I MWJPVX3&?*< X#,_E'7IZ%/I 3=]O*&/+T1W#HH-\Q[1PC@VZCNTQ/[1Y;PHW M[DW1W%%G"4 Q2B#+"7D: 9<;G6$+A,B1@'%.)B+5LB'SJ@-"?5#PMNV^^M?G MV:ECT&P-AV4[=;2UIC9H5]+M06LW^X-!)2TH6LU!IYI)J8-F7RO[\KU,:G>- M,:K]V3"SR\:"<5;#RO)[;K%1[<\*VULUWX1M6W5LW13A^.C5WB$XCX,(W]DS M=O J@)NJ6V;4GS8E6[A( E5]H;[6<<K>NK@$>^,LQ 9[\8>TRVUV6KQ%V<'O!<34\07_2Y_+CM@6_8+C;?9 MK&:T*L<:]BM<9I43&_37#Y937:&[HKJ"#(FO-9=NZ> QCH(K2]'9>I/]),.] M,CQ>07A\ ;#:JBHL,F1^CA'AV\B*^A9;49)8FQ)K S4AP^LRO"ZCCCN,.FI; M1!W3B=%CZR:!IFKO94A2QMYKQP755DS16AL$DL5X[E M:BMP:%B!8^NZ=*<"U[/WA#^>BR=\R&B;TP<=-"<%SJ M07%/HY4\HH]\UPZ#_$?V>Q5ES["GFSL@9*[F9YW^$U> 0L)B[;$VU'3-&'74 MSE =C[J,J6-=:S'6[G3ZH__M@QDO'IK$YNL,)-'5R&/ZCRM]#(N^UNU7_$?Z?F6-8S/]H^8;M M^J''GF" #[9K_$@D*OA(# 3M#.?LA6S=*G:^^?W,S?_B!DP9*E=*:IE4\6UN MH;VK5K)8;%FM5 A@1"_+A?QO**U-TCRE^./HOUM&#SU]TSW)#7['9LVYC MXSO0@JC_@)B>Y<-?L-8?UA)T/?A8][!&88BE^-QQJOZ>%=5_G1L!U+CR.K&, M";Z72OI9#H!.!]4/HV AP&?65/@E&7P%%IE3)LQC[CB>JN,&RDSW@C><+)9( M7)XH54*$GQNAYP')[3=EQ&R+P>M>+=O>HI9@)&P;V64$L9ZA;?T56J85O.VJ MIN A+TPN<9ZJH??W^)^'CU?J\)Q9Z]$1M[I4?JNKU2 _^EZMJG\B^EV,%$> MO6?=L?[F3O(E&JE:Z_V?_WJDOZGOWP&:'; _#69R!%L.XI$#B_.# SQB@T#S M7$=_L3S@TLN(^.\ UB;@W'"!O8$ )IM:!B]YZ<9S:Z?G]D?S>Q-\=8;U19T@ M]7)=^4)S!,#?@V)!R?FF<(L$^!E%![*FY3/=!VY]P-'?<-RV6/._'M'0MX%9 M0?B*Z2G(W7AC5E>>;7<$0T\X45CTAJ9R%]?\A ^P*"@P;HB"!;CQ,_O[;R"> MPX!8G8'V/NK(Z9,T\G1>XI/JB(XMD":T;LZ8,&=NIBC, :*Y#E<-?@@4T:D$ MZA@D#(H@SW6GQ,0NK,.#5S ?/1#:+P"5P?QF5-B(5HCR@60:SC [!A*+$9)= M,P_<'P_0IY@A"6';?847P5[!?!L*D.R9P9> MW^(%,3\N3DO?A5P%S"9O/KI!T49PNBFTOGA5()(Y5OC*B88!,R8.3/89M33A MGSETG1DL*MA('XAJS)'XU0HF7!7Y+-Z>QQ#KS^HV3 *A8<)4@F@\?"%5K(75 MI%Z\$EX-TC66$<+> #&$ZB,#$/3'!%<<$1"5PMA&&L,&CCQ71\K 5E$!]"FQ MV!2V@MZ7E+?U0'MYI"B)P1FL G3,&]] YX7Y9,G@B^=73\8^QX!N@8QC@HK+ MK)!&?5-80V%\N1UH"$, _DU1:=?0<2?'H4<\$,/,@)_?F(-SJO1=Z3# M;>L'LANY/E#%6 %C0]NOJ5TM'\<". M8K<21W&@5>(H#IN[]A/ICT-X90]/]Y\5K:E\OOUR^]O]Y_LO3X+SOBL?'[[? M_?']^\/C%^7VRT?X_]O?_^_WA^_*XR?ET\.7VR]W#[>_@W#]\O'A*?K-M_OO M?_S^1#]Y_'K_[1:_^%["6MS4RCR02_OX@AG^[/6<#>L_N=>GHT9^(6,#C0R0 MU@X*["E(9NO*!S6A3Q<49&P@HJ">BBL3OK@R0?H+AW,7GL(?.RQX=;T?B8KE ME>]CE19[E5P=<.4(C\#H= ?*,/"S[<*&,/J%.^PQH2%]4E*QT0C. M,86D+6$W1!N8L1/:"/]WASN19R.AG0$C@N/-E>*E]F[%-'<.F(CNB[=D-J#X MMJBI,=]6@18:\=H"-\$R"DBS1?RL!(G:U=A>9Q=QIO(8H;G&N]((>2'6A90V/,2?^I\FX M6.7ZE3ZR74,$0B]]EO8AX5%K%GFDB"(*AGP+HSYN)_ K#P)F",4B K\%R;H*][GNX\,W[XYF!_ M(V0&W6%NZ&.8:XR'+G1.(;BCP24"&ABP2!%?LF!Y <7SD'/0(O'U:3(H0 6C M>?!7RV,8'0J2W]"!#OX E0:%WGBVA!^%+L29C>GI\"E((.9,\,2%AT&Q?Y0; M3##*AN%/6M*+Y04HEPK@V%</\K'UZF MFY'@C"45@L;!X4QK3(L(E%=X'K\!.I%8ID,DV,21%7AXF,6S5U!.B"1K'.3\S+-8@,^]XJ^X3%S)Q?72C[OF8O^@[#OR PPV4AA;@-Y7 M3/WM*G"OX#\QSJ>,!71P2#L;!Z+?N/[6#0/0S!T]3&#R$0-3_0=!UYJB7TJQ M\.DT=*R(Q3EF# S_,C\R"*P7/!=4KX8QD3SB;N1Z7+=2L M+3%4*-P):]2Y:V0YCOO"V9B']OSW$??AL8;E_ "N'_F-]/$*C]%SVOA6(&+0 M=.CRGCXTW5='1):9Z 0'ZFDO M=@1>PW[.8"%(61&@$):HD,3^]3/ZDDZ1=-M'=05SG.HH'QTZQZ?=%3@B/4E!>XI3XRF2NW36LJ^# M\EJ&MY1_67[@>JBVT5A(SH7H- /L;[,^1Y^W"'@?IHBS&C%0PXVHZ>-X_A0M M=AEI%2- 3'0:@P>*=!")0[PM'VSZ,SPC7'^N&9_ -97?K1\,0S5O:"@'J-3O$6SYBB0S-Q>LA/O8!G^2(!B&28),>R#F K.?NC)40$!0L# M"#_#S\$1T[T?I+D:U$F3M@*#I:]DDR*)Z<"=6X'4NW&"IBH-R)^-CYY3;\=T M5X$H0Y^1?"-RC?#T]*_0\C@;XRDQS-_EB3/ [=Q00JJYSK-+$(4@3R/- MXWK&!)@*33F /-H[8+[9T6$T!CM22A69!!;-L4V<[Y$=9+IQ)",K% PZ% _! M7?!4Y@[ZA3!02!Q3BU[2H<(FX+UOHR6),6#9D[>19\6+32P+5^321%^ 2L=! MX/7@9PEIO/1J/EW+&7LZ$ &D"4FA%)GG,Q-(Q%GO8HK/>X/"<6,H;L!F %$2 MSM+2,VY0O.!$"G<*QO78%%,VHR7PY[A@B\>-9J9U?NW'5D7R%DJ-0+DV][+Y MC(<39Z$J!,\7?G1QXI1:=\RX@@N6SG:BR"YF3*-Y8&$LH:%,8,2KO\"EC#)X M?&;@+T#DH&T6RXP&9K;J26 !QF]&NY"( 53E=+8FI-?*C[<,, W0*D*W@^(?W,+1?=\%"PSE9&S9S$(0E[H?16/0(K0I:A4E MYP!3.RSR:@\!GD,=RX\PI2ZV[KXE^4&/L<%S1N18;O-[4"]]/R_/DZ[ ,OR6 M6=3= ;UJMN,YE3WJ/"2)Q.D\D>:3Y?F!\N]0]T &QEG0Y+H)F8=R**^-]!R= MVT1G)1F]G3WZ.>NX.^8%.AX4./R @()W>.W2<_(\URBC)8[*\1 1]Z1!_\WU M].9X1UU!]"?MYD>AA"ADH%R2%^R&L!+3?[>'SDGS678RBLS)VB=! MEAMNO^VTAD"!GOI+?C>M7S+[0@V::JN?^56KJ69^GC>4VFYVVN6&RO]\H-5P M4NU!#2=5):4ZJU^^32][33W2SCQY]L/*!ERR/=;&I<9EJZQMB^)("D84]&9( MOR*-HB31(G&'Q\1E1-I)5* 2US)WUA(DLRA/[:CPC]VMO]X%;[J:5K>>,/F" MIDP1*0G@\P"PVNI( $L 'R^ 1WWHZSD[E,FATB5 MRW>33[-N=;LW/$"1Z!+"\7Q+BFN]EMR:>F[-9C:'W)Z]:=,#";5S"'AQRO(_ M?Z-[-S//'5N!C("=I^FJ=MLU-%VE[R4!7'#AEVJW]TZ"5X+W&,$KHU\2Q$3OB<2]96LL.M337>6+K^"A84N3T'E-.-5NFD1[DYI[\YYQ##21^_T57:"F(Y9WM M7GK]]6:]K;RE6F1Y;.%*21"?!H@W=L(D@&NUC^<+X T,( EA">$:+5QMJ(,Z M2F%Y@B^?/^L3_ ?'<*=,N;1=WW_'.PBXRS6=Y1'^,1X^E+X@)8^Y)-(VRD[5 M^OW]9J=*E)TARL@/DCBKPUZ<.,[406?O.#N'(_L'+!Z*+2ZI<1HUWK/( &U@ M!Y_LUUYM? M6" 4912I&;&QBWW6])_;7)(M5@+\2$"H#KH51YCKX#N<[79>:CVUM!$NM[*6 M6[F9YRXWLZ:;J;9+V,@[W\SS<)Q)^8.ZCW+RSLQ9E@Z W!ZY/7)[Y/9(/[I" M/WI#*T9TN6S#LDTWQ)Z99,EL8>?5CE2;IJIM1YIZ\^FV$8:M:%/3LTO)$>?, M$=L$:20W2&XX,6[8*LXE^4'RP\GQPQ:APKWS WE"OU([>_BO:;W<_!/^B*:; M&N>_H1]8XS<^M.68S FNVSVZ,\!7.O)P.+'JD@.I W[Y *<1DXJOV< &RS.? M74=_>6]:_LS6WZXMAZA/#[V?ZMZSY43TZ\Z6EDROXU^_Y_W2A\-FMZ?^8KFU1[4,-)54FISNJ7;]-G7E.7?I>A$^K8FWKB,:9\ MAM]-?.4>&-Q4/NN>,5'::D/16EJ[3-_JHA=<3J2O]V?=T9^!8-^9]V(9*RKZ MR)[H&=T%04&,7'Z/1_GJN69H!)*"I2CHS9!^^0=MDFC+X@[KAY01:2=Q./N- MM_"4CSF]X8;5B6IQ.5^VP3E[ +<[ PE@">#C!;!L1B9!?/0@5ANM M=AWE\#E4P;AS_4!QQXK'+?G-B@<7O->$L!'#.!.3^)7XO=X\2O#7A+$1P]B MK5]'*7PB02\:\=H*X&U&2:M>R6_%?9K^8OL0U5+KT,5:AA+6AN8E-+:'QJ&? M/TUH:OTSA::LW"^?/^O*_;7Y;MD=36Y/>>W/6I#'9:-K\K-.?W- M.8<8#MV7K2!^<[:'X:777V]VV\I#JD5&QQ;NDP3Q:8!X8\=+ KA6^WBV -[$ MZ)$0EA"NT<+51J<_K"&$Y:F]?/ZL3^T?YKJXC3UW&KE_KB./[8_[P*'T?2AY MM"61MEG5]8[L@UZ+G3AIE)$?)'%6A[TX<9QIK?WC[!R.Z1^P0BCS T5W3,4- M)LR+CAB42]X'Z5U#<=C2%?X3/]62QXTUW9A+K;OW/N)R5V0"Q5%OSZ6F[9UI MSJEIX'S(9L3&KL>B+H*!_G.[:G$GU1I:V_0V6JU[')WM=EYJ:@EU++>RSENY MF2\O-[.NFSG8N.WBKAIGG;PK'2G\R(4^,Z>YK&J7]O^^HAFJW)EZ[HQTG&N] M/9N66Y?.10.E9K3'C=?6%^0 %TR)&QJC/V:' M)@-1Y >^8H8>_C28,&Q(WJ%4H71G\MVNII^Y&F4_+\\FY2?+\P/EWZ'N!4QP7L#]CAC6V#"5P%5V9Z8CKT-8]Q6?/4X" ,@KYCY^9 YM@X^^0 MLLAUL_<1Y4WZ26ISC-#SX-.QZRFZ.;4$QW0?,=%J_('?'[#N'7MC<*8 4 M?B9PB(P]_Y.F\@2?CUV0'J\D!U 8*WXXG>H>3,^GQXR)[CQS,8(CN@[LD8\- M\]S0B^=T2=-P0UBEZ;_C4,.'?=ADY!D=V",U4/08LH)I^4;HXW+@BRGF5Y@L MT"U;&3&85C,718)"G6&S"T2:SZ^@O[P&6,UM_N[8+"C2!(K\NOQY>]!L=8:97[6: M:N;G>4.I[6:WIY4:*O_S;KLM)[7_2?56#K7F3&'UZ8ZZ]+L,_T\P4YV\G:>) MQYCR&7XW\95[!PVKS[IG3)2VVL@J%KX1=5)^>M&;T>VFUJT]\=!:*%+LO\BB M3X-P@V)EZ-'N$2;A-LT2SHBPQ1'9EHBL$)$5Y67Q:&!K?3AP:IFFS0Z$'D& M:U !#EBHIO*=>2^6L2(]NP E*L':K@HHR,GM9W)5YFO4GHW^8YG,5<@%&KF\ M+H7BYW!2&0*W)0L_U'1K!F73?*O8F3K('PF-M9I)/= U M#;DU:[?F7+GVK")"7]-91*G\H6V,B.,UE+O2@ZGGQI2]!7LJ'DR5R-BNV'+] M*#78&:4D#YT2#YU5%(#O\>H_>;;IXDEJE+-9UMX[VZX2I==?;Z;I:F5/*LH2 MX C\M.W 7+]-'6P8%-O=GM9!(U0 *BD5ST,J]H8;AD&D5*SQII8]$#L+J9C3 MOJE3JGU318[H;A+,Y.2.:G)GY;C%&:YW<]EY7SW7#(U@JSS70R=DRN?/.^?4 M#W5[(>ETQF&MN.,QPQOJ>=FGIV,I'Y'-J[969W+)XXZ=[\"&I=:/W@:52:-G MEC3:[I1- )%GKGO;FC,50FO,LZAP@.,Z+!])Y_@K23A)N%H1KE2(H-UI]KLU M=Z;F"@5M&+Z4U0-W1)IZZ[B>MEW4N[;U-*L]Y*B>.^H'!?CSB*!0!Y-P?R?& M4CJ?I716&ZU-.U9(^2SE\[G+Y\*UAE=792Q=U[0F94SY>DQFB/.5:X &\_!7 M%S>Y%7-V5OY5H.D*%0_57WZ_9NBK U6$S:Y/C(V=M%[,>WL&-^[F' '5#A;8 MQ'IX2678=(E5K"O\LJ*NBV+YRE2W'/M-T8/ LT8AKX\9N(KMOK*DQ.O8$QCD0<&@@ M]DPVQ7_@T%AM.![VV8)W\NK$$5I>F,*<%\MS':K%C8_-/.;[H0<(Y%#DI<[U M@*/8CTHG+TUZ%/I "=]?AE_],;:RRF]-$?4)MA5."Z M 3O)8J LDRFA#-E.* J>'DW%II*T1>T&_ 3@*RO3S->,VBM?HU$RU[0\B49I\:U+(:E6N M?R5"\WL5[-K&O/4LW M&6COHSPMKDH]W21EKJ.E-T;+CRZ,QPU)N&^5UM+ F2%(7]U'IAPSCSGPD.>Z M4Q^-1G[5')4X_%08K3/=P!X5:(.\,=V[/5^I0 M@4V%P2R#2&'!.X%BMNN@= *''(08+ 8$VHC9%LPYY]DQ\*Z.]*+-T&V@(N/M M%5[UMW@5C*CH@ZG/E1UMVEB93=Y\=,JC/>$D5&A]\:H"^ZU!#Z4,KH 9$PQ2OX 5RF^BS>J4<@/XAC&R:!*#$M;%,CQL,7 MDL, JUFP]'*1UD@U7@%B"!E.O0BF>C#!%4<$;,#@8QMI#!LX\ES=)&]&1U+Y MW$@$4^"9WI<8GQY[UCW3$EUQ'&9@^0/19,5R7I@?T*/6XNJIA03'@&X!^XJ6 M+AEAI*,5G3A\8.J;! L[0)VY$S8( N6"Q6"@WHP(U*,S[%-M\/RN'HOG M.OP+;:A1$D%. XB27\ DJAL,OMC@D42S MF+A&YWZN0U2F,Y0%-;DV,Y*?P.B^[^+1#@R )Z#B&&;Y,-H,O>A4D?*+9K * MUVS@J:#/ CQ+ 9)83O(@_A(S71R?I8]Y<-IXTN*]B -N[%[/?(.?3?-EX4&E M$[C>&\X.!E]S$"X.6)M4K?-?Z)9HU M!F*53Y8'Y/QWJ'L!T6HZTSV^ GVS=\!?M7[Z'>WY=S3STT'FF]'/7)^.9*^) MJM8+RVU/+SBUE3RBC^B@-_^173#2ZJST??/1E3JXFI]U^L^)EZC89W8U CC_ MN*+S^6O=?M7??)1%Z<,^R[F:WY[=4/8<)=[CJF0X#W/#\+A)5[3A+VNYT-=! MR/"4AO447 MUS2"ATX]N6+MWJ\6]VD$..R9)&%!&,!?U"[(^X)PT!6UO1YAL=JM #ASP,!\ MBWG5.J\CYS1HI%IA0O]H=QNP206U6FFE5"T(:X"X.--/6"U >H]5EQ8RM\PV M3P:N3)'N-W]DT&L.!X-?\M-'?LG.'FGVNKW,KUI--?/SO*'4;K/?*C=4_N>= MOB8GM?=)J=E?14.M*7UR7+DTPVI3:;8ZJ-_QS[;9MY-,49$I/=ND]%0"SN-8 M^S^4NXGN/!?)ZSG)]?^2M?Z**F#5.E"];'A>%Y$9I$7?G6%@8*MZLB=VM'5\)7.[93.=ZE,Q5P+MF(!6MEZ@ MQ)G$V4:YFXK\738ZO MW_YWRTJA^EQ5./&=T=0-*V/*K=GUUERJO6RDN8_72E4;K?XA&F9)%Z+0YJBE+X'*S=F7GAAJQ?6$ MW)5][!.'1$%MO) 3K[I#(Q9O\C!W[>#C\K6#/6\:S:FIY%V&2"ZSBXX)1=LQ MB#'0+1LS'7M,\00ZYDQTQV"\_XVHYQ.W511M3K H$,-R0:+73;IV@;=VH@6K M,F07+."='*RI[ED9=146ZBA@'9_0QIDW>+.?,/!A/=C0A0I/"*J,6/#*6-0: MAA<^DJU/YA&89%A^CC(LE?L%=_XPG+%8-\M?S@6=Q]X.<,?K>?"V0PZ+N$TT M;8IZ"&&-& .4#^_^:&-GI[@TC&GY1IB4AJ%?1,\ERY!P+0K7=';1[5QV44U0 MFY_^M"S13,C;2H#Y9HM)JB,A8#@L6"*J%. ML$#P*R 4L>04EH6Z4_+?',"7CFMO,XYKZZ$O5C>_J@Z2BT"D0HR6'Y7NXSP$ M UD>F4L(-' ;=)@A%4GTTQ4:J:4@[Q"++Y/@F]OC![2 F<_U[".U:7QP8)- MKGUAP6$;L0M,3<'%$),P=EB4A#O'D6&@L $BL:D ^S6(K3T/U)),&C M[H34IS&IZQF/(+!>JB;8Z:'G=RP#1]WB1>$&<"(.BYE%B45M.%'F.&^4"M)_ M[_->]31K-YYUC*:UG:N71-C:5M1KJ\\NG_IEHX__.EU\K[%EK<1-(;G_MD^\ M+MUX?/5!M\G<^CYA0)5;S\-"*>2"G[AD7XG[6Y\W- ?<\:..I-'Z*U,F8+LY M+B+I:B3(YQ/Y]!3Y]B++#@2_G2%&>/U8LIA,%X9UW"!N5VQ%!"*L MZ(H/\[?&EJ%C-(K:&V-!:BY-<2$H;>[2I9\_D1<$$DOY'L '/"86"57A>"<% M)&6!Y_UL^94Z/,T"STA6#DC*H M\ED<3S.A;/HJMY$JRDG^**;D/3"M HG5I!P!AZV2X&)],#)(^% M#O8Z1]M52_(7ZF']%P'U(4!%Q%+?XU;5DFY?P;17'AZ:R@/H2:7?/"2M=NVL ME21-8J+$WMI'S@IQ<,S1[3??(G,WL3G0*$E"0]\H_D@_2?S2.B 2G+579MOX M7U&ZO(PU%4FGL>L&8+NAC$3Q&;@-A>D@@D0,W(S&)M_SUG%"&.8;PV#V*9OX MOUM_A1: X(WH=*?/$'0(!1YW/VWT>ZUHA+Y/! &5'QUO1]TF":H MB97T.XU.NX>_;"J?BL9,Z#T S]#S1(^"@$=A<$"UH?(!Z94A\L(_>FT^&?@> M?TL30E3'@1+= &< .)Z5S;!1,]F,]-B#>8_L* <5YT MFV3,JP7B:82G7^,Q*G(P@+!Y1T@9 5XZ8$:GQAA#P,\7@>+AF%[*"X09V$SW M \*+ [135"U"#(7B2+!9-@Z"(A!W/L 6$5QP)?V8OM_?'3;"F"(L9C0%_" L M6GA$/T$ LQ$%(6W7>;X"SVK:2 @Z3\R9Y[Y8)O7M>(7%1B,F9XY(Z%GH^:%% M1QXS4 $.Q@@5.A1DSY:AZ#;EL*"C')TTPM\"O@]6^K"Q$2>HI!-/\)&,I "P M45TT>_$@*]$,CH,/]2]MT2L>?Q1 MW7GCQGSTMG@D.J?UICX1839W+B6BRV#-C?'=:+V'3GR"2LO,P F];ZJ_T1J M)GA D?V.$,^=\40[M$WN*>D*^B,>[KQNOC /WK 8HN%3VEB>=9O]]3TY+//_ MN[!8>ZP--5TS1AVU,U3'HRYCZEC76HRU.YW^Z'\'@XO40P>*_CW=?U;:3>7? M?]Q^>7IXNGUZ^,^]_3OCP_?[WY__/['M_OORNV'QS^>E,^WW_[G M_DGY]O#]?PZO8M)=4@Y@/^CU=*7\J6[;#+OHH9;@>3^$_9I8^R8;P]W7]$CCX$_];FE!8]:+"V0X^"]X'GVAR#7SW78"9F MY!Q>O!VVE^CB"?$T#D,T$LN33F0-:\:/2033+CYY-['86+F/LL.41S2C04"1 M3TK?):Z]^*X!6AW<)K# 0YZ-,(GT.0S@,-_/>Y>9[*N1WM=9O*_*)8Q,%@U: M%HJ5""2PA[Z!,%+4MGZE=B_9.WI2[9KB7SSLB&^]_\DCLLJM$;Q#F9;M2C:5 M#[K/K1AZH5@/D*I1%:&X]0-+%6$.M*$:^3/*?F\!HJ$ CC< I2]SZ/=DLZ53 M]](2>L2BH1-Q+]X=N0!<26$("#T=,G?]<#0%XRZ;VKA?46._!I\@AH0;\-04 MTUO^9J;0)3BN"#&+=P76-#EV\V?,L,96,C%0-3%!$IV$"Q,]]L@(QR@X7]P! M"0#&<#@->9X.3^&<3D/',J+$G:P]3K-OXCY5QJZ8=VC=\>$2N!WF+A%;932G3CF 6@\1+E"OE\>E?]]^4AR^?'K]]!F_V\4O9!J-;DJF_ADP' M3OY!WT!M*K_?_W;[.W<*[C\^?/FMC%=P[.+C$\58T2A G6EA#JUP-4$#_Q=C M1_!Y= F";BYP@X.A^D*3B,?.A")W4:M1! TXVJ=@[2B$'X!]DM:XZ1$P"/PZ ML< R?!4'_I83Q>T,% &@L9O*;6SL4A 8(WWN>,XK1BO\C=]?>\N8:!0")(GG M!/9;'*RE4-[Z^!F*J&0MB5B*LHH:XG8#332)?9(DM*,CJ%HEF1_=0#(#K,H, M,*VU(@.LN(P'VL5"_OCSQ@ZC@FZ;%$Q6/MW>/3U^.TA0JBZPO$7_TO"L63J8 M DKF!UXA\UV\8Y3.F[TL<#1^2NTA13$C"NR2J87LY(33$5XW&<,V^: J@>K\<'XNX9'< M+\Z4N!$>&$].R!IQ^E&4N($&&)W:(O-B!F,\*&V/SU[H[JH8)CJI2?V('VFF M@##1O>G+"A@^"U=)#!E,JRD=ZFD&:3N5/^OFU MREIE%*U3 M!MHO><'A@.H)&NFD,C%E+CSPG"RZ3AEM46JU"4#(;GY!8Y]6QV.*5X%[Q?_& M"?KM7-6IXRBH#;.%9..Q(%= M.ETADVX@4I-=P_<&^H]D!)YNP*5=.E"*5.'!E)0KHSLH>F%T?OI +Q;!DP8/ MMNM^_%3J3B,.'$TAQD6F-#628%SF0Q$_1IDF;SB%M/.3'B!.,8DEAH5SQ5P3 M ;94E@KAD*4+IG#IH?LB8AS=)!?72 P&#YD8M[(I+837);E:.B^A7!DQ8%-Y MA'_IS\!O4Y'DQ(]TTC(K2L8PT".U49M2.D=*.J&9:_"CH'@LTD-("[J=&NT! MUD[!TUHQCRC0%6V5A3P)4S5H_LF&@/@S_8DU2Y)#Q/(QYSP!D\B2PM>.=.>' M%\X"@WOB 2XY8)S.^C,H;A]#ZSX#K0PK,N /"PTN4HYUE'B!N)-<)0>KH?!?="%07:Q=):6LSIXU1'C./F^4 F?\P/L?P R(BLR8/: M(,QT$8*W13HE&5FP?<8/0#<7A8=-ZG^DS/(I&!?*=YH66"DX6:[*$-5?=-_4 M_XK3I'FA(F(H*N VMU021V*M%(N;A@AK02*L2C(-IRD )M?U(W5OQJ2:2PRE M;,.(NDWE*Y@*&'\D_0TS!P^+D:+7Q$5J>KG'A X .XL%>'@1YX]&+R'M@!S' ME2V\8CQ&_(M%\V0:2@4$H1#]CB\3AQE9>!R,94U(M"_2$O.EHV-.=/F4?ZC- M5@N5D^)/T-.*;SV*]2CM%AEBT2%CK$U-_%+*%J:L.(U,78,:CPR2N M476196!;."E*/UWZE)_OXT[@'!.Z",$Z1T]"+,]6QC1H#!=G;IL>TQDGOW+; M>+HHA=1'#*U8GKCQB#A7E4"#MD$FXQ1(MP0#;@P2E'?"+.U)ZH)(%"E@G^3G$S MF6=I? &N71+)RV,T%B36O#?X?_SDJ(9 [G/)1?!=Q'_DSI3B@_EM(Q^O.+7. MF0$>YC8JN9!?F'KIJ&$JP7P)P(U(FM/F1(FDF7PUGTXCTGU 3\^)TB@EWF3< MH@!'5WC]_%@Q/0(:X?ILQG3A_/!GZ(X'0R/<7?H2= M1+X,\+2G\QM(&>^(J84+"3$K*,X2>,%*T!-VQ4.6Z:'I?3 OH(CG.I8!2@6\ MX #!XH(SD"!*!#I#1^P$Q3+HWE\<3L%7?;6<'[PBD#B-8,KCTYWR(1KU XY* MIJY(3N6Y@4',[810?OG(PCP_#+L@=:GH'!*?\.R.>)$Y3*C"8 +7N3$9*9J^ M#*@X= ZC\_>))*D16PPI\$@'SX; )$JQ7 REX;7GU"5@A[WZ8#V8ECX/OP0V M^=9P AME''HXL850BA7?34JH0=O@K[S49(W3F1J)PZDK7,Y3PIIUI2I"X'_G%B)(<3R;E(0//1(QXT M4O:8T$,Z' MS..U%*^8HECBUU9Y4&,,]BJ^&B.NB?1(I M_8Y.JD%"V-<:/Q#1PU,C4C/+7 M@T@M"C4U"T'3&$EIQYPH7X.TAI!QI0FS6!B7.[E+=%B0PVOC,)?6RSM.Y^A, M";/BYC>=/L? IA\[G*OF.:9\8'Z>0K'-Q#/,W#A*WQ7Z!E7OJWM%)5=%$(CH M@J<7E,2/_B.%1Y &6K<5>:71&S!N[D17A:D\V;SQ LRHAR"280@C=G7 L3?8 MG^V_U'Y?OM[_??E<=/ROV__WAX^K]X,>6/;P]/#_?\ M\? MW^_Q2Y&R>^H)4R5O4/SA@!1"5D=_AO<< *:ZY_?EOR>2C*T])P0IQ;>*%"3D&KYO%YQO)E2TZVKT3QY#B4=!I MGUQOJ@RN_J=6D8=MY5.O_O*IW50^WG^Z_>/WI^_*'U\?OX! ^O+P^"TEE^JT M(?N_@^3LU%LK"J1A_8'4:2J?'[[<@X+[= ]Z+55>MZMZ<+A=^6!C3^#*['UD]F E%LGUT01,=7O3;>JRC\&A#!F[])O;C1^0/_ M_'7NC3>+_T:2;+;V)V_J!$4GI&VQ]%(O M^0J- ->,*GL=\RVM>;.( PG^%2NPUE?O__U\/'QZ>UIA3 MFR%R_BE>B2WF%NIO"JNU]9G/KJ._O,>3(EM_N[8:]&,56]\$&OR:\7F[V>UIF5^UFFK)S[OM=JDG M\B8U@$FUNBN'HIZJ8J$9/7X7>L;6I,WT$C")'^]_3JR1%1"\OE @?K&S[HH% M9O8J/DXZ?$SN]2VWS\W?ZN6"J8;!6*J=<\&U!^YL_SJ#%MYNJ@5V?.TZUT"A M*CK%&-G0[QF/=T9*/G43*Q^1W7--YT+X*YB.GJFD&&>^]P>?H#+QT'2=!,', MO_[UU]?7UR;,L_GLOOQZZQD3K,OZ*S.?=>]74P_T7_N=GJ:V?L7Y\K]J;?S[ M_VOO;)M:Q:$X_E5XL[-ZQQ82:('=V=WI@][K3E<[]L[LOG,HH&6DX-96Z[>_ M.4DHO95*'[ FFC=:+2*DR2]_SDG^QS+T=!C?0O*+*-N0KB A_R'GT# TQNL?")ERIA[?A<"AIRB1T_!=I1>^M.4 MKD9V>:6[#;F2^Z^MS7RL(7ND9FVX+[BQ'(%BY>P=72#.N K@9BKA9= M?AS-8].E)2\Q8M6;6V.$G7T]2Q:[*=B!L)D"$XXJP5*&%)D$BT**8$BQ4,-Q M7,,EK['AZ/R.K.LJ>**U:O@%3'A*)\=&(5XJ52FMV2UL.$1TWZKA*I%21A13 M(I&B(B="$@717FKE1-E3H?3#R7TX!1,MSI:V"&3A%D$TM@(1%B557@>+I:2* M LN>8$$TNF(3L)@UPS%<,O+0-7DFJ%/131, OH&*5@ M7@=-0R(%HT C%FAX[!;9\-IT6>R6T ;-V::IH9\!II0W=,40)0PA3_I$?1:7 M" 0_1(]DU-]F- H)+:+#"/->@Z2K@ @R=+8-N7( MP0/$\DD:1TD:Q9%*.1+F',$[<>1T:X[@C\81^?2(J_2(XLBN\6",3,(0;!JX MX=BV'GK(;F+7AK@PNDZ'X-B[,4G<)9*<":!(6O>3*-9,M69WPU5UAA(D"B25 M@\1: 0G-U!!B2A 2ZD0:X07@/"]D\; MH@)!-GE@HCKZ(I$^4)MZW@P'L(V/IG+1-=CU&Z:)YO_SN"4813!9CDR/#DW\ M.[*.O&,=-8+EGY?V]2T5ENB,HO"&C/?,E_^269A\VFF8C#J\VZA[GWE8C;JW M'W7XC4;=V<*^O>I1)]UR6AATNF.P&K"QA-O(:QE:3&A6<;SWT M9)OPD('JYQ<#0:>\S(A(F.;ZKWW5T\X3*#CGAUHW]6>PU7D_CQ+9: U=9M#Y M)BBNQ>PRW[UYFJ3C9T*EK";8P!^%8^]SV=M U^FT>HHV^W6=CA?[F9]?+TKN MH,#TYV-0]_1,,6B_CM0%N\BHPGXD(Y!ZK;8"TG[]J.<-P_@3HZA_=:I0M%\7 MZD_"!R*ERR8UG9IBBN&W76S[^H4\7<8\FP$9D&T+UO?/7LFAH&C\2A7K MQ4JWI5)$I[SDH];R:14TY)K6LAW="3_)8J\SE)$+9C&OAAHP9_\)K["3TBJ] MI'%8'3@H1C8,1UY\D[G:T0 E.^"$U=^<)5#[$D[HS::C=$+N.*BSF.3+KZ)\ MOH@?JA<[YZ0V,S#IN%+^W]H]>.5NE)]O@TKC879DHD<5:8GOW MYN:N[LV'T'?%ULV7[=[EQ=<3[?RB4R]Z$*BL;?8_;(\K$LM$NUAI@X&N0Q?; M;&)@(F '*[ZM]O-O'^EV] ==ZT,52.T;N8O"5,+[#1D^49#6(0TYU8A6CP(M M:Q-IFEC8YI6F!==D5%5K[M2:1_U)E/C1O1>_;-+C;4,>\E4G4>)0R0UY!NL' ME!M=[Y%,XYW8F]R)1?"/(3>$;5YI6G#-(BW5FOO*C;Q)82U'-D[5U+<]LX M$K[G5V!UV6S5T'K83B)7["E9DB>N=2ROI22SIRF(A&1L*$(!0#_^_0(@:5%\ M" 0EQX&^NMNH!LD\O'WQX4+[A%EF'BGC?9!JP&09Q,'>_/3QI?) MA?6A\?O9FS WR'PC=#O^!Z"&Q?R M&:$+RSI39'VR?*)X?L=!I]4YBII%3^G).P>VWAUWIE;7:1];1TS5K6 MS&X==U'WL-,^[OXV/^ET$9RUNVW+<> [ZPA.6U:WTW6LXR-D=UO.X9$CGDFF MC^R$V7=H 8$8FL=.'MEIXX[SY4FS^?#P$#HO-EIM=K-/S]?C5731MC6 MQ=[WM=:/4^I&[0^;\O$4,A0UG[OD8:VYO+$DV.,'-EDTY7A;AX?MJ+EDAC>P MQQ[CT+.?V3N<6OQIB5@[FT@\;\KG4E#+:K6M3CM%JJ?L6*U#:[V3#G\FB_?P MN!D\; #(.<53GZ,+ ?0 S:#O"A+?^^%#%\\PHKHUR2'39 8 E7Q(9<&;ALR:)AI=HW MD/S&DTBTOUF36'<&DD.4X32 _OF/0@9M;M;K?;?)1VFMV#3+M3 M[2UY:;4[PA0,Q.89<''9XI<5T>VB#RL?->M#1+=E'S)],L\6=)3J-]NV&\\. M;MR-D-*H&]D!HR 6$8$$X=A$($/VP9S<-VWB>YP^%?'!+)+HAXGWK3%S$#:1 M'367%Z5E(MLQD1DUEQ<9,J'G$:[HY9WPWG*)O1D);HA;TE=.(H>Y1;-HZDA- MGQE12?US JE-B:L)8[4:4,1"&OYI@PD<7!2HJ,KC=]#,=/R"!'OX;S%Z%TY- M1R](D/O+#]R&KNG !8GMNV6L7I)/Q'. G=-&GXC,H0'DO2^WEQO6<$IHT#IB M%S%<6>!92_UI VN595A 47UL)MLFN/@,.2/O3%TG?3HD#IML($QHI3#=NA-E MDH4W(^UMTNGH>C"\'@\'XF(\NKH<]";#P7GOJG?='XX_#8>3<7&%ZUEIT>@( M",9"ERB"(^()XDQ!R!4$;%_ABNGX!E(QO#O$L>CP#K%;YZL%\K ,D.#MFI1_ MU1W8\43\_7EX/1F/+D8WP]O>Y%(\W0[4')Y:0(^* ;IB#T878"7@%GT=5@>#L>_N?+Y>2_.T(TD[46V&-#8"6N<3G_!(&D5X0WP+##J&P@ M1XO]NQUA_QJX\X-LOS?^='$U^K;#N+UBJ47X?9FP+?D#):!&0)[[#'N(L0%B M-L5+R15ZSAC//3P31NWQGJW*-=B;WQ 7VR)?*HQH&=Y::#_(S 4SVR7,ITC\ MB*2 F!@@Y("8(+"2!")1-0+Y"O_PL8/Y4V'H5A1:0+I)0)YI:Z1A85_41\[P M<8D\AI@POY&8%FC?IW*"N,)PBEW,39RG.$<=0NU6$J&0-XB8*W=1[$'('\0$ MU C&/EQB#MTQ)_;WXA-7G$@+1CL)1D@.%'V-='U#T0P)8W/,M)T@T^J[D]3W M,X/::5R-]QP*ZCY92,]7_2FL^1QR+0*'2004(Z X@3BK&D%QC?@58>P&T?&= MR"$*8Y"DTRK_**E\P0%(%D#P (I)C=0^1G.9$=PBN>4G%H/%;3])J%7\<-]"Z\?(&Y'+Y1C&%-$6H!2I_"Z>6FB^192#BJ4M3,#5LM-!MW@@*2U0B/H;+]E>@(@WW;([O2\3% M@NRTP*4J$1N!B]C7'L%OD%(QO[.1S^6':/+CUVT0W,!.BZ"F4F&!B#F(<7\% M,%3*+OPOCY<6NE1](Q>Z6CO>>O'H6NI$: .90J9AHT4K5?9(5J-$VATQ?<7I MN_Q.WO%=1&9C1,7R[")1 Q2&S: M11LO/;<6I,4Z55!)8QV)!60& L'@(M4L M+KR6-I%=:2SMPP79:?%-EVCR2IAU=^ILC:]\;J0*']LLA,I+T,*<*MIL@#GN MSZ'(VJ^8=-#<(L8IMGD8:H6F$G>^B*Z476+M1;C69%+EHX(FLY(=4LA:1>JF M[%*]%W.)'8[2,X&.CP[H;JK:E+%G4O?@GU#RRO>D(_C!J,A,^(:L=CL#[/K" MU.,46Z):7J 6_E3%*A/^N(?'NB!_JDXH+P^[D=IP>S68%7[#V0S9G,QZ'L>. MU)=PJ3&R?5JJ]KRE&*UQI*IB6N,(!,NKN&BPDEU+8F<\'D\YC85RM8 T@H%L[G%,W#P'Z+[I'GFV>%905H MT4]5Z'3HKPL,%H9*Y"OR:\#TB6>+)U1U4 15^0/.=XB\1H 6>?TK[ZGE04P@ M6$G\NP/_L;E^WE?P>^U,,'DB6'BZHS(+">1??9]QLD#TVE],$9T\D,](7C0 MG(JD"=K\M,&ICQKJ,+/31FYS#[NN?)DF:J[.S#Q9(HJ),U'G$CD^#3\.8K[@ MC;DO?_U!B;\\;03-,4>+!@B.,5H=HGGBD 7$WJ5X*#FMCCS3#.:"^-1D-/'V ME1C.N'8\@ L1KNO M$7(JEV;Z$7[%#B)](CM! CEC1.]%%S=;IY:L$A[W&7I"\T[8-;9Y2#F-*S&0 M'(=98FKN92'12[M69N\N")TA;!PZ8F0O/2S!1Z30E,PP7ZU63TWJ?-K<, MY&P9_&+!>ILXF,GFI4.BQ ,Q>1([='OA"WC%0D@1RDK$D^3B0CNNG.:5&,PU MX@^$?B\&44[C2@PDN0.//"CD#Q2Y%II,FDH,*WSA= Q=^2W?(V(]N:DTE^D4 MH4\72'X\D!,?BY#JQQB<:\ZC1U/HRE/.3QNV4!OF1D%D03R1=]*G L-6!6]QUK1#M546@=&KO[39PG?"N_H&4+)*6+U)JT^\>_F_!8@.!9+MKY$ METI4WM:H]V3 $=&6=<5=1JV_1:@*HFZLT\_M\A/8TOSVYMV[U4:I"G2:_J5# MN39?9IJ$^2MBPK(O0]?>3\Z^RSY49 4=A?_VYIP]U:P2N7I809@9U,(WDKQT M@I>8F97O#!##^P@SV%9B:1,A417@S.T)% M!VFQ#=J\UI482N0L&>/^=.E>I=91)H;$1 W.[2.JA*.O6D#I]2N3T4->U5U%;/@ M\[='?>BZR#E_>@Y,06/#6I I[TI4?3>_A+<[GR_(LB+%C-PB?J+WB9J^^:: MCE\U E]N]R=WPA?OB"M/Z&?"Y&5LFU"HSB" 3_G^4YYA!0KMZQ]:B X;+4_7 M"*H;^V-S=,DW>;,YO/2L($ 0GE;@Q8V,AE5?E^XA;)MSKT;$&J E89BS\!C, M_&0YV:ZJKR!&GPX11QV=&^@OK]:7U;:JR7[/^9^(CVI39$)ZCJ.^L(/N#<3. MI1>=(J>\.W:,X_#1OI,E'T<8I9Q+?,]9O=&<_PKJ'D3]M'BF/AMD]AU:P+,W M_P=02P,$% @ :8"H6.\1_^\U$@ :Z( !4 !G;&]W+3(P,C0P,S,Q M7V-A;"YX;6S=75ES&SF2?N]?H?6^;K9P'QW=/2%+\HPCW+;#=F_/&P-'PF8T MQ=)64;8UOWX3E&C=-D6",BT?E$26JKY$?L@#2 "__N/ST63G(_;#N)O^]H3_ MS)[LX#1U>3Q]_]N3/]\] _?D'[__]-.O_P7P[Z=O7NP<=.GD"*>SG?T>PPSS MSJ?Q[,/.[ /N_-7U?X\_AIW7DS K77\$\/O\U_:[X]-^_/[#;$0N?[\K M&).[BZN?G%_^^<;UG^3\:NZ]WYU_^N7287S;A71;OOOO/UZ\31_P*,!X.LS" M--4'#.-?AOF;+[H49O-6_R:NG3NOJ#_!XC*H;P$7(/G/GX?\Y/>?=G;.FJ/O M)O@&RT[]^N>;YU<>^7[2?3KNQM/9SZD[VJU7[.Z_>GEP^/+MX0%]\_;5B^<' M>^\.#Y[NO=A[N7_X]E^'A^_>DB#S&\].C_&W)\/XZ'B"B_<^]%A^>U)O"U7C M3)[!^>\E[KI[ 3F%23J9S%OH!?U\?N\*KS5Z_#S#:<:S]EH\?M*E*Q=-JK:Z M?O&;DQ!Q,G]W=#+ ^Q".1R_&(8XGX]D8A_V3OJ<^,N+&R2BS@)Q\ E42D3RP M",K*&)CC27-SM=6J9 .)-M=R"4.'DZ&A^ M3QC/\&CQ^Z7OCIKR8]9M6"UG?""IUB7,JV/LJ4&F[U\@&:4;F(S@,B624@C- M0&5I(/(B 2/3QI,C8%$VILK7$2U#$O%CDJ2A*IK18R^E_@3S+9(JHJ1@#D$& M$E*E4B 0!F!%,D8\MMJ)QLRX$\PRI) _)BG:** E'[J3Z6QX'4Y#G. 7;@8K MG0X!3#8UWM," H\1N*._*E5JMO8HMR-9A@GJAV7"NDW?C :71!NA)JKY@O18 M)$FR]^!B]E"L2)D[QC1KK?M+C]]HP/2RFZ:%<_;6QB@U"&I7TARE0(YE#93/ MH*/L)X=8'C)FNH"VI6'3O7AQKWAI1:UL@OR+3L@2S]2E&025J5]SQ< II2"B M4E$)EH3,#YP[;$UHM!81UFSK=GYO&'#V!8(I2F4A!134!"$' ;$("])Y8PN3 M H-M[>XN UA7FN?3CW27KC]]B;,16BN5$"2'898\D7"DGA) )Q=9SEB4<(V% MN?S\;3)?JVOY.F]7;N%FC-T/PX?Z__#_3L8?PX30#&]PF/7C-,-S7[@/W5)A&<6*\<^6J7%2BO)810:L^022-7-J;0F%Q+P-JF M)+(=A5KKHWDF^083$F4IHR%3N4!D)2K.A8%D*H["$P3*;\ 9)E H8W7@&\HG M;\.S35EE.VHTT\ F(FMBZMM9E_[^T$VH>8=JUV:G(ZSS2=Q9"#)P8JKR$+T, MP(-G4N><2]Y@G'TKIO43T*.C\:S.TM7[U\1G/'V/TU0C9RFE4-)0J&L9:=XOS499WM&K*F C8R[V2QS++H 6J-!Z5S ^T(Q7E1! MI)!5L.JAQMVV9LB]O>I7;?)-=G[R\Q&YX.2<%3EGY1UXD0IP@UQZ^N]BZ^RL MO>/;RWE-&D_5L.,12D+.7,TI\!<F-Y!/7\:P# WT MCTF#M9J[\4S=R!/;BD4&L;XH:2E4QUIN87)A,3C)9?/0&H[Z[RJP_@/-].X#;-S]]+LC0!WY<;=4,'EF]INK\J? \ZA MC92,)12N( 3N005/H14:#C9P+5D*2?G6 ]]?!;1-(SP-]-^N\=OQX6(^YE)A M2U#"V$)Y%0N93">BABB5AER"#EZKX'SKHJI;@6Q31-M"_VLW]C6]_[I[O6%> MT,]MUW*\?4>O?QR^?/?VU;-7KP_?[+U[3I]>!;3&HHX[;K^YU1W+R--HFRZ=^$S#H>?9WT@9H^GH3]]3H2< M,Z76HW43>LS[Y],9]C@0:P(W1B ':MT(RM0")R448"DZ)598XJUGL3MUW94QB2::9([&")6&4IN#?:<4!HW HE27!6M=R7WK\^@-@'W%Z M@@MM7R^3IK:>G-05P37,H7^95#Z*2D>Z4R$=REKA0[E]4#J!S2YGTG#(LK6O M6@'F-EGJ5?ER-QC&L];CKZ? MX%PMT[QWU/6S\7_F[X]8*4G$^1QXHCBZE%CSZ>HV8K!&H>.L]2#\^JBW:MZF M%>L>6)GMW#_.+OS9WL8*ISO+(4F"G43+@3'I0"2UX8S@(F01%@=%&V]HS7 &P30'[0U)H M=2UL:+;^8/QQG'&:AS-8;V>!V@JGL^='QQ09C8)BV0H30:OHB*K:@U.9@]8A M(WY-CPB IIS3H&"@7#00FZJX)BBG/HV0E M/IR]V:YQ2VTR-]39H;! Z@F,$G%NB18Z!6TE3Z%Y)/!@XY;?-V=L,3#%!31,IW=&"7)(5&;/AHC1?Z','E*W* M ULS:;V&?X#1W;IJFSN?(7M6J^E] B>4A9@2.L6U\Z:U45IR='?%&=V;=Q\9 MS8./.0")6-6H'/E%3""9Q*@\BS(VGPZY'VB$@)7.NP]9L3INM-M=2YPI29!*%,G>O)Y+H"*F Y MB>0=R>5;,_S.J9;O:^?6U?=U-J_:RDTG#.KH\GDO&D8L>^HI18/ *@TZ5P>+ M)105J0LQ([)JO2#M.H:MLF*M-;Y6@V].[3KR['3Q0 )(4()[\-PX"(D%GH6/ M+K9?I/PUM:]@L2@H[L.D3H'DH_%T/,RJXCY^\3I*"^GK>E^-,8$BC4'D&B$8 M:9.2.GK1>OCR&Y"VR;*MQ8@;9JVA*AJN.1F0;E.W6SG CSCICNMPUP*2%A0X M(G+@,B&HDB-XM(10""N-D5*RUCGL5P%MTV!W4VZT4T.[Q;DX'UPA1'^$_F^\ M'%4:SZ7U*8.AV)*8&C)$3=])7AC+G%-DV;IT_VXTVU3'VY03C130C!"7Y]:O M3ZD72B^E%1:L+1R4] *"CI2+)DT-D%$5V7JGM:_ V:8%:4TIT4H%W[G4>W_O M[;^>O7CUUV8JO2_N_C"%WG=(TZC.>[V-TK)!^N<1>"X!E*5P(GJ,@#RH$!B& MDEKWRX:;W:W66B-OHU,V>4##*7F(W$&,0H,MR%-)HF!J?@@ /7>K M<'8\UM M&_O=2P/MTCN(=AE<6Q78?C_NM-;@=FPY^AK[<9>?3\^*FRZ*G,YK%@\_ MIP]A^A[?D-B'A>#/1LHRINOB9&'0@DK4?[PD05V)E O$:'7SHJ*'E;!!342% M\+KO:KU&?GKZYX#T_&?C:9BF&C0GRJS/=C;BO&Y890KD[/AYI3^3#M"%Z P% M8K[YW-3RZ!Z-S]@LQV\I_MJ$^EN6[-R&[\NPZ25\C MK,1DH,9$YD\Z"S[$. M=[H2K-"4SFV@?G!)=(_&+6T%/==5_Z;I>5OW"99E^B/!AU!/Q?,%O+'4?3RS MPB%C)6^+]5RE@+-+B'E>B?1\&$[JT7BORNN>6#/#UY.0YK5_HVAD*BX6X+QN MC,F\A!"MAY ]C\KSDK#]IL[+(-LF[[$A3MTLUVRNLN]A]957)F6=R0T93TV@ M(@3N$A1N@TT-I2ZS^2MWJX[@>Y/FLZP^ZDS@K)Y/%CLRC2';3J7I$D)=U M9B]2?F#K.DFB@=;9*.%;2_XU/#] %UJ7/[=TH3;JVAYM!*5\@<2%J$[T67%O7>M)A XOL'@.!FJNK92WNM0#OVM%B(YU"W$LH M0#E'_(XFD>^12I'8]&'K.J1O@MJF&:P'HE!;16V0/_/*N@OIS_;I*0*M")0; M>%DMI68:HD$)C',954H!16M3M!RR>TY\;;S2^_M0:6V=;9!/YX>6')PO.KKU M\))1CM+$4!3HD.:EFQ$\SQJRCUX%#,R%UFM_5T-ZSRT?'RG?FNNT70U'73'[ ME$#F_>ZHHCKSS:9HD] (X"$+4-RY6JIGP E4CA41A&D]078[DF7X8QZ7YVN@ MD@V:I\7A;E5*'R2/F=73".OAABD$B%YX\*R.?QG%LVJ]U_!7 2U#%OOHC T+V!L$K+D9&UH/7QV7XS+4,L]+CNT M435N-J&[=FKXPM%>2'3I7)/BLD(I,A0?L)YKXB 8KB!%EH7C5FC9>D.L=3$O M0T;_N,CXH&K>(#F_>KCS*'(1$%T *K;K3C!M3I.X4]3@?)9&1RC) M2S)Y6M=1$T394%;1AR^Y$33332S D=DJWH3I<_R0 MKEM@R5!\UDBP8DEU2PQ;3SJM7I* <2,]-I]<^2:H;2HBV Q7VNIE;;I44[Z0 M]&V8X##?:&Q>0?J^-GW7GS[#ZHTY"ND(BM6.O+&5==:00BKRQ:8NJ5,H_;<\ MTY+/VJ8J@+8N!%([,ZJ"CM4NJ^ M=N-M6I"Z =VNTXSM3L<[D^L- ?@BD''1* MN&04?&36?"'.'5#N.='] _*BA0Z6'+(X?[^^Q##@[S_]/U!+ P04 " !I M@*A8@1D X[TS 6@( %0 &=L;W_\*KN9UO1GWT3;=8Q1)]!OB__L^>3SE^GHP\?Y$\&$NORSR]]. M_V(2,J-% )^X!J58@J *@Q*9]ME+P;7_WQ_^(GS&PCV'E-" PL# "Y] JQP] M2U(E^EW]T//1^)]_J?\$G.4GM+SQ;/'M7[_[.)]__LO3I[_]]MN??P_3\S]/ MIA^>"L;DT\N__F[UY[_?^?O?Y.*ON??^Z>*W7_]T-EKWA_2Q_.E__OS3N_@Q M?T(8C6=S',>K!]#CT_SK?W@=C7ZZ_"7]Z6STE]GBO_]I$G&^4-#6)3S9^!?U M.[C\,Z@_ BY \C__/DO?_>U/3YXL)8?3.)VY/%E]^'\2_VTIP=C M^DA IO$B9*"?YG&E>$.,ZS[]<,Q?/PM2+GAQ/F^(^.YG-\4[^82CE@*^\]$- MT"X^"#[E3R%/6T*]\;G7<%Z"O(VP?N2'\\EOGR<$\<]Q\NGI M_SUZ]>O'SU M[N4+^N+=ZY]^?/'L_/JNC[7ES^?9['*2\W MJTLTYY-XXX_.ZU8Y^:K;G'.\2%^\M_8N,V:73"LX"PMNK!Y!'!'R:3Z?SRY_4N4O M%[+?C&(IXP;K>H_A/)^A#1*3]I"$IV,U,@&>1TT;OLZ\T&HC%WVM:8'@YGJN M6/-L>KFRU5O9Z7 IT\FGIOJ<3YJ)<:DI OW=D\DTY2G94_2KQ5;QEW@^F>7T MU^_FTXM\]$ZL?GF^>""]OOE#_:(9$U[^OXO1_,OSR:?/DS%].WOV^VAV M5J)41<4(UCH$)9"#CR4"URPA;1(H6.R+&.L ->3)/0?^/;S90]&;.'.PP-=1 MZ$ VW,+T8G%4[03J[)8)TH@-:P$U9,%&$^H>#ARNN$E?4A^,$C':PI%+",+0 MKJD2O0&"O#$=T:)*)8K2^A0DOSR=YO1N/HG__'EA MMY[9F*S,B99%"$#5S=!KS)"-=^@#!B=58P*LP]%2_^OL_;O*;Z"B26/YWM4Y M.U3GM+Y/D_%U0-(5X;QR( LM3H5BP4ME@17%')'U M?C_-.+N8?EE 6J); 2O:FAR5 "-JM(U,'D#+##A3K(O!*U76.,$'J7PCF%-0 M?1M)WZ6 .)0"SU):"!//W^ H_3A^CI]'9R14TFLB M:1$%G(T,-/2 J7WK&2>>PM[W09S2E& @P3=PU%P'<^*YKL@ZLG]OXOF M@7W_P]1UVQ1L(^L>;,(UR'2Q.79#VO=467HK"LB@Q.:5IKJH><-;7TF,.WH/W"*M=[^-\,9 MW@ X5%NWM_]&HN[!\_]Q'*N;DE_DY?__N/15/T[.Z?-G2T/H[>3\_(?)]#>< MIC-C7$I)!2B>$5SF)/C((VAML20?Z1!L;1ATA#@\6QI?,_6IDAX8=)/5[S[B M-,]>7\QK5DM-%3H3: +'0K2V"D$YY&1 ,[*;T'//F5<\M;YMW )I>(;TJM)[ MXXN'Z:,/6^,J(+;$]N-L=I'36=!2&2,2.,RTOV:,X)-20!X72B<8%Z&YP;$> MRFG3HX7\>W!$U@3+EO#.I"#[U]!BI7<6E*05>QX\T.GHF'?&H6@=A]@(YK2I MT48'/42H[B[YS O!@Y(.$D8&RA=-!ZR.])6++J"VGKGF 8K;*$Z;#@=*O8=X MU:L\)P%,/N6?)K/9F= >@M;TK:<=3!I49)HWIL - *>M_?UE M?5?Q^O ;B_^^F,VKB3U[/]D03%]L536!.=7 +3G[B[SHMYFD,AO-,_E@OXYB M?D.NV"2]S7'R8:FM_\#SBWR6C='DSUN0AA&QR:$#9W6&E)CC*K.DL?7=5]]K M.FUZ'A4C[C+>-#GREJ;9BXLIV>U+F,OS^/EDO*K+>%V67\]'X9P6%.E/YR,Z ML'G26K,D(&8M0<64P)N< #$)':3BF8<^CL>]$9\V6P?4YETNVIZXN'A/MH/7 ME@5,C-"J4D!9,A=\(=O16Y&2]'2>R#(,%7<#_$TRL0==WB6B.Y2(+T:_CE(> MI]G-&,<9PQA2-49C#F2=)&_(=]4>G!*\6-K$C6^=M[P!RFF3IX7\[]+"]WI6 MOLJ_+7XU.\LY"2KY'V" YC H:./!G+2V1^R#/Q*[+3)DT/VED3ECPX MC'W?QGB%DD@96:0.*4J0SGP)BWAO/(5: :4,@QFM3^XF^';".]@V) M>#S_F.>CB#M4LKIL+UGV?V5VP;KN?&Y0$*?:EB9WBI;$H3D:.?2U2,@;8T^VW+:+/K>4VW81X]&5 MV][))0M&ZF!RAABB!*6M H_T3R@A%"=*EJ+U=?>Q)]AV4O#.";9=!#U,:N4N MB+[9!-M.ZMJ>8[F/K(=A 9/)YN3]U>-!"^EK):!.-:$"C07/BX+,A"B,2\G*M]AQHXDI<+# >TAS6U]9M@NH M;[WC1B?%[=1G81^I#]9Q@ZGL!W'8=IT$!%NW3S9.KR;CN/SFC'GFF&4"'#HR72(F<-;SFG7'C TH M>&G=A&,77$=187-(9*FY\#<2I''L>I77=BW^OS"@:W'Y^6ROT/3]G]@D\MP! M=*/ \G7OXHHQ'(M ;ST4$2TH,B/)L4P,DM0N.8,BB-;W;VN!'.Q1Q(\Y79SG MU>=^_V7QE%61>HXA8_#@I*[=J%BAK\@$I[U.*72!&];*4M3R"L)]O)&P^I]9#U,DD+4-F81%#C'%2A%YQ/RI, ZD751R2C>.@OTZ),4&BN_ MBX@'3E*P6"*+*"&+>G/NA 6D4^_(3;L*Z7MQ7+B)N*?&1?+]1UXH#.*C T7X?GI.DP;[R M[J$GU_5F =<0KOH&Y,3/Z,2**0I7Z^)HY58HP(2A1KCJJK,IKO6MTE90I\&* MEI+OH4W73ND5UEB;H^5@E*KIOKE 2,(#Y]DS'JPWZMO(;6E/D.;R[Z&CUP82 M+\\Y?H8B"22G")B62,N/!IQ'#XY%Y:(EW*R]LW$?HE/@14.9;^QX-4C"T[,X M)XK/O[1/?+K]R3TF0-V[B'X3H51FSD@!UA9Z];F-4+M2 Q?*%2<-"ZIUC'_P M1"BGZ64(ALX\VN?J3!U&-C-])9,-:+22QC1O]G*TB5 =]-TE$:J+C!]'(I3G MR=I:&8VD]F4>RL_?RR)4)VTWBD1JHOT!\MZV074MYX( MU4EQ.Z6_["/UP2A!],_.LPC:A$+@E")'B[RMR'UD*IJ,IG4B\6-)A&K/A"[" M'B01RFC#I16T.JP#6[(J=)H:"=+G6"1FKYJ?$4>;"-5).5L3H;I(]@A&X2#R MS#D=A%%:!BI)MFAP!;$X%I+SR?K6@PF.?A1.>P.T3ZWT4>Y]/5PODR J.PZ9 M&UWO:A(@&4^ 15FI8U#)B@UX;YY%T8J$7RR73K/HA9PVFSX25=C3S=#_T?.)TB66HO?R=/ M<$0N]YGQ6J*-])XX5X?:!0XN!P1F15&29*73K2/L;B1MC^>>)GWZ5D!?@W4V MH5W\^_WM\0EG**2T09%-S^K%@8UTF!='1&?>A\*$X;KUQ,$^38D/IK>&E MX.*MV'E:Q^R:5_#R]_@1QQ]R(HG5I+F+&A"_?(7.O-.2Z8J_U'["SH@Z/MU! M2<49E[+)@>VT=;7'=IK<.P9%]G 1><.,5%&ZXNG +D)E4$+QI3_KBX@QFH+* MMRY[:=FM^,9:O./),O0@HY=5QP9\3 5D(J&FY!GWS??I03HO:YUI25& %.A M!>?!LV0!?4(1G>'6ME;2$0T$;.]AMY'TT.EF,9*G1YL#89-U%$GMIBY=!"M< MD F5BLT[\3^*=+,#B-!,WALMU;;9 37K>T%D G'QMHQE"S-451[(RT!D# MM$2GR,C(D36_SSW6+( N^NZ2!=!%Q@^=!3";SL_>5E-T<5G%:=="Z10D4:OV MZWC+8"792D(+%L@#MV6G6?;TJ=>80=]=L>+& X_Q-K^3]B:'2K%AZ/4KB-7E MT2XPNMS3[Z+4]I=QVV_D#Q#^;?4=(+D>%1GK9D2/A6)4;>](_WB3%"!CV3$? M8MCM=OVA%;CA'KV]_KH(K+'>?L;?1Y\N/JV Y&!=28R#1U<;6?#: (5S^LKS MDJ,.M+LTT-R-APYG=Q\D]DD+F?79G?I.F;/#+'A@#HHTHDZK(F86%8'

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end XML 63 glow-20240331_htm.xml IDEA: XBRL DOCUMENT 0000746210 2024-01-01 2024-03-31 0000746210 2024-05-03 0000746210 2024-03-31 0000746210 2023-12-31 0000746210 2023-01-01 2023-03-31 0000746210 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0000746210 us-gaap:CommonStockMember 2023-12-31 0000746210 us-gaap:TreasuryStockCommonMember 2023-12-31 0000746210 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000746210 us-gaap:RetainedEarningsMember 2023-12-31 0000746210 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000746210 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000746210 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0000746210 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0000746210 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000746210 us-gaap:CommonStockMember 2024-03-31 0000746210 us-gaap:TreasuryStockCommonMember 2024-03-31 0000746210 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000746210 us-gaap:RetainedEarningsMember 2024-03-31 0000746210 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0000746210 us-gaap:CommonStockMember 2022-12-31 0000746210 us-gaap:TreasuryStockCommonMember 2022-12-31 0000746210 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000746210 us-gaap:RetainedEarningsMember 2022-12-31 0000746210 2022-12-31 0000746210 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000746210 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000746210 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0000746210 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0000746210 us-gaap:CommonStockMember 2023-03-31 0000746210 us-gaap:TreasuryStockCommonMember 2023-03-31 0000746210 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000746210 us-gaap:RetainedEarningsMember 2023-03-31 0000746210 2023-03-31 0000746210 us-gaap:SeriesFPreferredStockMember 2024-01-01 2024-03-31 0000746210 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0000746210 2021-06-28 0000746210 2023-01-01 2023-12-31 0000746210 srt:MaximumMember 2024-03-31 0000746210 us-gaap:SeriesFPreferredStockMember us-gaap:PrivatePlacementMember 2023-03-30 2023-03-30 0000746210 us-gaap:SeriesFPreferredStockMember us-gaap:PrivatePlacementMember 2023-03-30 0000746210 glow:PreferredWarrantsMember us-gaap:PrivatePlacementMember 2023-03-30 0000746210 glow:InvestorWarrantsMember us-gaap:PrivatePlacementMember 2023-03-30 0000746210 us-gaap:SeriesFPreferredStockMember us-gaap:PrivatePlacementMember 2023-03-31 2023-03-31 0000746210 us-gaap:SeriesFPreferredStockMember 2023-03-30 0000746210 us-gaap:SeriesFPreferredStockMember 2023-03-30 2023-03-30 0000746210 2023-10-06 0000746210 us-gaap:SeriesFPreferredStockMember 2024-03-31 0000746210 us-gaap:SeriesFPreferredStockMember glow:Scenario1Member 2024-01-01 2024-03-31 0000746210 us-gaap:SeriesFPreferredStockMember 2023-01-01 2023-12-31 0000746210 us-gaap:SeriesFPreferredStockMember 2023-03-31 2023-03-31 0000746210 us-gaap:SeriesFPreferredStockMember 2023-03-31 0000746210 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-12-31 0000746210 us-gaap:SeriesFPreferredStockMember 2023-12-31 0000746210 us-gaap:CommonStockMember 2023-04-01 2024-03-31 0000746210 glow:A2019EquityIncentivePlanMember 2023-12-31 0000746210 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-03-31 0000746210 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-03-31 0000746210 us-gaap:RestrictedStockMember 2024-03-31 0000746210 us-gaap:RestrictedStockMember 2023-12-31 0000746210 us-gaap:RestrictedStockMember 2023-01-01 2023-03-31 0000746210 us-gaap:RestrictedStockMember 2024-01-01 2024-03-31 0000746210 us-gaap:RestrictedStockMember 2023-03-31 0000746210 us-gaap:RestrictedStockMember 2022-12-31 0000746210 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0000746210 us-gaap:RestrictedStockMember 2023-01-01 2023-12-31 0000746210 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-12-31 0000746210 us-gaap:RestrictedStockUnitsRSUMember 2023-12-31 0000746210 us-gaap:RestrictedStockUnitsRSUMember 2024-03-31 0000746210 us-gaap:RestrictedStockMember 2024-01-01 2024-03-31 0000746210 us-gaap:RestrictedStockMember 2023-01-01 2023-03-31 0000746210 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-03-31 0000746210 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-03-31 0000746210 us-gaap:ConvertibleDebtSecuritiesMember 2024-01-01 2024-03-31 0000746210 us-gaap:ConvertibleDebtSecuritiesMember 2023-01-01 2023-03-31 0000746210 glow:PreferredWarrantMember 2024-01-01 2024-03-31 0000746210 glow:PreferredWarrantMember 2023-01-01 2023-03-31 0000746210 us-gaap:WarrantMember 2024-01-01 2024-03-31 0000746210 us-gaap:WarrantMember 2023-01-01 2023-03-31 0000746210 us-gaap:OperatingSegmentsMember glow:ManagedServicesMember 2024-01-01 2024-03-31 0000746210 us-gaap:OperatingSegmentsMember glow:CollaborationProductsMember 2024-01-01 2024-03-31 0000746210 us-gaap:CorporateNonSegmentMember 2024-01-01 2024-03-31 0000746210 us-gaap:OperatingSegmentsMember glow:ManagedServicesMember us-gaap:MaterialReconcilingItemsMember 2024-01-01 2024-03-31 0000746210 us-gaap:OperatingSegmentsMember glow:CollaborationProductsMember us-gaap:MaterialReconcilingItemsMember 2024-01-01 2024-03-31 0000746210 us-gaap:CorporateNonSegmentMember us-gaap:MaterialReconcilingItemsMember 2024-01-01 2024-03-31 0000746210 us-gaap:MaterialReconcilingItemsMember 2024-01-01 2024-03-31 0000746210 us-gaap:OperatingSegmentsMember glow:ManagedServicesMember us-gaap:CorporateNonSegmentMember 2024-01-01 2024-03-31 0000746210 us-gaap:OperatingSegmentsMember glow:CollaborationProductsMember us-gaap:CorporateNonSegmentMember 2024-01-01 2024-03-31 0000746210 us-gaap:CorporateNonSegmentMember us-gaap:CorporateNonSegmentMember 2024-01-01 2024-03-31 0000746210 us-gaap:CorporateNonSegmentMember 2024-01-01 2024-03-31 0000746210 us-gaap:OperatingSegmentsMember glow:ManagedServicesMember 2023-01-01 2023-03-31 0000746210 us-gaap:OperatingSegmentsMember glow:CollaborationProductsMember 2023-01-01 2023-03-31 0000746210 us-gaap:CorporateNonSegmentMember 2023-01-01 2023-03-31 0000746210 us-gaap:OperatingSegmentsMember glow:ManagedServicesMember us-gaap:MaterialReconcilingItemsMember 2023-01-01 2023-03-31 0000746210 us-gaap:OperatingSegmentsMember glow:CollaborationProductsMember us-gaap:MaterialReconcilingItemsMember 2023-01-01 2023-03-31 0000746210 us-gaap:CorporateNonSegmentMember us-gaap:MaterialReconcilingItemsMember 2023-01-01 2023-03-31 0000746210 us-gaap:MaterialReconcilingItemsMember 2023-01-01 2023-03-31 0000746210 us-gaap:OperatingSegmentsMember glow:ManagedServicesMember us-gaap:CorporateNonSegmentMember 2023-01-01 2023-03-31 0000746210 us-gaap:OperatingSegmentsMember glow:CollaborationProductsMember us-gaap:CorporateNonSegmentMember 2023-01-01 2023-03-31 0000746210 us-gaap:CorporateNonSegmentMember us-gaap:CorporateNonSegmentMember 2023-01-01 2023-03-31 0000746210 us-gaap:CorporateNonSegmentMember 2023-01-01 2023-03-31 0000746210 country:US 2024-01-01 2024-03-31 0000746210 country:US 2023-01-01 2023-03-31 0000746210 us-gaap:NonUsMember 2024-01-01 2024-03-31 0000746210 us-gaap:NonUsMember 2023-01-01 2023-03-31 0000746210 glow:VideoCollaborationServiceMember us-gaap:ProductConcentrationRiskMember glow:ManagedServicesMember 2024-01-01 2024-03-31 0000746210 glow:VideoCollaborationServiceMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember glow:ManagedServicesMember 2024-01-01 2024-03-31 0000746210 glow:VideoCollaborationServiceMember us-gaap:ProductConcentrationRiskMember glow:ManagedServicesMember 2023-01-01 2023-03-31 0000746210 glow:VideoCollaborationServiceMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember glow:ManagedServicesMember 2023-01-01 2023-03-31 0000746210 glow:NetworkServicesMember us-gaap:ProductConcentrationRiskMember glow:ManagedServicesMember 2024-01-01 2024-03-31 0000746210 glow:NetworkServicesMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember glow:ManagedServicesMember 2024-01-01 2024-03-31 0000746210 glow:NetworkServicesMember us-gaap:ProductConcentrationRiskMember glow:ManagedServicesMember 2023-01-01 2023-03-31 0000746210 glow:NetworkServicesMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember glow:ManagedServicesMember 2023-01-01 2023-03-31 0000746210 glow:ProfessionalAndOtherServicesMember us-gaap:ProductConcentrationRiskMember glow:ManagedServicesMember 2024-01-01 2024-03-31 0000746210 glow:ProfessionalAndOtherServicesMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember glow:ManagedServicesMember 2024-01-01 2024-03-31 0000746210 glow:ProfessionalAndOtherServicesMember us-gaap:ProductConcentrationRiskMember glow:ManagedServicesMember 2023-01-01 2023-03-31 0000746210 glow:ProfessionalAndOtherServicesMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember glow:ManagedServicesMember 2023-01-01 2023-03-31 0000746210 us-gaap:ProductConcentrationRiskMember glow:ManagedServicesMember 2024-01-01 2024-03-31 0000746210 us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember glow:ManagedServicesMember 2024-01-01 2024-03-31 0000746210 us-gaap:ProductConcentrationRiskMember glow:ManagedServicesMember 2023-01-01 2023-03-31 0000746210 us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember glow:ManagedServicesMember 2023-01-01 2023-03-31 0000746210 glow:VideoCollaborationServiceMember us-gaap:ProductConcentrationRiskMember glow:CollaborationProductsMember 2024-01-01 2024-03-31 0000746210 glow:VideoCollaborationServiceMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember glow:CollaborationProductsMember 2024-01-01 2024-03-31 0000746210 glow:VideoCollaborationServiceMember us-gaap:ProductConcentrationRiskMember glow:CollaborationProductsMember 2023-01-01 2023-03-31 0000746210 glow:VideoCollaborationServiceMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember glow:CollaborationProductsMember 2023-01-01 2023-03-31 0000746210 us-gaap:ProductConcentrationRiskMember 2024-01-01 2024-03-31 0000746210 us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember 2024-01-01 2024-03-31 0000746210 us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-03-31 0000746210 us-gaap:RevenueFromContractWithCustomerMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-03-31 0000746210 glow:CustomerNumberOneMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember glow:ManagedServicesMember 2024-01-01 2024-03-31 0000746210 glow:CustomerNumberOneMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember glow:ManagedServicesMember 2023-01-01 2023-03-31 0000746210 glow:CustomerNumberOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember glow:ManagedServicesMember 2024-01-01 2024-03-31 0000746210 glow:CustomerNumberOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember glow:ManagedServicesMember 2023-01-01 2023-03-31 0000746210 glow:CustomerNumberTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember glow:ManagedServicesMember 2024-01-01 2024-03-31 0000746210 glow:CustomerNumberTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember glow:ManagedServicesMember 2023-01-01 2023-03-31 0000746210 glow:CustomerNumberThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember glow:CollaborationProductsMember 2024-01-01 2024-03-31 0000746210 glow:CustomerNumberThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember glow:CollaborationProductsMember 2023-01-01 2023-03-31 0000746210 glow:CustomerNumberFourMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember glow:CollaborationProductsMember 2024-01-01 2024-03-31 0000746210 glow:CustomerNumberFourMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember glow:CollaborationProductsMember 2023-01-01 2023-03-31 0000746210 glow:CustomerNumberFiveMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember glow:CollaborationProductsMember 2024-01-01 2024-03-31 0000746210 glow:CustomerNumberFiveMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember glow:CollaborationProductsMember 2023-01-01 2023-03-31 shares iso4217:USD iso4217:USD shares glow:segment pure 0000746210 --12-31 2024 Q1 false 10-Q true 2024-03-31 false 001-35376 OBLONG, INC. DE 77-0312442 110 16th Street Suite 1400-1024 Denver CO 80202 213 683-8863 ext. 5 Common Stock, par value $0.0001 per share OBLG NASDAQ Yes Yes Non-accelerated Filer true false false 20286675 5360000 5990000 15000 424000 127000 239000 421000 243000 5923000 6896000 0 17000 12000 12000 5935000 6925000 351000 211000 1031000 1038000 105000 132000 0 17000 1487000 1398000 14000 26000 1501000 1424000 0.0001 0.0001 1102150 1102150 42000 42000 1008 1008 1930 1930 0 0 0.0001 0.0001 150000000 150000000 20294228 20285675 16692124 16683572 2000 2000 8000 8000 181000 181000 233980000 233911000 -229367000 -228231000 4434000 5501000 5935000 6925000 626000 1038000 629000 762000 -3000 276000 50000 6000 54000 218000 1077000 1169000 0 86000 1181000 1479000 -1184000 -1203000 0 5000 48000 27000 48000 22000 -1136000 -1181000 0 38000 -1136000 -1219000 44000 0 0 25000 -1180000 -1244000 -0.07 -0.07 -0.60 -0.60 17123000 17123000 2065000 2065000 1930 0 16692000 2000 8000 -181000 233911000 -228231000 5501000 -1136000 -1136000 31000 31000 82000 -922 3602000 82000 82000 44000 44000 1008 0 20294000 2000 8000 -181000 233980000 -229367000 4434000 0 0 2071000 0 8000 -181000 227645000 -223847000 3617000 -1219000 -1219000 31000 31000 6550 1473000 1473000 6550 0 2071000 0 8000 -181000 229149000 -225066000 3902000 -1136000 -1219000 0 86000 0 -24000 17000 43000 31000 31000 -409000 -47000 -112000 -89000 178000 298000 0 -9000 140000 23000 31000 591000 -39000 -125000 -17000 -97000 -630000 -844000 0 1473000 0 1473000 -630000 629000 5990000 3085000 5360000 3714000 4860000 3714000 500000 0 5360000 3714000 5000 2000 0 31000 44000 0 0 25000 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1 - Business Description and Significant Accounting Policies</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Description</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Oblong, Inc. (“Oblong” or “we” or “us” or the “Company”) was formed as a Delaware corporation in May 2000 and is a provider of patented multi-stream collaboration technologies and managed services for video collaboration and network applications.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's fiscal year ends on December 31 of each calendar year. The accompanying interim Condensed Consolidated Financial Statements are unaudited and have been prepared on substantially the same basis as our annual Consolidated Financial Statements for the fiscal year ended December 31, 2023. In the opinion of the Company's management, these interim Condensed Consolidated Financial Statements reflect all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The December 31, 2023 year-end Condensed Consolidated Balance Sheet data in this document was derived from audited consolidated financial statements. The Condensed Consolidated Financial Statements and notes included in this quarterly report on Form 10-Q do not include all disclosures required by U.S. generally accepted accounting principles and should be read in conjunction with the Company's audited consolidated financial statements as of and for the year ended December 31, 2023 and notes thereto included in the Company's fiscal 2023 Annual Report on Form 10-K, filed with the Securities and Exchange Commission (“SEC”) on March 19, 2024 (the “2023 Annual Report”).</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations and cash flows for the interim periods included in these Condensed Consolidated Financial Statements are not necessarily indicative of the results to be expected for any future period or the entire fiscal year. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Condensed Consolidated Financial Statements include the accounts of Oblong and our 100%-owned subsidiaries (i) GP Communications, LLC (“GP Communications”), whose business function is to provide interstate telecommunications services for regulatory purposes, and (ii) Oblong Industries, Inc. All inter-company balances and transactions have been eliminated in consolidation. The U.S. Dollar is the functional currency for all subsidiaries.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024, our total cash balance of $5,360,000 is available. Of this balance $500,000 was held in short-term certificates of deposit with MidFirst Bank. As of December 31, 2023, our total cash balance of $5,990,000 was available with $500,000 held in short-term certificates of deposit with MidFirst Bank. The Company considers highly liquid investments with original maturities of three months or less to be cash equivalents.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segments</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company currently operates in two segments: (1) “Collaboration Products” which represents the business surrounding our </span><span style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mezzanine™ product offerings, and (2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> “Managed Services” which represents the business surrounding managed services for video collaboration and network solutions. See Note 8 - Segment Reporting for further discussion.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparation of the Condensed Consolidated Financial Statements in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual amounts could differ from the estimates made. We continually evaluate estimates used in the preparation of our consolidated financial statements for reasonableness. Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation. The significant areas of estimation include determining the allowances for inventory obsolescence and estimated credit losses and the inputs used in the fair value of equity-based awards.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024 and December 31, 2023, we had no intangible assets. During the three months ended March 31, 2023, we recorded $86,000 in amortization expense related to intangible assets.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Lease Right-of-use-Assets and Liabilities</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2024, we exited our warehouse lease in City of Industry, California, and are no longer a party to any operating leases. Right-of-use assets, net totaled $17,000 as of December 31, 2023, consisting of the warehouse lease discussed above. As of March 31, 2024, the Company had no right-of-use assets remaining. The remaining operating lease liability as of December 31, 2023 was $17,000, consisting of the warehouse lease discussed above. As of March 31, 2024, the Company had no lease liability remaining. During the three months ended March 31, 2024, we recorded $17,000 in lease expenses. During the three months ended March 31, 2023, we recorded $46,000 in lease expenses, net of common charges, and sublease proceeds of $16,000.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant accounting policies used in preparation of these Condensed Consolidated Financial Statements are disclosed in our 2023 Annual Report, and there have been no changes to the Company’s significant accounting policies during the three months ended March 31, 2024.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Recently Issued Accounting Pronouncements</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU No. 2023-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic280)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Improvements to Reportable Segment Disclosures. The new guidance is intended to improve reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. The amendments are effective retrospectively for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. The Company is in the process of evaluating the impact that the adoption of this ASU will have on the financial statements and related disclosures, which is not expected to be material.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU No. 2023-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Improvements to Tax Disclosures (Topic 740)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to enhance the transparency and decision usefulness of income tax disclosures through changes to the rate reconciliation and income taxes paid information. This guidance is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is evaluating the impact of adopting this new accounting guidance on its Consolidated Financial Statements.</span></div> <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's fiscal year ends on December 31 of each calendar year. The accompanying interim Condensed Consolidated Financial Statements are unaudited and have been prepared on substantially the same basis as our annual Consolidated Financial Statements for the fiscal year ended December 31, 2023. In the opinion of the Company's management, these interim Condensed Consolidated Financial Statements reflect all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The December 31, 2023 year-end Condensed Consolidated Balance Sheet data in this document was derived from audited consolidated financial statements. The Condensed Consolidated Financial Statements and notes included in this quarterly report on Form 10-Q do not include all disclosures required by U.S. generally accepted accounting principles and should be read in conjunction with the Company's audited consolidated financial statements as of and for the year ended December 31, 2023 and notes thereto included in the Company's fiscal 2023 Annual Report on Form 10-K, filed with the Securities and Exchange Commission (“SEC”) on March 19, 2024 (the “2023 Annual Report”).</span></div>The results of operations and cash flows for the interim periods included in these Condensed Consolidated Financial Statements are not necessarily indicative of the results to be expected for any future period or the entire fiscal year. <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Condensed Consolidated Financial Statements include the accounts of Oblong and our 100%-owned subsidiaries (i) GP Communications, LLC (“GP Communications”), whose business function is to provide interstate telecommunications services for regulatory purposes, and (ii) Oblong Industries, Inc. All inter-company balances and transactions have been eliminated in consolidation. The U.S. Dollar is the functional currency for all subsidiaries.</span></div> 5360000 500000 5990000 500000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segments</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company currently operates in two segments: (1) “Collaboration Products” which represents the business surrounding our </span><span style="color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mezzanine™ product offerings, and (2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> “Managed Services” which represents the business surrounding managed services for video collaboration and network solutions. See Note 8 - Segment Reporting for further discussion.</span></div> 2 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparation of the Condensed Consolidated Financial Statements in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual amounts could differ from the estimates made. We continually evaluate estimates used in the preparation of our consolidated financial statements for reasonableness. Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation. The significant areas of estimation include determining the allowances for inventory obsolescence and estimated credit losses and the inputs used in the fair value of equity-based awards.</span></div> 0 0 86000 17000 0 17000 0 17000 46000 16000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Recently Issued Accounting Pronouncements</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU No. 2023-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic280)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Improvements to Reportable Segment Disclosures. The new guidance is intended to improve reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. The amendments are effective retrospectively for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. The Company is in the process of evaluating the impact that the adoption of this ASU will have on the financial statements and related disclosures, which is not expected to be material.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU No. 2023-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Improvements to Tax Disclosures (Topic 740)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to enhance the transparency and decision usefulness of income tax disclosures through changes to the rate reconciliation and income taxes paid information. This guidance is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is evaluating the impact of adopting this new accounting guidance on its Consolidated Financial Statements.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2 - Liquidity</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024, we had $5,360,000 in cash and working capital of $4,436,000. For the three months ended March 31, 2024, we incurred a net loss of $1,136,000 and used $630,000 of net cash in operating activities. </span></div>We believe that our existing cash will be sufficient to fund our operations and meet our working capital requirements for at least the next 12 months from the filing date of this Report with the SEC. 5360000 4436000 -1136000 -630000 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3 - Accrued Expenses and Other Current Liabilities </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities consisted of the following (in thousands): </span></div><div style="margin-top:5pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes and regulatory fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued dividends on Series F Preferred Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses and liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities consisted of the following (in thousands): </span></div><div style="margin-top:5pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes and regulatory fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued dividends on Series F Preferred Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses and liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,031 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 526000 448000 86000 118000 129000 104000 19000 22000 170000 202000 94000 136000 7000 8000 1031000 1038000 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4 - Capital Stock</span></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</span></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s common stock, par value $0.0001 per share (the “Common Stock”), is listed on the Nasdaq Capital Market (“Nasdaq”), under the ticker symbol “OBLG”. As of March 31, 2024, we had 150,000,000 shares of our Common Stock authorized, with 20,294,000 and 20,286,000 shares issued and outstanding, respectively. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2024, 922 shares of Series F Preferred Stock, plus $82,000 accrued dividends, were converted to 3,602,103 shares of the Company’s common stock. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5 - Preferred Stock, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further detail.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common Stock activity for the three months ended March 31, 2024 is presented below (in thousands).</span></div><div style="margin-top:12pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.421%"><tr><td style="width:1.0%"></td><td style="width:69.626%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.320%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued Shares as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,071 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances from Preferred Stock conversions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,102 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances related to warrant exercises</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances related to stock compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common shares exchanged for prepaid warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(407)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued Shares as of December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,692 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances from Preferred Stock conversions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,602 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued Shares as of March 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,294 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less Treasury Shares:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding Shares as of March 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,286 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock Warrants</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrants outstanding as of March 31, 2024 are as follows:</span></div><div style="text-align:center;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.210%"><tr><td style="width:1.0%"></td><td style="width:25.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.511%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.514%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issue Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Warrants Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expiration Date</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 28, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.00 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,136,850 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.71 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2028</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,137,600 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrant activity for the three months ended March 31, 2024 and the year ended December 31, 2023 is presented below.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:center;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.947%"><tr><td style="width:1.0%"></td><td style="width:60.196%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.725%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.421%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding and Exercisable</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Warrants</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants outstanding and exercisable, December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343,099 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.34 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,543,626 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.71 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(746,027)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.78 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,601)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.93 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(247)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants outstanding and exercisable, December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,137,850 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.72 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.00 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants outstanding and exercisable, March 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,137,600 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.72 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Treasury Shares</span></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains treasury stock for the Common Stock shares bought back by the Company when withholding shares to cover taxes on transactions related to equity awards. There were no treasury stock transactions during the three months ended March 31, 2024 or the year ended December 31, 2023.</span></div> 0.0001 150000000 20294000 20286000 922 82000 3602103 <div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common Stock activity for the three months ended March 31, 2024 is presented below (in thousands).</span></div><div style="margin-top:12pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.421%"><tr><td style="width:1.0%"></td><td style="width:69.626%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.320%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued Shares as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,071 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances from Preferred Stock conversions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,102 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances related to warrant exercises</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances related to stock compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common shares exchanged for prepaid warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(407)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued Shares as of December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,692 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuances from Preferred Stock conversions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,602 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued Shares as of March 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,294 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less Treasury Shares:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding Shares as of March 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,286 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 2071000 14102000 746000 180000 407000 16692000 3602000 20294000 -8000 20286000 <div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrants outstanding as of March 31, 2024 are as follows:</span></div><div style="text-align:center;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.210%"><tr><td style="width:1.0%"></td><td style="width:25.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.511%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.514%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issue Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Warrants Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expiration Date</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 28, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.00 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,136,850 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.71 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2028</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,137,600 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrant activity for the three months ended March 31, 2024 and the year ended December 31, 2023 is presented below.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:center;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.947%"><tr><td style="width:1.0%"></td><td style="width:60.196%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.725%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.421%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding and Exercisable</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Warrants</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants outstanding and exercisable, December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343,099 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.34 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,543,626 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.71 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(746,027)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.78 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,601)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.93 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(247)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants outstanding and exercisable, December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,137,850 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.72 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.00 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants outstanding and exercisable, March 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,137,600 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.72 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 750 66.00 4136850 1.71 4137600 343099 343099 66.34 66.34 4543626 4543626 1.71 1.71 746027 -746027 0.78 0.78 -2601 2601 76.93 76.93 247 247 0 0 4137850 4137850 1.72 1.72 250 -250 60.00 60.00 4137600 4137600 1.72 1.72 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5 - Preferred Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Certificate of Incorporation authorizes the issuance of up to 5,000,000 shares of preferred stock. As of March 31, 2024, we had 1,983,250 designated shares of preferred stock and 1,008 shares of preferred stock issued and outstanding. As of December 31, 2023, we had 1,930 shares of preferred stock issued and outstanding.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Series F Preferred Stock</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 30, 2023, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which we issued and sold, in a private placement (the “Private Placement”) (i) 6,550 shares of our newly designated Series F Preferred Stock, $0.0001 par value per share (the “Series F Preferred Stock”), (ii) preferred warrants (the “Preferred Warrants”) to acquire 32,750 shares of Series F Preferred Stock, and (iii) common warrants (“Common Warrants” and with the Preferred Warrants the “Investor Warrants”) to acquire up to 3,830,417 shares of Common Stock. Please refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4 - Capital Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional detail regarding the Series F Preferred Stock and Preferred Warrants. The terms of the Series F Preferred Stock are as set forward in the Certificate of Designations of Series F Preferred Stock of Oblong, Inc. (the “Certificate of Designations”), which was filed and became effective with the Secretary of State of the State of Delaware on March 31, 2023. The Private Placement closed on March 31, 2023, in exchange for gross and net proceeds of $6,386,000 and $5,364,000, respectively. The financing fees associated with the Purchase Agreement were $1,022,000.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series F Preferred Shares are convertible into fully paid and non-assessable shares of the Company’s Common Stock at the election of the holder at any time at an initial conversion price of $1.71 (the “Conversion Price”). The holders of the Series F Preferred Shares may also elect to convert their shares at an alternative conversion price equal to the lower of (i) 80% of the applicable Conversion Price as in effect on the date of the conversion, (ii) 80% of the closing price on the trading day immediately preceding the delivery of the conversion notice, and (iii) the greater of (a) the Floor Price (as defined in the Certificate of Designations) and (b) the quotient of (x) the sum of the five lowest Closing Bid Prices (as defined in the Certificate of Designations) for trading days in the 30 consecutive trading day period ending and including the trading day immediately preceding the delivery of the applicable Conversion Notice, divided by (y) five. The Conversion Price is subject to customary adjustments for stock splits, stock dividends, stock combination recapitalization, or other similar transactions involving the Common Stock, and subject to price-based adjustment, on a full ratchet basis, in the event of any issuances of our common stock, or securities convertible, exercisable or exchangeable for Common Stock, at a price below the then-applicable Conversion Price (subject to certain exceptions).</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 6, 2023, the Company and Investors holding a majority of the outstanding shares of the Preferred Stock agreed to waive any and all provisions, terms, covenants and obligations in the Certificate of Designations or Common Warrants to the </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">extent such provisions permit the conversion or exercise of the Preferred Stock and the Common Warrants, respectively, to occur at a price below $0.2792. Notwithstanding anything to the contrary in the Certificate of Designations, each of the “Alternate Conversion Price” and the “Floor Price” as set forth in the Certificate of Designations shall in no event be less than $0.2792 (as adjusted for stock splits, stock dividends, stock combinations, recapitalizations and similar events). </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Certificate of Designations, the Series F Preferred Shares have an initial stated value of $1,000 per share (the “Stated Value”). The holders of the Series F Preferred Shares are entitled to dividends of 9% per annum, which will be payable in arrears quarterly. Accrued dividends may be paid, at our option, in cash and if not paid, shall increase the stated value of the Series F Preferred Shares. Upon the occurrence and during the continuance of a Triggering Event (as defined in the Certificate of Designations), the Series F Preferred Shares will accrue dividends at the rate of 20% per annum (the “Default Rate”). The Series F Preferred Shares have no voting rights, other than with respect to certain matters affecting the rights of the Series F Preferred Shares. On matters with respect to which the holders of the Series F Preferred Shares have a right to vote, holders of the Preferred Shares will have voting rights on an as-converted basis.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to settle conversions is subject to certain limitations set forth in the Certificate of Designations. Further, the Certificate of Designations contains a certain beneficial ownership limitation after giving effect to the issuance of shares of common stock issuable upon conversion of the Series F Preferred Shares.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Certificate of Designations includes certain Triggering Events (as defined in the Certificate of Designations), including, among other things, (i) the failure to file and maintain an effective registration statement covering the sale of the holder’s securities registrable pursuant to the Registration Rights Agreement, (ii) the failure to pay any amounts due to the holders of the Series F Preferred Shares when due, and (iii) if Peter Holst ceases to be the chief executive officer of the Company other than because of his death, and a qualified replacement, reasonably acceptable to a majority of the holders of the Series F Preferred Shares, is not appointed within thirty (30) business days. In connection with a Triggering Event, the Default Rate is triggered. We are subject to certain affirmative and negative covenants regarding the incurrence of indebtedness, acquisition transactions, the existence of liens, the repayment of indebtedness, the payment of cash in respect of dividends (other than dividends pursuant to the Certificate of Designations), maintenance of properties and the transfer of assets, among other matters.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2023 and the three months ended March 31, 2024, 4,620 and 922 shares of Series F Preferred Stock, plus accrued dividends, were converted to 14,102,477 and 3,602,103 shares of the Company’s common stock, respectively. There were 1,008 shares of Series F Preferred Stock outstanding and accrued dividends of $94,000 as of March 31, 2024. Series F Preferred Stock transactions are summarized in the table below (in thousands except for shares of Series F Preferred Stock:</span></div><div style="margin-top:12pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.649%"><tr><td style="width:1.0%"></td><td style="width:27.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.380%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.380%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.616%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.382%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series F Preferred Stock Shares</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred Stock Dividends</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Conversion Price</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Shares Issued from Conversions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023 Issuance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,550 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Accrued Dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Conversions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,620)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,102 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023 Balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,930 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,102 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Accrued Dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Conversions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(922)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.28 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,602 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2024 Balance</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,704 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Series F Preferred Stock Warrants</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Preferred Warrants are exercisable for Series F Preferred Shares at an exercise price of $975. The exercise price is subject to customary adjustments for stock splits, stock dividends, stock combination recapitalizations or other similar transactions involving the Common Stock. The Preferred Warrants expire three years from the date of issuance and are exercisable for cash. For each Preferred Warrant exercised, the Investors shall receive Common Warrants to purchase a number of shares of Common Stock equal to 100% of the number of shares of Common Stock the Investors would receive if the Series F Preferred Shares issuable upon exercise of such Warrant were converted at the applicable Conversion Price. The fair value of the Preferred Warrants was recorded within additional paid-in capital upon issuance. As of March 31, 2024, no Preferred Warrants have been exercised.</span></div> 5000000 1983250 1008 1008 1930 1930 6550 0.0001 32750 3830417 6386000 5364000 1022000 1.71 0.80 0.80 P30D 0.2792 0.2792 1000 0.09 0.20 4620 922 14102477 3602103 1008 94000 Series F Preferred Stock transactions are summarized in the table below (in thousands except for shares of Series F Preferred Stock:<div style="margin-top:12pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.649%"><tr><td style="width:1.0%"></td><td style="width:27.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.380%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.380%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.616%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.382%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series F Preferred Stock Shares</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred Stock Dividends</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Conversion Price</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Shares Issued from Conversions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023 Issuance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,550 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Accrued Dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 Conversions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,620)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,102 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2023 Balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,930 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,102 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Accrued Dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 Conversions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(922)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.28 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,602 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2024 Balance</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,704 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 6550 0 343000 -4620 211000 0.34 14102000 1930 132000 14102000 44000 -922 82000 0.28 3602000 1008 94000 0.33 17704000 975 P3Y 1 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6 - Stock Based Compensation </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019 Equity Incentive Plan</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 19, 2019, the Oblong, Inc. 2019 Equity Incentive Plan (the “2019 Plan”) was approved by the Company’s stockholders at the Company’s 2019 Annual Meeting of Stockholders. The 2019 Plan is an omnibus equity incentive plan pursuant to which the Company may grant equity and cash incentive awards to certain key service providers of the Company and its subsidiaries. As of December 31, 2023, the share pool available for new grants under the 2019 Plan was 3. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of stock option activity under our plans, and options outstanding as of, and changes made during the three months ended March 31, 2024 and year ended December 31, 2023 is presented below:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:46.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.257%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Options</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Options</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding and exercisable, December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,668 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.63 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.85 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,336 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.75</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,668)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285.89</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,668)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285.89</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding and exercisable, December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.75 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,668 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.75 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding and exercisable, March 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.75 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,668 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.75 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intrinsic value of vested and unvested options was not significant for all periods presented. Stock compensation expense related to stock options for the three months ended March 31, 2024 and 2023 was $31,000 and was recorded as a general and administrative expense on our Condensed Consolidated Statements of Operations. The remaining unrecognized stock-based compensation expense for options as of March 31, 2024 is $30,000, which will be recognized over a weighted average period of 3 months. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024 and December 31, 2023, there were no outstanding restricted stock awards or restricted stock units (“Restricted Stock”). For the three months ended March 31, 2024 and 2023, there was no stock compensation expense recorded for Restricted Stock and there was no unamortized expense related to Restricted Stock. The following table shows a summary of Restricted Stock activity for the year ended December 31, 2023. There was no Restricted Stock activity during the three months ended March 31, 2024.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"></td><td style="width:30.801%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.314%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Units</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Grant Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Grant Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested shares, December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.87 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,564 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.87 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177,564)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested Shares, December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested Shares, March 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 3 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of stock option activity under our plans, and options outstanding as of, and changes made during the three months ended March 31, 2024 and year ended December 31, 2023 is presented below:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:46.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.257%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Options</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Options</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding and exercisable, December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,668 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.63 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.85 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,336 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.75</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,668)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285.89</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,668)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285.89</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding and exercisable, December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.75 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,668 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.75 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding and exercisable, March 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.75 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,668 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.75 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div> 16668 143.63 10000 206.85 0 0 3336 48.75 6668 285.89 6668 285.89 10000 48.75 6668 48.75 10000 48.75 6668 48.75 0 0 31000 31000 30000 P3M 0 0 0 0 0 0 The following table shows a summary of Restricted Stock activity for the year ended December 31, 2023. There was no Restricted Stock activity during the three months ended March 31, 2024.<div style="margin-top:12pt;text-align:justify;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"></td><td style="width:30.801%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.314%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Units</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Grant Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Grant Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested shares, December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.87 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,564 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.87 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177,564)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested Shares, December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested Shares, March 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0 42 235.87 0 0 0 177564 2.14 42 235.87 177564 2.14 0 0 0 0 0 0 0 0 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7 - Net Loss Per Share</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. The weighted-average number of shares of common stock outstanding does not include any potentially dilutive securities or unvested Restricted Stock. Unvested Restricted Stock, although classified as issued and outstanding at March 31, 2023, was considered contingently returnable until the restrictions lapsed and was not included in the basic net loss per share calculation for the three months ended March 31, 2023. Unvested Restricted Stock does not contain non-forfeitable rights to dividends and dividend equivalents. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted net loss per share is computed by giving effect to all potential shares of common stock, including stock options, preferred stock, warrants, and unvested Restricted Stock, to the extent they are dilutive. For the three months ended March 31, 2024 and 2023, all such common stock equivalents have been excluded from diluted net loss per share as the effect to net loss per share would be anti-dilutive (due to the net loss).</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of the Company’s basic and diluted net loss per share (in thousands, except per share data): </span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.590%"><tr><td style="width:1.0%"></td><td style="width:62.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.336%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.339%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,136)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,219)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: preferred stock dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: warrant modification</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,180)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,244)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of shares of common stock for basic and diluted net loss per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,123 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,065 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net loss per share</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.07)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.60)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the potential shares that were excluded from the computation of weighted-average number of shares of common stock in computing the diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect (due to the net loss):</span></div><div style="margin-top:5pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.672%"><tr><td style="width:1.0%"></td><td style="width:69.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.165%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.065%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock awards</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,167 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issuable upon conversion of Series F Preferred Stock (1)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,947,529 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,830,409 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issuable upon conversion of Series F Preferred Warrants (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,299,427 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issuable upon conversion of Common Stock warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,137,600 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,479,947 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Calculation assumes conversion of the stated value, and accrued dividends, of the Series F Preferred Stock into Common Stock at the Floor Price as of March 31, 2024, and at the initial conversion price of $1.71 as of March 31, 2023.</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Calculation assumes exercise of the Series F Preferred Warrants for cash into Series F Preferred Stock and subsequent conversion of the Series F Preferred Stock into Common Stock at the Floor Price as of March 31, 2024. The Series F Preferred Stock Warrants were not exercisable as of March 31, 2023.</span></div> 0 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of the Company’s basic and diluted net loss per share (in thousands, except per share data): </span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.590%"><tr><td style="width:1.0%"></td><td style="width:62.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.336%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.339%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,136)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,219)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: preferred stock dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: warrant modification</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,180)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,244)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of shares of common stock for basic and diluted net loss per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,123 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,065 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net loss per share</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.07)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.60)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> -1136000 -1219000 44000 0 0 25000 -1180000 -1244000 17123000 17123000 2065000 2065000 -0.07 -0.07 -0.60 -0.60 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the potential shares that were excluded from the computation of weighted-average number of shares of common stock in computing the diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect (due to the net loss):</span></div><div style="margin-top:5pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.672%"><tr><td style="width:1.0%"></td><td style="width:69.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.165%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.065%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested restricted stock awards</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,167 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issuable upon conversion of Series F Preferred Stock (1)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,947,529 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,830,409 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issuable upon conversion of Series F Preferred Warrants (2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,299,427 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issuable upon conversion of Common Stock warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,137,600 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,479,947 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) Calculation assumes conversion of the stated value, and accrued dividends, of the Series F Preferred Stock into Common Stock at the Floor Price as of March 31, 2024, and at the initial conversion price of $1.71 as of March 31, 2023.</span></div><div style="margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2) Calculation assumes exercise of the Series F Preferred Warrants for cash into Series F Preferred Stock and subsequent conversion of the Series F Preferred Stock into Common Stock at the Floor Price as of March 31, 2024. The Series F Preferred Stock Warrants were not exercisable as of March 31, 2023.</span></div> 0 42 10000 10167 3947529 3830409 117299427 0 4137600 4479947 1.71 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8 - Segment Reporting </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company currently operates in two segments: (1) “Managed Services”, which represents the business surrounding managed services for video collaboration and network applications; and (2) “Collaboration Products” which represents the business </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">surrounding our </span><span style="background-color:#ffffff;color:#2b2b2b;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mezzanine™ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">product offerings.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information concerning the Company’s segments for the three months ended March 31, 2024 and 2023 is presented in the following tables (in thousands):</span></div><div style="margin-bottom:12pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:32.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed Services</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration Products</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Gross profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">  Gross profit %</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocated operating expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Total operating expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(277)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,060)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,184)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) before tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(261)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,060)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,136)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(261)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,060)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,136)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:32.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed Services</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration Products</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gross profit %</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocated operating expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,193 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,193 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,193 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,193)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,203)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other expense (income), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,193)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,181)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,193)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,219)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:center;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unallocated operating expenses in Corporate include costs for the three months ended March 31, 2024 and 2023 that are not specific to a particular segment but are general to the group; included are expenses incurred for administrative and accounting staff, general liability and other insurance, professional fees, and other similar corporate expenses. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2024, and 2023, there was no material revenue attributable to any individual foreign country. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue by geographic area is allocated as follows (in thousands):</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.818%"><tr><td style="width:1.0%"></td><td style="width:32.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.764%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disaggregated information for the Company’s revenue has been recognized in the accompanying Condensed Consolidated Statements of Operations and is presented below according to contract type (in thousands): </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:51.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.127%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.127%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.127%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.672%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 7.75pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 3.25pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 3.25pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of Revenue</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 3.25pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 3.25pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of Revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue: Managed Services</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Video collaboration services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Network services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional and other services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">      Total Managed Services revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue: Collaboration Products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Visual collaboration product offerings</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:center;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers a significant customer to be one that comprises more than 10% of the Company’s consolidated revenues or accounts receivable. The loss of or a reduction in sales or anticipated sales to our most significant or several of our smaller customers could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concentration of consolidated revenues was as follows:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"></td><td style="width:32.283%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.721%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.722%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of Revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concentration of accounts receivable was as follows:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:501.00pt"><tr><td style="width:1.0pt"></td><td style="width:175.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:123.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:97.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:87.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of March 31, 2024</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of Accounts Receivable</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of Accounts Receivable</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration Products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer D</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer E</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration Products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 2 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information concerning the Company’s segments for the three months ended March 31, 2024 and 2023 is presented in the following tables (in thousands):</span></div><div style="margin-bottom:12pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:32.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed Services</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration Products</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Gross profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">  Gross profit %</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocated operating expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Total operating expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(277)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,060)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,184)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) before tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(261)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,060)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,136)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(261)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,060)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,136)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:32.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.872%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed Services</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration Products</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gross profit %</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allocated operating expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unallocated operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,193 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,193 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,193 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,193)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,203)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other expense (income), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,193)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,181)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,193)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,219)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concentration of consolidated revenues was as follows:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"></td><td style="width:32.283%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.721%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.722%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of Revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concentration of accounts receivable was as follows:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:501.00pt"><tr><td style="width:1.0pt"></td><td style="width:175.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:123.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:97.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:87.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of March 31, 2024</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of Accounts Receivable</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of Accounts Receivable</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration Products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer D</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer E</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration Products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 522000 104000 0 626000 369000 260000 0 629000 153000 -156000 0 -3000 0.29 -1.50 0 0 121000 0 121000 0 0 1060000 1060000 0 121000 1060000 1181000 153000 -277000 -1060000 -1184000 32000 16000 0 48000 185000 -261000 -1060000 -1136000 0 0 0 0 185000 -261000 -1060000 -1136000 690000 348000 0 1038000 460000 302000 0 762000 230000 46000 0 276000 0.33 0.13 0.27 0 286000 0 286000 0 0 1193000 1193000 0 286000 1193000 1479000 230000 -240000 -1193000 -1203000 3000 25000 0 22000 227000 -215000 -1193000 -1181000 7000 31000 0 38000 220000 -246000 -1193000 -1219000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue by geographic area is allocated as follows (in thousands):</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.818%"><tr><td style="width:1.0%"></td><td style="width:32.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.764%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 261000 563000 365000 475000 626000 1038000 <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disaggregated information for the Company’s revenue has been recognized in the accompanying Condensed Consolidated Statements of Operations and is presented below according to contract type (in thousands): </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:51.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.127%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.127%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.127%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.672%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 7.75pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 3.25pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 3.25pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of Revenue</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 3.25pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 3.25pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of Revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue: Managed Services</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Video collaboration services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Network services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional and other services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">      Total Managed Services revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue: Collaboration Products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Visual collaboration product offerings</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 14000 0.02 64000 0.06 503000 0.80 618000 0.60 5000 0.01 8000 0.01 522000 0.83 690000 0.66 104000 0.17 348000 0.34 626000 1 1038000 1 0.82 0.52 0 0.41 0 0.11 0 0.14 0 0.15 0.73 0 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9 - Commitments and Contingencies </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we are subject to various legal proceedings arising in the ordinary course of business, including proceedings for which we have insurance coverage. As of the date hereof, we are not party to any legal proceedings that we currently believe will have a material adverse effect on our business, financial position, results of operations or liquidity.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">COVID-19</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11, 2020, the World Health Organization (“WHO”) announced that infections of the novel Coronavirus (COVID-19) had become pandemic, and on March 13, 2020, the U.S. President announced a National Emergency relating to the disease. In May 2023, the WHO declared COVID-19 over as a global health emergency. Customers generally use our Mezzanine™ products in traditional office and operating center environments such as conference rooms or other presentation spaces. Revenue declines for our Collaboration Products business are primarily due to lower demand, largely a consequence of the commercial reactions to the COVID-19 pandemic and its prolonged effects. We believe the COVID-19 pandemic fundamentally altered the way businesses consider the use of physical office spaces and, consequently, the demand for technologies that enable in-person collaboration within these spaces. Our analysis indicates that the reduced demand for our Mezzanine™ products, particularly in the aftermath of COVID-19, reflects a broader reassessment among our customers regarding the necessity and investment in collaboration solutions tailored for traditional office environments. Continuation of this trend could cause further declines in our revenue for this business. Although the Company cannot presently quantify the future financial impacts of this trend, such impacts will likely continue to have a material adverse impact on the Company’s consolidated financial condition, results of operations, and cash flows.</span></div> false false false false